td,ss_tss,ss_tp,vrnt_d,cll_d,b_frmt,crtd_b,cnfdnc_scr,rltnshp_tp,tss_d,src_d,ss_strn,ss_cll_tp,ss_tst_tp,chmbl_d,ss_ctgr,ss_d,ss_sbclllr_frctn,src_ss_d,dscrptn,dc_d,ss_rgnsm,ss_tx_d
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL618647,,7524,,,Biodistribution in normal rat kidney in the presence of 0.005 M Gd/0.01 M lig at 2 hr,9866,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL618648,,7525,,,Biodistribution in normal rat kidney in the presence of 0.01 M Gd/0.05 M lig,9866,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL618649,,7526,,,Biodistribution in normal rat kidney in the presence of NAC Gd 0.01 M lig at 2 hr,9866,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL618650,,7527,,,Biodistribution in normal rat liver in the presence of 0.005 M Gd/0.01 M lig at 2 hr,9866,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL618651,,7528,,,Biodistribution in normal rat liver in the presence of 0.01 M Gd/0.05 M lig,9866,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL876497,,7529,,,Biodistribution in normal rat liver in the presence of NAC Gd 0.01 M lig at 2 hr,9866,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL618652,,7530,,,Biodistribution in normal rat lung in the presence of 0.005 M Gd/0.01 M lig at 2 hr,9866,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL618653,,7531,,,Biodistribution in normal rat lung in the presence of 0.01 M Gd/0.05 M lig,9866,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL618654,,7532,,,Biodistribution in normal rat lung in the presence of NAC Gd 0.01 M lig at 2 hr,9866,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618655,,7533,,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats; Not tested,6351,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618656,,7534,,,Compound was tested for solubility in water,1465,Rattus norvegicus,10116.0
22229,,P,,,BAO_0000100,Intermediate,0,U,,1,,,,CHEMBL618657,,7535,,,Solubility in phosphate buffered saline (1% DMSO) at pH 6.5 (24 hr equilibration),5182,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618658,,7536,,,Solubility was determined,17847,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618659,,7537,,,solubility in water (ug/mL) at 37 degree C.,15339,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618660,,7538,,,First pass metabolism and metabolic bioavailability using rat hepatic microsomes,5202,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618661,,7539,,,In vitro stability relative to (+)-AJ76 in rat hepatocyte assay,1088,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL873807,,7540,,,Half life in rats,3169,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618662,,7541,,,Half life in Dawley rat,5353,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618663,,7542,,,Half life period after 3 mg/kg iv administration,2864,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618664,,7543,,,Half life period after 3 mg/kg iv administration in rat,2864,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618665,,7544,,,Half life period after 3 mg/kg iv administration in the rat,2864,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL876498,,7545,,,Half life period in female Sprague-Dawley rats,6362,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618666,,7546,,,Half life period in rat,6249,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL620440,,7547,,,Half-life in rats was determined,3169,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL620441,,7548,,,Half-life in rats with metabolic oxidation,3169,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL620442,,7549,,,Half-life in rats,3169,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620443,,7550,,,T 1/2 at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,17260,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620444,,7551,,,T 1/2 at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,17260,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620445,,7552,,,T max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,17260,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620446,,7553,,,T max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,17260,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL620447,,7554,,,Biological half-life measured in plasma of rat,2879,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL621129,,7555,,,Biological half-life measured in plasma of rat; 22-25,2879,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL621130,,7556,,,Biological half-life measured in plasma of rat; 9-16,2879,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL873808,,7557,,,Compound was evaluated for its half life when administered intravenously in rat,3184,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL876598,,7558,,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 8 h,4891,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621131,,7559,,,Evaluated for pharmacokinetic parameter half-life in rat at the dose 50 mg/kg,429,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621132,,7560,,,Half life (T1/2) after oral administration in rat,5656,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621133,,7561,,,Half life of compound after iv administration of 20 mg/kg dose in rat,4413,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Expert,1,N,,1,,,In vivo,CHEMBL621312,,7562,,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,3598,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621313,,7563,,,Half life of compound was determined in rat,17267,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL621314,,7564,,,Half life of compound was determined in rat blood,4727,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621315,,7565,,,Half life at 1 mg/kg was determined in rat,17651,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621316,,7566,,,Half life at 10 mg/kg was determined in rat,17651,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621317,,7567,,,Half life in rats,401,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621318,,7568,,,Half life in rats in hours,4942,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621319,,7569,,,Half life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,17735,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621377,,7570,,,Half life was calculated at a single intravenous administration of 20 mg/kg in rat,6056,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621378,,7571,,,Half life was determined,5213,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL876599,,7572,,,Half life after i.v. administration,6616,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621379,,7573,,,Half life in rat after intravenous administration at a concentration 0.5 mg/kg,5937,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL621380,,7574,,,Half life in rat plasma,5819,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL621381,,7575,,,Half life in rat plasma; Not detected,5819,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618515,,7576,,,Half life in rats,6803,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618516,,7577,,,Half life period of compound was determined after peroral administration,17804,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618517,,7578,,,Half life period of compound was determined at a dose of 3 mg/kg by intravenous administration,17804,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618518,,7579,,,Half life period in rat,5948,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618519,,7580,,,Half life period was evaluated against Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,1916,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618698,,7581,,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,1916,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618862,,7582,,,Half life period was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration; Not available,1916,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618863,,7583,,,Half life period was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,4890,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618864,,7584,,,Half life period was determined for compound after intravenous administration in rats at 24 uM/kg,17764,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618865,,7585,,,Half life time in rat the dose of 2 mg/kg,4727,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618866,,7586,,,Half-life 24 hr after 10 mg/kg iv administration in rats,17509,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618867,,7587,,,Half-life 24 hr after 2 mg/kg iv administration in rats,17509,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL875828,,7588,,,Half-life consistent with the observed metabolic steady state in rats,6597,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618868,,7589,,,Half-life following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,17735,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618869,,7590,,,Half-life for oxidative metabolic stability was determined using male human,6597,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618870,,7591,,,"Half-life in fischer rats at 5 mg/kg dose, administered intravenously",17670,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL618871,,7592,,,Half-life in rat plasma,1696,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL618872,,7593,,,Half-life in rat plasma was determined,1742,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL873816,,7594,,,Half-life in rats was determined,17800,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL618873,,7595,,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by gavage method in dog,12923,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL621602,,7596,,,Area under curve after oral dose of 0.1 mg//kg,11954,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL621603,,7597,,,Area under curve after oral dose of 0.3 mg/kg,11954,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL621604,,7598,,,Area under curve after oral dose of 1 mg/kg,11954,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL621605,,7599,,,Area under curve after oral dose of 10 mg/kg,11954,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL621606,,7600,,,Area under curve after oral dose of 23.4 mg/kg,11954,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL621607,,7601,,,Area under curve after oral dose of 3 mg/kg,11954,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL621608,,7602,,,Area under curve after oral dose of 3.87 mg/kg,11954,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL621609,,7603,,,Area under curve was determined,5237,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL621610,,7604,,,Area under curve at a dose of 10 mg/kg,4026,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621611,,7605,,,Area under curve was determined; ND=No data,5237,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621612,,7606,,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,14793,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622308,,7607,,,Area under curve was evaluated in rat brain when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,14793,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622309,,7608,,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,14793,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622310,,7609,,,Area under curve was evaluated in rat brain when administered intravenously at a dose of 10 mg/kg for infinite hours,14793,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622311,,7610,,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,14793,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622312,,7611,,,Area under curve was evaluated in rat brain when administered perorally at a dose of 100 mg/kg for infinite hours; Not calculated,14793,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622931,,7612,,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,14793,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622932,,7613,,,Area under curve was evaluated in rat brain when administered perorally at a dose of 10 mg/kg for infinite hours; Not calculated,14793,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622736,,7614,,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for 4 or 6 hours,14793,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622737,,7615,,,Area under curve was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg for infinite hours,14793,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622738,,7616,,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for 4 or 6 hours,14793,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622739,,7617,,,Area under curve was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg for infinite hours,14793,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622740,,7618,,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for 4 or 6 hours,14793,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622741,,7619,,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 100 mg/kg for infinite hours,14793,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622742,,7620,,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for 4 or 6 hours,14793,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622743,,7621,,,Area under curve was evaluated in rat plasma when administered perorally at a dose of 10 mg/kg for infinite hours,14793,Rattus norvegicus,10116.0
50594,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622744,,7622,,,AUC in mice,11637,Mus musculus,10090.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL624134,,7623,,,Area under curve was measured from the graph obtained from concentration Vs time,11149,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL624135,,7624,,,Area under curve value of compound per hour after oral administration,10016,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624136,,7625,,,Area under curve was determined after oral administration in rats,17796,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624137,,7626,,,Area under curve was determined after oral administration in rats; No data,17796,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624320,,7627,,,Area under curve was determined after oral administration in rats;No data,17796,Rattus norvegicus,10116.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624321,,7628,,,Area under curve was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,12923,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624322,,7629,,,Area under curve was determined for the compound after iv dose of 4.74 mg/kg in rats,15372,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624323,,7630,,,Area under curve was determined for the compound after iv dose of 5.06 in rats,15372,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624324,,7631,,,Area under curve was determined for the compound after iv dose of 5.10 mg/kg in rats,15372,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624325,,7632,,,Area under curve was determined for the compound after po dose of 5.01 mg/kg in rats,15372,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624326,,7633,,,Area under curve was determined for the compound after po dose of 5.03 mg/kg in rats,15372,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624327,,7634,,,Area under curve was determined for the compound after po dose of 5.22 mg/kg in rats,15372,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624328,,7635,,,Area under curve was determined for the compound after po dose of 5.46 mg/kg in rats,15372,Rattus norvegicus,10116.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627848,,7636,,,Area under curve was determined in Dogs after peroral administration,14169,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627849,,7637,,,Area under curve was determined in Rats after peroral administration,14169,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627850,,7638,,,Area under curve was determined in carotid blood of rat when administered intradermally,14258,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627851,,7639,,,Area under curve was determined in portal blood of rat when administered intradermally,14258,Rattus norvegicus,10116.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627852,,7640,,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,15011,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627853,,7641,,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,15011,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627854,,7642,,,Area under curve was determined using 0.4% Methyl cellulose (MC) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),15011,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627855,,7643,,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg,15011,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627856,,7644,,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered intravenously to nude mice at a dose of 25 mg/kg (run time 7 hr),15011,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL875339,,7645,,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg,15011,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627857,,7646,,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (Run time = 7 hr),15011,Mus musculus,10090.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL627858,,7647,,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 65 mins after i.v. administration,11195,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL627859,,7648,,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in blood; Expressed as percent dose/organ,10130,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL627860,,7649,,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in brain; Expressed as percent dose/organ,10130,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL627019,,7650,,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in heart; Expressed as percent dose/organ,10130,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL627020,,7651,,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in liver; Expressed as percent dose/organ,10130,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL627021,,7652,,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in lung; Expressed as percent dose/organ,10130,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL627022,,7653,,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in muscle; Expressed as percent dose/organ,10130,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627023,,7654,,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in skin; Expressed as percent dose/organ,10130,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL627024,,7655,,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in spleen; Expressed as percent dose/organ,10130,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL627025,,7656,,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in thyroid; Expressed as percent dose/organ,10130,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL627026,,7657,,,In vivo biodistribution in rats after an intravenous injection at 15 min was determined in kidney; Expressed as percent dose/organ,10130,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL627027,,7658,,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in blood; Expressed as percent dose/organ,10130,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL627028,,7659,,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in brain; Expressed as percent dose/organ,10130,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL627029,,7660,,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in heart; Expressed as percent dose/organ,10130,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL627030,,7661,,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in kidney; Expressed as percent dose/organ,10130,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL627031,,7662,,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in liver; Expressed as percent dose/organ,10130,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL627032,,7663,,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in lung; Expressed as percent dose/organ,10130,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL627033,,7664,,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in muscle; Expressed as percent dose/organ,10130,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627034,,7665,,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in skin; Expressed as percent dose/organ,10130,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL627035,,7666,,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in spleen; Expressed as percent dose/organ,10130,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL627036,,7667,,,In vivo biodistribution in rats after an intravenous injection at 2 min was determined in thyroid; Expressed as percent dose/organ,10130,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL875340,,7668,,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in blood; Expressed as percent dose/organ,10130,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL627037,,7669,,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in heart; Expressed as percent dose/organ,10130,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL627038,,7670,,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in kidney; Expressed as percent dose/organ,10130,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL627039,,7671,,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in liver; Expressed as percent dose/organ,10130,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL627040,,7672,,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in muscle; Expressed as percent dose/organ,10130,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL624663,,7673,,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in spleen; Expressed as percent dose/organ,10130,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL625963,,7674,,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in thyroid; Expressed as percent dose/organ,10130,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL876799,,7675,,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in brain; Expressed as percent dose/organ,10130,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL626133,,7676,,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in lung; Expressed as percent dose/organ,10130,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626134,,7677,,,In vivo biodistribution in rats after an intravenous injection at 60 min was determined in skin; Expressed as percent dose/organ,10130,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626135,,7678,,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,6295,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626136,,7679,,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg,6296,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626137,,7680,,,In vivo concentration in rat liver exposure 8 hour after oral administration 50 mg/kg; Below detection limit,6296,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626138,,7681,,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,6295,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626139,,7682,,,In vivo concentration in rat plasma exposure at 8 hour after oral administration 50 mg/kg,6296,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626140,,7683,,,C max at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,17260,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626141,,7684,,,C max at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,17260,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626142,,7685,,,C24h in rat p.o. at 20 mg/kg concentration,17686,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL627930,,7686,,,Biodistribution in normal rat muscle in the presence of 0.005 M Gd/0.01 M lig at 2 hr,9866,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL627931,,7687,,,Biodistribution in normal rat muscle in the presence of 0.01 M Gd/0.05 M lig,9866,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL627932,,7688,,,Biodistribution in normal rat muscle in the presence of NAC Gd 0.01 M lig at 2 hr,9866,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL627933,,7689,,,Biodistribution in normal rat spleen in the presence of 0.005 M Gd/0.01 M lig at 2 hr,9866,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL627934,,7690,,,Biodistribution in normal rat spleen in the presence of 0.01 M Gd/0.05 M lig,9866,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL627935,,7691,,,Biodistribution in normal rat spleen in the presence of NAC Gd 0.01 M lig at 2 hr,9866,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL627936,,7692,,,Biodistribution in rat blood in the presence of 0.001 M/0.008 M GdDTPA-AEP,9866,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL627937,,7693,,,Biodistribution in rat blood in the presence of 0.01 M GdDTPA-BDP,9866,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL627938,,7694,,,Biodistribution in rat blood in the presence of 0.01 M/0.01 M GdDTPA-AEP,9866,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL627939,,7695,,,Biodistribution in rat blood in the presence of 0.05 M Gd/0.15 M lig,9866,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL627940,,7696,,,Biodistribution in rat blood in the presence of 0.05 M GdDTPA-BDP,9866,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL627941,,7697,,,Biodistribution in rat blood in the presence of 0.05 M/0.05 M GdDTPA-AEP,9866,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL876800,,7698,,,Biodistribution in rat blood in the presence of 0.05 M/0.08 M GdDTPA-HPDP,9866,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL627942,,7699,,,Biodistribution in rat blood in the presence of 0.10 M GdDTPA-BDP,9866,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL627943,,7700,,,Biodistribution in rat blood in the presence of 0.10 M/0.11 M GdDTPA-AEP,9866,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL627944,,7701,,,Biodistribution in rat blood in the presence of 50 Gd/kg at 15 min,9866,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL627945,,7702,,,Biodistribution in rat blood in the presence of 50 Gd/kg at 2 hr,9866,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL628584,,7703,,,Biodistribution in rat blood in the presence of 50 Gd/kg at 6 hr,9866,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL628585,,7704,,,Biodistribution in rat blood in the presence of GdDTPA at 15 min,9866,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL628586,,7705,,,Biodistribution in rat blood in the presence of GdDTPA at 1 hr,9866,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL628587,,7706,,,Biodistribution in rat blood in the presence of GdDTPA at 30 min,9866,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL628588,,7707,,,Biodistribution in rat blood in the presence of GdDTPA at 4 hr,9866,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL628589,,7708,,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 15 min,9866,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL625304,,7709,,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 30 min,9866,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL625305,,7710,,,Biodistribution in rat blood in the presence of GdDTPA-BDP at 4 hr,9866,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL625306,,7711,,,Biodistribution in rat blood in the presence of GdDTPA-BDPat 1 hr,9866,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL625307,,7712,,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 15 min,9866,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL625308,,7713,,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 30 min,9866,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL627740,,7714,,,Biodistribution in rat blood in the presence of GdDTPA-HPDP at 4 hr,9866,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL627741,,7715,,,Biodistribution in rat blood in the presence of GdDTPA-HPDPat 1 hr,9866,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL627742,,7716,,,Biodistribution in rat blood in the presence of NAC Gd/0.01 M GdDTPA-HPDP,9866,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL627743,,7717,,,Biodistribution in rat blood in the presence of NCA Gd/0.01 M lip,9866,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL627744,,7718,,,Biodistribution in rat blood in the presence of NCAGd/0.01 M lig,9866,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL627745,,7719,,,Biodistribution in rat bone in the presence of 0.01 M GdDTPA-BDP,9866,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL627746,,7720,,,Biodistribution in rat bone in the presence of 0.01 M/0.01 M GdDTPA-AEP,9866,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL627747,,7721,,,Biodistribution in rat bone in the presence of 0.01 M/0.08 M GdDTPA-AEP,9866,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL876810,,7722,,,Biodistribution in rat bone in the presence of 0.05 M Gd/0.15 M lig,9866,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL627748,,7723,,,Biodistribution in rat bone in the presence of 0.05 M GdDTPA-BDP,9866,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL627749,,7724,,,Biodistribution in rat bone in the presence of 0.05 M/0.05 M GdDTPA-AEP,9866,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL627750,,7725,,,Biodistribution in rat bone in the presence of 0.05 M/0.08 M GdDTPA-HPDP,9866,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL618728,,7726,,,Biodistribution in rat bone in the presence of 0.10 M GdDTPA-BDP,9866,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL618729,,7727,,,Biodistribution in rat bone in the presence of 0.10 M/0.11 M GdDTPA-AEP,9866,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL618730,,7728,,,Biodistribution in rat bone in the presence of GdDTPA at 15 min,9866,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL618731,,7729,,,Biodistribution in rat bone in the presence of GdDTPA at 1 hr,9866,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL618732,,7730,,,Biodistribution in rat bone in the presence of GdDTPA at 30 min,9866,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL618733,,7731,,,Biodistribution in rat bone in the presence of GdDTPA at 4 hr,9866,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL618734,,7732,,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 15 min,9866,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL618735,,7733,,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 1 hr,9866,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL876602,,7734,,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 30 min,9866,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL618736,,7735,,,Biodistribution in rat bone in the presence of GdDTPA-BDP at 4 hr,9866,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL618737,,7736,,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 15 min,9866,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL618738,,7737,,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 1 hr,9866,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL618739,,7738,,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 30 min,9866,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL618740,,7739,,,Biodistribution in rat bone in the presence of GdDTPA-HPDP at 4 hr,9866,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL618741,,7740,,,Biodistribution in rat bone in the presence of NAC Gd/0.01 M GdDTPA-HPDP,9866,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL618742,,7741,,,Biodistribution in rat bone in the presence of NCA Gd/0.01 M lip,9866,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL618743,,7742,,,Biodistribution in rat bone in the presence of NCAGd/0.01 M lig,9866,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL618744,,7743,,,Half-life from rat plasma at a single oral dose of 25 mg/kg,17752,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618745,,7744,,,Half-life in male rat,5610,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620479,,7745,,,Half-life in rat after peroral administration at 10 mg/kg concentration,5939,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620480,,7746,,,Half-life in rat after peroral administration at 5 mg/kg concentration,5939,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620481,,7747,,,Half-life in rat at a dose of 3 mg/kg,17771,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL620482,,7748,,,Half-life was evaluated in rats,1974,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL876603,,7749,,,Half-life was measured in rat,4239,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620483,,7750,,,Half-life period for the compound was determined in rats at 50 mg/kg dose,6681,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620484,,7751,,,Half-life period in rats after intravenous administration at 5 mg/kg,17752,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620485,,7752,,,Half-life period in rat at 10 mg/kg,6046,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620486,,7753,,,"Half-life period was determined in rats at 10 mg/kg, p.o. dose",6685,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620487,,7754,,,"Half-life period was determined in rats at 20 mg/kg, i.p. dose",6685,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620488,,7755,,,"Half-life period was determined in rats at 2 mg/kg, i.v. dose",6685,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620489,,7756,,,Half-life time in rat the dose of 2 mg/kg,4727,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620490,,7757,,,Half-life was estimated from the elimination phase of the oral [C] vs time curves in 4 rats,1088,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620491,,7758,,,In vivo activity against Staphylococcus aureus when administered orally for 1 hr in rat at a dose of 15 mg/kg,5610,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL876604,,7759,,,"In vivo half life of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",3032,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620492,,7760,,,Oral half life was determined,5199,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620493,,7761,,,"Pharmacokinetic Parameter, half life period measured in Female Wistar Rats at 100 mg/kg by po administration",14941,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620494,,7762,,,Pharmacokinetic property (t1/2) in rat,4408,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL620495,,7763,,,Plasma elimination half-life was determined,2552,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL620496,,7764,,,Plasma elimination half-life was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,5199,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL620497,,7765,,,Plasma half life was observed after intravenous administration in rat,15662,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL620498,,7766,,,Plasma half-life was determined,1465,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL620499,,7767,,,Plasma half-life following oral administration in Fisher rats,1446,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL620500,,7768,,,Plasma half-life in rat,6824,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL873809,,7769,,,Plasmatic Half-life after intravenous administration to rat,17533,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620501,,7770,,,T1/2 (half life) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,5979,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620502,,7771,,,Terminal half life after intravenous administration (1 mg/kg) in rat,4689,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620503,,7772,,,Terminal half life in Rat at a oral dose of 5 mg/kg,4689,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620504,,7773,,,Terminal phase half-life was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,2463,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL876605,,7774,,,Tested for half life value after intravenous administration at dose of 0.2 mg/kg in rat,4883,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620505,,7775,,,Tested for half life value after oral administration at dosage of 4 mg/kg in rat,4883,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL873811,,7776,,,plasma half life was observed after intravenous administration in rat,15662,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Expert,1,N,,1,,,In vivo,CHEMBL624016,,7777,,,Half life of compound determined in rat after iv administration at a dose of 10 mg/kg,3598,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624017,,7778,,,Half life of compound determined in rat,4576,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624018,,7779,,,Mean residence time determined in rat,4576,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624019,,7780,,,Plasma half life determined in rat,4576,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL624020,,7781,,,Compound was evaluated for Tmax in brain after intravenous administration in male rats,4910,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624201,,7782,,,Compound was evaluated for pharmacokinetic parameter maximum time period,4891,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL872528,,7783,,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,429,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624202,,7784,,,In vivo Tmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624203,,7785,,,In vivo Tmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624350,,7786,,,In vivo Tmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621320,,7787,,,In vivo Tmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621321,,7788,,,In vivo maximum time required for clearance of compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,17582,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621322,,7789,,,Maximum time (Tmax) required to reach Cmax in rats,4026,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621323,,7790,,,Maximum time constant was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,4890,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621324,,7791,,,Maximum time of clearance of compound in rats after peroral administration,6571,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621325,,7792,,,Maximum time at the dose of 2 mg/kg in rat,4727,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL875837,,7793,,,Maximum time to achieve peak plasma concentration was determined in rat at 1 mg/kg,17651,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL621326,,7794,,,Maximum time to achieve peak plasma concentration was determined in rat at 10 mg/kg,17651,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621327,,7795,,,Tmax in Guinea pig (PO dose),14465,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621328,,7796,,,"Pharmacokinetic Parameter, Tmax is the time at which maximum concentration (Cmax) is reached in Female Wistar Rats at 100 mg/kg by po administration",14941,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621329,,7797,,,Pharmacokinetic parameter (Tmax) in rat,5960,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621330,,7798,,,Pharmacokinetic parameter (Tmax) was estimated,5022,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621331,,7799,,,Pharmacokinetic property (Tmax) in rat,4408,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621332,,7800,,,Pharmacokinetic property (Tmax) was measured in rat at the dose of 0.32 mg/kg p.o.,5983,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621333,,7801,,,T max in Rat at a oral dose of 5 mg/kg,4689,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621334,,7802,,,T max was determined at 10 mg/kg po dose in rats,2792,Rattus norvegicus,10116.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621335,,7803,,,Area under curve was determined using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. Compound was administered orally to nude mice at a dose of 25 mg/kg (run time 7 hr),15011,Mus musculus,10090.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621336,,7804,,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in dogs,14180,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621337,,7805,,,Area under curve was evaluated after intravenous injection of 1 mg/kg of compound in rats,14180,Rattus norvegicus,10116.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621338,,7806,,,Area under curve was measured after i.v. administration into Beagle dog.,14599,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL875838,,7807,,,Area under curve was measured after iv administration into Beagle dog,14599,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621339,,7808,,,Area under curve was measured after po administration into Beagle dog,14599,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621340,,7809,,,Area under curve was measured after po administration into Beagle dog.,14599,Canis lupus familiaris,9615.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL621341,,7810,,,Area under curve was measured at peroral dose of 3 mg/kg,15675,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL621342,,7811,,,Area under curve was measured by using concentration Vs time,12706,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL621343,,7812,,,Area under curve was measured by using concentration Vs time; not tested,12706,,
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621344,,7813,,,Area under curve(AUC) was measured in mice after oral administration (50 mg/kg),9750,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621345,,7814,,,Area under curve(AUC) was measured in mice after oral administration.,9750,Mus musculus,10090.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL621346,,7815,,,Area under curve(AUC) value of the compound,14691,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL621347,,7816,,,Area under curve(AUC) value of the compound in dogs at 0.5 mg/kg dose upon oral administration,14691,,
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621348,,7817,,,Area under curve(AUC) value of the compound in dogs at 1 mg/kg dose upon oral administration,14691,Canis lupus familiaris,9615.0
22224,Blood,A,,,BAO_0000019,Autocuration,0,U,178.0,1,,,,CHEMBL621349,,7818,,,Area under curve(carotid artery) was determined by the availability in blood,2939,,
22224,Blood,A,,,BAO_0000019,Autocuration,0,U,178.0,1,,,,CHEMBL621350,,7819,,,Area under curve(carotid artery) was determined by the availability in blood; ND means no data,2939,,
22224,Blood,A,,,BAO_0000019,Autocuration,0,U,178.0,1,,,,CHEMBL875839,,7820,,,Area under curve(carotid artery) was determined by the availability in blood; No data,2939,,
22224,Blood,A,,,BAO_0000019,Autocuration,0,U,178.0,1,,,,CHEMBL620211,,7821,,,Area under curve(portal vein) was determined by the availability in blood,2939,,
22224,Blood,A,,,BAO_0000019,Autocuration,0,U,178.0,1,,,,CHEMBL620212,,7822,,,Area under curve(portal vein) was determined by the availability in blood; ND means no data,2939,,
22224,Blood,A,,,BAO_0000019,Autocuration,0,U,178.0,1,,,,CHEMBL620213,,7823,,,Area under curve(portal vein) was determined by the availability in blood; No data,2939,,
50797,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL620214,,7824,,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",9552,Macaca mulatta,9544.0
50797,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL620215,,7825,,,"Area under plasma concentration vs time curve observed in Rhesus monkeys after, iv administration of single 30 mg/kg dose",9552,Macaca mulatta,9544.0
50797,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL620216,,7826,,,Area under plasma concentration vs time curve observed in Rhesus monkeys after oral administration of single 30 mg/kg dose,9552,Macaca mulatta,9544.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL620888,,7827,,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, iv administration of single 15 mg/kg dose",9552,Canis lupus familiaris,9615.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL620889,,7828,,,"Area under plasma concentration vs time curve observed in female mongrel dogs after, oral administration of single 15 mg/kg dose",9552,Canis lupus familiaris,9615.0
22224,Plasma,A,,,BAO_0000019,Autocuration,0,U,1969.0,1,,,,CHEMBL620890,,7829,,,Area under plasma concentration vs time curve observed in rats for 0-3 h,9552,,
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL620891,,7830,,,Area under plasma time curve determined in male rat,11911,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL620892,,7831,,,Area under the MAP curve measured over 5 min.,16618,,
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621079,,7832,,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through iv route in mice,14387,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621080,,7833,,,Area under the concentration time curve (AUC) taken for 0-24 hr was measured when administered through oral route in mice,14387,Mus musculus,10090.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621081,,7834,,,Area under the concentration vs time curve in dog at 10 mg/kg oral dose,12836,Canis lupus familiaris,9615.0
100712,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621082,,7835,,,Area under the concentration vs time curve in hamster at 10 mg/kg oral dose,12836,Cricetinae,10026.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621083,,7836,,,Area under the concentration vs time curve in rat at 10 mg/kg oral dose,12836,Rattus norvegicus,10116.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621084,,7837,,,Area under the concentration-time curve from time zero to infinity after intravenous administration of 2.5 mg/kg in dogs,14339,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621085,,7838,,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fasted dogs,14339,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621086,,7839,,,Area under the concentration-time curve from time zero to infinity in oral (5 mg/kg) fed dogs,14339,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621087,,7840,,,Area under the concentration/ time determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),10524,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622607,,7841,,,Area under the concentration/ time in plasma after oral administration in dog (25 mg/kg),9994,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622608,,7842,,,Serum AUC in marmosets (IV dose),11325,Canis lupus familiaris,9615.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL624481,,7843,,,Area under the curve after intravenous administration at a dose of 10 umol/kg,12536,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL624482,,7844,,,Area under the curve after intravenous administration at a dose of 2 umol/kg,12536,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL624483,,7845,,,Area under the curve after intravenous administration at a dose of 4 umol/kg,12536,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL624484,,7846,,,Area under the curve after intravenous administration at a dose of 40 umol/kg,12536,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL624485,,7847,,,Area under the curve after intravenous administration at a dose of 5 umol/kg,12536,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624486,,7848,,,Area under the curve for fumarate salt was evaluated in F344 Rats.,15556,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL624487,,7849,,,Area under the curve for the compound was calculated.,2809,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL624488,,7850,,,Area under the curve in concentration/ time,9511,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624489,,7851,,,Area under the curve administered intraintestinal in rats.,12818,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625184,,7852,,,Area under the curve administered intravenously in rats.,12818,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625185,,7853,,,Area under the curve during intravenous administration,15118,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL875954,,7854,,,Area under the curve during intravenous administration; Not determined,15118,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625186,,7855,,,Area under the curve during systemic administration,15118,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625187,,7856,,,Area under the curve during systemic administration; Not determined,15118,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625188,,7857,,,Area under the curve was calculated for the compound.,2632,,
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625189,,7858,,,Area under the curve was determined after intravenous administration of 1.8 mg/kg in male Beagle dogs,14346,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625190,,7859,,,Area under the curve was determined after intravenous administration of 10 mg/kg in male Beagle dogs,14346,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621733,,7860,,,Area under the curve was determined after intravenous administration of 2.5 mg/kg in male Dawley rats,14346,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621734,,7861,,,Area under the curve was determined after intravenous administration of 2.6 mg/kg in male Dawley rats,14346,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621735,,7862,,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate after oral administration to male F344 rats,11149,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL621736,,7863,,,Clearance of the drug was measured in the plasma of rat; No data,17796,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL621737,,7864,,,The pharmacokinetic parameter plasma clearance in vivo in rats,5247,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621738,,7865,,,Plasma clearance at the dose of 2 mg/kg in rat,4727,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622806,,7866,,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,5654,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623519,,7867,,,CL (clearance) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,5654,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623520,,7868,,,CL at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,17260,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623521,,7869,,,Clearance measured after intravenous bolus administration of 50 mg/kg of compound to rats,17065,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623522,,7870,,,Clearance in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,17671,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623523,,7871,,,Clearance rate in rat,6672,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623690,,7872,,,Clearance rate in rat,6673,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623691,,7873,,,Clearance (Cl) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623692,,7874,,,Clearance (Cl) of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623693,,7875,,,Clearance (Cl) of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623694,,7876,,,Clearance (Cl) of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623695,,7877,,,Clearance of compound after iv administration of 20 mg/kg dose in rat,4413,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623696,,7878,,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to female wistar rats,2661,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623697,,7879,,,Compound was evaluated for clearance after treatment with iv dose of 1 mgkg to male wistar rats,2661,Rattus norvegicus,10116.0
22224,Plasma,A,,,BAO_0000218,Intermediate,0,U,1969.0,1,,,In vivo,CHEMBL623698,,7880,,,Compound was tested for its plasma clearance rate in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,5005,Macaca mulatta,9544.0
22224,Plasma,A,,,BAO_0000218,Intermediate,0,U,1969.0,1,,,In vivo,CHEMBL623699,,7881,,,Compound was tested for its plasma clearance rate in Sprague Dawley rats,5005,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623700,,7882,,,Mean (%CV) PK parameters for CL(mL/min/kg).,15765,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623701,,7883,,,Pharmacokinetic studies were carried out to determine the clearance after administration at 20 mg/kg intravenously in rat,3747,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623702,,7884,,,Pharmacokinetic parameter plasma clearance was determined at when a dose of 1 mg/kg is administered,16366,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623703,,7885,,,Plasma Clearance measured at steady-state following iv infusion at 0.6 mg/kg/h in rats,4199,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623704,,7886,,,Plasma clearance in rat was determined,17267,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623705,,7887,,,Plasma clearance in rat after administration of 2 mg/kg iv,6535,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623706,,7888,,,Plasma clearance in rat after administration of 2 mg/kg iv,6535,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623707,,7889,,,Plasma clearance was determined,5041,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623708,,7890,,,Plasma clearance in rat,5960,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623709,,7891,,,Plasma clearance in rat after intravenous administration at a concentration 0.5 mg/kg,5937,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623710,,7892,,,Plasma clearance in rat by iv administration,5871,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623711,,7893,,,Plasma clearance in rat by iv administration at a dose of 3 mg/kg,5874,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623712,,7894,,,Plasma clearance in rat p.o.,6504,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623713,,7895,,,Plasma clearance in rats,6803,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623714,,7896,,,Plasma clearance was determined; ND denotes no data,5041,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623715,,7897,,,Plasma clearance was determined; ND denotes not determined,5041,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623716,,7898,,,Plasma clearance was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,1916,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622980,,7899,,,Plasma clearance was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,5199,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622981,,7900,,,Plasma administration to rats,16367,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622982,,7901,,,Plasma clearance of the compound in female Sprague-Dawley rats,6362,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622983,,7902,,,Plasma clearance was observed after intravenous administration in rat,15662,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622984,,7903,,,Systemic clearance after intravenous administration (5.0 mg/kg) was determined in rat,6215,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622985,,7904,,,Tested for systemic clearance upon intravenous administration of 5.0 mg/Kg dose in rat,1466,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623631,,7905,,,plasma clearance was observed after intravenous administration in rat,15662,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623632,,7906,,,In vivo CL/F determined,4723,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623633,,7907,,,Pharmacokinetic parameter plasma clearance was determined at 2 mg/kg i.v. dose in rats,2792,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623634,,7908,,,Pharmacokinetic parameter plasma clearance was determined at 5 mg/kg i.v. dose in rats,2792,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623635,,7909,,,Compound was tested for the lower blood clearance in rat,5213,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621195,,7910,,,Evaluated for the low clearance in rat (in vivo),4687,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621196,,7911,,,Pharmacokinetic property (CLb)of the compound was determined in rat,3371,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL875287,,7912,,,Rapid clearance after intravenous administration in rat was determined,4690,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621197,,7913,,,Clearance measured in rat,5702,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL621198,,7914,,,Compound was evaluated for plasma clearance in rat,740,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL621199,,7915,,,Low plasma clearance was calculated in rat,4853,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621200,,7916,,,Pharmacokinetic property (Clp) in rat,5789,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621201,,7917,,,Plasma clearance in dog at a dose of 1 uM/kg in rat was determined,4527,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621202,,7918,,,Plasma clearance in rat at a dose of 10 uM/kg in rat was determined,4527,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621203,,7919,,,Plasma clearance after IV dosing at 0.5 mg/kg in rat,6518,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621204,,7920,,,Plasma clearance after IV dosing at 1 mg/kg in rat,6518,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL621205,,7921,,,Biodistribution in rat heart in the presence of 0.01 M Gd/0.01 M GdDTPA-AEP,9866,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL621206,,7922,,,Biodistribution in rat heart in the presence of 0.01 M GdDTPA-BDP,9866,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL621207,,7923,,,Biodistribution in rat heart in the presence of 0.01 M/0.08 M GdDTPA-AEP,9866,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL621208,,7924,,,Biodistribution in rat heart in the presence of 0.05 M /0.05 M GdDTPA-AEP,9866,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL621209,,7925,,,Biodistribution in rat heart in the presence of 0.05 M Gd/0.15 M lig,9866,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL876484,,7926,,,Biodistribution in rat heart in the presence of 0.05 M GdDTPA-BDP,9866,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL621210,,7927,,,Biodistribution in rat heart in the presence of 0.05 M/0.08 M GdDTPA-HPDP,9866,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL621211,,7928,,,Biodistribution in rat heart in the presence of 0.10 M GdDTPA-BDP,9866,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL621212,,7929,,,Biodistribution in rat heart in the presence of 0.10 M/0.11 M GdDTPA-AEP,9866,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL621213,,7930,,,Biodistribution in rat heart in the presence of GdDTPA at 15 min,9866,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL621214,,7931,,,Biodistribution in rat heart in the presence of GdDTPA at 1 hr,9866,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL621215,,7932,,,Biodistribution in rat heart in the presence of GdDTPA at 30 min,9866,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL621216,,7933,,,Biodistribution in rat heart in the presence of GdDTPA at 4 hr,9866,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL621217,,7934,,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 1 hr,9866,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL621218,,7935,,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 30 min,9866,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL621219,,7936,,,Biodistribution in rat heart in the presence of GdDTPA-BDP at 4 hr,9866,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL621220,,7937,,,Biodistribution in rat heart in the presence of GdDTPA-BDPat 15 min,9866,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL621221,,7938,,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 1 hr,9866,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL621222,,7939,,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 30 min,9866,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL621223,,7940,,,Biodistribution in rat heart in the presence of GdDTPA-HPDP at 4 hr,9866,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL876485,,7941,,,Biodistribution in rat heart in the presence of GdDTPA-HPDPat 15 min,9866,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL621224,,7942,,,Biodistribution in rat heart in the presence of NAC Gd/0.01 M GdDTPA-HPDP,9866,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL621225,,7943,,,Biodistribution in rat heart in the presence of NCA Gd/0.01 M lip,9866,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL621226,,7944,,,Biodistribution in rat heart in the presence of NCAGd/0.01 M lig,9866,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL621227,,7945,,,Biodistribution in rat kidney in the presence of 0.01 M GdDTPA-BDP,9866,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL621228,,7946,,,Biodistribution in rat kidney in the presence of 0.01 M/0.01 M GdDTPA-AEP,9866,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL621229,,7947,,,Biodistribution in rat kidney in the presence of 0.01 M/0.08 M GdDTPA-AEP,9866,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL621230,,7948,,,Biodistribution in rat kidney in the presence of 0.05 M Gd/0.15 M lig,9866,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL621231,,7949,,,Biodistribution in rat kidney in the presence of 0.05 M GdDTPA-BDP; ND=No data,9866,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL621232,,7950,,,Biodistribution in rat kidney in the presence of 0.05 M/0.05 M GdDTPA-AEP,9866,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL621233,,7951,,,Biodistribution in rat kidney in the presence of 0.05 M/0.08 M GdDTPA-HPDP,9866,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL621234,,7952,,,Biodistribution in rat kidney in the presence of 0.10 M GdDTPA-BDP,9866,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL621235,,7953,,,Biodistribution in rat kidney in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,9866,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL621236,,7954,,,Biodistribution in rat kidney in the presence of NAC Gd/0.01 M GdDTPA-HPDP,9866,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL621237,,7955,,,Biodistribution in rat kidney in the presence of NCA Gd/0.01 M lip,9866,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL876486,,7956,,,Biodistribution in rat kidney in the presence of NCAGd/0.01 M lig,9866,Rattus norvegicus,10116.0
50597,Intestine,A,,,BAO_0000218,Intermediate,1,N,160.0,1,,,In vivo,CHEMBL622436,,7957,,,Biodistribution in rat l. intestine in the presence of 0.01 M carrier at 1 hr,9866,Rattus norvegicus,10116.0
50597,Intestine,A,,,BAO_0000218,Intermediate,1,N,160.0,1,,,In vivo,CHEMBL622437,,7958,,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 2 hr,9866,Rattus norvegicus,10116.0
50597,Intestine,A,,,BAO_0000218,Intermediate,1,N,160.0,1,,,In vivo,CHEMBL622438,,7959,,,Biodistribution in rat l. intestine in the presence of 50 Gd/kg at 6 hr,9866,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL622439,,7960,,,Biodistribution in rat liver by in the presence 50 Gd/kg at 15 min,9866,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL622440,,7961,,,Biodistribution in rat liver by in the presence of 0.05 M Gd/0.15 M lig,9866,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL622441,,7962,,,Biodistribution in rat liver by in the presence of NCAGd/0.01 M lig,9866,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL622442,,7963,,,Biodistribution in rat liver in the presence of 0.001 M/0.008 M GdDTPA-AEP,9866,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL622443,,7964,,,Biodistribution in rat liver in the presence of 0.01 M GdDTPA-BDP,9866,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL622444,,7965,,,Biodistribution in rat liver in the presence of 0.01 M/0.01 M GdDTPA-AEP,9866,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL622445,,7966,,,Biodistribution in rat liver in the presence of 0.05 M GdDTPA-BDP,9866,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL622446,,7967,,,Biodistribution in rat liver in the presence of 0.05 M/0.05 M GdDTPA-AEP,9866,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL622447,,7968,,,Biodistribution in rat liver in the presence of 0.05 M/0.08 M GdDTPA-HPDP,9866,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL622448,,7969,,,Biodistribution in rat liver in the presence of 0.10 M GdDTPA-BDP,9866,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL622449,,7970,,,Biodistribution in rat liver in the presence of 0.10 M/0.11 M GdDTPA-AEP; ND=No data,9866,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL622450,,7971,,,Biodistribution in rat liver in the presence of 50 Gd/kg at 2 hr,9866,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL622451,,7972,,,Biodistribution in rat liver in the presence of 50 Gd/kg at at 6 hr,9866,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL622452,,7973,,,Biodistribution in rat liver in the presence of GdDTPA at 15 min,9866,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL622453,,7974,,,Biodistribution in rat liver in the presence of GdDTPA at 1 hr,9866,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL622454,,7975,,,Biodistribution in rat liver in the presence of GdDTPA at 30 min,9866,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL622455,,7976,,,Biodistribution in rat liver in the presence of GdDTPA at 4 hr,9866,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL876024,,7977,,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 15 min,9866,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622456,,7978,,,T max was determined at 3 mg/kg po dose in rats,2792,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622457,,7979,,,"The Tmax value in female wistar rat at 100 mg/kg, p.o. dose",15078,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622458,,7980,,,"The Tmax value in male wistar rat at 100 mg/kg, p.o. dose",15078,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622459,,7981,,,The time to reach maximum concentration of compound was measured at the dose of 100 umol/kg,15022,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL873343,,7982,,,The time to reach maximum concentration of compound was measured at the dose of 300 umol/kg,15022,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622460,,7983,,,The time to reach maximum concentration of compound was measured at the dose of 30 umol/kg,15022,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622461,,7984,,,Time for maximum plasma concentration determined in rat,4576,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622462,,7985,,,Time for maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,6681,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622463,,7986,,,Time of maximum concentration of the drug when administered orally a dose of 10 mg/kg to a fasting rat,16365,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622464,,7987,,,Time of maximum concentration of the drug when administered orally a dose of 1 mg/kg to a fasting rat,16365,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622465,,7988,,,Time of maximum concentration of the drug when administered orally a dose of 30 mg/kg,16365,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622466,,7989,,,Time of maximum concentration of the drug when administered orally a dose of 3 mg/kg to a fasting rat,16365,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622467,,7990,,,Time of maximum concentration of the drug when administered orally at dose of 3 mg/kg,16365,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622468,,7991,,,Time of maximum plasma concentration in rat,6824,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL876025,,7992,,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 10 mg/kg, p.o. dose",6685,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622469,,7993,,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 20 mg/kg, i.p. dose",6685,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622470,,7994,,,"Time required by compound for reaching maximum plasma concentration was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",6685,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622471,,7995,,,Time required to reach maximum concentration (Cmax) after oral administration in rat,15662,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622472,,7996,,,Time required to reach maximum concentration in rat plasma,1742,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622473,,7997,,,Time taken by the compound to achieve maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,2774,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL624282,,7998,,,Time taken by the compound to achieve maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,5199,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL624283,,7999,,,Time taken for maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,12873,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL624284,,8000,,,Time taken for maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,12873,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL624285,,8001,,,Time taken to reach maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,1916,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624286,,8002,,,Time to reach Cmax after oral administration to rats,16367,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624287,,8003,,,Time to reach Cmax when a dose of 1 mg/kg is administered orally,16366,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624288,,8004,,,Time to reach maximum concentration following oral administration of 200 mg/kg in rat; value ranges from 2-4,216,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL624289,,8005,,,Time to reach maximum plasma concentration was evaluated at an intravenous dose of 3 mg/kg; Not applicable,6410,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL873344,,8006,,,Time to reach maximum plasma concentration was evaluated at an oral dose of 30 mg/kg,6410,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL619623,,8007,,,Tmax after peroral administration (10 mg/kg) was determined in rat,6215,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Expert,1,N,,1,,,In vivo,CHEMBL621399,,8008,,,Tmax of compound determined in rat after iv administration at a dose of 10 mg/kg,3598,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621400,,8009,,,Tmax by oral administration at a dose of 100 uM/kg in rat was determined,4527,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621401,,8010,,,"Tmax in fischer rats at 5 mg/kg dose, administered intravenously",17670,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621402,,8011,,,Tmax was determined,1465,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621403,,8012,,,Tmax was determined,2552,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621121,,8013,,,Tmax after oral administration in rat,5656,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL872525,,8014,,,Tmax after peroral administration in rats at 2.4 uM/kg,17764,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621122,,8015,,,Tmax in male rat,5610,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621123,,8016,,,Tmax in rat at 10 mg/kg,6046,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621124,,8017,,,Tmax in rat by po administration at a dose of 40 mg/kg,5874,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621125,,8018,,,Tmax in rats,17596,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621126,,8019,,,Tmax was measured in rats after peroral administration at 5 mg/kg,17804,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621127,,8020,,,Tmax value after oral dose at a dose of 10 mg/kg in rats.,1908,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621128,,8021,,,Tmax value after administration of 20 mg/Kg oral dose in rat,2959,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618263,,8022,,,Tmax value at a dose of 10 mg/kg in male SD rats,6757,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618264,,8023,,,Tmax value at a dose of 100 mg/kg in male SD rats,6757,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618265,,8024,,,Tmax value at a dose of 50 mg/kg in male SD rats,6757,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL618266,,8025,,,Total concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,4186,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618267,,8026,,,time required to reach maximum concentration (Cmax) after oral administration in rat,15662,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL618450,,8027,,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg ( 0-24 hr ),429,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL618451,,8028,,,Evaluated for pharmacokinetic parameter urine recovery in rat at the dose 50 mg/kg (0-24 hr),429,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618452,,8029,,,Unbound plasma was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,5546,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL618453,,8030,,,Amount of urine output was measured in rat at a dose of 1 mg/kg/po,3173,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL618454,,8031,,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po,3173,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL618455,,8032,,,Amount of urine output was measured in rat at a dose of 10 mg/kg/po; NT-Not tested,3173,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618456,,8033,,,Volume of distribution was determined in rat after a 3 mg/kg of iv dose,4257,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618457,,8034,,,Compound distribution in rat tissues was determined,6011,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618458,,8035,,,Volume of distribution was evaluated in rat,5472,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618459,,8036,,,Area under the curve was determined after intravenous administration of 2.7 mg/kg in male Dawley rats,14346,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL876733,,8037,,,Area under the curve was determined after intravenous administration of 2.8 mg/kg in male Dawley rats,14346,Rattus norvegicus,10116.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618460,,8038,,,Area under the curve was determined after intravenous administration of 4.9 mg/kg in male Beagle dogs,14346,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618461,,8039,,,Area under the curve was determined after intravenous administration of 5.1 mg/kg in male Dawley rats,14346,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL618462,,8040,,,Area under the curve was determined after oral administration (300 uM/Kg),15469,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618463,,8041,,,Area under the curve was determined after peroral administration of 5.0 mg/kg in male Dawley rats,14346,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618464,,8042,,,Area under the curve was determined after peroral administration of 5.1 mg/kg in mal Dawley rats,14346,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618465,,8043,,,Area under the curve was determined after peroral administration of 5.1 mg/kg in male Dawley rats,14346,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618466,,8044,,,Area under the curve was determined after peroral administration of 5.2 mg/kg in mal Dawley rats,14346,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618467,,8045,,,Area under the curve was determined after peroral administration of 5.2 mg/kg in male Dawley rats,14346,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618468,,8046,,,Area under the curve was determined for the compound after iv dose of 4.97 mg/kg in rats,15372,Rattus norvegicus,10116.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL618469,,8047,,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 100 mg/kg,12935,Canis lupus familiaris,9615.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL618470,,8048,,,Area under the plasma concentration was determined in fasted Beagle dogs after peroral administration of 20 mg/kg,12935,Canis lupus familiaris,9615.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL618471,,8049,,,Plasma drug AUC in rat (PO dose),14813,,
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618472,,8050,,,Area under the tumor growth curve (AUC) in the B-6 Melanoma Model in C57/b1 mice at the dose of 1 mg/kg.,15792,Mus musculus,10090.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL618473,,8051,,,Area under was determined at a dose of 30 mg/kg,3579,,
50506,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621699,,8052,,,Average area under curve for compound at 1 mg/kg dose intravenous administration to Ferret,12487,Mustela putorius furo,9669.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621700,,8053,,,Average area under curve for the compound at 10 mg/kg dose after intraduodenal administration to rat,12487,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621701,,8054,,,Average area under curve for the compound at 1 mg/kg dose after intravenous administration to rat,12487,Rattus norvegicus,10116.0
50506,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621702,,8055,,,Average area under curve at 10 mg/kg dose after intraduodenal administration to Ferret,12487,Mustela putorius furo,9669.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621703,,8056,,,Average area under curve at 10 mg/kg intraduodenal administration to salt depleted dog,12487,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621704,,8057,,,Average area under curve at 1 mg/kg intravenous administration to salt depleted dog,12487,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624259,,8058,,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 1.0(pmol/g/h)",12902,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624260,,8059,,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 2.0(pmol/g/h)",12902,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624430,,8060,,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 4.0(pmol/g/h)",12902,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624431,,8061,,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 5.0(pmol/g/h)",12902,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624432,,8062,,,"Bioavailability in male Sprague-Dawley rats, after the iv administration at a dose of 54.0(pmol/g/h)",12902,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624433,,8063,,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 10.0(pmol/g/h)",12902,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624434,,8064,,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 20.0(pmol/g/h)",12902,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624435,,8065,,,"Bioavailability in male Sprague-Dawley rats, after the po administration at a dose of 40.0(pmol/g/h)",12902,Rattus norvegicus,10116.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618570,,8066,,,Bioavailability in mouse brain after intravenous administration of 105.1 mg/kg of dose,12745,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618571,,8067,,,Bioavailability in mouse brain after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),12745,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618572,,8068,,,Bioavailability in mouse brain after oral administration of 100 mg/kg of dose,12745,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618573,,8069,,,Bioavailability in mouse brain after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),12745,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL619267,,8070,,,Bioavailability in mouse serum after intravenous administration of 105.1 mg/kg of dose,12745,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL619431,,8071,,,Bioavailability in mouse serum after intravenous administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),12745,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL619432,,8072,,,Bioavailability in mouse serum after oral administration of 100 mg/kg of dose,12745,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL619433,,8073,,,Bioavailability in mouse serum after oral administration of equimolar doses of ( 2'F-ara-ddI + 2'F-ara-ddP),12745,Mus musculus,10090.0
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,,CHEMBL619434,,8074,,,AUC in mice after oral dose (50 mg/kg),13298,,
50594,Serum,A,,,BAO_0000218,Intermediate,1,N,1977.0,1,,,,CHEMBL619435,,8075,,,Blood level after oral administration in mice (50 mg/kg) was determined by bioassay procedure and represent total activity present in the serum,12226,Mus musculus,10090.0
22224,Plasma,A,,,BAO_0000019,Autocuration,0,U,1969.0,1,,,,CHEMBL619436,,8076,,,AUC (0-4 hr) ug/ml/h,12634,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL619437,,8077,,,Compound at a dose of 10 mg/kg was orally administered to rats and Area under curve was reported,14810,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL619438,,8078,,,Compound evaluated for AUC = Area under the nucleoside serum or brain concentration versus time curve after iv administration,13889,,
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL619439,,8079,,,Compound was evaluated for Area under curve in mice,10018,Mus musculus,10090.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL619440,,8080,,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,8758,Rattus norvegicus,10116.0
22224,,F,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL619441,,8081,,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,8758,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL619442,,8082,,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,8758,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL875156,,8083,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 1,2249,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL619443,,8084,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 0.5 mpk on day 4,2249,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL619444,,8085,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 1,2249,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL623464,,8086,,,Compound was evaluated for area under curve of growth hormone release after chronic oral dosing at 1.0 mpk on day 4,2249,,
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623465,,8087,,,Compound was evaluated for area under curve when administered through oral route in mouse,15115,Mus musculus,10090.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623466,,8088,,,Plasma clearance after oral administration at a dose of 2 mg/kg in rat; no data,6518,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623467,,8089,,,Plasma clearance after oral administration at a dose of 4 mg/kg in rat; no data,6518,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623468,,8090,,,Plasma clearance in rat,6249,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622660,,8091,,,Plasma clearance was evaluated in vivo in rat at a dose of 5 mg/kg by intra venous administration,2463,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622661,,8092,,,Plasma clearance rate in Sprague-Dawley rats,4969,Rattus norvegicus,10116.0
50597,,F,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622662,,8093,,,CLtot at a dose of 4 mg/kg in Rat Plasma after iv administration,17720,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622663,,8094,,,Pharmacokinetic property (total body clearance) in rat,3457,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622664,,8095,,,Pharmacokinetic property (CLtot)of the compound was measured in rat at the dose of 0.32 mg/kg i.v.,5983,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622665,,8096,,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,6295,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622666,,8097,,,In vivo concentration in rat liver exposure 0-8 hour after oral administration 50 mg/kg,6296,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621615,,8098,,,Cl in rat i.v. at 2 mg/kg concentration,17686,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621616,,8099,,,Clearance of compound after intravenous administration in rats at 24 uM/kg,17764,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621617,,8100,,,Clearance was determined,5503,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621618,,8101,,,Clearance by intravenous administration of 3.4 mg/kg in rat,4368,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621619,,8102,,,Clearance was evaluated after i.v. administration in rat at a dose of 1 mg/kg,6005,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621620,,8103,,,Clearance rate after i.v. administration in rats,5031,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621786,,8104,,,Clearance was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,4890,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621787,,8105,,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,5182,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621788,,8106,,,Clearance (Cl) of compound after 2 h iv infusion of 8.4 mg/kg in three rat,5979,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621789,,8107,,,Clearance (Cl) after oral administration in rat,5656,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621790,,8108,,,Compound clearance in rats was measured after intravenous administration at 3 mg/kg,17804,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL621791,,8109,,,Compound was tested for plasma clearance in rat,4839,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vitro,CHEMBL621792,,8110,Microsomes,,In vitro microsome metabolism clearance in rat was determined,5041,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vitro,CHEMBL621793,,8111,Microsomes,,In vitro microsome metabolism clearance in rat was determined; ND denotes no data,5041,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621794,,8112,,,In vivo Clearance (Cl) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL621795,,8113,,,In vivo plasma clearance was determined,5496,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621796,,8114,,,Pharmacokinetic property (Clearance) for the compound (5 mg/kg iv) was determined in rats,5739,Rattus norvegicus,10116.0
50597,Liver,A,,401.0,BAO_0000218,Intermediate,1,N,2107.0,1,,Hepatocyte,In vivo,CHEMBL621797,,8115,,,Pharmacokinetic property (Clearance) in rat hepatocyte i.v.,5676,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621798,,8116,,,Pharmacokinetic property (Plasma clearance) was measured in rat,4239,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621799,,8117,,,Pharmacokinetic property (clearance) in rat i.v.,5676,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621800,,8118,,,"Plasma Clearance was evaluated in rats, iv",1918,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621801,,8119,,,Plasma clearance (in vivo) in rats was determined,17800,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621802,,8120,,,Plasma clearance for the compound was calculated at a single intravenous administration of 20 mg/kg in rat,6056,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618596,,8121,,,Plasma clearance was determined,5496,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618597,,8122,,,Plasma clearance in rat after peroral administration at 10 mg/kg concentration,5939,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618598,,8123,,,Plasma clearance in rat after peroral administration at 5 mg/kg concentration,5939,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618599,,8124,,,Plasma clearance in rats,17752,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618600,,8125,,,Plasma clearance rate determined in rat,4576,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618601,,8126,,,Plasma clearance was determined in rat,6011,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618602,,8127,,,Plasma clearance was determined,5510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618603,,8128,,,Plasma clearance value in rat,5948,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,Ex vivo,CHEMBL618604,,8129,,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,6125,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618605,,8130,,,Clearance in rat,4839,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618606,,8131,,,Total body clearance in rat i.v. at 2 mg/kg concentration,17686,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618607,,8132,,,Clearance of compound in rats after intravenous administration,6571,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618608,,8133,,,Clearance after iv administration to rats,3364,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618609,,8134,,,Clearance at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,13569,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618610,,8135,,,Clearance at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,13569,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618611,,8136,,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,13569,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618612,,8137,,,Clearance at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,13569,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618613,,8138,,,Clearance at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,13569,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621076,,8139,,,Clearance at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,13569,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621077,,8140,,,Clearance at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,13569,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621078,,8141,,,"Clearance in fischer rats at 5 mg/kg dose, administered intravenously",17670,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621251,,8142,,,Clearance in rat,5970,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621252,,8143,,,Clearance in rat after oral administration at 10 mg/kg,6495,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621253,,8144,,,Clearance in rat.,4590,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621254,,8145,,,Clearance rate following an oral dose of 20 mg/kg in rats,6193,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621255,,8146,,,Compound was evaluated for the rate of clearance in rat upon intravenous administration.,2832,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL621256,,8147,,,Compound was tested for plasma clearance in rats after 5 mg/kg of intravenous dosing,1052,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL621257,,8148,,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 1 hr,9866,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL621258,,8149,,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 30 min,9866,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL621259,,8150,,,Biodistribution in rat liver in the presence of GdDTPA-BDP at 4 hr,9866,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL621260,,8151,,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 15 min,9866,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL876494,,8152,,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 1 hr,9866,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL621261,,8153,,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 30 min,9866,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL621262,,8154,,,Biodistribution in rat liver in the presence of GdDTPA-HPDP at 4 hr,9866,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL621263,,8155,,,Biodistribution in rat liver in the presence of NAC Gd/0.01 M GdDTPA-HPDP,9866,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL621264,,8156,,,Biodistribution in rat liver in the presence of NCA Gd/0.01 M lip,9866,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL621265,,8157,,,Biodistribution in rat muscle in the presence of 0.01 M GdDTPA-BDP,9866,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL621266,,8158,,,Biodistribution in rat muscle in the presence of 0.05 M Gd/0.15 M lig,9866,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL621267,,8159,,,Biodistribution in rat muscle in the presence of 0.05 M GdDTPA-BDP,9866,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL621268,,8160,,,Biodistribution in rat muscle in the presence of 0.10 M GdDTPA-BDP,9866,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL621269,,8161,,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 1 hr,9866,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL621270,,8162,,,Biodistribution in rat muscle in the presence of GdDTPA-BDP at 4 hr,9866,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL621271,,8163,,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 15 min,9866,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL621272,,8164,,,Biodistribution in rat muscle in the presence of GdDTPA-BDPat 30 min,9866,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL621273,,8165,,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 1 hr,9866,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL621274,,8166,,,Biodistribution in rat muscle in the presence of GdDTPA-HPDP at 4 hr,9866,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL876495,,8167,,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 15 min,9866,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL621275,,8168,,,Biodistribution in rat muscle in the presence of GdDTPA-HPDPat 30 min,9866,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL621276,,8169,,,Biodistribution in rat muscle in the presence of NCA Gd/0.01 M lip,9866,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL621277,,8170,,,Biodistribution in rat muscle in the presence of NCAGd/0.01 M lig,9866,Rattus norvegicus,10116.0
50597,Intestine,A,,,BAO_0000218,Intermediate,1,N,160.0,1,,,In vivo,CHEMBL621278,,8171,,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 2 hr,9866,Rattus norvegicus,10116.0
50597,Intestine,A,,,BAO_0000218,Intermediate,1,N,160.0,1,,,In vivo,CHEMBL621279,,8172,,,Biodistribution in rat s. intestine in the presence of 50 Gd/kg at 6 hr,9866,Rattus norvegicus,10116.0
50597,Intestine,A,,,BAO_0000218,Intermediate,1,N,160.0,1,,,In vivo,CHEMBL621280,,8173,,,Biodistribution in rat s. intestine in the presence of NCA (No carrier added),9866,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL621281,,8174,,,Biodistribution in rat spleen in the presence of 0.01 M GdDTPA-BDP,9866,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL621282,,8175,,,Biodistribution in rat spleen in the presence of 0.05 M Gd/0.15 M lig; ND=No data,9866,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL621283,,8176,,,Biodistribution in rat spleen in the presence of 0.05 M GdDTPA-BDP; ND=No data,9866,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL621284,,8177,,,Biodistribution in rat spleen in the presence of 0.10 M GdDTPA-BDP,9866,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL621285,,8178,,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 15 min,9866,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL621286,,8179,,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 2 hr,9866,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL623220,,8180,,,Biodistribution in rat spleen in the presence of 50 Gd/kg at 6 hr,9866,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL623221,,8181,,,Biodistribution in rat spleen in the presence of NCA Gd/0.01 M lip,9866,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL876029,,8182,,,Biodistribution in rat spleen in the presence of NCAGd/0.01 M lig,9866,Rattus norvegicus,10116.0
50597,Stomach,A,,,BAO_0000218,Intermediate,1,N,945.0,1,,,In vivo,CHEMBL623222,,8183,,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 15 min,9866,Rattus norvegicus,10116.0
50597,Stomach,A,,,BAO_0000218,Intermediate,1,N,945.0,1,,,In vivo,CHEMBL623223,,8184,,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 2 hr,9866,Rattus norvegicus,10116.0
50597,Stomach,A,,,BAO_0000218,Intermediate,1,N,945.0,1,,,In vivo,CHEMBL621445,,8185,,,Biodistribution in rat stomach in the presence of 50 Gd/kg at 6 h; ND=No data,9866,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL621446,,8186,,,Biodistribution of [123I]-label in rat blood was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL621447,,8187,,,Biodistribution of [123I]-label in rat blood was reported at 1 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL619681,,8188,,,Biodistribution of [123I]-label in rat blood was reported at 2 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL619682,,8189,,,Biodistribution of [123I]-label in rat blood was reported at 24 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL619683,,8190,,,Biodistribution of [123I]-label in rat blood was reported at 4 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL619684,,8191,,,Biodistribution of [123I]-label in rat brain was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL619685,,8192,,,Biodistribution of [123I]-label in rat brain was reported at 1 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL619686,,8193,,,Biodistribution of [123I]-label in rat brain was reported at 2 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL619687,,8194,,,Biodistribution of [123I]-label in rat brain was reported at 24 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL619688,,8195,,,Biodistribution of [123I]-label in rat brain was reported at 4 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL619689,,8196,,,Biodistribution of [123I]-label in rat heart was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL619690,,8197,,,Biodistribution of [123I]-label in rat heart was reported at 1 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL619691,,8198,,,Biodistribution of [123I]-label in rat heart was reported at 2 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL619692,,8199,,,Terminal phase volume of distribution was measured in rat after an iv dose of 1 mg/kg,6062,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Expert,1,N,,1,,,,CHEMBL619693,,8200,,,Apparent volume of the central plasma compartment (Vc) of compound determined in rat after iv administration at a dose of 10 mg/kg,3598,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL619694,,8201,,,Vc value after IV dose at a dose of 5 mg/kg in rats.,1908,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL619695,,8202,,,Apparent volume of distribution at 10 mg/kg in rat upon intravenous administration,17596,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL619696,,8203,,,Compound was evaluated for pharmacokinetic parameter volume of distribution,4891,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL619697,,8204,,,Compound was evaluated for volume of distribution in rat,740,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL619698,,8205,,,Steady state volume distribution was determined; steady state(ss),16366,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL619699,,8206,,,Steady state volume of distribution after iv administration to rats,3364,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL619700,,8207,,,Steady state volume of distribution dosing at 3 mg/kg iv,2552,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL619701,,8208,,,The compound was evaluated for volume of distribution in rat,406,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL619702,,8209,,,The compound was tested for volume of distribution in rat,12500,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620335,,8210,,,The compound was tested for volume of distribution in rat at dose of 3-10 mgkg,12500,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620336,,8211,,,Volume distribution (VD) after oral administration in rat,5656,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620337,,8212,,,Volume distribution of compound in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,17671,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620520,,8213,,,Volume distribution in rat,1094,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620521,,8214,,,Volume distribution in rat,5833,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL875825,,8215,,,Volume distribution in rat after peroral administration at 10 mg/kg,5939,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620522,,8216,,,Volume distribution in rat after peroral administration at 5 mg/kg,5939,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620523,,8217,,,Volume distribution was evaluated after i.v. administration in rat at a dose of 1 mg/kg,6005,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620524,,8218,,,Volume of distribution in rat.,1696,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620525,,8219,,,Volume of distribution in rat,6672,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620526,,8220,,,Volume of distribution in rat,6673,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620527,,8221,,,Volume of distribution in rat by iv administration,5871,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620528,,8222,,,Volume of distribution in rats,6803,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620529,,8223,,,Volume of distribution was determined in female Sprague-Dawley rats following intravenous (iv) administration of drug (1 mg/kg).,5199,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL620530,,8224,,,Volume distribution at the dose of 2 mg/kg in rat,4727,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620531,,8225,,,Steady state volume of distribution was determined,16367,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Intermediate,0,U,,1,,,In vivo,CHEMBL620532,,8226,,,Compound was tested for its plasma volume distribution in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po,5005,Macaca mulatta,9544.0
22224,,A,,,BAO_0000218,Intermediate,0,U,,1,,,In vivo,CHEMBL620533,,8227,,,Compound was tested for its plasma volume distribution in Sprague Dawley rats,5005,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Intermediate,0,U,,1,,,In vivo,CHEMBL620534,,8228,,,Compound was tested for its plasma volume distribution in Sprague Dawley rats; ND is not determined,5005,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620535,,8229,,,Mean (%CV) PK parameters for Vdss(mL/kg).,15765,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL875826,,8230,,,Pharmacokinetic parameter Vdss was determined at 2 mg/kg i.v. dose in rats,2792,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620536,,8231,,,Pharmacokinetic parameter Vdss was determined at 5 mg/kg i.v. dose in rats,2792,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620537,,8232,,,Pharmacokinetic parameter volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,5334,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618526,,8233,,,Pharmacokinetic parameter volume of distribution was reported in Sprague-Dawley rat; ND=Not determined,5334,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618527,,8234,,,Pharmacokinetic property (Vdss) for the compound (5 mg/kg iv) was determined in rats,5739,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618528,,8235,,,Pharmacokinetic property (Vdss) in rat,5789,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618529,,8236,,,Pharmacokinetic property (vdss) was measured in rat,4239,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618530,,8237,,,Steady state volume of distribution for the compound after intravenous administration of 1 mg/kg in rat,4709,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618531,,8238,,,Volume of distribution in rat,6642,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618532,,8239,,,The pharmacokinetic parameter volume of distribution in vivo in rats,5247,Rattus norvegicus,10116.0
50597,,F,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618533,,8240,,,Vdss at a dose of 4 mg/kg in Rat Plasma after iv administration,17720,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618534,,8241,,,Vdss in rat i.v. at 2 mg/kg concentration,17686,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618535,,8242,,,Volume distribution after intravenous administration (1 mg/kg) in rat,4689,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618536,,8243,,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,5654,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618537,,8244,,,Volume distribution of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,5654,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618538,,8245,,,Volume distribution at a dose of 10 uM/kg in rat was determined,4527,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618539,,8246,,,Volume distribution in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,4521,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618540,,8247,,,Volume distribution was calculated in rat,6057,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618541,,8248,,,Volume distribution was determined,5510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618542,,8249,,,Volume of distribution after intravenous administration was evaluated in rat,2938,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622544,,8250,,,Volume of distribution at steady state was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,6679,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622545,,8251,,,"Volume of distribution at steady state was determined in rats at 10 mg/kg, p.o. dose; n/a: not applicable",6685,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622546,,8252,,,"Volume of distribution at steady state was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",6685,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622547,,8253,,,"Volume of distribution at steady state was determined in rats at 2 mg/kg, i.v. dose",6685,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622548,,8254,,,Volume of distribution in steady state was determined in rat,5145,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622549,,8255,,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration,6467,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622550,,8256,,,Volume of distribution in steady state was determined in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,6467,Rattus norvegicus,10116.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622551,,8257,,,Compound was evaluated for area under curve when administered through oral route to mouse,15115,Mus musculus,10090.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622552,,8258,,,Compound was evaluated for area under curve doses in rat at 100 mg/kg po,8758,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622553,,8259,,,Compound was evaluated for area under curve doses in rat at 50 mg/kg po,8758,Rattus norvegicus,10116.0
22224,,F,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL622554,,8260,,,Compound was evaluated for its bioavailability after oral administration (100 mg) to Beagle dogs,8267,,
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622555,,8261,,,Compound was evaluated for its bioavailability after oral administration (200 mg) to Beagle dogs,8267,Canis lupus familiaris,9615.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622556,,8262,,,Compound was evaluated for the area under the concentration - time curve by administering intravenously at 25 mg/kg in mice,14239,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622557,,8263,,,Compound was evaluated for the area under the concentration - time curve by administering orally at 25 mg/kg in mice,14239,Mus musculus,10090.0
50594,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL622558,,8264,,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg intramuscular administration to mice,10754,Mus musculus,10090.0
50594,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL622559,,8265,,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to mice,10754,Mus musculus,10090.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622560,,8266,,,Compound was evaluated in vivo in for its concentration using Area under the time-concentration curve after 40 mg/kg peroral administration to dogs.,10754,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622561,,8267,,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose,14681,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622562,,8268,,,Compound was tested for area under concentration -time curve from time 0 to time infinity in three male Wistar rats at a single 5 mg/kg oral gavage dose. ,14681,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622563,,8269,,,Compound was tested for area under concentration -time curve from time 0 to time of last detectable concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,14681,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL622564,,8270,,,Concentration of compound in Central nervous system,13118,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL622565,,8271,,,Concentration of compound in Central nervous system; Not detectable,13118,,
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622566,,8272,,,"Concentration of diester in the blood, following oral administration in mice",13318,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624515,,8273,,,"Concentration of monoester in the blood, following oral administration in mice",13318,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624516,,8274,,,Concentration of the 9-[2-(Phosphonomethoxy)ethoxy]adenine in the blood following oral administration in mice,13318,Mus musculus,10090.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL624517,,8275,,,Evaluated for Pharmacokinetic property: Area under the curve,15692,,
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624518,,8276,,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after a peroral dose of 25 mg/kg in nude mice,14839,Mus musculus,10090.0
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624519,,8277,,,In vivo antitumor efficacy expressed as plasma area under the curve 0.4 hr after iv dose of 25 mg/kg in nude mice,14839,Macaca fascicularis,9541.0
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624520,,8278,,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after iv dose of 5 mg/kg expressed as Area under the curve,14839,Macaca fascicularis,9541.0
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624521,,8279,,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 10 mg/kg expressed as Area under the curve,14839,Macaca fascicularis,9541.0
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624522,,8280,,,In vivo antitumor efficacy in cynomolgus monkeys 0-48 hr after peroral dose of 5 mg/kg expressed as Area under the curve,14839,Macaca fascicularis,9541.0
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624523,,8281,,,In vivo antitumor efficacy in cynomolgus monkeys 0-8 hours after peroral dose of 25 mg/kg expressed as Area under the curve,14839,Macaca fascicularis,9541.0
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624409,,8282,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",14839,Macaca fascicularis,9541.0
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624410,,8283,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-8 hr)",14839,Macaca fascicularis,9541.0
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624411,,8284,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",14839,Macaca fascicularis,9541.0
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623531,,8285,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, iv and the total drug exposure was determined. (0-8 hr)",14839,Macaca fascicularis,9541.0
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623532,,8286,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as the micronised free base in corn oil, perorally and the total drug exposure was determined (0-8 hr)",14839,Macaca fascicularis,9541.0
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623533,,8287,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, intravenously and the total drug exposure was determined (0-8 hr)",14839,Macaca fascicularis,9541.0
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623534,,8288,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-8 hr)",14839,Macaca fascicularis,9541.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623535,,8289,,,In vivo antitumor efficacy in nude mice 0-24 hr after intravenous dose of 25 mg/kg expressed as Area under the curve,14839,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623536,,8290,,,In vivo antitumor efficacy in nude mice 0-24 hr after iperoral dose of 25 mg/kg expressed as Area under the curve,14839,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623537,,8291,,,In vivo antitumor efficacy in nude mice 0-24 hr after iv dose of 25 mg/kg expressed as Area under the curve,14839,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623538,,8292,,,In vivo antitumor efficacy in nude mice 0-24 hr after peroral dose of 25 mg/kg expressed as Area under the curve,14839,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623539,,8293,,,In vivo antitumor efficacy in nude mice after peroral dose of 10 mg/kg expressed as Area under the curve,14839,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623540,,8294,,,In vivo antitumor efficacy in nude mice after peroral dose of 25 mg/kg expressed as Area under the curve,14839,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623541,,8295,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined.",14839,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623542,,8296,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-24hr)",14839,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623543,,8297,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, iv and the total drug exposure was determined. (0-4 hr)",14839,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623544,,8298,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined",14839,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623545,,8299,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-24hr)",14839,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623546,,8300,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the total drug exposure was determined (0-4 hr)",14839,Mus musculus,10090.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623547,,8301,,,Evaluated for plasma clearance after iv administration of 5 mg/kg to male Sprague-Dawley rats,5408,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623548,,8302,,,High i.v. clearance in Dawley rats,6827,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vitro,CHEMBL623549,,8303,Microsomes,,In vitro clearance in rat liver microsomes,17538,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vitro,CHEMBL623550,,8304,Microsomes,,Intrinsic clearance in rat liver microsomes was determined,6331,Rattus norvegicus,10116.0
50597,Liver,A,,401.0,BAO_0000218,Intermediate,1,N,2107.0,1,,Hepatocyte,In vitro,CHEMBL875276,,8305,,,Intrinsic clearance in rat hepatocytes was determined,5948,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621872,,8306,,,Plasma Clearance was determined,4026,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621873,,8307,,,Plasma clearance after intravenous administration of 0.4 mg/kg of dose in rats was determined,6647,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621874,,8308,,,Plasma clearance in rat.,1696,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621875,,8309,,,Plasma clearance in rats,6597,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621876,,8310,,,Plasma clearance was estimated from the AUC after 5 mg/kg intravenous dosing in rats,347,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621877,,8311,,,Plasma clearance was evaluated after 10 uM/kg of intra arterial administration,16423,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621878,,8312,,,Plasma clearance was measured in rat,2879,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621879,,8313,,,Clearance after iv administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,4883,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL621880,,8314,,,"Tested for the plasma clearance in Dawley rat at a dose of 1 mg/kg intravenous, 2 mg/kg orally",5328,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621881,,8315,,,The clearance rate in mature male rat at a intravenous dose of 3 mg/kg,5160,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621882,,8316,,,Total body clearance was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,17582,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL875283,,8317,,,Total clearance at 1 mg/kg was determined in rat,17651,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621883,,8318,,,Total clearance at 10 mg/kg was determined in rat,17651,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621884,,8319,,,Clearance in rat,6596,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621885,,8320,,,Plasma clearance rate determined in rats,4796,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621886,,8321,,,Clearance of compound in rat was evaluated,6850,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL621887,,8322,,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,5932,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621888,,8323,,,Pharmacokinetic property (blood clearance) in rat,3371,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621889,,8324,,,Plasma clearance in rat,2083,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621890,,8325,,,Plasma clearance in rats,4942,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vitro,CHEMBL621891,,8326,Microsomes,,Intrinsic clearance of compound against NADPH-fortified rat liver microsomes,6838,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621892,,8327,,,Clearance in Dawley rat,5353,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621893,,8328,,,Clearance rat,6641,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621894,,8329,,,Clearance rat (dosed at 0.5 mpk IV and 2.0 mpk po.),6641,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621895,,8330,,,Clearance rat; Not determined,6641,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL875284,,8331,,,Clearance rate was determined in rat at a dose of 1 mpk i.v.,6444,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618699,,8332,,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND means not determined,6444,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618700,,8333,,,Clearance rate was determined in rat at a dose of 1 mpk i.v.; ND=not determined,6444,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618701,,8334,,,Clearance was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,6211,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL876600,,8335,,,"Clearance in plasma calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",12873,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618702,,8336,,,Clearance of compound in rat after 1 mg/kg i.v. administration,6570,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618703,,8337,,,Compound was evaluated for Hepatic clearance in rat,3341,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618704,,8338,,,In vivo clearance after 5 mg/kg dose,4891,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL618705,,8339,,,Compound was tested for plasma clearance in rats,1094,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618706,,8340,,,Hepatic clearance after intravenous administration was evaluated in rat,2938,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618707,,8341,,,Lower clearance in rat (i.v.) at 0.5 mpk,17853,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL618708,,8342,,,Pharmacokinetic parameter expressed as plasma clearance in rat,6049,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618709,,8343,,,Pharmacokinetic property (Clp) in rat,5789,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618710,,8344,,,Plasma clearance in Sprague-Dawley rats,4514,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618711,,8345,,,Plasma clearance (Clp) in rat,6448,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618712,,8346,,,Plasma clearance for the compound was measured in rat after an iv dose of 1 mg/kg,6062,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618713,,8347,,,Plasma clearance in fasted male Sprague dawely rats on administration of 0.5 mg/Kg i.v. of the compound,5710,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618714,,8348,,,Plasma clearance after intravenous administration of 1 mg/kg in rat,4709,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618715,,8349,,,Plasma clearance in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,4521,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618716,,8350,,,Plasma clearance in rat was determined,1742,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL876601,,8351,,,Plasma clearance measured in rat,6057,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618717,,8352,,,Plasma clearance was calculated in rat,6057,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618718,,8353,,,Plasma clearance in rat,5145,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618719,,8354,,,Plasma clearance in rat,5833,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618720,,8355,,,Plasma clearance in rat,6453,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618721,,8356,,,Plasma clearance in rat,6640,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621477,,8357,,,Plasma clearance in rats,6305,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621478,,8358,,,Plasma clearance in rat,6642,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621479,,8359,,,Plasma clearance was evaluated in rat,5472,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621480,,8360,,,Plasma clearance was evaluated in rat; Not tested,5472,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621481,,8361,,,Plasma clearance rate was determined for the compound in rat,5144,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621482,,8362,,,"Plasma clearance rate was determined in rats at 10mg/kg, p.o. dose; n/a: not applicable",6685,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621483,,8363,,,"Plasma clearance rate was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",6685,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621484,,8364,,,"Plasma clearance rate was determined in rats at 2 mg/kg, i.v. dose",6685,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL621485,,8365,,,Biodistribution of [123I]-label in rat heart was reported at 24 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL621486,,8366,,,Biodistribution of [123I]-label in rat heart was reported at 4 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Intestine,A,,,BAO_0000218,Intermediate,1,N,160.0,1,,,In vivo,CHEMBL621487,,8367,,,Biodistribution of [123I]-label in rat intestine was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Intestine,A,,,BAO_0000218,Intermediate,1,N,160.0,1,,,In vivo,CHEMBL621488,,8368,,,Biodistribution of [123I]-label in rat intestine was reported at 1 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Intestine,A,,,BAO_0000218,Intermediate,1,N,160.0,1,,,In vivo,CHEMBL621489,,8369,,,Biodistribution of [123I]-label in rat intestine was reported at 2 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Intestine,A,,,BAO_0000218,Intermediate,1,N,160.0,1,,,In vivo,CHEMBL621490,,8370,,,Biodistribution of [123I]-label in rat intestine was reported at 24 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Intestine,A,,,BAO_0000218,Intermediate,1,N,160.0,1,,,In vivo,CHEMBL621491,,8371,,,Biodistribution of [123I]-label in rat intestine was reported at 4 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL621492,,8372,,,Biodistribution of [123I]-label in rat kidneys was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL621493,,8373,,,Biodistribution of [123I]-label in rat kidneys was reported at 1 h post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL621494,,8374,,,Biodistribution of [123I]-label in rat kidneys was reported at 2 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL621495,,8375,,,Biodistribution of [123I]-label in rat kidneys was reported at 24 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL621496,,8376,,,Biodistribution of [123I]-label in rat kidneys was reported at 4 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL621497,,8377,,,Biodistribution of [123I]-label in rat liver was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL621498,,8378,,,Biodistribution of [123I]-label in rat liver was reported at 1 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL621499,,8379,,,Biodistribution of [123I]-label in rat liver was reported at 2 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL618634,,8380,,,Biodistribution of [123I]-label in rat liver was reported at 24 h post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL618635,,8381,,,Biodistribution of [123I]-label in rat liver was reported at 4 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL618636,,8382,,,Biodistribution of [123I]-label in rat lung was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL619737,,8383,,,Biodistribution of [123I]-label in rat lung was reported at 1 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL619738,,8384,,,Biodistribution of [123I]-label in rat lung was reported at 2 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL624329,,8385,,,Biodistribution of [123I]-label in rat lung was reported at 24 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL624330,,8386,,,Biodistribution of [123I]-label in rat lung was reported at 4 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL624331,,8387,,,Biodistribution of [123I]-label in rat muscle was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL624332,,8388,,,Biodistribution of [123I]-label in rat muscle was reported at 1 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL624333,,8389,,,Biodistribution of [123I]-label in rat muscle was reported at 2 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL624334,,8390,,,Biodistribution of [123I]-label in rat muscle was reported at 24 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL624335,,8391,,,Biodistribution of [123I]-label in rat muscle was reported at 4 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL620016,,8392,,,Biodistribution of [123I]-label in rat spleen was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL620169,,8393,,,Biodistribution of [123I]-label in rat spleen was reported at 1 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL620170,,8394,,,Biodistribution of [123I]-label in rat spleen was reported at 2 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL620171,,8395,,,Biodistribution of [123I]-label in rat spleen was reported at 24 h post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL620172,,8396,,,Biodistribution of [123I]-label in rat spleen was reported at 4 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Stomach,A,,,BAO_0000218,Intermediate,1,N,945.0,1,,,In vivo,CHEMBL620173,,8397,,,Biodistribution of [123I]-label in rat stomach was reported at 0.33 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Stomach,A,,,BAO_0000218,Intermediate,1,N,945.0,1,,,In vivo,CHEMBL620174,,8398,,,Biodistribution of [123I]-label in rat stomach was reported at 1 h post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Stomach,A,,,BAO_0000218,Intermediate,1,N,945.0,1,,,In vivo,CHEMBL620175,,8399,,,Biodistribution of [123I]-label in rat stomach was reported at 2 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Stomach,A,,,BAO_0000218,Intermediate,1,N,945.0,1,,,In vivo,CHEMBL620176,,8400,,,Biodistribution of [123I]-label in rat stomach was reported at 24 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Stomach,A,,,BAO_0000218,Intermediate,1,N,945.0,1,,,In vivo,CHEMBL620177,,8401,,,Biodistribution of [123I]-label in rat stomach was reported at 4 hr post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Cerebellum,A,,,BAO_0000218,Intermediate,1,N,2037.0,1,,,,CHEMBL620178,,8402,,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 20 min post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Cerebellum,A,,,BAO_0000218,Intermediate,1,N,2037.0,1,,,,CHEMBL620179,,8403,,,Distribution of [123I]-label in rat brain (cerebellum) was reported at 60 min post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL620180,,8404,,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 20 min post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620181,,8405,,,Volume of distribution of compound in rat after 1 mg/kg i.v. administration,6570,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620182,,8406,,,Volume of distribution of compound in rats after intravenous administration,6571,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620183,,8407,,,Volume of distribution in rat,6453,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620184,,8408,,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.,6444,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620185,,8409,,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND means not determined,6444,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620186,,8410,,,Volume of distribution was determined in rat at a dose of 1 mpk i.v.; ND=not determined,6444,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620187,,8411,,,Volume of distribution was determined in Dawley rat,5353,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620188,,8412,,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,5334,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620189,,8413,,,Volume of distribution was reported in Sprague-Dawley rat,5334,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620190,,8414,,,Volumes of distribution in rat after peroral administration,6641,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620191,,8415,,,Volumes of distribution in rat after po administration,6641,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620192,,8416,,,Volumes of distribution in rat after po administration; Not determined,6641,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620193,,8417,,,Pharmacokinetic property (Volume) in rat i.v.,5676,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620194,,8418,,,Apparent volume of distribution when 3 mg/Kg dose was administered intravenously,6410,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL876730,,8419,,,"Volume distribution in fischer rats at 5 mg/kg dose, administered intravenously",17670,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620195,,8420,,,Volume distribution in rat after oral administration at 10 mg/kg,6495,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620196,,8421,,,Evaluated for Volume of distribution after iv administration of 5 mg/kg to male Sprague-Dawley rats,5408,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620197,,8422,,,Tested for volume of distribution after intravenous administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,4883,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620198,,8423,,,Volume of distribution after oral administration of 6 mg/kg of dose in rats was determined,6647,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620199,,8424,,,Volume of distribution in rats,6495,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620200,,8425,,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to female wistar rats,2661,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620201,,8426,,,Compound was evaluated for volume of distribution (steady state) after treatment with iv dose of 1 mgkg to male wistar rats,2661,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620202,,8427,,,In vivo Volume distribution (Vss) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620203,,8428,,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620204,,8429,,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat;no value,5974,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620205,,8430,,,In vivo Volume distribution (Vss) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624664,,8431,,,Pharmacokinetic parameter (Vss) in rat,5960,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624665,,8432,,,Pharmacokinetic property (Volume) in rat i.v.,5676,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624666,,8433,,,Pharmacokinetic property (Vss) in rat,5948,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624667,,8434,,,Steady state volume distribution (Vss) of compound after 2 hr iv infusion of 8.4 mg/kg in three rat,5979,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624668,,8435,,,Steady state volume distribution (Vss) of compound after iv administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624669,,8436,,,Steady state volume distribution (Vss) of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624670,,8437,,,Steady state volume distribution (Vss) of compound(9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624671,,8438,,,Steady state volume distribution (Vss) of compound(9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624672,,8439,,,Steady state volume distribution in rat,6448,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL624673,,8440,,,"Steady state volume of distribution calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv.",12873,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624674,,8441,,,Steady state volume of distribution determined in rat,4576,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624675,,8442,,,Steady-state volume of distribution was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,17582,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621728,,8443,,,Tested for volume of distribution at steady state upon intravenous administration of 5.0 mg/Kg dose in rat,1466,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621729,,8444,,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined,5182,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621730,,8445,,,Volume at steady state distribution by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat was determined; NC means not calculated,5182,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621731,,8446,,,Volume distribution in rat after administration of 2 mg/kg iv,6535,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621732,,8447,,,Volume distribution in rat after administration of 2 mg/kg iv,6535,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621908,,8448,,,Volume in steady state distribution value was determined,5041,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL875347,,8449,,,Volume in steady state distribution value was determined; ND denotes no data,5041,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621909,,8450,,,Volume in steady state distribution value was determined; ND denotes not determined,5041,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621910,,8451,,,Volume of distribution at a steady state measured after intravenous bolus administration of 50 mg/kg of compound to rats,17065,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621911,,8452,,,Volume of distribution at steady state was evaluated in rats,6597,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621912,,8453,,,Volume of distribution at steady state was observed after intravenous administration in rat,15662,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621913,,8454,,,Volume of distribution in steady state was determined in rat,6485,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621914,,8455,,,Volume of distribution in steady state was determined in rat,17655,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621915,,8456,,,Volume of distribution after i.v. administration,6616,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621916,,8457,,,Volume of distribution was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after iv administration,1916,Rattus norvegicus,10116.0
50594,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL621917,,8458,,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",16438,Mus musculus,10090.0
50594,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL621918,,8459,,,"Biodistribution of compound (oxidized form) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",16438,Mus musculus,10090.0
50594,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL621919,,8460,,,Biodistribution of compound (oxidized form) in spleen tissue,16438,Mus musculus,10090.0
50594,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL621920,,8461,,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO sol.",16438,Mus musculus,10090.0
50594,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL621921,,8462,,,"Biodistribution of compound (oxidized form) in spleen tissue, animals were sacrificed 10 minutes after dosing, in DMSO solution",16438,Mus musculus,10090.0
50594,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL622401,,8463,,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",16438,Mus musculus,10090.0
50594,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL875348,,8464,,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO sol.",16438,Mus musculus,10090.0
50594,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL622402,,8465,,,"Biodistribution of compound (oxidized form) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO solution",16438,Mus musculus,10090.0
50594,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL622403,,8466,,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood,16438,Mus musculus,10090.0
50594,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL622404,,8467,,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in blood tissues, animals were sacrificed 60 minutes after dosing, in DMSO",16438,Mus musculus,10090.0
50594,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL622405,,8468,,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues,16438,Mus musculus,10090.0
50594,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL622406,,8469,,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 10 minutes after dosing, in DMSO",16438,Mus musculus,10090.0
50594,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL622407,,8470,,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in brain tissues, animals were sacrificed 60 minutes after dosing, in DMSO",16438,Mus musculus,10090.0
50594,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL622408,,8471,,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues,16438,Mus musculus,10090.0
50594,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL622409,,8472,,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 10 minutes after dosing, in DMSO",16438,Mus musculus,10090.0
50594,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL622410,,8473,,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in heart tissues, animals were sacrificed 60 minutes after dosing, in DMSO",16438,Mus musculus,10090.0
50594,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL622411,,8474,,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney,16438,Mus musculus,10090.0
50594,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL627864,,8475,,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing in DMSO",16438,Mus musculus,10090.0
50594,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL627865,,8476,,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in kidney tissues, animals were sacrificed 60 minutes after dosing, in DMSO",16438,Mus musculus,10090.0
50594,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL627866,,8477,,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver,16438,Mus musculus,10090.0
50594,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL627751,,8478,,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in liver tissues, animals were sacrificed 60 minutes after dosing, in DMSO",16438,Mus musculus,10090.0
50594,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL627752,,8479,,,Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen,16438,Mus musculus,10090.0
50594,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL627753,,8480,,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing in DMSO",16438,Mus musculus,10090.0
50594,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL627754,,8481,,,"Biodistribution of compound (total concentration of both oxidized and reduced forms) in spleen tissues, animals were sacrificed 60 minutes after dosing, in DMSO",16438,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627755,,8482,,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK2 murine fibrosarcoma cells,12467,Mus musculus,10090.0
50594,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL627756,,8483,,,Biodistribution of radioactivity in normal mice (ICR) brain after 1 hour of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL627757,,8484,,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL627758,,8485,,,Biodistribution of radioactivity in normal mice (ICR) brain after 2 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL627759,,8486,,,Biodistribution of radioactivity in normal mice (ICR) brain after 24 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL627760,,8487,,,Biodistribution of radioactivity in normal mice (ICR) brain after 30 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL627761,,8488,,,Biodistribution of radioactivity in normal mice (ICR) brain after 6 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL876811,,8489,,,Biodistribution of radioactivity in normal mice (ICR) heart after 1 hour of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL627762,,8490,,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL627763,,8491,,,Biodistribution of radioactivity in normal mice (ICR) heart after 2 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL627764,,8492,,,Biodistribution of radioactivity in normal mice (ICR) heart after 24 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL627765,,8493,,,Biodistribution of radioactivity in normal mice (ICR) heart after 30 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL627766,,8494,,,Biodistribution of radioactivity in normal mice (ICR) heart after 6 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL627767,,8495,,,Biodistribution of radioactivity in normal mice (ICR) kidney after 1 hour of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL627768,,8496,,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL628422,,8497,,,Biodistribution of radioactivity in normal mice (ICR) kidney after 2 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL628423,,8498,,,Biodistribution of radioactivity in normal mice (ICR) kidney after 24 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628424,,8499,,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing) in Dawley rat,5089,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628425,,8500,,,Plasma clearance value at intravenous dose of 1 mg/kg (2 mg/kg po (cassette dosing)) in Dawley rat,5089,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628426,,8501,,,Plasma clearance value was determined in rat after a 3 mg/kg of iv dose,4257,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628427,,8502,,,Plasma clearance was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,6679,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626938,,8503,,,Plasma clearance was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,5546,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626939,,8504,,,Plasma clearance was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,6141,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626940,,8505,,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,5334,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626941,,8506,,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,5334,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626942,,8507,,,Plasma clearance was reported in Sprague-Dawley rat,5334,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL876812,,8508,,,Plasma clearance after intravenous administration (1 mg/kg) in rat,4689,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626943,,8509,,,Plasma clearance of compound in rats was evaluated,6848,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626944,,8510,,,Plasma clearance of compound in rats was evaluated; ND indicates not determined,6848,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626945,,8511,,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration,6467,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626946,,8512,,,Plasma clearance in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,6467,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626856,,8513,,,Plasma clearance rate in Sprague-Dawley rats,4956,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626857,,8514,,,Plasma clearance was determined in rat after intravenous administration (0.5 mg/kg),5529,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626858,,8515,,,The compound was evaluated for plasma clearance in rat,406,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL627018,,8516,,,Total plasma clearance in rat,17655,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL625331,,8517,,,Absorption behavior was judged by the peak blood concentration determined after oral dose of 30 mg/kg in rats.,3293,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL625332,,8518,,,Blood level after a 10 mg/kg oral dose in rat expressed as Cmax was determined,4075,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL877590,,8519,,,C max was determined at 10 mg/kg po dose in rats,2792,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625333,,8520,,,C max was determined at 3 mg/kg po dose in rats,2792,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625334,,8521,,,Cmax after repeated oral dose of compound at 1 mg/kg in rats,17594,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625335,,8522,,,Cmax after single intravenous bolus of 1 mg/kg in rats,17594,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625336,,8523,,,Cmax of compound at 5 mg/kg after po administration was determined in rat,4762,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625337,,8524,,,Cmax 24 hr after 10 mg/kg oral administration in rats,17509,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625338,,8525,,,Cmax 24 hr after 2 mg/kg oral administration in rats,17509,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL625339,,8526,,,Cmax in plasma was determined upon peroral administration of 10.0 mg/Kg dose in rat,1466,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625340,,8527,,,Cmax in rat after administration of 2 mg/kg iv,6535,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625341,,8528,,,Cmax in rat after administration of 2 mg/kg iv,6535,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622687,,8529,,,Cmax in rats determined 6 hours after oral dosing of 20 mg/kg,3169,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622688,,8530,,,Cmax wa determined in rat plasma at 30 mg/kg after po administration,6515,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL622689,,8531,,,Cmax was calculated as maximum concentration reached in the blood after oral administration to male F344 rats,11149,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL620295,,8532,,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate after oral administration to male F344 rats,11149,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620296,,8533,,,Cmax after 10 mg/kg oral administration in rat,17858,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620297,,8534,,,Cmax after IV dosing at 0.5 mg/kg in rat; no data,6518,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620298,,8535,,,Cmax after IV dosing at 1 mg/kg in rat; no data,6518,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620299,,8536,,,Cmax after oral administration at 20 mpk in rats,4426,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620300,,8537,,,Cmax after oral administration at 20 mpk in rats; Not performed.,4426,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620301,,8538,,,Cmax after oral administration at 20 mpk in rats d; Not performed.,4426,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620302,,8539,,,Cmax after oral administration in rat,5656,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620303,,8540,,,Cmax after oral administration at a dose of 2 mg/kg in rat,6518,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620304,,8541,,,Cmax after oral administration at a dose of 4 mg/kg in rat,6518,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620305,,8542,,,Cmax in rats after 20 mg/kg oral dose,6113,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620306,,8543,,,Cmax after peroral administration in rats at 2.4 uM/kg,17764,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620307,,8544,,,Cmax at the dose of 2 mg/Kg administered perorally in rats,4756,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620308,,8545,,,Cmax at the dose of 5 mg/Kg administered perorally in rats,4756,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620309,,8546,,,Cmax by administering at 20 mg/kg p.o. in rats,6402,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620310,,8547,,,Cmax in male rat,5610,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620311,,8548,,,Cmax in rat,5207,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620312,,8549,,,Cmax in rat,6011,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620313,,8550,,,Cmax in rat,6504,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620314,,8551,,,Cmax in rat at 10 mg/kg,6046,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620315,,8552,,,Cmax in rat at the dose of 1 mg/kg i.v.,6504,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620316,,8553,,,Cmax in rat by po administration at a dose of 40 mg/kg,5874,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620317,,8554,,,Cmax in rat p.o. at 20 mg/kg concentration,17686,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620318,,8555,,,Cmax in rats,5836,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620319,,8556,,,Cmax in rats,17596,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620320,,8557,,,Cmax was evaluated after 20 uM/kg of peroral administration,16423,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620321,,8558,,,Cmax was measured in rats after peroral administration at 3 mg/kg,17804,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620322,,8559,,,Cmax value after oral dose at a dose of 10 mg/kg in rats.,1908,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL620323,,8560,,,Distribution of [123I]-label in rat brain (diencephalon) was reported at 60 min post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Frontal cortex,A,,,BAO_0000218,Intermediate,1,N,1870.0,1,,,,CHEMBL620324,,8561,,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Frontal cortex,A,,,BAO_0000218,Intermediate,1,N,1870.0,1,,,,CHEMBL620325,,8562,,,Distribution of [123I]-label in rat brain (frontal cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Hippocampus,A,,,BAO_0000218,Intermediate,1,N,10000000.0,1,,,,CHEMBL620326,,8563,,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 20 min post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Hippocampus,A,,,BAO_0000218,Intermediate,1,N,10000000.0,1,,,,CHEMBL620327,,8564,,,Distribution of [123I]-label in rat brain (hippocampus) was reported at 60 min post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL620328,,8565,,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 20 min post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL620329,,8566,,,Distribution of [123I]-label in rat brain (medulla pons) was reported at 60 min post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Midbrain,A,,,BAO_0000218,Intermediate,1,N,1891.0,1,,,,CHEMBL620330,,8567,,,Distribution of [123I]-label in rat brain (midbrain) was reported at 20 min post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Midbrain,A,,,BAO_0000218,Intermediate,1,N,1891.0,1,,,,CHEMBL875286,,8568,,,Distribution of [123I]-label in rat brain (midbrain) was reported at 60 min post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL620331,,8569,,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 20 min post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL620332,,8570,,,Distribution of [123I]-label in rat brain (posterior cortex) was reported at 60 min post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Striatum,A,,,BAO_0000218,Intermediate,1,N,2435.0,1,,,,CHEMBL620333,,8571,,,Distribution of [123I]-label in rat brain (striatum) was reported at 20 min post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Striatum,A,,,BAO_0000218,Intermediate,1,N,2435.0,1,,,,CHEMBL620334,,8572,,,Distribution of [123I]-label in rat brain (striatum) was reported at 60 min post injection. Value shown is %ID/g of tissue,13950,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL621015,,8573,,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,16434,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL621016,,8574,,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,16434,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL621191,,8575,,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,16434,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL621192,,8576,,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,16434,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL621193,,8577,,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,16434,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL621194,,8578,,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,16434,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL624204,,8579,,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,16434,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL624205,,8580,,,Radioactivity distribution in blood of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,16434,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL624206,,8581,,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,16435,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL624207,,8582,,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,16435,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL624208,,8583,,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,16435,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL624209,,8584,,,Radioactivity distribution in blood of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,16435,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL624210,,8585,,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,16435,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL624211,,8586,,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,16435,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL624212,,8587,,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,16435,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL624213,,8588,,,Radioactivity distribution in blood of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,16435,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL876611,,8589,,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,16434,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL624214,,8590,,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,16434,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL624215,,8591,,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,16434,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL624216,,8592,,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,16435,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL624217,,8593,,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,16435,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL624218,,8594,,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,16435,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL624219,,8595,,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,16435,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL624220,,8596,,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,16435,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL624221,,8597,,,Radioactivity distribution in blood of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624222,,8598,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624223,,8599,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624224,,8600,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624225,,8601,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622420,,8602,,,Volume of solubility in solution after intravenous administration in rats at 24 uM/kg,17764,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622421,,8603,,,Volume of steady state distribution after i.v. administration in rats,5031,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622422,,8604,,,Vss after intravenous administration (5.0 mg/kg) was determined in rat,6215,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622423,,8605,,,Vss in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,17671,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622424,,8606,,,Vss was determined,17752,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622425,,8607,,,Vss in rat,6596,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL876612,,8608,,,Vss was evaluated after 10 uM/kg of intra arterial administration,16423,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622426,,8609,,,volume of distribution at steady state was observed after intravenous administration in rat,15662,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622427,,8610,,,Volume of distribution was measured in rat after an iv dose of 1 mg/kg,6062,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622428,,8611,,,Pharmacokinetic (PK) parameter Vz in rat,5874,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622429,,8612,,,Volume distribution in rats,4942,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622430,,8613,,,Volume of distribution in rat; No data,17796,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622431,,8614,,,Volume of distribution was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,4890,Rattus norvegicus,10116.0
50597,Ileum,A,,,BAO_0000218,Intermediate,1,N,2116.0,1,,,,CHEMBL622432,,8615,,,% absorption predicted from in vitro rat ileum transport studies,15765,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622433,,8616,,,Bioavailability at an iv dose of 12 mg/Kg and po dose of 23 mg/Kg,13569,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622434,,8617,,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 15 mg/Kg,13569,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622435,,8618,,,Bioavailability at an iv dose of 14 mg/Kg and po dose of 28 mg/Kg,13569,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618748,,8619,,,Bioavailability (dose 15 mg/kg i.v. and 30 mg/kg p.o.),13569,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618749,,8620,,,Bioavailability at an iv dose of 15 mg/Kg and po dose of 30.2 mg/Kg,13569,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618750,,8621,,,Bioavailability at an iv dose of 15.6 mg/Kg and po dose of 31.2 mg/Kg,13569,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618751,,8622,,,Bioavailability at an iv dose of 15.7 mg/Kg and po dose of 31.4 mg/Kg,13569,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618752,,8623,,,Bioavailability at an iv dose of 16 mg/Kg and po dose of 35 mg/Kg,13569,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618753,,8624,,,Oral bioavailability in rat,4576,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL618754,,8625,,,Oral bioavailability estimated by measurement of the circulating plasma levels of BMS-183920 after intravenous and oral dosing to rats for 4 determinations,750,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618755,,8626,,,Oral bioavailability in rat,750,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618756,,8627,,,Oral bioavailability in rat,4590,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618757,,8628,,,Oral bioavailability in rat,1716,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618758,,8629,,,Bioavailability in rat,1974,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621088,,8630,,,Oral bioavailability in rat (dose 30 mg/kg),4502,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621089,,8631,,,Pharmacokinetic property (cLogP) in rat,3371,Rattus norvegicus,10116.0
50597,Blood,F,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL621090,,8632,,,Hyperglycemic activity and change in blood glucose concentration was reported 2 hours after administration of 100 mg/Kg perorally,9099,Rattus norvegicus,10116.0
50597,Blood,F,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL621091,,8633,,,Hyperglycemic activity and change in blood glucose concentration was reported 4 hours after administration of 100 mg/Kg perorally,9099,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL876731,,8634,,,Clearance in rat.,4590,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621092,,8635,,,Compound was evaluated for its clearance when administered intravenously in rat,3184,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621093,,8636,,,Plasma clearance in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,16456,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621094,,8637,,,Blood: Brain distribution ratio is determined in rat,4199,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621095,,8638,,,Blood: Brain distribution ratio is determined in rat; NQ: non quantifable,4199,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621096,,8639,,,Blood: Brain distribution ratio is determined in rat; NQ:non quantifable,4199,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL621097,,8640,,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,10116.0
50597,,F,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621098,,8641,,,Percent dose excreted in 0-48 hours administered ip to male rat,7449,Rattus norvegicus,10116.0
50597,Cerebellum,A,,,BAO_0000218,Intermediate,1,N,2037.0,1,,,,CHEMBL621099,,8642,,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Cerebellum,A,,,BAO_0000218,Intermediate,1,N,2037.0,1,,,,CHEMBL621100,,8643,,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Cerebellum,A,,,BAO_0000218,Intermediate,1,N,2037.0,1,,,,CHEMBL621101,,8644,,,Uptake of radioligand [125I]-FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),11977,Rattus norvegicus,10116.0
50597,Cerebellum,A,,,BAO_0000218,Intermediate,1,N,2037.0,1,,,,CHEMBL621102,,8645,,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Cerebellum,A,,,BAO_0000218,Intermediate,1,N,2037.0,1,,,,CHEMBL876732,,8646,,,Uptake of radioligand [125I]FIDA1 by cerebellum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621103,,8647,,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 120 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621104,,8648,,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 2 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621105,,8649,,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 2 rats),11977,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621106,,8650,,,Uptake of radioligand [125I]-FIDA1 by cortex in rat after 30 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621107,,8651,,,Uptake of radioligand [125I]FIDA1 by cortex in rat after 60 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621108,,8652,,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621109,,8653,,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50594,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL621110,,8654,,,Biodistribution of radioactivity in normal mice (ICR) kidney after 30 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL621111,,8655,,,Biodistribution of radioactivity in normal mice (ICR) kidney after 6 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL622541,,8656,,,Biodistribution of radioactivity in normal mice (ICR) liver after 1 hour of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL622542,,8657,,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL622543,,8658,,,Biodistribution of radioactivity in normal mice (ICR) liver after 2 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL624412,,8659,,,Biodistribution of radioactivity in normal mice (ICR) liver after 24 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL624413,,8660,,,Biodistribution of radioactivity in normal mice (ICR) liver after 30 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL624414,,8661,,,Biodistribution of radioactivity in normal mice (ICR) liver after 6 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL624415,,8662,,,Biodistribution of radioactivity in normal mice (ICR) lung after 1 hour of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL624416,,8663,,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL624417,,8664,,,Biodistribution of radioactivity in normal mice (ICR) lung after 2 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL624418,,8665,,,Biodistribution of radioactivity in normal mice (ICR) lung after 24 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL624419,,8666,,,Biodistribution of radioactivity in normal mice (ICR) lung after 30 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL624420,,8667,,,Biodistribution of radioactivity in normal mice (ICR) lung after 6 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL624421,,8668,,,Biodistribution of radioactivity in normal mice (ICR) muscle after 1 hr of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL624422,,8669,,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL624423,,8670,,,Biodistribution of radioactivity in normal mice (ICR) muscle after 2 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL625123,,8671,,,Biodistribution of radioactivity in normal mice (ICR) muscle after 24 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL625124,,8672,,,Biodistribution of radioactivity in normal mice (ICR) muscle after 30 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL625125,,8673,,,Biodistribution of radioactivity in normal mice (ICR) muscle after 6 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Zone of skin,A,,,BAO_0000218,Intermediate,1,N,14.0,1,,,In vivo,CHEMBL625126,,8674,,,Biodistribution of radioactivity in normal mice (ICR) skin after 1 hour of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Zone of skin,A,,,BAO_0000218,Intermediate,1,N,14.0,1,,,In vivo,CHEMBL626947,,8675,,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Zone of skin,A,,,BAO_0000218,Intermediate,1,N,14.0,1,,,In vivo,CHEMBL626948,,8676,,,Biodistribution of radioactivity in normal mice (ICR) skin after 2 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Zone of skin,A,,,BAO_0000218,Intermediate,1,N,14.0,1,,,In vivo,CHEMBL626949,,8677,,,Biodistribution of radioactivity in normal mice (ICR) skin after 24 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Zone of skin,A,,,BAO_0000218,Intermediate,1,N,14.0,1,,,In vivo,CHEMBL626950,,8678,,,Biodistribution of radioactivity in normal mice (ICR) skin after 30 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Zone of skin,A,,,BAO_0000218,Intermediate,1,N,14.0,1,,,In vivo,CHEMBL626951,,8679,,,Biodistribution of radioactivity in normal mice (ICR) skin after 6 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL626952,,8680,,,Biodistribution of radioactivity in normal mice (ICR) spleen after 1 hour of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL626953,,8681,,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL626954,,8682,,,Biodistribution of radioactivity in normal mice (ICR) spleen after 2 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL626955,,8683,,,Biodistribution of radioactivity in normal mice (ICR) spleen after 24 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL626956,,8684,,,Biodistribution of radioactivity in normal mice (ICR) spleen after 30 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL626957,,8685,,,Biodistribution of radioactivity in normal mice (ICR) spleen after 6 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL626958,,8686,,,Biodistribution of radioactivity in normal mice blood after 1 hour of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL626959,,8687,,,Biodistribution of radioactivity in normal mice blood after 2 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL626960,,8688,,,Biodistribution of radioactivity in normal mice blood after 2 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL626961,,8689,,,Biodistribution of radioactivity in normal mice blood after 24 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL627589,,8690,,,Biodistribution of radioactivity in normal mice blood after 30 minutes of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL627590,,8691,,,Biodistribution of radioactivity in normal mice blood after 6 hours of intravenous injection of [125I]-16(IMPY),17208,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627591,,8692,,,Time taken for EC90 was determined when tested in mouse,3132,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627592,,8693,,,Time taken for EC90 was determined when tested in mouse at dose 25 mg/kg,3132,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627593,,8694,,,At a dose 50 mg/kg (114 umol/kg) was administered intraperitoneally to mice and was evaluated for half life (T1/2),16597,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627594,,8695,,,Half life in mice,5727,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL876813,,8696,,,Half life period in mouse after 10 mg/Kg dose,5302,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627595,,8697,,,Half life period in mouse after 10 mg/kg dose,5302,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627596,,8698,,,Half life was determined in mouse after 5 mg/kg (i.v.) and 6 mg/kg (p.o.) administration,6348,Mus musculus,10090.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627597,,8699,,,Cmax value at 5 mg/kg po was determined in rat,5964,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627598,,8700,,,Cmax value evaluated in rat,6078,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL627599,,8701,,,Cmax value was calculated by applying at a dose of 10 mg/Kg ip in rat brain,5206,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627600,,8702,,,Cmax value after administration of 20 mg/Kg oral dose in rat,2959,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627601,,8703,,,Cmax value at 1 mg/kg po in rat,5964,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627776,,8704,,,Cmax value at 5 mg/kg po in rat,5964,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627777,,8705,,,Cmax value at a dose of 10 mg/kg in male SD rats,6757,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627778,,8706,,,Cmax value at a dose of 100 mg/kg in male SD rats,6757,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627779,,8707,,,Cmax value at a dose of 50 mg/kg in male SD rats,6757,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL876814,,8708,,,Cmax value in rats at 10 mg/kg,17617,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627780,,8709,,,Cmax value was evaluated in rats at a dose of 20 mg/kg,1445,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627781,,8710,,,Cmax value was determined after peroral administration of 20 mg/kg in rat,6082,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627782,,8711,,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,1446,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL627783,,8712,,,Compound was evaluated for its pharmacokinetic parameter maximum plasma concentration (Cmax) after oral administration to rats,5407,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL627784,,8713,,,Compound was evaluated for maximal plasma concentration in rat upon 5 mg/kg upon oral administration,2690,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627785,,8714,,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to female wistar rats,2661,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627786,,8715,,,Compound was evaluated for maximum concentration after treatment with oral dose of 2 mgkg to male wistar rats,2661,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL627787,,8716,,,Compound was evaluated for pharmacokinetic parameter maximum plasma concentration,4891,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL627788,,8717,,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 0.5 hr,2807,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626579,,8718,,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 1 hr,2807,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626580,,8719,,,Compound was evaluated for plasma concentration in rats when administered at 20 mg/kg in methocel at 2 hr,2807,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL876815,,8720,,,Compound was evaluated for the pharmacokinetic property in rats after an oral dose of 10 mg/kg,3634,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626581,,8721,,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 1 hr,1881,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626582,,8722,,,Compound was tested for plasma concentration in rats when administered at 20 mg/kg in 1% methocel at 2 hr,1881,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626583,,8723,,,Evaluated for pharmacokinetic parameter Cmax in rat at the dose 50 mg/kg,429,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626205,,8724,,,In vivo Cmax was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626206,,8725,,,In vivo Cmax was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626207,,8726,,,In vivo Cmax was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623882,,8727,,,In vivo Cmax was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623883,,8728,,,Maximal concentration in male Sprague-Dawley rats after 5 mg/kg intravenous dose,17582,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623884,,8729,,,Maximal concentration in male Sprague-Dawley rats after 10 mg/kg oral dose,17582,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623885,,8730,,,"In vivo maximum concentration of compound in rat plasma after a oral dose of 10 mg/kg (in water, N=4)",3032,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623886,,8731,,,In vivo maximum concentration in rat plasma exposure after oral administration 50 mg/kg,6295,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623887,,8732,,,Maximal concentration in rat was determined,6619,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623888,,8733,,,Maximal concentration after i.v. administration,6616,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623889,,8734,,,Maximal concentration (Cmax) in the rat plasma at a dose of 10 mg/kg,3249,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623890,,8735,,,Maximal plasma concentration in rat after oral administration at 50 mg/kg,17791,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623891,,8736,,,Cmax in rat plasma after oral dose (50 mg/Kg),17791,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623892,,8737,,,Maximal plasma concentration was determined.,1360,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623893,,8738,,,Maximal plasma drug concentration was determined,2552,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL877616,,8739,,,Maximal concentration in rats after peroral administration,6571,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623894,,8740,,,Maximum concentration in rat after 2 mg/kg peroral administration,6570,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623895,,8741,,,Maximum concentration in rat plasma after 5 mg/kg oral gavage,6567,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623896,,8742,,,Maximum concentration of compound in rat was evaluated.,3031,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623897,,8743,,,Maximum concentration at 0.5 hr by peroral administration at a dose of 20 mg/kg in rats,3436,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623898,,8744,,,Maximum concentration at 2 hr by peroral administration at a dose of 20 mg/kg in rats,3436,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623899,,8745,,,Maximum concentration at 4 hr after administration of 5 mg/kg dose peroral in rat,2083,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623900,,8746,,,Maximum concentration at 4 hr by peroral administration at a dose of 20 mg/kg in rats,3436,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623901,,8747,,,Maximum concentration by oral administration at a dose of 100 uM/kg in rat was determined,4527,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623902,,8748,,,Maximum concentration was evaluated in rats,1974,Rattus norvegicus,10116.0
50597,Cerebrospinal fluid,A,,,BAO_0000218,Intermediate,1,N,1359.0,1,,,In vivo,CHEMBL623903,,8749,,,Maximum concentration in CSF at 30 min following 24 mg/kg subcutaneous dose in rats,3307,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623904,,8750,,,Maximum concentration in plasma at 30 min following 24 mg/kg subcutaneous dose in rats,3307,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL877617,,8751,,,Maximum concentration in plasma was evaluated in Sprague-Dawley rats at a dose of 15 mg/kg after po administration,1916,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623905,,8752,,,Maximum concentration in portal vein was determined at a concentration of 10 mg/kg in rats,1500,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623906,,8753,,,Maximum concentration in portal vein was determined at a concentration of 20 mg/kg in rats,1500,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623907,,8754,,,Maximum concentration in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,4186,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623908,,8755,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623909,,8756,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 30 min.,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623910,,8757,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623911,,8758,,,Radioactivity distribution in bone of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623912,,8759,,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624616,,8760,,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624617,,8761,,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624618,,8762,,,Radioactivity distribution in bone of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624619,,8763,,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624794,,8764,,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624795,,8765,,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623921,,8766,,,Radioactivity distribution in bone of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623922,,8767,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623923,,8768,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623924,,8769,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623925,,8770,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623926,,8771,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623927,,8772,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623928,,8773,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623929,,8774,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623930,,8775,,,Radioactivity distribution in bone of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,16435,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL623931,,8776,,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,16434,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL622165,,8777,,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,16434,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL621249,,8778,,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,16434,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL621250,,8779,,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,16434,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL621448,,8780,,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,16434,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL621449,,8781,,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,16434,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL621450,,8782,,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,16434,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL621451,,8783,,,Radioactivity distribution in brain of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,16434,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL621452,,8784,,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,16435,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL621453,,8785,,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,16435,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL621454,,8786,,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,16435,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL621455,,8787,,,Radioactivity distribution in brain of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,16435,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL621456,,8788,,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,16435,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL625145,,8789,,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,16435,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL875847,,8790,,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,16435,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL625146,,8791,,,Radioactivity distribution in brain of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,16435,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL625147,,8792,,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,16434,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL625148,,8793,,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,16434,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL625149,,8794,,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,16434,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL625150,,8795,,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,16435,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL625151,,8796,,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,16435,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL625152,,8797,,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,16435,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL625153,,8798,,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,16435,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL625154,,8799,,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,16435,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL625155,,8800,,,Radioactivity distribution in brain of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625156,,8801,,,Uptake of radioligand [125I]FIDA1 by hippo-campus in rat after 30 minutes after an intravenous injection is given (average of 2 rats),11977,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624354,,8802,,,Uptake of radioligand [125I]-FIDA1 by hippo-campus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Hippocampus,A,,,BAO_0000218,Intermediate,1,N,10000000.0,1,,,,CHEMBL624355,,8803,,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 120 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Hippocampus,A,,,BAO_0000218,Intermediate,1,N,10000000.0,1,,,,CHEMBL624356,,8804,,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 2 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Hippocampus,A,,,BAO_0000218,Intermediate,1,N,10000000.0,1,,,,CHEMBL624357,,8805,,,Uptake of radioligand [125I]-FIDA1 by hippocampus in rat after 30 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Hippocampus,A,,,BAO_0000218,Intermediate,1,N,10000000.0,1,,,,CHEMBL624358,,8806,,,Uptake of radioligand [125I]FIDA1 by hippocampus in rat after 60 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Striatum,A,,,BAO_0000218,Intermediate,1,N,2435.0,1,,,,CHEMBL624359,,8807,,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 120 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Striatum,A,,,BAO_0000218,Intermediate,1,N,2435.0,1,,,,CHEMBL624360,,8808,,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 2 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Striatum,A,,,BAO_0000218,Intermediate,1,N,2435.0,1,,,,CHEMBL624361,,8809,,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 2 rats),11977,Rattus norvegicus,10116.0
50597,Striatum,A,,,BAO_0000218,Intermediate,1,N,2435.0,1,,,,CHEMBL624362,,8810,,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 30 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Striatum,A,,,BAO_0000218,Intermediate,1,N,2435.0,1,,,,CHEMBL624363,,8811,,,Uptake of radioligand [125I]FIDA1 by striatum in rat after 60 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL624364,,8812,,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 120 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL624365,,8813,,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 2 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL624366,,8814,,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 30 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL624367,,8815,,,Biodistribution of radioligand [125I]FIDA1 in blood of rat after 60 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL624368,,8816,,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 120 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL624369,,8817,,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 2 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL624370,,8818,,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 2 rats),11977,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL625069,,8819,,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 30 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL625070,,8820,,,Biodistribution of radioligand [125I]FIDA1 in brain of rat after 60 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL626051,,8821,,,Biodistribution of radioligand [125I]-FIDA1 in heart of rat after 120 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL626052,,8822,,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 2 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL626053,,8823,,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 2 rats),11977,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL626054,,8824,,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 30 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL626055,,8825,,,Biodistribution of radioligand [125I]FIDA1 in heart of rat after 60 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL626056,,8826,,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 120 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL626057,,8827,,,Biodistribution of radioligand [125I]-FIDA1 in kidney of rat after 2 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL625193,,8828,,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 30 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL625194,,8829,,,Biodistribution of radioligand [125I]FIDA1 in kidney of rat after 60 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL625195,,8830,,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 120 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL625196,,8831,,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL625197,,8832,,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 2 rats),11977,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL625198,,8833,,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 30 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL627929,,8834,,,Biodistribution of radioligand [125I]FIDA1 in liver of rat after 60 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL627074,,8835,,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 120 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL627075,,8836,,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 2 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL627076,,8837,,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 2 rats),11977,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL627077,,8838,,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 30 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL627078,,8839,,,Biodistribution of radioligand [125I]FIDA1 in lung of rat after 60 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL627079,,8840,,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 2 rats),11977,Rattus norvegicus,10116.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL873824,,8841,,,Half life (t1/2) determined at a dose 10 mg/kg administered intraperitoneally to mice,4573,Mus musculus,10090.0
50594,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL627080,,8842,,,Half life in mouse plasma was determined at dose 25 mg/kg,3132,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627081,,8843,,,Half life was determined,17718,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627082,,8844,,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,17728,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627083,,8845,,,Half-life in male mice after 1 mg/kg intravenous dose,5961,Mus musculus,10090.0
50594,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL627085,,8847,,,Half life in mice plasma,17731,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627086,,8848,,,Half life in mouse,17592,Mus musculus,10090.0
50594,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL627087,,8849,,,Half life in mouse plasma at dose 25 mg/kg,3132,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627088,,8850,,,Half life when injected i.p. in mice at a dose of 50 mg/kg was determined,17729,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627089,,8851,,,Half life when injected intravenously in mice at a dose of 20 mg/kg was determined,17729,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627090,,8852,,,Half life when injected perorally in mice at a dose of 50 mg/kg was determined,17729,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627091,,8853,,,Half life was determined in mice at a single subcutaneous administration of 40 mg/kg (n=4),3277,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627092,,8854,,,"Half life was evaluated at 5 mg/kg of compound dose, administered perorally in mice",3760,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL876785,,8855,,,"Half life was evaluated at 50 mg/kg of compound dose, administered perorally in mice",3760,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627093,,8856,,,Half-life by iv administration in mouse,2862,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627094,,8857,,,Half-life by oral administration in mouse,2862,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627095,,8858,,,Half-life in mice,5980,Mus musculus,10090.0
50594,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL627096,,8859,,,Half-life using mouse brain homogenate,6159,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627097,,8860,,,Half-life was measured in mice,6254,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627098,,8861,,,Half-life was measured in mouse after an iv dose of 1 mg/kg,6062,Mus musculus,10090.0
50594,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL627099,,8862,,,Half-life period was determined in mouse blood,1574,Mus musculus,10090.0
50594,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL627100,,8863,,,"Half-times of inhibition of PEP in in an ex vivo enzyme studies, using mice brain",56,Mus musculus,10090.0
50594,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL627101,,8864,,,Plasma half life in mouse,993,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627102,,8865,,,Stability of the peptide in the presence of mouse serum,6652,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627103,,8866,,,Terminal half life of compound was determined in mouse,17852,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627104,,8867,,,Terminal half life was evaluated in mice after intravenous administration,2675,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627105,,8868,,,Terminal half life was evaluated in mice after oral administration,2675,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL876786,,8869,,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 5.,499,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL873825,,8870,,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7.,499,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627106,,8871,,,The compound was evaluated for half life (release of DOX) in mice at 37 degree Celsius at the pH 7; ND means no data,499,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626336,,8872,,,half life period is evaluated by administering intravenously at 25 mg/kg in mice,14239,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL877462,,8873,,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice",5506,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626337,,8874,,,"Half life beta(2,4,6,8h) value was determined at a dose of 200 mg/kg (i.p.) in Mice; NC: not calculable",5506,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626338,,8875,,,Half life after intraperitoneal administration of 100 mg/kg in mice,17734,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626339,,8876,,,Half life in BALB/C mice at the dose of 20 mg/kg by i.p. administration,17728,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626340,,8877,,,Half life in BALB/C mice at the dose of 20 mg/kg by i.v. administration,17728,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625377,,8878,,,Half life in BALB/C mice at the dose of 20 mg/kg by p.o. administration,17728,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625378,,8879,,,Half life in BALB/C mice at the dose of 50 mg/kg by i.p. administration,17728,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625379,,8880,,,Half life in BALB/C mice at the dose of 50 mg/kg by p.o. administration,17728,Mus musculus,10090.0
22224,,A,,,BAO_0000251,Autocuration,0,U,,1,,,,CHEMBL625380,,8881,Microsomes,,Metabolism of compound in mini pig S9 microsomes ('+''indicates <20% largest observed peak),14294,Sus scrofa,9823.0
22224,,A,,,BAO_0000251,Autocuration,0,U,,1,,,,CHEMBL625381,,8882,Microsomes,,Metabolism of compound in mini pig S9 microsomes ('++++' indicates largest observed peak),14294,Sus scrofa,9823.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625382,,8883,,,Stability to porcine renal DHP-I,6056,Sus scrofa,9823.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL873828,,8884,,,Compound was tested for its half-life period at an intravenous dose of 30 ug/kg,1317,Sus scrofa,9823.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625383,,8885,,,Compound was tested for its half-life period at an intravenous dose of 3 ug/kg,1317,Sus scrofa,9823.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625384,,8886,,,Half-life of the parent prodrug in porcine esterase solution,5229,Sus scrofa,9823.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625385,,8887,,,"First order rate constant, k was determined in in pig liver Esterase",4231,Sus scrofa,9823.0
22224,Liver,A,,,BAO_0000221,Autocuration,0,U,2107.0,1,,,,CHEMBL625386,,8888,,,Half life of the in pig liver Esterase,4231,Sus scrofa,9823.0
22224,Liver,A,,,BAO_0000221,Autocuration,0,U,2107.0,1,,,,CHEMBL623571,,8889,,,Tested for half life period at 37 degree Celsius in PBS buffer at 11.8 pH containing porcine liver esterase,5318,Sus scrofa,9823.0
22224,Liver,A,,,BAO_0000221,Autocuration,0,U,2107.0,1,,,,CHEMBL623572,,8890,,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH containing porcine liver esterase,5318,Sus scrofa,9823.0
22224,Liver,A,,,BAO_0000221,Autocuration,0,U,2107.0,1,,,,CHEMBL623573,,8891,,,Tested for half life period at 37 degree Celsius in PBS buffer at 7.3 pH in containing porcine liver esterase,5318,Sus scrofa,9823.0
22224,Liver,A,,,BAO_0000221,Autocuration,0,U,2107.0,1,,,,CHEMBL623574,,8892,,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay,3305,Sus scrofa,9823.0
22224,Liver,A,,,BAO_0000221,Autocuration,0,U,2107.0,1,,,,CHEMBL623575,,8893,,,Compound was evaluated for esterase half-life (t 1/2) period using Pig Liver Esterase (PLE) assay; ND is not determined,3305,Sus scrofa,9823.0
22224,Liver,A,,,BAO_0000221,Autocuration,0,U,2107.0,1,,,,CHEMBL623749,,8894,,,Half-life in the presence of pig liver esterase(PLE) was evaluated.,2842,Sus scrofa,9823.0
22224,Liver,A,,,BAO_0000221,Autocuration,0,U,2107.0,1,,,,CHEMBL623750,,8895,,,Half-life in the presence of pig liver esterase(PLE) was evaluated; Stable,2842,Sus scrofa,9823.0
22224,Liver,A,,,BAO_0000221,Autocuration,0,U,2107.0,1,,,In vitro,CHEMBL623751,,8896,,,Half-life in vitro in pig liver,889,Sus scrofa,9823.0
22224,Liver,A,,,BAO_0000221,Autocuration,0,U,2107.0,1,,,,CHEMBL623752,,8897,,,Half-life time was determined for esterase-catalyzed hydrolysis of the phenol ester bond in porcine liver esterase,1904,Sus scrofa,9823.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623753,,8898,,,Maximum concentration in rat plasma after administration of 50 mg/kg dose through subcutaneous route,4186,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623754,,8899,,,Maximum concentration in rat plasma at 30 mg/Kg upon oral administration.,2774,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623755,,8900,,,Maximum concentration in rat plasma was determined,1742,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623756,,8901,,,Maximum concentration in rats,3169,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623757,,8902,,,Maximum concentration in rats at 1-2 hours,3169,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623758,,8903,,,Maximum concentration in rats at 1 hr was determined when dosed at 20 mg/Kg perorally,2081,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL623759,,8904,,,Maximum concentration in whole brain at 30 min following 24 mg/kg subcutaneous dose in rats,3307,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623760,,8905,,,Maximum concentration at the dose of 2 mg/kg in rat,4727,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623761,,8906,,,Maximum concentration was evaluated in rats,6597,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623762,,8907,,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 10 mg/kg to a fasting rat,16365,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL877594,,8908,,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 1 mg/kg to a fasting rat,16365,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623763,,8909,,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 30 mg/kg,16365,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623764,,8910,,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg,16365,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623765,,8911,,,Maximum concentration of uncharged drug in plasma recorded in the period of 0-24 hr after administering orally a dose of 3 mg/kg to a fasting rat,16365,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL623766,,8912,,,Maximum concentration value was evaluated for high sustained blood levels in rat after 1 hr of administration,2591,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL623767,,8913,,,Maximum concentration value was evaluated for high sustained blood levels in rat after 2 hr of administration,2591,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL623768,,8914,,,Maximum concentration value was evaluated for high sustained blood levels in rat after 30 min of administration,2591,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623769,,8915,,,Maximum plasma concentration (Cmax) of compound (19.2 mg/kg) after po administration was determined Sprague-Dawley rat,5978,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623770,,8916,,,Maximum plasma concentration (Cmax) of compound (19.76 mg/kg) after po administration was determined Sprague-Dawley rat,5978,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623771,,8917,,,Maximum plasma concentration (Cmax) of compound (20.73 mg/kg) after po administration was determined Sprague-Dawley rat,5978,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623772,,8918,,,Maximum plasma concentration (Cmax) of compound (25 mg/kg) after po administration was determined Sprague-Dawley rat,5978,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623773,,8919,,,Maximum plasma concentration (Cmax) of compound (9.83 mg/kg) after iv administration was determined Sprague-Dawley rat,5978,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623774,,8920,,,Maximum plasma concentration (Cmax) of compound (9.84 mg/kg) after iv administration was determined Sprague-Dawley rat,5978,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623775,,8921,,,Maximum plasma concentration (Cmax) of compound (9.92 mg/kg) after iv administration was determined Sprague-Dawley rat,5978,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623776,,8922,,,Cmax in rat (PO dose),14465,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622191,,8923,,,Maximum plasma concentration determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,4723,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622192,,8924,,,Maximum plasma concentration determined after 3 mg/kg oral administration in potassium oxonate treated rats,4723,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622193,,8925,,,Maximum plasma concentration determined in rat,4576,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622194,,8926,,,Maximum plasma concentration for the compound in solution form (formulation) was determined in rats at peroral dose of 5 mg/kg,12873,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622195,,8927,,,Maximum plasma concentration for the compound in suspension form (formulation) was determined in rats at peroral dose of 5 mg/kg,12873,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622196,,8928,,,Maximum plasma concentration in rat,6824,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622197,,8929,,,Maximum plasma concentration measured after intravenous bolus administration of 50 mg/kg of compound to rats,17065,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622198,,8930,,,Maximum plasma concentration of compound present in rats at the dose of 37 mg/kg in 15 min,2932,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622199,,8931,,,Maximum plasma concentration of compound present in rats at the dose of 38 mg/kg in 15 min,2932,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622200,,8932,,,Maximum plasma concentration of compound was measured in rat,2879,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622201,,8933,,,Maximum plasma concentration after 20 mg/kg oral administration in rat,2864,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623990,,8934,,,Maximum plasma concentration after oral administration to rats,16367,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623991,,8935,,,Maximum plasma concentration at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,17717,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623992,,8936,,,"Maximum plasma concentration at a concentration of 3 mg/kg in rats, intravenously",17717,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623993,,8937,,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,17717,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623994,,8938,,,Maximum plasma concentration at a concentration of 60 mg/kg perorally in rats along with control,17717,Rattus norvegicus,10116.0
50597,Plasma,F,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623995,,8939,,,Maximum plasma concentration at a dose of 100 mg/kg in Rat Plasma after iv administration,17720,Rattus norvegicus,10116.0
50597,Plasma,F,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623996,,8940,,,Maximum plasma concentration at a dose of 4 mg/kg in Rat Plasma after iv administration,17720,Rattus norvegicus,10116.0
50597,Plasma,F,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623997,,8941,,,Maximum plasma concentration at a dose of 50 mg/kg in Rat Plasma after iv administration,17720,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623998,,8942,,,Maximum plasma concentration dosed orally in rats,4516,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623999,,8943,,,Maximum plasma concentration dosed orally in rats after 6 hours,4516,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL624000,,8944,,,Maximum plasma concentration dosed orally in rats after 6 hours; ND is not detected,4516,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL624001,,8945,,,Maximum plasma concentration at a 1 mg/kg oral dose in female Sprague-Dawley rats,5199,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL624002,,8946,,,Maximum plasma concentration in rat after po administration,17538,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL624003,,8947,,,"Maximum plasma concentration in rats at 10 mg/kg, p.o. dose",6685,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL624004,,8948,,,"Maximum plasma concentration in rats at 20mg/kg, i.p. dose",6685,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624005,,8949,,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,16434,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624006,,8950,,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,16434,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624007,,8951,,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,16434,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624008,,8952,,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,16434,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624009,,8953,,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,16434,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL874387,,8954,,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,16434,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624010,,8955,,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,16434,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624011,,8956,,,Radioactivity distribution in heart of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,16434,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624012,,8957,,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,16435,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624013,,8958,,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,16435,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624736,,8959,,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,16435,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624737,,8960,,,Radioactivity distribution in heart of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,16435,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624738,,8961,,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,16434,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624739,,8962,,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,16434,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624740,,8963,,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,16434,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624896,,8964,,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,16435,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624897,,8965,,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,16435,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624108,,8966,,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,16435,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624109,,8967,,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,16435,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624110,,8968,,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,16435,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624111,,8969,,,Radioactivity distribution in heart of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,16435,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624112,,8970,,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,16435,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624113,,8971,,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,16435,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL619709,,8972,,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,16435,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL619710,,8973,,,Radioactivity distribution in heart of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,16435,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL619711,,8974,,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,16434,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL619712,,8975,,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,16434,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL619713,,8976,,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,16434,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL619714,,8977,,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,16434,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL619715,,8978,,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,16434,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL619716,,8979,,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,16434,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL619717,,8980,,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,16434,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL619718,,8981,,,Radioactivity distribution in kidney of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,16434,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL619719,,8982,,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,16435,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL875329,,8983,,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,16435,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL619720,,8984,,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,16435,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL619721,,8985,,,Radioactivity distribution in kidney of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,16435,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL619722,,8986,,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,16435,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL619723,,8987,,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,16435,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL619724,,8988,,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,16435,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL619725,,8989,,,Radioactivity distribution in kidney of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,16435,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL619726,,8990,,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,16434,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL619727,,8991,,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,16434,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL619728,,8992,,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,16434,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL619729,,8993,,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,16435,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL619730,,8994,,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 120 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL619731,,8995,,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 2 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL619732,,8996,,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 2 rats),11977,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL619733,,8997,,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 30 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL619734,,8998,,,Biodistribution of radioligand [125I]FIDA1 in muscle of rat after 60 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Zone of skin,A,,,BAO_0000218,Intermediate,1,N,14.0,1,,,In vivo,CHEMBL619735,,8999,,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 120 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Zone of skin,A,,,BAO_0000218,Intermediate,1,N,14.0,1,,,In vivo,CHEMBL875330,,9000,,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 2 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Zone of skin,A,,,BAO_0000218,Intermediate,1,N,14.0,1,,,In vivo,CHEMBL628465,,9001,,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 2 rats),11977,Rattus norvegicus,10116.0
50597,Zone of skin,A,,,BAO_0000218,Intermediate,1,N,14.0,1,,,In vivo,CHEMBL628466,,9002,,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 30 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Zone of skin,A,,,BAO_0000218,Intermediate,1,N,14.0,1,,,In vivo,CHEMBL628467,,9003,,,Biodistribution of radioligand [125I]FIDA1 in skin of rat after 60 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL628468,,9004,,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 120 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL628469,,9005,,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 2 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL628470,,9006,,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 2 rats),11977,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL628471,,9007,,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 30 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL628472,,9008,,,Biodistribution of radioligand [125I]FIDA1 in spleen of rat after 60 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,In vivo,CHEMBL625191,,9009,,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 120 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,In vivo,CHEMBL625192,,9010,,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 2 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,In vivo,CHEMBL875337,,9011,,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 2 rats),11977,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,In vivo,CHEMBL626341,,9012,,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 30 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,In vivo,CHEMBL626342,,9013,,,Biodistribution of radioligand [125I]FIDA1 in thyroid of rat after 60 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL621943,,9014,,,Biodistribution of radioligand [125I]-FIDA1 in liver of rat after 2 minutes after an intravenous injection is given (average of 3 rats),11977,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621944,,9015,,,Half life in rats,3748,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621945,,9016,,,Mean percent inhibition of joint damage reduction in fasted rats at 35 mg/kg administered orally twice daily,15765,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621946,,9017,,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver),4871,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621947,,9018,,,Compound was evaluated for rate of clearance by using IPRL (Isolated Perfused Rat Liver); ND=Not determined,4871,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621948,,9019,,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver),4872,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621949,,9020,,,Compound was evaluated for rate of clearance in IPRL (Isolated Perfused Rat Liver); ND=Not determined,4872,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621950,,9021,,,Rate constant (k) of clearance from isolated perfused rat liver (IPRL),5413,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621951,,9022,,,Tested for rate of clearance from isolated perfused rat liver (IPRL) and expressed in terms of rate constant (k); not determined,5413,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL621952,,9023,,,Maximal blood concentration after oral administration of a 30 uM/kg dose of compound,15272,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL621953,,9024,,,Stability (%) in rat liver microsomes,4689,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621954,,9025,,,Area under curve was calculated after intravenous administration,6057,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621955,,9026,,,Area under the curve was calculated after iv administration in rat,6057,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621956,,9027,,,Area under the curve was calculated in rat after peroral administration,6057,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621957,,9028,,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,6211,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621958,,9029,,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral dose of 2 mg/Kg,5710,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621959,,9030,,,Dose-normalized AUC measured in fasted male Sprague dawely rats when the compound was administered at a peroral of 2 mg/Kg,5710,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621960,,9031,,,Dose-normalized area under curve in rat (i.v.) at 0.5 mpk,17853,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621961,,9032,,,Dose-normalized area under curve in rat (p.o.) at 2.0 mpk,17853,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621962,,9033,,,p value of the compound,15765,Rattus norvegicus,10116.0
50597,,F,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL876787,,9034,,,p value of the compound,15765,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621963,,9035,,,p value of the compound,15765,Rattus norvegicus,10116.0
50597,Stomach,A,,,BAO_0000218,Intermediate,1,N,945.0,1,,,,CHEMBL622637,,9036,,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),6175,Rattus norvegicus,10116.0
50597,Stomach,A,,,BAO_0000218,Intermediate,1,N,945.0,1,,,,CHEMBL622638,,9037,,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (20 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),6175,Rattus norvegicus,10116.0
50597,Stomach,A,,,BAO_0000218,Intermediate,1,N,945.0,1,,,,CHEMBL626561,,9038,,,pH of the gastric juice (Control value = 1.42+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),6175,Rattus norvegicus,10116.0
22224,,F,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL626562,,9039,,,Negative log of minimum effective dose (moles per kilogram) in rabbits (hypnotic),7991,Oryctolagus cuniculus,9986.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL626563,,9040,,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg ( 0-4 hr ),429,Oryctolagus cuniculus,9986.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL626564,,9041,,,Evaluated for pharmacokinetic parameter area under curve in rabbit at the dose 20 mg/kg (0-4 hr ),429,Oryctolagus cuniculus,9986.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626565,,9042,,,Clearance was measured at the concentration of 1.11 mg/kg in rabbit blood sample,6253,Oryctolagus cuniculus,9986.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626566,,9043,,,Clearance was measured at the concentration of 2.0 mg/kg in rabbit blood sample,6253,Oryctolagus cuniculus,9986.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626567,,9044,,,Clearance rate in rabbits,3615,Oryctolagus cuniculus,9986.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626568,,9045,,,Plasma clearance was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,4059,Oryctolagus cuniculus,9986.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626569,,9046,,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,5124,Oryctolagus cuniculus,9986.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626570,,9047,,,Clearance in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,5124,Oryctolagus cuniculus,9986.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626571,,9048,,,Clearance in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,5124,Oryctolagus cuniculus,9986.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626572,,9049,,,Evaluated for pharmacokinetic parameter Cmax in rabbit at the dose 20 mg/kg,429,Oryctolagus cuniculus,9986.0
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL626573,,9050,,,Maximum plasma concentration was determined in rabbit at a dose of 5 mg/kg/h administered i.v.,4059,Oryctolagus cuniculus,9986.0
22224,Liver,A,,,BAO_0000251,Autocuration,0,U,2107.0,1,,,,CHEMBL626574,,9051,Microsomes,,Oxidation by dutch rabbit liver microsomes in presence of NADPH/O2,9659,Oryctolagus cuniculus,9986.0
22224,Liver,A,,,BAO_0000251,Autocuration,0,U,2107.0,1,,,,CHEMBL626575,,9052,Microsomes,,Oxidation by dutch rabbit liver microsomes in presence of cumene hydroperoxide,9659,Oryctolagus cuniculus,9986.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL626576,,9053,,,Dose at which bioavailability of intravenously administered compound was tested in rabbit,3639,Oryctolagus cuniculus,9986.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL626577,,9054,,,Dose at which bioavailability of perorally administered compound was tested in rabbit,3639,Oryctolagus cuniculus,9986.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626578,,9055,,,The compound was tested for its bioavailability in rabbit (by oral dosage).,3639,Oryctolagus cuniculus,9986.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625263,,9056,,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,5124,Oryctolagus cuniculus,9986.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625264,,9057,,,Mean retention time in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,5124,Oryctolagus cuniculus,9986.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625265,,9058,,,Mean retention time in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,5124,Oryctolagus cuniculus,9986.0
22224,,A,,,BAO_0000251,Autocuration,0,U,,1,,,,CHEMBL625266,,9059,Microsomes,,Metabolism of compound in rabbit S9 microsomes ('+''indicates <20% largest observed peak),14294,Oryctolagus cuniculus,9986.0
22224,,A,,,BAO_0000251,Autocuration,0,U,,1,,,,CHEMBL876796,,9060,Microsomes,,Metabolism of compound in rabbit S9 microsomes ('++++' indicates largest observed peak),14294,Oryctolagus cuniculus,9986.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625267,,9061,,,Evaluated for pharmacokinetic parameter half-life in rabbit at the dose 20 mg/kg,429,Oryctolagus cuniculus,9986.0
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL625268,,9062,,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 4.9 mg/kg,5124,Oryctolagus cuniculus,9986.0
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL625269,,9063,,,Plasma half-life in male New Zealand white rabbits after administration via an indwelling catheter in an ear vein at 5 mg/kg,5124,Oryctolagus cuniculus,9986.0
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL624689,,9064,,,Plasma half-life in male New Zealand white rabbits after i.v. administration at 2.0 mg/kg,5124,Oryctolagus cuniculus,9986.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL624690,,9065,,,Evaluated for pharmacokinetic parameter tmax in rabbit at the dose 20 mg/kg,429,Oryctolagus cuniculus,9986.0
22224,Urine,A,,,BAO_0000218,Autocuration,0,U,1088.0,1,,,,CHEMBL624691,,9066,,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg ( 0-24 hr ),429,Oryctolagus cuniculus,9986.0
22224,Urine,A,,,BAO_0000218,Autocuration,0,U,1088.0,1,,,,CHEMBL624692,,9067,,,Evaluated for pharmacokinetic parameter urine recovery in rabbit at the dose 20 mg/kg (0-24 hr),429,Oryctolagus cuniculus,9986.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL624693,,9068,,,The compound was evaluated for volume of distribution in rabbit at a dose of 5 mg/kg/h administered i.v.,4059,Oryctolagus cuniculus,9986.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL624694,,9069,,,Volume of distribution after intravenous administration of 1 mg/kg/h in dog,4137,Oryctolagus cuniculus,9986.0
22224,,A,,,BAO_0000221,Autocuration,0,U,,1,,,In vitro,CHEMBL877596,,9070,,,In vitro Biological half-life in crude homogenate of rabbit renal cortex,11672,Oryctolagus cuniculus,9986.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL624695,,9071,,,Time within which only 10% of the drug was degraded,12886,Oryctolagus cuniculus,9986.0
22224,Liver,A,,,BAO_0000221,Autocuration,0,U,2107.0,1,,,,CHEMBL624696,,9072,,,Half life period in rabbit liver homogenate,3853,Oryctolagus cuniculus,9986.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL624697,,9073,,,Half life value in rabbits,3615,Oryctolagus cuniculus,9986.0
22224,Blood,A,,,BAO_0000218,Autocuration,0,U,178.0,1,,,In vivo,CHEMBL624698,,9074,,,Half-life was measured at the concentration of 1.11 mg/kg in rabbit blood sample,6253,Oryctolagus cuniculus,9986.0
22224,Blood,A,,,BAO_0000218,Autocuration,0,U,178.0,1,,,In vivo,CHEMBL624699,,9075,,,Half-life was measured at the concentration of 2.0 mg/kg in rabbit blood sample,6253,Oryctolagus cuniculus,9986.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL624700,,9076,,,Half-life period in rabbits following intravenous administration at 2 mg/kg,6077,Oryctolagus cuniculus,9986.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622903,,9077,,,AUC 0-8 hr value in rats at 10 mg/kg,17617,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622904,,9078,,,AUC after administration at 2000 mg/kg/day in rats,17594,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622905,,9079,,,AUC of compound for a 2 mpk po dose of the sodium salt in rats.,6149,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622906,,9080,,,AUC at a dose of 10 mg/Kg administered intravenously in female hanover-wistar rat,17260,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622907,,9081,,,AUC at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,17260,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622908,,9082,,,AUC in rat after oral administration at 10.5 mg/kg dose,6644,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622909,,9083,,,AUC in rat after oral administration at 11.2 mg/kg dose,6644,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622910,,9084,,,AUC in rat after oral administration at 9.7 mg/kg dose,6644,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL622911,,9085,,,AUC in rat brain after oral administration at 10 mg/kg,6495,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622912,,9086,,,AUC in rat p.o.,6504,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622913,,9087,,,AUC in rat p.o. at 20 mg/kg concentration,17686,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622914,,9088,,,AUC in rat plasma after oral administration at 10 mg/kg,6495,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622915,,9089,,,AUC in rats,216,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622916,,9090,,,AUC value after IV dose at a dose of 5 mg/kg in rats.,1908,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622917,,9091,,,AUC value after oral dose at a dose of 10 mg/kg in rats.,1908,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622918,,9092,,,"Maximum plasma concentration in rats at 2 mg/kg, i.v. dose; n/a: not applicable",6685,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622919,,9093,,,Maximum plasma concentration in rats when a oral dose of 200 mg/kg was given,216,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622920,,9094,,,Maximum plasma concentration was evaluated in rat,6049,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622921,,9095,,,Maximum plasma concentration was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,2463,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622922,,9096,,,Maximum plasma concentration reached by compound was determined after 2 mg/kg (p.o.) administration,6679,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622923,,9097,,,Maximum plasma concentration reached by compound was determined in rats at 50 mg/kg dose,6681,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL877604,,9098,,,Maximum plasma concentration was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,4890,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622924,,9099,,,Maximum plasma concentration was evaluated in rats at an intravenous dose of 3 mg/kg,6410,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622925,,9100,,,Maximum plasma concentration was evaluated in rats at an oral dose of 30 mg/kg,6410,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622926,,9101,,,Maximum plasma concentration was measured when a dose of 1 mg/kg is administered orally,16366,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623625,,9102,,,Maximum plasma concentration (Cmax) in rat (in vivo) at a dose of 10 mg/kg,6227,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Expert,1,N,1969.0,1,,,In vivo,CHEMBL623626,,9103,,,Maximum plasma drug concentration of compound determined in rat after iv administration at a dose of 10 mg/kg,3598,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623627,,9104,,,Maximum plasma drug concentration was determined,1465,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623628,,9105,,,Maximum concentration by intravenous administration of 3.4 mg/kg in rat,4368,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623629,,9106,,,Mean peak plasma concentration was observed after intravenous administration in rat,15662,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623630,,9107,,,Mean peak plasma concentration was observed after oral administration in rat,15662,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623804,,9108,,,Peak concentration (Cmax) at a dose of 10 mg/kg in rats,5355,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623805,,9109,,,Peak concentration (Cmax) at a dose of 20 mg/kg in rats,5355,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623806,,9110,,,Peak oral plasma concentration was determined in rats by oral administration,1567,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623807,,9111,,,Peak plasma concentration (Cmax) was determined,4026,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623808,,9112,,,Peak plasma concentration (Cmax) following an oral dose of 20 mg/kg in rats,6193,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623809,,9113,,,Peak plasma concentration (Cmax) in rats,4026,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623810,,9114,,,Peak plasma concentration at 1 mg/kg peroral administration,6485,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623811,,9115,,,Peak plasma concentration in rat,17655,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623812,,9116,,,"Pharmacokinetic Parameter, Cmax is observed maximum plasma concentration in Female Wistar Rats at 100 mg/kg by po administration",14941,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL877605,,9117,,,Pharmacokinetic parameter Cmax was measured after administration into rat at 10 mg/kg,5394,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623813,,9118,,,Pharmacokinetic property (Cmax) in rat,4408,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623814,,9119,,,Pharmacokinetic property (Cmax) was measured in rat at the dose of 0.32 mg/kg p.o.,5983,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623815,,9120,,,Cmax in rat after 3mg/kg oral dose,4878,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,Sprague-Dawley,,In vivo,CHEMBL623816,,9121,,,Clearance in Sprague-Dawley rats after 2mg/kg oral dose,5862,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623145,,9122,,,Cmax in rats after 20 mg/kg oral dose,4517,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623146,,9123,,,Cmax in rat plasma after 30mg/kg oral dose,5932,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623147,,9124,,,Plasma concentration after oral administration of 100 mg/kg to rats,5436,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL623042,,9125,,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,4910,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623043,,9126,,,Tested for the Cmax in rat at 10 mg/kg per orally,4950,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623044,,9127,,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",15078,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623045,,9128,,,"The Cmax value in male wistar rat at 100 mg/kg, p.o. dose",15078,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623046,,9129,,,Bioavailability as oral Cmax in rats at 30 mins,3360,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623226,,9130,,,Bioavailability as oral Cmax in rats at 6hr,3360,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623227,,9131,,,The maximum concentration of compound was measured at the dose of 100 umol/kg,15022,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623228,,9132,,,The maximum concentration of compound was measured at the dose of 300 umol/kg,15022,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623229,,9133,,,The maximum concentration of compound was measured at the dose of 30 umol/kg,15022,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623230,,9134,,,The maximum plasma levels for the compounds were determined by LC-MS.,5160,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623231,,9135,,,mean peak plasma concentration was observed after intravenous administration in rat,15662,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623232,,9136,,,mean peak plasma concentration was observed after oral administration in rat,15662,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623233,,9137,,,Concentration in the plasma after intravenous administration of 1 mg/kg in rat,4709,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623234,,9138,,,Concentration in plasma (portal) following oral dose in rats at 0.25 hr,3535,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623235,,9139,,,Concentration in plasma (portal) following oral dose in rats at 1 hr,3535,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623236,,9140,,,Concentration in plasma (portal) following oral dose in rats at 2 hr,3535,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623237,,9141,,,Concentration in plasma (systemic) following oral dose in rats at 0.25 hr,3535,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623238,,9142,,,Concentration in plasma (systemic) following oral dose in rats at 1 hr,3535,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623239,,9143,,,Concentration in plasma (systemic) following oral dose in rats at 2 hr,3535,Rattus norvegicus,10116.0
22224,Plasma,A,,,BAO_0000218,Intermediate,0,U,1969.0,1,,,In vivo,CHEMBL623240,,9144,,,Compound was evaluated for the plasma concentration in rats versus time curves (AUC) in vivo,5005,Rattus norvegicus,10116.0
50597,Hypothalamus,A,,,BAO_0000218,Intermediate,1,N,1898.0,1,,,,CHEMBL623241,,9145,,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 2 hours",6326,Rattus norvegicus,10116.0
50597,Hypothalamus,A,,,BAO_0000218,Intermediate,1,N,1898.0,1,,,,CHEMBL623242,,9146,,,"Concentration (30 mg/kg, p.o.) in rat hypothalamus after 6 hours",6326,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL874394,,9147,,,"Concentration (30 mg/kg, p.o.) in rat plasma after 2 hours",6326,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623243,,9148,,,"Concentration (30 mg/kg, p.o.) in rat plasma after 6 hours",6326,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623244,,9149,,,Kidney concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,17411,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL623245,,9150,,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,16435,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL623246,,9151,,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,16435,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL623247,,9152,,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,16435,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL623248,,9153,,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,16435,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL623249,,9154,,,Radioactivity distribution in kidney of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,16435,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625072,,9155,,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,16434,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625073,,9156,,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,16434,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625074,,9157,,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,16434,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625075,,9158,,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,16434,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625076,,9159,,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min.,16434,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625077,,9160,,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,16434,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625078,,9161,,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,16434,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL874395,,9162,,,Radioactivity distribution in liver of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,16434,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625079,,9163,,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,16435,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625080,,9164,,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,16435,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625081,,9165,,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,16435,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625082,,9166,,,Radioactivity distribution in liver of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,16435,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625083,,9167,,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,16435,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625084,,9168,,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,16435,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625085,,9169,,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,16435,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625086,,9170,,,Radioactivity distribution in liver of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,16435,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625087,,9171,,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,16434,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625088,,9172,,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,16434,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL622205,,9173,,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,16434,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL622206,,9174,,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,16435,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL622207,,9175,,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,16435,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL622366,,9176,,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,16435,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL622367,,9177,,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,16435,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL875331,,9178,,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,16435,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL622368,,9179,,,Radioactivity distribution in liver of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,16435,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL622369,,9180,,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,16434,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL622370,,9181,,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,16434,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL622371,,9182,,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,16434,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL622372,,9183,,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,16434,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL622373,,9184,,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,16434,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL622374,,9185,,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,16434,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL622375,,9186,,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,16434,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL622376,,9187,,,Radioactivity distribution in lung of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,16434,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL622377,,9188,,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,16435,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL622378,,9189,,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,16435,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL622379,,9190,,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,16435,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL622380,,9191,,,Radioactivity distribution in lung of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,16435,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL622381,,9192,,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,16435,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL622382,,9193,,,Radioactivity distribution in lung of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,16435,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL622383,,9194,,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 120 min,16434,Rattus norvegicus,10116.0
50597,Stomach,A,,,BAO_0000218,Intermediate,1,N,945.0,1,,,,CHEMBL875332,,9195,,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured ( 5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),6175,Rattus norvegicus,10116.0
50597,Stomach,A,,,BAO_0000218,Intermediate,1,N,945.0,1,,,,CHEMBL622384,,9196,,,pH of the gastric juice (Control value = 1.44+/-0.01) of stomach content of pylorus ligated rats was measured (10 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),6175,Rattus norvegicus,10116.0
50597,Stomach,A,,,BAO_0000218,Intermediate,1,N,945.0,1,,,,CHEMBL622385,,9197,,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (2.5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),6175,Rattus norvegicus,10116.0
50597,Stomach,A,,,BAO_0000218,Intermediate,1,N,945.0,1,,,,CHEMBL622386,,9198,,,pH of the gastric juice (control value = 1.39+/-0.02) of stomach content of pylorus ligated rats was measured (5 mg/kg po of the Compound was administered 1 hr before the pylorus ligation),6175,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622387,,9199,,,The compound was tested for the plasma binding in rat,10839,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622388,,9200,,,"Plasma concentration after intravenous aministration at 1hr, (1 mg/kg, n=3)",16459,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622389,,9201,,,"Plasma concentration after intravenous aministration at 30 min. (1 mg/kg, n=3)",16459,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622390,,9202,,,"Plasma concentration after intravenous aministration at 60 min. (1 mg/kg, n=3)",16459,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622391,,9203,,,Plasma concentration after oral aministration at 1 hr. (10 mg/kg),16459,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622392,,9204,,,Plasma concentration after oral aministration at 2 hr. (10 mg/kg),16459,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622393,,9205,,,Plasma concentration after oral aministration at 4 hr. (10 mg/kg),16459,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622394,,9206,,,Plasma level at 2 hr after administration of the compound,3278,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622395,,9207,,,plasma level at 2 hr after administration of the compound,3278,Rattus norvegicus,10116.0
50597,Serum,A,,,BAO_0000218,Intermediate,1,N,1977.0,1,,,,CHEMBL622396,,9208,,,Stability in rat serum measured as % recovery at 1 min,4684,Rattus norvegicus,10116.0
50597,Serum,A,,,BAO_0000218,Intermediate,1,N,1977.0,1,,,,CHEMBL624894,,9209,,,Stability in rat serum measured as % recovery at 10 min,4684,Rattus norvegicus,10116.0
50597,Serum,A,,,BAO_0000218,Intermediate,1,N,1977.0,1,,,,CHEMBL624895,,9210,,,Stability in rat serum measured as % recovery at 10 mins,4684,Rattus norvegicus,10116.0
50597,Serum,A,,,BAO_0000218,Intermediate,1,N,1977.0,1,,,,CHEMBL624058,,9211,,,Stability in rat serum measured as % recovery at 2 hr,4684,Rattus norvegicus,10116.0
50597,Serum,A,,,BAO_0000218,Intermediate,1,N,1977.0,1,,,,CHEMBL624059,,9212,,,Stability in rat serum measured as % recovery at 3 min,4684,Rattus norvegicus,10116.0
50597,Serum,A,,,BAO_0000218,Intermediate,1,N,1977.0,1,,,,CHEMBL624060,,9213,,,Stability in rat serum measured as % recovery at 3 mins,4684,Rattus norvegicus,10116.0
50597,Serum,A,,,BAO_0000218,Intermediate,1,N,1977.0,1,,,,CHEMBL624061,,9214,,,Stability in rat serum measured as % recovery at 5 min,4684,Rattus norvegicus,10116.0
50597,Serum,A,,,BAO_0000218,Intermediate,1,N,1977.0,1,,,,CHEMBL624062,,9215,,,Stability in rat serum measured as % recovery at 5 mins,4684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624063,,9216,,,Alpha-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,16456,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624064,,9217,,,Beta-elimination half-life in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,16456,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL624065,,9218,,,Half life in plasma was determined against ovariectomized rats; t 1/2 (h) is short in plasma,723,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL624066,,9219,,,Half life in plasma was determined against ovariectomized rats; t1/2 is longer in plasma.,723,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL877490,,9220,,,Half life tested in mature male rat at a dose of 30 mg/kg,5160,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL874442,,9221,,,Half life after intravenous administration of 1 mg/kg in rat,4709,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626890,,9222,,,Half life period after administration (30 mg/kg) in rat,5633,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626891,,9223,,,Half life period in rat after 5 mg/Kg dose,5302,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626892,,9224,,,Half life period in rat after 5 mg/kg dose,5302,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626893,,9225,,,Half life period was determined,17791,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626894,,9226,,,Half life period was evaluated in rat,17791,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626895,,9227,,,Half life period was evaluated in rat; 0.5-1.0,17791,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626896,,9228,,,Half life period was evaluated in rat; 5.9-7.5,17791,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626897,,9229,,,Half-life in rat plasma,14512,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626898,,9230,,,Half-life time in rat was determined,6230,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626899,,9231,,,Terminal half-life after iv administration to rats,3364,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626900,,9232,,,Tested for iv terminal half-life dosed as a solution in male Han Wistar rats,6874,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626901,,9233,,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg,857,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626902,,9234,,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 0.5 umol/kg (iv),858,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626903,,9235,,,Time required to return to 50% inhibition of pressor response after AI-challenge in normotensive rats at 5 umol/kg (iv),858,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL874443,,9236,,,Time for peak concentration (tmax) at a dose of 10 mg/kg in rats,5355,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626904,,9237,,,Time for peak concentration (tmax) at a dose of 20 mg/kg in rats,5355,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626905,,9238,,,Half life in rats,6305,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL873830,,9239,,,Apparent Half life was determined from the linear portion of the log plasma concentration-time profile after oral administration of compound 18 at a dose of 4 mg/kg to rat,13501,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626906,,9240,,,Apparent half-life after single intravenous bolus of 1 mg/kg in rats,17594,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL631076,,9241,,,Apparent terminal elimination half-life in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,4186,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL631077,,9242,,,Biological half-life was measured in plasma of rats,2932,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL631078,,9243,,,Circulatory half life measured after intravenous bolus administration of 50 mg/kg of compound to rats,17065,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL631079,,9244,,,Compound demonstarted an oral bioavailability of 6% with the half-life time as given in rats.,15765,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL631080,,9245,,,Compound was evaluated for half life (t1/2) upon intravenous administration of 1 mg/Kg in rats,2713,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL631081,,9246,,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to female wistar rats,2661,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL631239,,9247,,,Compound was evaluated for half life after treatment with iv dose of 1 mgkg to male wistar rats,2661,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL631240,,9248,,,Compound was evaluated for plasma half life in rat,740,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL631241,,9249,,,AUC value at a dose of 5 mg/kg (p.o.) in rats,6597,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL631242,,9250,,,AUC value after administration of 20 mg/Kg oral dose in rat,2959,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL631243,,9251,,,AUC0-24 after repeated oral dose of compound at 1 mg/kg in rats,17594,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL874444,,9252,,,AUC0-96 after administration at 50 mg/kg,17596,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL631244,,9253,,,AUC0-infinity after single intravenous bolus of 1 mg/kg in rats,17594,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631245,,9254,,,"Absorption behavior was judged by the area under the curve, determined after oral dose of 30 mg/kg in rats.",3293,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627162,,9255,,,Area under curve (0-24 hr) at a dose of 10 mg/kg in male SD rats,6757,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627163,,9256,,,Area under curve (0-24 hr) at a dose of 100 mg/kg in male SD rats,6757,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627164,,9257,,,Area under curve (0-24 hr) at a dose of 50 mg/kg in male SD rats,6757,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL627165,,9258,,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat kidney,5979,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627166,,9259,,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat liver,5979,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627167,,9260,,,Area under curve (AUC) at a dose 1 mg/kg was determined in rat lung,5979,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627822,,9261,,,Area under curve (AUC) at a dose of 30 mg/kg in rats,4026,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627823,,9262,,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,5355,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627824,,9263,,,Area under curve (AUC) was calculated using trapezoidal rule. at a dose of 10 mg/kg in rats,5355,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627825,,9264,,,Area under curve (AUC) was calculated using trapezoidal rule at a dose of 20 mg/kg in rats,5355,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627826,,9265,,,Area under curve (AUC0-24 h) after administration (30 mg/kg) in rat,5633,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627827,,9266,,,Area under curve (Pharmacokinetic property) was determined,1716,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627828,,9267,,,Area under curve (Pharmacokinetic property) of the compound; Not determined,1716,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627829,,9268,,,Area under curve after intravenous administration (1 mg/kg) in rat,4689,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627830,,9269,,,Area under curve by intravenous administration at a dose of 10 uM/kg in rat was determined,4527,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627831,,9270,,,Area under curve by oral administration at a dose of 100 uM/kg in rat was determined,4527,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627832,,9271,,,Area under curve in male SD rats was observed after oral administration in rat,15662,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627833,,9272,,,Area under curve of compound after iv administration of 20 mg/kg dose in rat,4413,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Expert,1,N,,1,,,,CHEMBL627834,,9273,,,Area under curve of compound determined in rat after iv administration at a dose of 10 mg/kg,3598,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Expert,1,N,,1,,,,CHEMBL628004,,9274,,,Area under curve of compound from zero time to infinity determined in rat after iv administration at a dose of 10 mg/kg,3598,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628005,,9275,,,Area under curve at 5 mg/kg po was determined in rat,5964,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628006,,9276,,,Area under curve in Rat at a oral dose of 5 mg/kg,4689,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628007,,9277,,,Area under curve in rat plasma after administration of 3.5 mg/kg dose through subcutaneous route,4186,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625676,,9278,,,Area under curve was determined,5510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631309,,9279,,,Area under curve after 10 mg/kg oral administration in rat at 0-24 hr,17858,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631310,,9280,,,Area under curve after intravenous administration at 3 mg/kg,17804,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631311,,9281,,,Area under curve after peroral administration at 10 mg/kg in rat for 0-6 h,6106,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631312,,9282,,,Area under curve at 4 hr in rat,5964,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631313,,9283,,,Area under curve at a dose of 30 mg/kg,4026,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631314,,9284,,,Area under curve at the dose of 2 mg/Kg administered perorally in rats,4756,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631315,,9285,,,Area under curve at the dose of 5 mg/Kg administered perorally in rats,4756,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631316,,9286,,,Area under curve for a 2-mpk po dose in SD rats,5862,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631317,,9287,,,Area under curve in SD rats,5862,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL874471,,9288,,,Area under curve in rat after oral administration at 13 mg/kg dose,6644,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631318,,9289,,,Area under curve in rat by po administration at 0-24 hr,5871,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL631319,,9290,,,Area under curve in rat plasma,5919,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631320,,9291,,,Area under curve in rat plasma for 0-4 hr after peroral administration at 10 mg/kg,5939,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631321,,9292,,,Area under curve in rat plasma for 0-4 hr after peroral administration at 5 mg/kg,5939,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631322,,9293,,,Area under curve was evaluated in rat at 3 mg/kg dose administered intravenously,10,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631323,,9294,,,Area under curve was measured from the graph obtained from concentration Vs time after oral administration to male F344 rats,11149,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631324,,9295,,,Area under curve value in rat at a dose of 5 mg/kg,5302,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631325,,9296,,,Area under curve was determined after oral administration in rats,17796,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631326,,9297,,,Area under curve was determined after oral administration at a dose 10 mg/kg to male Sprague-Dawley rats,4890,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631327,,9298,,,Area under curve was determined after peroral administration in rat,6011,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631328,,9299,,,Area under curve was determined at a dose 30 mpk administered orally.,5375,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631329,,9300,,,Area under curve was determined for compound after intravenous administration in rats at 24 uM/kg,17764,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627217,,9301,,,Area under curve was determined for the compound by intravenous administration of 3.4 mg/kg in rat,4368,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626352,,9302,,,Area under curve was determined in male rat,5610,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626353,,9303,,,Area under curve was determined in rat after PO administration,5833,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626354,,9304,,,Area under curve was determined in rat after a 3 mg/kg of oral dose,4257,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626355,,9305,,,Area under curve was determined in rat after oral administration at a concentration 1 mg/kg,5937,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626356,,9306,,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg,5932,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626357,,9307,,,Area under curve was determined in rat after oral administration at a concentration 30 mg/kg; NA= Not active,5932,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626358,,9308,,,Liver concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,17411,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626359,,9309,,,Lung concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,17411,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626360,,9310,,,Peak plasma concentration in rat at a dose of 3 mg/kg,17771,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626361,,9311,,,Plasma concentration at 2 hr in rats was evaluated.,1628,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626362,,9312,,,Plasma concentration at 2 hr in rats was evaluated; Not available,1628,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626363,,9313,,,Serum concentration was determined after 5 min. of intravenous administration to rats (n=4) at dose of 20 mg/kg,17411,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626970,,9314,,,Tested for concentration in brain after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,4910,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626971,,9315,,,Tested for concentration in brain after 2 hrs of intravenous administration (5 mg/kg) to male rats,4910,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626972,,9316,,,Tested for plasma concentration after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,4910,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626973,,9317,,,Tested for plasma concentration after 2 hrs of intravenous administration (5 mg/kg) to male rats,4910,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626974,,9318,,,Tested for plasma concentration in the after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,4910,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL874592,,9319,,,Tested for plasma concentration in the after 2 hrs of intravenous administration (5 mg/kg) to male rats,4910,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626975,,9320,,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C,5510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626976,,9321,,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Converted to an unknown compound,5510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626977,,9322,,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not determined,5510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626978,,9323,,,Percentage converted to BMS-191011 after 30 min incubation in rat plasma at 37 degree C; Not tested,5510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626979,,9324,,,PK study was carried to determine the relative absorption ranking in rat.,16427,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626980,,9325,,,Maximum plasma concentration in Rat at a oral dose of 5 mg/kg,4689,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL626981,,9326,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.57-0.75 % dose/g",11450,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL626982,,9327,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.63 % dose/g",11450,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL626983,,9328,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.40-0.55 % dose/g",11450,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL622522,,9329,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.28-0.37% dose/g",11450,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL622523,,9330,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.56-0.74 % dose/g",11450,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL622524,,9331,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in blood of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from % dose/g",11450,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL622525,,9332,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.20-2.85 % dose/g",11450,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL622526,,9333,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.16-1.76 % dose/g",11450,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL619849,,9334,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.96-3.72 % dose/g",11450,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL619850,,9335,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.57-3.59 % dose/g",11450,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL623864,,9336,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.36-1.53 % dose/g",11450,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL623865,,9337,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in brain of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.81-1.08 % dose/g",11450,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL623866,,9338,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.84-0.98 % dose/g",11450,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL623867,,9339,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.06-0.53 % dose/g",11450,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL877615,,9340,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.22-1.48 % dose/g",11450,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL623868,,9341,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.85-1.13 % dose/g",11450,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL623869,,9342,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.55-0.63 % dose/g",11450,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL623870,,9343,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in heart of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.33-0.42 % dose/g",11450,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL623871,,9344,,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,16434,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL623872,,9345,,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,16434,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL622129,,9346,,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,16435,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL622130,,9347,,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,16435,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL622131,,9348,,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,16435,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL622132,,9349,,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,16435,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL622133,,9350,,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,16435,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL622134,,9351,,,Radioactivity distribution in lung of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,16435,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL622135,,9352,,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,16435,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL622136,,9353,,,Radioactivity distribution in lungs of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,16435,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL622137,,9354,,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,16434,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL622138,,9355,,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,16434,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL623017,,9356,,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,16434,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL623018,,9357,,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,16434,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL623019,,9358,,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,16434,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL623020,,9359,,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,16434,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL623021,,9360,,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min.,16434,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL623022,,9361,,,Radioactivity distribution in muscle of normal fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min.,16434,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL623023,,9362,,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,16435,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL623024,,9363,,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,16435,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL623025,,9364,,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,16435,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL620545,,9365,,,Radioactivity distribution in muscle of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,16435,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL620546,,9366,,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,16435,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL620547,,9367,,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,16435,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL620548,,9368,,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,16435,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL620549,,9369,,,Radioactivity distribution in muscle of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,16435,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL620550,,9370,,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,16434,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL620551,,9371,,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,16434,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL620552,,9372,,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,16434,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL620553,,9373,,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,16435,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL620554,,9374,,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,16435,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL875845,,9375,,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,16435,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL620555,,9376,,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,16435,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL620556,,9377,,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,16435,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL620557,,9378,,,Radioactivity distribution in muscle of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL620558,,9379,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL620559,,9380,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622939,,9381,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622940,,9382,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622941,,9383,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622942,,9384,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622943,,9385,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622944,,9386,,,Radioactivity distribution in pancreas of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622945,,9387,,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622946,,9388,,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622947,,9389,,,Compound was evaluated for terminal half life in rat,3341,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622948,,9390,,,Compound was evaluated in vivo in rat for the plasma half-life at a iv dose of 3 mg/kg and oral dose of 10 mg/kg and experiment by using concentration vs time curve,3634,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622949,,9391,,,Compound was evaluated in vivo in rat for the plasma half-life at a oral dose of 20 mg/kg experiment by using concentration vs time curve,3634,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622950,,9392,,,Compound was tested for its half life in rat,4839,Rattus norvegicus,10116.0
22224,Plasma,A,,,BAO_0000218,Intermediate,0,U,1969.0,1,,,In vivo,CHEMBL622951,,9393,,,Compound was tested for its plasma half life in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po; ND is not determined.,5005,Macaca mulatta,9544.0
22224,Plasma,A,,,BAO_0000366,Intermediate,0,U,1969.0,1,,,,CHEMBL622952,,9394,,,Compound was tested for its plasma half life in Sprague Dawley rats,5005,Rattus norvegicus,10116.0
22224,Plasma,A,,,BAO_0000366,Intermediate,0,U,1969.0,1,,,,CHEMBL622953,,9395,,,Compound was tested for its plasma half life in Sprague Dawley rats; ND is not determined,5005,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL873818,,9396,,,Compound was tested for plasma half-life period in rat,1094,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622954,,9397,,,Elimination half life after i.v. administration of compound in rats,5031,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622955,,9398,,,Elimination half-life after IV dosing at 0.5 mg/kg in rat,6518,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL875229,,9399,,,Elimination half-life after IV dosing at 1 mg/kg in rat,6518,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622956,,9400,,,Elimination half-life after oral administration at a dose of 2 mg/kg in rat,6518,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622957,,9401,,,Elimination half-life after oral administration at a dose of 4 mg/kg in rat,6518,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL622958,,9402,,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,5408,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622959,,9403,,,Evaluated for half-life after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,5408,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL622960,,9404,,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,5408,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622961,,9405,,,Evaluated for half-life after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,5408,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622962,,9406,,,Evaluated for the half life in rat (in vivo),4687,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622963,,9407,,,Hafl life in rat,6640,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622964,,9408,,,Hafl life rat,6640,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622965,,9409,,,Hafl life rat,6641,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622966,,9410,,,Hafl life rat; Not determined,6640,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622967,,9411,,,Hafl life rat; Not determined,6641,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL622968,,9412,,,Half life in kidney was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,17411,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL622969,,9413,,,Half life in liver was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,17411,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL875327,,9414,,,Half life in lung was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,17411,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628638,,9415,,,Half life in rat after 1 mg/kg i.v. administration,6570,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628639,,9416,,,Half life in rat after 2 mg/kg peroral administration,6570,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625840,,9417,,,Half life in serum was determined after intravenous administration to rats (n=4) at dose of 20 mg/kg,17411,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625841,,9418,,,Half life of 10 mg/kg oral dose determined in rats,4722,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625842,,9419,,,Half life of compound (10 mg/kg) after iv administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625843,,9420,,,Half life of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625844,,9421,,,Half life of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL873822,,9422,,,Half life of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625845,,9423,,,Half life of compound (9.83 mg/kg) after iv administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627059,,9424,,,Half life of compound (9.84 mg/kg) after iv administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627060,,9425,,,Half life of compound (9.84 mg/kg) after po administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627061,,9426,,,Half life of compound (9.92 mg/kg) after iv administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627709,,9427,,,Half life of compound at 5 mg/kg after po administration was determined in rat,4762,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627710,,9428,,,Half life of compound determined after intravenous administration to rat,5327,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627711,,9429,,,Half life of compound was determined in rat,4847,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL627712,,9430,,,Half life at a dose of 4 mg/kg in Rat Plasma after iv administration,17720,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627713,,9431,,,Half life determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,4723,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627714,,9432,,,Half life determined after 3 mg/kg oral administration in potassium oxonate treated rats,4723,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Intermediate,0,U,,1,,,In vivo,CHEMBL627889,,9433,,,Half life determined after intravenous administration at a dose of 3 mg/kg in cynomolgus monkey,4256,Macaca fascicularis,9541.0
22224,,A,,,BAO_0000218,Intermediate,0,U,,1,,,In vivo,CHEMBL627890,,9434,,,Half life determined in rat by intravenous administration,4256,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627891,,9435,,,Half life determined in rats after iv administration,4722,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL627892,,9436,,,Half life in rat plasma after administration of 2 mg/kg iv,6535,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL627893,,9437,,,Half life in rat plasma after administration of 2 mg/kg iv,6535,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL627894,,9438,,,Half life in rat plasma was determined,1435,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL627895,,9439,,,Half life in rat plasma was determined; NA means not applicable,1435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627896,,9440,,,Half life in rat was tested,5206,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL627897,,9441,,,Half life measured in rat plasma,6080,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627898,,9442,,,Half life recorded in rats,4449,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627899,,9443,,,Half life was calculated,6057,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL873823,,9444,,,Half life was calculated in rat,6057,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627900,,9445,,,Half life was determined,3747,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627901,,9446,,,Half life after 10 mg/kg oral administration in rat,17858,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627902,,9447,,,Half life after administering orally a dose of 10 mg/kg to a fasting rat,16365,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627903,,9448,,,Half life after administering orally a dose of 30 mg/kg,16365,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627904,,9449,,,Area under the curve (Concentration) was determined for the compound as AUC with limits 0-8 after i.v. administration in rats,5031,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627905,,9450,,,Area under the curve determined under pharmacokinetic behavior of the 10 mg/kg oral dose of compound for 0-6 hours,4722,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627906,,9451,,,Area under the curve for the compound calculated from 0-24 hr after intravenous administration at a dose of 10 mg/kg in rat,6078,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627907,,9452,,,Area under the curve for the compound calculated from 0-24 hr after oral administration at a dose of 10 mg/kg in rat,6078,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL876783,,9453,,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg,6078,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627908,,9454,,,Area under the curve for the compound calculated from 0-6 hr after oral administration at a dose of 10 mg/kg; activity was not determined,6078,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627909,,9455,,,Area under the curve measured after intravenous bolus administration of 50 mg/kg of compound to rats,17065,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627910,,9456,,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats,1353,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627911,,9457,,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-1),1353,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627912,,9458,,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-2),1353,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627913,,9459,,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(0-5),1353,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627914,,9460,,,Area under the curve in plasma after oral administration of 30 mg/kg at 1 hr interval during 6 hrs in rats(5-10),1353,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627915,,9461,,,Area under the curve was evaluated after 10 uM/kg of intra arterial administration,16423,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627916,,9462,,,Area under the curve was evaluated after 20 uM/kg of peroral administration,16423,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627917,,9463,,,Area under the curve was measured in rat after an iv dose of 1 mg/kg,6062,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627918,,9464,,,Area under the curve was calculated for the compound at a single intravenous administration of 20 mg/kg in rat,6056,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627919,,9465,,,Area under the curve was determined by administering the compound at a dose of 1 mg/kg intravenously in male wistar rat,5182,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627920,,9466,,,Area under the curve was evaluated at an intravenous dose of 3 mg/kg,6410,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627921,,9467,,,Area under the curve was evaluated at an oral dose of 30 mg/kg,6410,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627922,,9468,,,Area under the effect time curves from time 0-24 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,4723,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL876784,,9469,,,Area under the effect time curves from time 0-24 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,4723,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627923,,9470,,,Area under the effect time curves from time 0-6 hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,4723,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626208,,9471,,,Area under the effect time curves from time 0-6 hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,4723,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626209,,9472,,,Area under the effect time curves from time 0-infinity hr determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,4723,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626210,,9473,,,Area under the effect time curves from time 0-infinity hr determined after 3 mg/kg oral administration in potassium oxonate treated rats,4723,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL627994,,9474,,,Area under the plasma concentration curve was evaluated in vivo in rat at a dose of 5 mg/kg by oral administration,2463,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627995,,9475,,,Bioavailability from area under the curve at time 0 to infinity after intravenous administration of 1 mg/kg in rat,4709,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627996,,9476,,,Blood level after a 10 mg/kg oral dose in rat expressed as AUC was determined,4075,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627997,,9477,,,Compound at a dose 10 mg/kg was administered orally to rat and the pharmacokinetic parameter area under curve (AUC) was measured,5394,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627998,,9478,,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to female wistar rats,2661,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628640,,9479,,,Compound was evaluated for AUC after treatment with iv dose of 1 mgkg to male wistar rats,2661,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628641,,9480,,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to female wistar rats,2661,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628642,,9481,,,Compound was evaluated for AUC after treatment with oral dose of 2 mgkg to male wistar rats,2661,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628643,,9482,,,Compound was evaluated for area under the curve expressed as (h*ug/ml),17791,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628644,,9483,,,Compound was tested for area under curve in rat,2591,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628645,,9484,,,Concentration in rat plasma after 5 mg/kg oral gavage for 8 hours,6567,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628646,,9485,,,Dose-normalized AUC was determined by po administration (10 mg/kg) in fasted male Sprague-Dawley rats,6211,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628647,,9486,,,Dose-normalized AUC was determined in rat after peroral administration (2 mg/kg),5529,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628648,,9487,,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in brain; not determined,5408,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625358,,9488,,,Evaluated for AUC after iv administration of 1 mg/kg to male Sprague-Dawley rats in plasma,5408,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625359,,9489,,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in brain,5408,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625360,,9490,,,Evaluated for AUC after iv administration of 5 mg/kg to male Sprague-Dawley rats in plasma,5408,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625361,,9491,,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg ( 0-8 hr ),429,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625362,,9492,,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr ),429,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625363,,9493,,,Evaluated for pharmacokinetic parameter area under curve in rat at the dose 50 mg/kg (0-8 hr),429,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625364,,9494,,,Hepatic portal AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,4796,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625365,,9495,,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625366,,9496,,,In vivo Area under curve (AUC) was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625367,,9497,,,In vivo Area under curve (AUC) was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL625368,,9498,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.98-2.56 % dose/g",11450,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL625369,,9499,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.15-1.43 % dose/g",11450,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL625370,,9500,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.43-4.52 % dose/g",11450,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL625371,,9501,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 2.12-3.14 % dose/g",11450,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL625372,,9502,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.40-1.60 % dose/g",11450,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL625373,,9503,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in kidney of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.74-0.85 % dose/g",11450,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625374,,9504,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 1.31-1.45 % dose/g",11450,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL877593,,9505,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.90 % dose/g",11450,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625375,,9506,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.02-2.78 % dose/g",11450,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625376,,9507,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.64-2.38 % dose/g",11450,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL621973,,9508,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.95-1.07 % dose/g",11450,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL621974,,9509,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in liver of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.61-0.81 % dose/g",11450,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL621975,,9510,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 5.01-7.13 % dose/g",11450,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL622166,,9511,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.51-3.71 % dose/g",11450,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL622167,,9512,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 10.84-13.77 % dose/g",11450,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL622168,,9513,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.92-8.51% dose/g",11450,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL622169,,9514,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 3.37-3.94 % dose/g",11450,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL622170,,9515,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in lungs of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 1.87-2.12 % dose/g",11450,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL622171,,9516,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 37.97-75.23 % dose/g",11450,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL622172,,9517,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 5.03-36.88 % dose/g",11450,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL622173,,9518,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 13.20-17.31 % dose/g",11450,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL622174,,9519,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 7.87-16.51 % dose/g",11450,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL622175,,9520,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 81.37-166.09 % dose/g",11450,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL622176,,9521,,,"Distribution of the radioiodinated compound expressed as percent dose per gram, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 31.90-39.98 % dose/g",11450,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL622177,,9522,,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.41-0.83 % dose/g",11450,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL622178,,9523,,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 30 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.05-0.38 % dose/g",11450,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL622179,,9524,,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (10.7 uCi/animal); value ranges from 0.16-0.20 % dose/g",11450,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL622180,,9525,,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 5 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.08-0.17 % dose/g",11450,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622181,,9526,,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622182,,9527,,,Radioactivity distribution in pancreas of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622183,,9528,,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622184,,9529,,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622185,,9530,,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622186,,9531,,,Radioactivity distribution in pancreas of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622187,,9532,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625002,,9533,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 5 min,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622090,,9534,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of [18F]-fluoro-2-methylpropanoic acid after 60 min,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622091,,9535,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622092,,9536,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622093,,9537,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622094,,9538,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622095,,9539,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622264,,9540,,,Radioactivity distribution in pancreas of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,16435,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL622265,,9541,,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,16434,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL622266,,9542,,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,16434,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL622267,,9543,,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,16434,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL622268,,9544,,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,16434,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL622269,,9545,,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,16434,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL625071,,9546,,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,16434,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL621621,,9547,,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,16434,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL621622,,9548,,,Radioactivity distribution in spleen of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,16434,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL621623,,9549,,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,16435,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL621624,,9550,,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,16435,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL621625,,9551,,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,16435,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL621626,,9552,,,Radioactivity distribution in spleen of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,16435,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL621627,,9553,,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,16435,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL621628,,9554,,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,16435,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL875328,,9555,,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,16435,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL621629,,9556,,,Radioactivity distribution in spleen of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,16435,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL621630,,9557,,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,16434,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL621631,,9558,,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,16434,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL621632,,9559,,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,16434,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL621633,,9560,,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,16435,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL621634,,9561,,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,16435,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL621635,,9562,,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,16435,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL621636,,9563,,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,16435,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL621637,,9564,,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,16435,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL621638,,9565,,,Radioactivity distribution in spleen of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618883,,9566,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618884,,9567,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 30 min.,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628627,,9568,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628628,,9569,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628629,,9570,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min.,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628630,,9571,,,Half life after administering orally a dose of 3 mg/kg,16365,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628631,,9572,,,Half life after administering orally a dose of 3 mg/kg to a fasting rat,16365,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628632,,9573,,,Half life after administering intravenously a dose of 1 mg/kg,16365,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628633,,9574,,,Half life after oral dosing in rats,526,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628634,,9575,,,Half life after the administered orally a dose of 1 mg/kg to a fasting rat,16365,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627789,,9576,,,Half life by intravenous administration of 3.4 mg/kg in rat,4368,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627790,,9577,,,Half life in rat,3371,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627791,,9578,,,Half life in rat,6448,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627792,,9579,,,Half life in rat,6453,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627793,,9580,,,Half life in rat after intravenous administration of the compound,4353,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL627794,,9581,,,Half life in rat after intravenous administration of the compound; nf:unable to estimate plasma elimination half life,4353,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627795,,9582,,,Half life in rat after po administration of the compound,4353,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627796,,9583,,,Half life in rat after po administration of the compound; ND means Not determined,4353,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL875335,,9584,,,Half life in rat after po administration of the compound; nf: unable to estimate plasma elimination half life,4353,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL627797,,9585,,,Half life in rat after po administration of the compound; nf:unable to estimate plasma elimination half life,4353,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627798,,9586,,,Half life in rat i.v.,5789,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627799,,9587,,,Half life in rat i.v. at 2 mg/kg concentration,17686,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627800,,9588,,,Half life in rats,6495,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627801,,9589,,,Half life in rats after intravenous administration,484,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627802,,9590,,,Half life in rats at the dose of 1.0 mpk by i.v. administration,6467,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Expert,1,N,,1,,,,CHEMBL627803,,9591,,,Half life in rat,6642,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL873820,,9592,,,Half life was evaluated after intravenous administration to rats,16367,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627804,,9593,,,Half life was evaluated by addition of 2 mM of 2-mercaptoethanol for inactivation of semicarbazide-sensitive amine oxidase (SSAO),1369,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627805,,9594,,,Half life was evaluated in rat,5472,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627806,,9595,,,Half life was evaluated in rat,6049,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627107,,9596,,,Half life was evaluated in rat; Not tested,5472,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627108,,9597,,,Half life was evaluated when a dose of 1 mg/kg was administered intravenously to rats,16366,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627109,,9598,,,Half life was measured as time taken to reach the half of the initial dose in air pouch exudate after oral administration to male F344 rats,11149,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL627110,,9599,,,Half life was measured as time taken to reach the half of the initial dose in the blood after oral administration to male F344 rats,11149,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Intermediate,0,U,,1,,,In vivo,CHEMBL627111,,9600,,,Half life was measured in monkey at dose of 10 mg/kg by po administration,2891,Primates,9443.0
22224,,A,,,BAO_0000218,Intermediate,0,U,,1,,,In vivo,CHEMBL627112,,9601,,,Half life was measured in monkey at dose of 10 mg/kg by po administration,2891,Primates,9443.0
22224,,A,,,BAO_0000218,Intermediate,0,U,,1,,,In vivo,CHEMBL627113,,9602,,,Half life was measured in rat at dose of 30 mg/kg by iv administration,2891,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Intermediate,0,U,,1,,,In vivo,CHEMBL627114,,9603,,,Half life was measured in rat at dose of 30 mg/kg by po administration,2891,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627115,,9604,,,Half life (t1/2) was determined,4026,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627116,,9605,,,Half life period at a dose of 10 uM/kg in rat was determined,4527,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627117,,9606,,,Half life period by oral administration at a dose of 100 uM/kg in rat was determined; ND is not determined,4527,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627118,,9607,,,Half life period was determined,5503,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627119,,9608,,,Half life period after intravenous administration at 20 mpk in rats,4426,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627120,,9609,,,Half life period after intravenous administration at 20 mpk in rats; Not performed.,4426,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626922,,9610,,,Half life period after intravenous administration in rat,6109,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626923,,9611,,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,5654,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626924,,9612,,,Half life period as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,5654,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626925,,9613,,,Half life period in 80% rat plasma at 37 degree Centigrade,4755,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626926,,9614,,,Half life period in SD rats,5862,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626927,,9615,,,Half life period in human plasma at 25 degree Celsius temperature (pH 7.4),1515,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626928,,9616,,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4),1515,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626929,,9617,,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,1515,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626930,,9618,,,Half life period in human plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,1515,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626931,,9619,,,Half life period in rat,5960,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626932,,9620,,,Half life period in rat,6103,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626933,,9621,,,Half life period in rat,6317,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL873826,,9622,,,Half life period in rat after oral administration at 10.5 mg/kg dose,6644,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626934,,9623,,,Half life period in rat after oral administration at 11.2 mg/kg dose,6644,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626935,,9624,,,Half life period in rat after oral administration at 13 mg/kg dose,6644,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626936,,9625,,,Half life period in rat after oral administration at 9.7 mg/kg dose,6644,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626937,,9626,,,In vivo Area under curve (AUC) was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625906,,9627,,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,6295,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625907,,9628,,,In vivo area under curve in rat plasma exposure after oral administration 50 mg/kg,6296,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625908,,9629,,,PK study was carried to determine AUC (area under curve) value in rat,16427,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625909,,9630,,,Pharmacokinetic parameter AUC after intravenous administration to rats,16367,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625910,,9631,,,Pharmacokinetic parameter AUC after oral administration to rats,16367,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625911,,9632,,,Pharmacokinetic parameter AUC was evaluated intravenous administration of 3 mg/kg,16365,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625912,,9633,,,Pharmacokinetic parameter AUC was evaluated when a dose of 10 mg/kg is administered orally to a fasting rat,16365,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626538,,9634,,,Pharmacokinetic parameter AUC was evaluated when a dose of 1 mg/kg is administered orally to a fasting rat,16365,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL876794,,9635,,,Pharmacokinetic parameter AUC was evaluated when a dose of 30 mg/kg is administered orally,16365,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626539,,9636,,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally,16365,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626540,,9637,,,Pharmacokinetic parameter AUC was evaluated when a dose of 3 mg/kg is administered orally to a fasting rat,16365,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626541,,9638,,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into monkey at 3 mg/kg,5394,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626542,,9639,,,Pharmacokinetic parameter area under curve (AUC) was measured after administration into rat at 10 mg/kg,5394,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626543,,9640,,,Pharmacokinetic parameter area under curve was determined at 10 mg/kg po dose in rats,2792,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626544,,9641,,,Pharmacokinetic parameter area under curve was determined at 2 mg/kg i.v. dose in rats,2792,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626545,,9642,,,Pharmacokinetic parameter area under curve was determined at 3 mg/kg po dose in rats,2792,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626546,,9643,,,Pharmacokinetic parameter area under curve was determined at 5 mg/kg i.v. dose in rats,2792,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626547,,9644,,,Pharmacokinetic parameter area under curve was reported,5334,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626548,,9645,,,Pharmacokinetic property (AUC) in rat,4408,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626549,,9646,,,Pharmacokinetic property (AUC) was measured in rat at the dose of 0.32 mg/kg p.o.,5983,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626550,,9647,,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.,4397,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626551,,9648,,,Pharmacokinetic property at the dose of 10 mg/kg (20% HPbetaCD) concentration in rat (0 to 6 hr) p.o.; Not tested,4397,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623777,,9649,,,Pharmacokinetic property was determined,5491,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623778,,9650,,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg,5491,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623779,,9651,,,Pharmacokinetic property when administered intravenously in rat at 2 mg/kg; Not tested,5491,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL623780,,9652,,,Pharmacokinetic property( plasma concentration) was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,4199,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622015,,9653,,,Pharmacokinetic property( plasma concentration) was determined upon 2 mg/kg in 1% methylcellulose peroral administration in rats,4199,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622016,,9654,,,Pharmacokinetic property( plasma concentration) was determined upon 3 mg/kg in 1% methylcellulose peroral administration in rats,4199,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622017,,9655,,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.25 h",5173,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622018,,9656,,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 0.5 h",5173,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622019,,9657,,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 1 h",5173,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622020,,9658,,,"Pharmacokinetic property, AUC determined by rapid rat PK assay observed at 2 h",5173,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622021,,9659,,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered intravenously,16366,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622022,,9660,,,Pharmacokinetic parameter AUC was determined when a dose of 1 mg/kg was administered orally,16366,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622023,,9661,,,Plasma concentration expressed as area under curve after intravenous administration was determined in rat,5327,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622024,,9662,,,Plasma concentration for the compound was determined in rats at 50 mg/kg dose,6681,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622693,,9663,,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of solution (formulation of compound),12873,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622694,,9664,,,Plasma concentration was calculated in rats at a peroral dose of 5 mg/kg of suspension (formulation of compound),12873,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622695,,9665,,,"Plasma concentration was determined in rats at 10 mg/kg, p.o. dose",6685,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622696,,9666,,,"Plasma concentration was determined in rats at 20 mg/kg, i.p. dose",6685,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622697,,9667,,,"Plasma concentration was determined in rats at 2 mg/kg, i.v. dose",6685,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622874,,9668,,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (20 mg/kg, 30 min pre-treatment)",6619,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622875,,9669,,,"Reduction in area under curve was determined in fa/fa Zucker rats by oral glucose tolerance test following a single i.p. dose (30 mg/kg, 30 min pre-treatment)",6619,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622876,,9670,,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,10363,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622877,,9671,,,Systemic AUC was determined by pharmacokinetic study conducted in portal vein cannulated rats,4796,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622878,,9672,,,Tested for concentration in brain after intravenous administration (4.7 mg/kg) to male rats,4910,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622879,,9673,,,Tested for plasma concentration after intravenous administration (4.7 mg/kg) to male rats,4910,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL877602,,9674,,,Tested for the pharmacokinetic parameter in rat and expressed as area under curve,4839,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622880,,9675,,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",15078,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622881,,9676,,,"The AUC(0-infinitive) value in male wistar rat at 100 mg/kg, p.o. dose",15078,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622882,,9677,,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",15078,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622883,,9678,,,"The AUC(0-t)value in male wistar rat at 100 mg/kg, p.o. dose",15078,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL622884,,9679,,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (10.7 uCi/animal); value ranges from 2.16-2.39% dose/g",11450,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL622885,,9680,,,"Distribution of the radioiodinated compound expressed as percent dose per organ, in thyroid of unfasted rats after 60 mins of intravenous administration (11.5 uCi/animal); value ranges from 0.99-1.40 % dose/g",11450,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622886,,9681,,,Antidiuretic activity expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,8151,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622887,,9682,,,Antidiuretic activity expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,8151,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622888,,9683,,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,8151,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL622889,,9684,,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL622890,,9685,,,"Biodistribution in Sprague-Dawley rat blood 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL622891,,9686,,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL877603,,9687,,,"Biodistribution in Sprague-Dawley rat blood 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL622892,,9688,,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL622893,,9689,,,"Biodistribution in Sprague-Dawley rat brain 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL622894,,9690,,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL622895,,9691,,,"Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL622896,,9692,,,Biodistribution in Sprague-Dawley rat brain 2 minutes after intravenous administration.,8677,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL622897,,9693,,,"Biodistribution in Sprague-Dawley rat heart 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL622898,,9694,,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL622899,,9695,,,"Biodistribution in Sprague-Dawley rat heart 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL622900,,9696,,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL624114,,9697,,,"Biodistribution in Sprague-Dawley rat kidneys(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL624115,,9698,,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL624116,,9699,,,"Biodistribution in Sprague-Dawley rat kidneys(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL624117,,9700,,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL624118,,9701,,,"Biodistribution in Sprague-Dawley rat liver 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL624119,,9702,,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL624120,,9703,,,"Biodistribution in Sprague-Dawley rat liver 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL624121,,9704,,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL624122,,9705,,,"Biodistribution in Sprague-Dawley rat lungs(2) 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL624123,,9706,,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL624124,,9707,,,"Biodistribution in Sprague-Dawley rat lungs(2) 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL624125,,9708,,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL624126,,9709,,,"Biodistribution in Sprague-Dawley rat muscle 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL624127,,9710,,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL624128,,9711,,,"Biodistribution in Sprague-Dawley rat muscle 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Zone of skin,A,,,BAO_0000218,Intermediate,1,N,14.0,1,,,In vivo,CHEMBL624129,,9712,,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Zone of skin,A,,,BAO_0000218,Intermediate,1,N,14.0,1,,,In vivo,CHEMBL624130,,9713,,,"Biodistribution in Sprague-Dawley rat skin 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Zone of skin,A,,,BAO_0000218,Intermediate,1,N,14.0,1,,,In vivo,CHEMBL622340,,9714,,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Zone of skin,A,,,BAO_0000218,Intermediate,1,N,14.0,1,,,In vivo,CHEMBL622341,,9715,,,"Biodistribution in Sprague-Dawley rat skin 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Intestine,A,,,BAO_0000218,Intermediate,1,N,160.0,1,,,In vivo,CHEMBL622342,,9716,,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Intestine,A,,,BAO_0000218,Intermediate,1,N,160.0,1,,,In vivo,CHEMBL622343,,9717,,,"Biodistribution in Sprague-Dawley rat small intestine 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Intestine,A,,,BAO_0000218,Intermediate,1,N,160.0,1,,,In vivo,CHEMBL622344,,9718,,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Intestine,A,,,BAO_0000218,Intermediate,1,N,160.0,1,,,In vivo,CHEMBL622345,,9719,,,"Biodistribution in Sprague-Dawley rat small intestine 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL622346,,9720,,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL622347,,9721,,,"Biodistribution in Sprague-Dawley rat spleen 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL622348,,9722,,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL622349,,9723,,,"Biodistribution in Sprague-Dawley rat spleen 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622350,,9724,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 30 min.,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622351,,9725,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min.,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622352,,9726,,,Radioactivity distribution in testis of normal fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min.,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622353,,9727,,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 120 min.,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622354,,9728,,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 30 min.,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622355,,9729,,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 5 min.,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622356,,9730,,,Radioactivity distribution in testis of normal fischer rat after injection of anti-[18F]FMACBC after 60 min.,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622357,,9731,,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 120 min.,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622358,,9732,,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 30 min.,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622359,,9733,,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 5 min.,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL874393,,9734,,,Radioactivity distribution in testis of normal fischer rat after injection of syn-[18F]-FMACBC after 60 min.,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622872,,9735,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622873,,9736,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623047,,9737,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623048,,9738,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623049,,9739,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623050,,9740,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623051,,9741,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623052,,9742,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626343,,9743,,,Radioactivity distribution in testis of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626344,,9744,,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 120 min.,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626345,,9745,,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 5 min.,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626346,,9746,,,Radioactivity distribution in tumor of normal fischer rat after injection of [18F]-fluoro-2-methyl-2-(methylamino)propanoic acid after 60 min.,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626347,,9747,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 120 min,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626348,,9748,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 5 min,16434,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626349,,9749,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of [18F]fluoro-2-methylpropanoic acid after 60 min,16434,Rattus norvegicus,10116.0
50597,,F,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626350,,9750,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 120 min,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626351,,9751,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 5 min,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627650,,9752,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of anti-[18F]FMACBC after 60 min,16435,Rattus norvegicus,10116.0
50597,,F,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627651,,9753,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 120 min,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627652,,9754,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 5 min,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627653,,9755,,,Radioactivity distribution in tumor of tumor-bearing fischer rat after injection of syn-[18F]-FMACBC after 60 min,16435,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627654,,9756,,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr blocked time interval,13091,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627835,,9757,,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr low time interval,13091,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627836,,9758,,,Tissue biodistribution into estrogen-primed immature female rat blood at 1 hr time interval,13091,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627837,,9759,,,Tissue biodistribution into estrogen-primed immature female rat blood at 3 hr time interval,13091,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627838,,9760,,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr blocked time interval,13091,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL875338,,9761,,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr low time interval,13091,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627839,,9762,,,Tissue biodistribution into estrogen-primed immature female rat bone at 1 hr time interval,13091,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627840,,9763,,,Tissue biodistribution into estrogen-primed immature female rat bone at 3 hr time interval,13091,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627841,,9764,,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr blocked time interval,13091,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627842,,9765,,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr low time interval,13091,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627843,,9766,,,Tissue biodistribution into estrogen-primed immature female rat brain at 1 hr time interval,13091,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627844,,9767,,,Tissue biodistribution into estrogen-primed immature female rat brain at 3 hr time interval,13091,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627845,,9768,,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr blocked time interval,13091,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627846,,9769,,,Half life period in rat by iv administration at a dose of 3 mg/kg,5874,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL627847,,9770,,,Half life period in rat plasma at 25 degree Centigrade temperature (pH 7.4),1515,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL873821,,9771,,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4),1515,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626079,,9772,,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,1515,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626080,,9773,,,Half life period in rat plasma at 37 degree Celsius temperature (pH 7.4); ND means no data,1515,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626081,,9774,,,Half life period was evaluated in rat plasma,5491,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL875344,,9775,,,Half life period was evaluated in rat plasma; Not tested,5491,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626082,,9776,,,Half life period was evaluated in rats,1918,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626250,,9777,,,"Half life period was evaluated in rats, iv",1918,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626251,,9778,,,Half life period after intravenous administration at 5 mg/kg in rat,6113,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626252,,9779,,,Half life period was determined in Sprague-Dawley rats at a dose of 1 mg/kg by iv administration,5546,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626253,,9780,,,Half life period was determined in rat after iv administration at a dose of 5 mg/kg,5553,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626254,,9781,,,Half life stability of compound was evaluated in rat plasma,4188,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626255,,9782,,,Half life time after intravenous administration (5.0 mg/kg) was determined in rat,6215,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626256,,9783,,,Half life time was evaluated at 1 mg/kg of iv administration in Sprague-Dawley rats,6141,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626257,,9784,,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,5182,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626258,,9785,,,Half life was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat; NC means not calculated,5182,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626259,,9786,,,Half life was measured in fasted male administration of compound 0.5 mg/Kg i.v.,5710,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626260,,9787,,,Half in rat i.v.,5789,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL875345,,9788,,,Half period in rat after intravenous administration,6011,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626261,,9789,,,Half-life after repeated oral dose of compound at 1 mg/kg in rats,17594,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vitro,CHEMBL626262,,9790,,,Half-life measured in in vitro Cathepsin B assay in rat liver,12357,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626263,,9791,,,Half-life of compound was determined in rats,5210,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625270,,9792,,,Half-life at 10 mg/kg in rat upon intravenous administration,17596,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625271,,9793,,,Half-life determined in rat,6672,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625272,,9794,,,Half-life determined in rat,6673,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL625273,,9795,,,Half-life in brain after intravenous administration (4.7 mg/kg) to male rats,4910,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL625274,,9796,,,"Half-life in chemical and enzymatic hydrolysis, in 80% rat plasma",3741,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625275,,9797,,,Half-life in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,17671,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL625276,,9798,,,Half-life in plasma after intravenous administration (4.7 mg/kg) to male rats,4910,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL625277,,9799,,,Half-life in rat plasma,17537,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL625278,,9800,,,Half-life in rat plasma was determined,4965,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL625279,,9801,,,Half-life in rat plasma; Not tested,17537,Rattus norvegicus,10116.0
50597,Serum,A,,,BAO_0000218,Intermediate,1,N,1977.0,1,,,,CHEMBL625280,,9802,,,Half-life in rat serum,6124,Rattus norvegicus,10116.0
50597,Serum,A,,,BAO_0000218,Intermediate,1,N,1977.0,1,,,,CHEMBL876797,,9803,,,Half-life in rat serum; na is not available,6124,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625281,,9804,,,Half-life was calculated in rat,6078,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL873827,,9805,,,Half-life was calculated in rat plasma,17668,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625282,,9806,,,Half-life was determined,3185,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625283,,9807,,,Half-life was determined,4883,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625284,,9808,,,Half-life after administration of 20 mg/Kg oral dose in rat,2959,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625285,,9809,,,Half-life after administration of 3.2 mg/kg intravenously in male rat,4029,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625286,,9810,,,Half-life after intravenous administration in female rat,4029,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625287,,9811,,,Half-life after intravenous administration in male rat,4029,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625288,,9812,,,Half-life after intravenous dose in rat,6180,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625289,,9813,,,Half-life in a rat liver homogenate preparation,1557,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL625290,,9814,,,Half-life in plasma of rat,12500,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL876798,,9815,,,Half-life in plasma of rat at dose of 3-10 mgkg,12500,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625291,,9816,,,Half-life in rat,5064,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625292,,9817,,,Half-life in rat,5145,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625293,,9818,,,Half-life in rat,5147,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622832,,9819,,,Half-life in rat,5833,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622833,,9820,,,Half-life in rat,6596,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622834,,9821,,,Half-life in rat,17655,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622835,,9822,,,Half-life in rat after oral administration at 10 mg/kg,6495,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622836,,9823,,,Half-life in rat after po administration at a dose of 10 mg/kg,17538,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622837,,9824,,,Half-life in rat after po administration at a dose of 10 mg/kg; nd is not determined,17538,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622838,,9825,,,Half-life in rat at 3 mg/kg dose administered intravenously,10,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL622839,,9826,,,Half-life in rat brain homogenate,17669,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622840,,9827,,,Half-life in rat plasma,17065,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622841,,9828,,,Half-life in rats,4333,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622842,,9829,,,Half-life in Dawley rats,6827,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vitro,CHEMBL622843,,9830,,,Half-life in vitro in rat plasma,889,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vitro,CHEMBL622844,,9831,,,Half-life in vitro in rat plasma; No detectable degradation over 2 hr; no detectable degradation over 2 hours,889,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622845,,9832,,,"The area under concentration-time curve(AUC) was determined at 20 mg/kg of compound dose, administered intravenously in rat",3747,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622846,,9833,,,The area under the curve of compound was measured at the dose of 100 umol/kg,15022,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622847,,9834,,,The area under the curve of compound was measured at the dose of 300 umol/kg,15022,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622848,,9835,,,The area under the curve of compound was measured at the dose of 30 umol/kg,15022,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622849,,9836,,,Bioavailability as oral AUC in rats,3360,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622850,,9837,,,The plasma concentration versus time curve (AUC) was determined,5334,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL876807,,9838,,,Total concentration in kidney was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,17411,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622851,,9839,,,Total concentration in liver was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,17411,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622852,,9840,,,Total concentration in lung was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,17411,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622853,,9841,,,Total concentration in rat after 1 mg/kg i.v. administration in 24 hours,6570,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622854,,9842,,,Total concentration in rat after 2 mg/kg peroral administration in 24 hours,6570,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622855,,9843,,,Total concentration in serum was determined after 6 hr of intravenous administration to rats (n=4) at dose of 20 mg/kg,17411,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622856,,9844,,,"Pharmacokinetic Parameter, AUC (0-infinity) is the area under the plasma concentration versus time curve extrapolated to infinity in Female Wistar Rats at 100 mg/kg by po administration",14941,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622857,,9845,,,"Pharmacokinetic Parameter, AUC (0-t) is the area under the plasma concentration versus time curve in Female Wistar Rats at 100 mg/kg by po administration",14941,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622858,,9846,,,AUC in rat after po administration at a dose of 10 mg/kg,17538,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622859,,9847,,,Area under the plasma concentration-time curve in rats after oral administration at 25 mg/kg,17752,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622860,,9848,,,Area under curve value 24 hr after 10 mg/kg iv administration in rats,17509,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622861,,9849,,,Area under curve value 24 hr after 10 mg/kg oral administration in rats,17509,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622862,,9850,,,Area under curve value 24 hr after 2 mg/kg iv administration in rats,17509,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622863,,9851,,,Area under curve value 24 hr after 2 mg/kg oral administration in rats,17509,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623817,,9852,,,Area under curve value 6 hr after po administration in rat,17509,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623818,,9853,,,Area under the curve at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,17717,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623819,,9854,,,"Area under the curve at a concentration of 3 mg/kg in rats, intravenously",17717,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623820,,9855,,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,17717,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623821,,9856,,,Area under the curve at a concentration of 60 mg/kg perorally in rats along with control,17717,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL623822,,9857,,,AUC normalized for dose (AUCN) in rat,6642,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623823,,9858,,,Area under curve in rat after p.o. administration,6640,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623824,,9859,,,Area under curve in rat after p.o. administration,6641,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623825,,9860,,,Area under curve in rat after p.o. administration; Not determined,6641,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622070,,9861,,,Area under curve in rat after peroral administration,6641,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622071,,9862,,,Area under curve (carotid artery) value of the compound,3603,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622072,,9863,,,Bioavailability expressed as the area under curve of rat carotid artery,3550,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622073,,9864,,,Area under curve in male SD rats was observed after intravenous administration in rat,15662,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622074,,9865,,,Area under curve of the compound was determined,17720,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622075,,9866,,,Compound was evaluated for its pharmacokinetic parameter maximum area under curve AUCmax,5407,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622076,,9867,,,Area under the plasma concentration-time curve in rats after oral administration at 20 mg/kg,17752,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622077,,9868,,,Area under the plasma concentration-time curve in rats following oral administration at 20 mg/kg,17752,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622078,,9869,,,Area under curve (portal vein) value of the compound,3603,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622079,,9870,,,Bioavailability expressed as the area under curve of rat portal vein,3550,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622080,,9871,,,Area Under plasma concentration time curve in rat upon peroral administration,17655,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL877612,,9872,,,In vivo area under curve was determined for the compound after i.v. administration at a dose of 5 mg/kg in rats,17582,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622081,,9873,,,In vivo area under curve was determined for the compound after oral (po) administration at a dose of 10 mg/kg in rats,17582,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622082,,9874,,,Compound was evaluated for oral bioavailability in rats,17791,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622083,,9875,,,Compound was evaluated for oral bioavailability in rats after iv administration,17791,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622084,,9876,,,Compound was evaluated for oral bioavailability in rats; 30-80,17791,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622085,,9877,,,Compound was evaluated for oral bioavailability in rats; 50-60,17791,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622086,,9878,,,Compound was evaluated for oral bioavailability in rats; no data,17791,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622087,,9879,,,Compound was evaluated for oral bioavailability in rats; peptide,17791,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL622088,,9880,,,"Distribution of radioactivity in blood of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.03",7768,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL622089,,9881,,,"Distribution of radioactivity in blood of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range-0.9-1.03",7768,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL623685,,9882,,,"Distribution of radioactivity in blood of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.88-1.15",7768,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL623686,,9883,,,"Distribution of radioactivity in blood of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range = 0.71-0.87",7768,Rattus norvegicus,10116.0
50597,Stomach,A,,,BAO_0000218,Intermediate,1,N,945.0,1,,,In vivo,CHEMBL623687,,9884,,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Stomach,A,,,BAO_0000218,Intermediate,1,N,945.0,1,,,In vivo,CHEMBL623688,,9885,,,"Biodistribution in Sprague-Dawley rat stomach 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Stomach,A,,,BAO_0000218,Intermediate,1,N,945.0,1,,,In vivo,CHEMBL623689,,9886,,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Stomach,A,,,BAO_0000218,Intermediate,1,N,945.0,1,,,In vivo,CHEMBL622485,,9887,,,"Biodistribution in Sprague-Dawley rat stomach 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,In vivo,CHEMBL622486,,9888,,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,In vivo,CHEMBL877613,,9889,,,"Biodistribution in Sprague-Dawley rat thyroid 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,In vivo,CHEMBL622487,,9890,,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,In vivo,CHEMBL622488,,9891,,,"Biodistribution in Sprague-Dawley rat thyroid 2 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL622489,,9892,,,"Biodistribution in Sprague-Dawley rats heart 15 minutes after intravenous administration, [99mTc]/[125I]IAP ratio)",8677,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622490,,9893,,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,6899,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622491,,9894,,,Compound was evaluated for percent dimer tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,6899,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL622492,,9895,,,Compound was evaluated for percent dose tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in liver,6899,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622493,,9896,,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,6899,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622494,,9897,,,Compound was evaluated for percent thiol tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine; na - not available,6899,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL622495,,9898,,,"Compound was evaluated for the biodistribution in Sprague-Dawley rats in muscle 15 minutes after intravenous administration, [99mTc]/[125I] IAP ratio)",8677,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622496,,9899,,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in rat kidney,6899,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622497,,9900,,,Compound was evaluated for tissue distribution 24 hours after a 50 mg/kg dose was administered intravenously in urine,6899,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622498,,9901,,,Percent of radioactive dose in urine and faeces excreted in 0-24 hr by rats,2189,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL624918,,9902,,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats,2189,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL624919,,9903,,,Percent of radioactive dose in urine and feces excreted in 0-24 hr by rats; NA is <10% inhibition at 1 uM for binding data,2189,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL624920,,9904,,,Biodistribution of compound in rat blood after 5 min of administration,10839,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL624921,,9905,,,Biodistribution of compound in rat blood after 5 min of administration.,10839,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL624922,,9906,,,Biodistribution of compound in rat brain after 5 min of administration,10839,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL624923,,9907,,,Biodistribution of compound in rat heart after 5 min of administration,10839,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL624924,,9908,,,Biodistribution of compound in rat heart after 5 min of administration.,10839,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL624925,,9909,,,Biodistribution of compound in rat kidney after 5 min of administration,10839,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL624926,,9910,,,Biodistribution of compound in rat kidney after 5 min of administration.,10839,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL624927,,9911,,,Biodistribution of compound in rat liver after 5 min of administration,10839,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL874402,,9912,,,Biodistribution of compound in rat liver after 5 min of administration.,10839,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL624928,,9913,,,Biodistribution of compound in rat lung after 5 min of administration,10839,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL624929,,9914,,,Biodistribution of compound in rat lung after 5 min of administration.,10839,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL624930,,9915,,,Biodistribution of compound in rat muscle after 5 min of administration,10839,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL624931,,9916,,,Biodistribution of compound in rat muscle after 5 min of administration.,10839,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624932,,9917,,,In vivo heart distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,4043,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624933,,9918,,,In vivo heart distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,4043,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL624934,,9919,,,In vivo liver distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,4043,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL624935,,9920,,,In vivo liver distribution of total doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,4043,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624936,,9921,,,In vivo plasma distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,4043,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624937,,9922,,,In vivo plasma distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,4043,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL624938,,9923,,,In vivo spleen distribution of free doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,4043,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL624939,,9924,,,In vivo spleen distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,4043,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624940,,9925,,,In vivo tumor distribution of free doxorubicin after 6 h intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,4043,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL874403,,9926,,,In vivo tumor distribution of total doxorubicin after 6 hr intravenous administration of 2.5 mg/kg of compound in rat bearing Walker 256 cells,4043,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624941,,9927,,,Compound was tested for the duration that the plasma drug concentrations remained above the IC95,1446,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL624942,,9928,,,Dose required to lower urine osmolality to 300 mOsm/kg in rat,9971,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL624943,,9929,,,Dose required to lower urine osmolality to 300 mOsm/kg in rat; NT=Not tested,9971,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624944,,9930,,,% Bioavailability after 1 day of the drug administration in rats,5765,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624945,,9931,,,% Bioavailability after 4 day of the drug administration in rats,5765,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624946,,9932,,,Absolute bioavailability was evaluated in rat,4257,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624947,,9933,,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr low time interval,13091,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624948,,9934,,,Tissue biodistribution into estrogen-primed immature female rat fat at 1 hr time interval,13091,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624949,,9935,,,Tissue biodistribution into estrogen-primed immature female rat fat at 3 hr time interval,13091,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL622025,,9936,,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr blocked time interval,13091,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL622026,,9937,,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr low time interval,13091,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL622027,,9938,,,Tissue biodistribution into estrogen-primed immature female rat kidney at 1 hr time interval,13091,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL622028,,9939,,,Tissue biodistribution into estrogen-primed immature female rat kidney at 3 hr time interval,13091,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL622029,,9940,,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr blocked time interval,13091,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL622208,,9941,,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr low time interval,13091,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL622209,,9942,,,Tissue biodistribution into estrogen-primed immature female rat liver at 1 hr time interval,13091,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL622210,,9943,,,Tissue biodistribution into estrogen-primed immature female rat liver at 3 hr time interval,13091,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622211,,9944,,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr blocked time interval,13091,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622212,,9945,,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr low time interval,13091,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622213,,9946,,,Tissue biodistribution into estrogen-primed immature female rat lung at 1 hr time interval,13091,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL874404,,9947,,,Tissue biodistribution into estrogen-primed immature female rat lung at 3 hr time interval,13091,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL620452,,9948,,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr blocked time interval,13091,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL620453,,9949,,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr low time interval,13091,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL620454,,9950,,,Tissue biodistribution into estrogen-primed immature female rat muscle at 1 hr time interval,13091,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL624067,,9951,,,Tissue biodistribution into estrogen-primed immature female rat muscle at 3 hr time interval,13091,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624068,,9952,,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr blocked time interval,13091,Rattus norvegicus,10116.0
50597,Female gonad,A,,,BAO_0000218,Intermediate,1,N,992.0,1,,,,CHEMBL624069,,9953,,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr low time interval,13091,Rattus norvegicus,10116.0
50597,Female gonad,A,,,BAO_0000218,Intermediate,1,N,992.0,1,,,,CHEMBL624070,,9954,,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 1 hr time interval,13091,Rattus norvegicus,10116.0
50597,Female gonad,A,,,BAO_0000218,Intermediate,1,N,992.0,1,,,,CHEMBL624071,,9955,,,Tissue biodistribution into estrogen-primed immature female rat ovaries at 3 hr time interval,13091,Rattus norvegicus,10116.0
50597,Uterus,A,,,BAO_0000218,Intermediate,1,N,995.0,1,,,,CHEMBL624072,,9956,,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr blocked time interval,13091,Rattus norvegicus,10116.0
50597,Uterus,A,,,BAO_0000218,Intermediate,1,N,995.0,1,,,,CHEMBL624073,,9957,,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr low time interval,13091,Rattus norvegicus,10116.0
50597,Uterus,A,,,BAO_0000218,Intermediate,1,N,995.0,1,,,,CHEMBL624788,,9958,,,Tissue biodistribution into estrogen-primed immature female rat uterus at 1 hr time interval,13091,Rattus norvegicus,10116.0
50597,Uterus,A,,,BAO_0000218,Intermediate,1,N,995.0,1,,,,CHEMBL624789,,9959,,,Tissue biodistribution into estrogen-primed immature female rat uterus at 3 hr time interval,13091,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624790,,9960,,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr blocked time interval,13091,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624791,,9961,,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr low time interval,13091,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624792,,9962,,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 1 hr time interval,13091,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624793,,9963,,,Tissue biodistribution into estrogen-primed immature female rat uterus/blood at 3 hr time interval,13091,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL877491,,9964,,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr blocked time interval,13091,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL624957,,9965,,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr low time interval,13091,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL624958,,9966,,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 1 hr time interval,13091,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL624959,,9967,,,Tissue biodistribution into estrogen-primed immature female rat uterus/muscle at 3 hr time interval,13091,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624960,,9968,,,Dissociation constant was determined,11977,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624961,,9969,,,"Pharmacokinetic Parameter, Kel is elimination rate constant in Female Wistar Rats at 100 mg/kg by po administration",14941,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624962,,9970,,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",15078,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624963,,9971,,,"The Kel value in male wistar rat at 100 mg/kg, p.o. dose",15078,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624964,,9972,,,Observed rate constant in 80% rat plasma at 37 degree Centigrade,4755,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624965,,9973,,,LogP value was evaluated in the in situ rat gut perfusion assay,589,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624966,,9974,,,In vivo retention time was evaluated for the compound after i.v. administration at a dose of 5 mg/kg was measured in rats,17582,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624967,,9975,,,Mean residence time (Pharmacokinetic property) after i.v. administration in rats,5031,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624968,,9976,,,Mean-residence time of compound after intravenous administration in rats at 24 uM/kg,17764,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624969,,9977,,,Mean residence time at a dose of 4 mg/kg in Rat Plasma after iv administration,17720,Rattus norvegicus,10116.0
50597,,F,,,BAO_0000218,Expert,1,N,,1,,,,CHEMBL624970,,9978,,,Streptococcal cell wall-washed arthritis model in rats at 10.0 mg/kg peroral dose,2862,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624971,,9979,,,Half-life was evaluated after 10 uM/kg of intra arterial administration,16423,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624972,,9980,,,Half-life was evaluated after 20 uM/kg of peroral administration,16423,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624973,,9981,,,Half-life was evaluated after i.v. administration in rat at a dose of 1 mg/kg,6005,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL624974,,9982,,,Half-life was evaluated in plasma of rat,2938,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624975,,9983,,,Half-life was evaluated in rats at an intravenous dose of 3 mg/kg,6410,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL877492,,9984,,,Half-life was evaluated in rats at an oral dose of 30 mg/kg,6410,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624976,,9985,,,Half-life was measured in rat after an iv dose of 1 mg/kg,6062,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624977,,9986,,,Half-life period of compound in rats after peroral administration,6571,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626848,,9987,,,Half-life period of compound was measured in rat plasma.,3136,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626849,,9988,,,Half-life period of compound was measured in rat plasma; ND is not determined,3136,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626850,,9989,,,Half-life period of compound was measured in rat plasma; not determined,3136,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626851,,9990,,,Half-life period in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,4521,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626852,,9991,,,Half-life period in rat by iv administration,5871,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626853,,9992,,,Half-life period in rats following intravenous administration at 2 mg/kg,6077,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626854,,9993,,,Half-life period was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,6679,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627486,,9994,,,Half-life period was determined for the compound in rat,5144,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627487,,9995,,,"Half-life period was evaluated in rat, after administering 1 mg/kg intravenously",4498,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627488,,9996,,,"Half-life period was evaluated in rat, after administering 10 mg/kg orally",4498,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627489,,9997,,,Half-life value after IV dose at a dose of 5 mg/kg in rats.,1908,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627490,,9998,,,Half-life was determined by iv administration (1.5 mg/kg) in fasted male Sprague-Dawley rats,6211,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL873829,,9999,,,Half-life was determined in rat after intravenous administration (0.5 mg/kg),5529,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627655,,10000,,,Half-life was determined in rat at a dose of 1 mpk i.v.,6444,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625994,,10001,,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND means not determined,6444,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625995,,10002,,,Half-life was determined in rat at a dose of 1 mpk i.v.; ND=not determined,6444,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625996,,10003,,,Half-life in rat,5207,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vitro,CHEMBL625850,,10004,,,In vitro half life in rat plasma,530,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vitro,CHEMBL625851,,10005,,,"In vitro half life at 1.5 -5.6ug/mL, 37 degree C in rat plasma",1116,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vitro,CHEMBL625852,,10006,,,In vitro half life in rat,3219,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625853,,10007,,,In vivo half life period after intravenous administration in rat,6109,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625854,,10008,,,In vivo half-life period for compound after i.v. administration at a dose of 5 mg/kg was measured in rats,17582,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL874450,,10009,,,In vivo half-life period for compound after oral (po) administration at a dose of 10 mg/kg was measured in rats,17582,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625855,,10010,,,In vivo t1/2 was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625856,,10011,,,In vivo t1/2 was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625857,,10012,,,In vivo t1/2 was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL873831,,10013,,,In vivo t1/2 was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625858,,10014,,,Longer half-life in rat (i.v.) at 0.5 mpk,17853,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625859,,10015,,,Longer half-life in rat (p.o.) at 2.0 mpk,17853,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625860,,10016,,,Pharmacokinetic property (half life) in rat,3457,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625861,,10017,,,Pharmacokinetic parameter half-life was determined at 10 mg/kg po dose in rats,2792,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625862,,10018,,,Pharmacokinetic parameter half-life was determined at 2 mg/kg i.v. dose in rats,2792,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625863,,10019,,,Pharmacokinetic parameter half-life was determined at 3 mg/kg po dose in rats,2792,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625864,,10020,,,Pharmacokinetic parameter half-life was determined at 5 mg/kg i.v. dose in rats,2792,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625865,,10021,,,Pharmacokinetic property (t1/2) for the compound (5 mg/kg iv) was determined in rats,5739,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625866,,10022,,,Pharmacokinetic half time was determined intravenously in rats.,15765,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL625867,,10023,,,Plasma half life in rat after 5 mg/kg oral gavage; 6-8 hours,6567,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL625868,,10024,,,Plasma half life of hydrolysis of the compound,2448,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL625869,,10025,,,Plasma half life was reported after a intravenous dose of 1 mg/kg in Dawley rat,5423,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL874451,,10026,,,Plasma half life period was calculated in rat,4853,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL625870,,10027,,,Plasma half-life in Sprague-Dawley rats,4514,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL625871,,10028,,,Plasma half-life in Sprague-Dawley rats; Not determined,4514,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL625872,,10029,,,Plasma half-life in rats,1500,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL625873,,10030,,,Plasma half-life in rats; <MQL,1500,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL625874,,10031,,,Plasma half-life period (0-8 h) was determined,5334,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL625875,,10032,,,Plasma half-life period (0-8 h) was determined in Sprague-Dawley rat,5334,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL625876,,10033,,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Sprague-Dawley rat,5334,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL631258,,10034,,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Sprague-Dawley rat,5334,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL631259,,10035,,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 h administration of the compound,4956,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL631260,,10036,,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr administration of the compound; Not determined,4956,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL631261,,10037,,,"Distribution of radioactivity in blood of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range = 0.68-1.03",7768,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL631262,,10038,,,"Distribution of radioactivity in blood of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.45-0.48",7768,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL631263,,10039,,,"Distribution of radioactivity in blood of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range-0.81-1",7768,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631264,,10040,,,"Distribution of radioactivity in brain tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.007-0.008",7768,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631265,,10041,,,"Distribution of radioactivity in brain tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.18-0.22",7768,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631266,,10042,,,"Distribution of radioactivity in brain tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.77-0.97",7768,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631267,,10043,,,"Distribution of radioactivity in brain tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.08-0.13",7768,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631268,,10044,,,"Distribution of radioactivity in brain tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.25-0.37",7768,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631269,,10045,,,"Distribution of radioactivity in brain tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.03-0.04",7768,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631270,,10046,,,"Distribution of radioactivity in brain tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.74-0.94",7768,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL631271,,10047,,,"Distribution of radioactivity in heart tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",7768,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL631272,,10048,,,"Distribution of radioactivity in heart tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.5-0.63",7768,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL631273,,10049,,,"Distribution of radioactivity in heart tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.35-1.55",7768,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL631274,,10050,,,"Distribution of radioactivity in heart tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.24-0.38",7768,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL631275,,10051,,,"Distribution of radioactivity in heart tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.55-0.82",7768,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL626984,,10052,,,"Distribution of radioactivity in heart tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.16-0.2",7768,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL626985,,10053,,,"Distribution of radioactivity in heart tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.13-1.29",7768,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL626986,,10054,,,"Distribution of radioactivity in liver tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.02",7768,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL626987,,10055,,,"Distribution of radioactivity in liver tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.71-0.93",7768,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL626988,,10056,,,"Distribution of radioactivity in liver tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.91-3.53",7768,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL626989,,10057,,,"Distribution of radioactivity in liver tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.42-0.62",7768,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL626990,,10058,,,"Distribution of radioactivity in liver tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.97-1.41",7768,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL626991,,10059,,,"Distribution of radioactivity in liver tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.19-0.23",7768,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL626992,,10060,,,"Distribution of radioactivity in liver tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 2.49-2.82",7768,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL626993,,10061,,,"Distribution of radioactivity in lung tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 0.02-0.03",7768,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL874593,,10062,,,"Distribution of radioactivity in lung tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.66-0.77",7768,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL626994,,10063,,,"Distribution of radioactivity in lung tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 1.17-1.42",7768,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL626995,,10064,,,"Distribution of radioactivity in lung tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.47-0.58",7768,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL626190,,10065,,,"Distribution of radioactivity in lung tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.65-0.87",7768,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL626191,,10066,,,"Distribution of radioactivity in lung tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 0.28-0.31",7768,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL626364,,10067,,,"Distribution of radioactivity in lung tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 0.98-1.22",7768,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL626365,,10068,,,"Distribution of radioactivity in thyroid tissue of rats at 1 day after an intravenous injection; Value expressed as mean % injected dose, Range- 406-499",7768,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL626366,,10069,,,"Distribution of radioactivity in thyroid tissue of rats at 1 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 53.0-96",7768,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL626367,,10070,,,"Distribution of radioactivity in thyroid tissue of rats at 2 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.65-8.0.8",7768,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL626368,,10071,,,"Distribution of radioactivity in thyroid tissue of rats at 2 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 92-159",7768,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL626369,,10072,,,"Distribution of radioactivity in thyroid tissue of rats at 30 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 18.74-30.84",7768,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL626370,,10073,,,"Distribution of radioactivity in thyroid tissue of rats at 4 hr after an intravenous injection; Value expressed as mean % injected dose, Range- 156-207",7768,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626371,,10074,,,"Bioavailability (F) was evaluated in rat, after administering 1 mg/kg intravenously",4498,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626372,,10075,,,"Bioavailability (F) was evaluated in rat, after administering 10 mg/kg orally",4498,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626373,,10076,,,Bioavailability after a dose of 10 mg/kg p.o.,3603,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626374,,10077,,,Bioavailability after peroral administration (10 mg/kg) was determined in rat,6215,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626375,,10078,,,Bioavailability in fasted male administration of 2 mg/Kg of compound p.o.,5710,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626376,,10079,,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 2 mg/kg),5710,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626377,,10080,,,Bioavailability in rat po was determined,5676,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626378,,10081,,,Bioavailability of compound at 10 mg/kg in rat after oral administration,17667,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626379,,10082,,,Bioavailability of compound at 3 mg/kg in rat after i.v. administration,17667,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626380,,10083,,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),6848,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626381,,10084,,,Bioavailability in rat (dose 1 mg/kg i.v. and 2 mg/kg p.o.),6848,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626382,,10085,,,Bioavailability in rat,17267,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626383,,10086,,,Bioavailability in rat (Sprague-Dawley) (female),6362,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL874652,,10087,,,Bioavailability in male Sprague-Dawley rats following an intravenous bolus dose at 10-20 mg/kg,17671,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626384,,10088,,,Bioavailability in rat (Sprague-Dawley) (male) (dose 10-20 mg/kg),17671,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626385,,10089,,,Bioavailability in rat (Sprague-Dawley) (male) (dose 1 mg/kg i.v. and 3 mg/kg p.o.) measured from 0.3 to 6 hr,4333,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626386,,10090,,,Bioavailability in rat at an oral dose of 2 mg/kg,6077,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626387,,10091,,,Bioavailability in rat,3278,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626388,,10092,,,Bioavailability in rat,5964,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626389,,10093,,,Bioavailability in rat,4884,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626390,,10094,,,Bioavailability in rat,4905,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626391,,10095,,,Bioavailability in rat was reported at the dose of 6 mg/kg in 25% PEG-300,4884,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626392,,10096,,,Bioavailability in rat,6850,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626393,,10097,,,Oral bioavailability in rat,2864,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623026,,10098,,,Bioavailability was determined in rat,5780,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623027,,10099,,,Bioavailability,1465,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623028,,10100,,,Bioavailability,5199,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623029,,10101,,,Bioavailability in rat after 1 day dosing,5765,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623030,,10102,,,Bioavailability in rat after 4 day dosing,5765,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623031,,10103,,,Bioavailability after IV dosing at 0.5 mg/kg in rat; no data,6518,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623032,,10104,,,Bioavailability after IV dosing at 1 mg/kg in rat; no data,6518,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623033,,10105,,,Bioavailability after oral administration at a dose of 2 mg/kg in rat,6518,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623034,,10106,,,Bioavailability after oral administration at a dose of 4 mg/kg in rat,6518,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623035,,10107,,,Bioavailability at 4 hr after administration of 5 mg/kg dose peroral in rat,2083,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623036,,10108,,,Bioavailability at a dose of 10 mg/Kg administered perorally in female hanover-wistar rat,17260,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623037,,10109,,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),4956,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623038,,10110,,,Bioavailability by intravenous administration of 3.4 mg/kg in rat,4368,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL874385,,10111,,,Bioavailability from rat plasma at a single oral dose of 25 mg/kg,17752,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623039,,10112,,,Bioavailability in rat (Fisher) (fasted),1446,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Intermediate,0,U,,1,,,In vivo,CHEMBL623040,,10113,,,Bioavailability in monkey after po administration of 10 mg/kg dose,2891,Primates,9443.0
22224,,A,,,BAO_0000218,Intermediate,0,U,,1,,,In vivo,CHEMBL623041,,10114,,,Oral bioavailability in monkey (dose 10 mg/kg),2891,Primates,9443.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623741,,10115,,,Bioavailability in rat,6672,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623742,,10116,,,Bioavailability in rat,6673,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623743,,10117,,,Bioavailability in rat,17655,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623744,,10118,,,Bioavailability in rat,17796,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623745,,10119,,,Bioavailability in rat (dose 2.0 mg/kg p.o.),17853,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623746,,10120,,,Bioavailability in rat (dose 5 mg/kg p.o. and 1 mg/kg i.v.),4521,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623747,,10121,,,Oral bioavailability in rat (dose 5 mg/kg p.o.),4940,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Intermediate,0,U,,1,,,In vivo,CHEMBL623748,,10122,,,Bioavailability in rat after po administration of 30 mg/kg dose,2891,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Intermediate,0,U,,1,,,In vivo,CHEMBL623916,,10123,,,Bioavailability in rat after po administration of 30 mg/kg dose,2891,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623917,,10124,,,Bioavailability in rat after 5 mg/kg by oral and 1 mg/kg by intravenous administration,4521,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623918,,10125,,,Bioavailability in rat (dose 2 mg/kg i.v.),17686,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL874386,,10126,,,Bioavailability in rat,17796,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623919,,10127,,,Bioavailability in rat; Only traces detected in rat plasma,17796,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623920,,10128,,,Bioavailability in rat,5064,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623148,,10129,,,Bioavailability upon oral administration of compound,5147,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623149,,10130,,,Oral bioavailability in rat (Sprague-Dawley) (dose 15 mg/kg),1916,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623150,,10131,,,Bioavailability in rat,6049,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623151,,10132,,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fasting state",1445,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623152,,10133,,,"Bioavailability was evaluated in rats at a dose of 20 mg/kg, under fed state",1445,Rattus norvegicus,10116.0
50597,,F,,,BAO_0000218,Expert,1,N,,1,,,,CHEMBL623153,,10134,,,Streptococcal cell wall-washed arthritis model in rats at 3.0 mg/kg peroral dose,2862,Rattus norvegicus,10116.0
50597,,F,,,BAO_0000218,Expert,1,N,,1,,,,CHEMBL623154,,10135,,,Streptococcal cell wall-washed arthritis model in rats at 30.0 mg/kg peroral dose,2862,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623155,,10136,,,In vitro and metabolic stability was determined,4194,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623156,,10137,,,In vitro metabolic stability in rat hepatocytes,4194,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623157,,10138,,,In vitro metabolic stability in rat was measured as pmol/min/mg/protein,5486,Rattus norvegicus,10116.0
50597,Liver,A,,401.0,BAO_0000218,Intermediate,1,N,2107.0,1,,Hepatocyte,In vitro,CHEMBL623158,,10139,,,Metabolic rate for compound was observed in rat hepatocytes,17582,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623159,,10140,,,In vitro metabolic stability determined after 30 min of incubation in rat hepatic microsomes,5600,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL874390,,10141,,,Metabolism of compound in rat S9 microsomes ('+''indicates <20% largest observed peak),14294,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623160,,10142,,,Metabolism of compound in rat S9 microsomes ('++++' indicates largest observed peak),14294,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623161,,10143,,,Metabolism of compound in rat S9 microsomes; Trace,14294,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623162,,10144,,,Metabolism was measured as percent loss at 4 hr in rat hepatocytes,17847,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623163,,10145,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HIAA,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623164,,10146,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex 5-HT,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623165,,10147,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DA,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623166,,10148,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex DOPAC,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624983,,10149,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex HVA,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624984,,10150,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Frontal cortex NE,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624985,,10151,,,Momoamine and metabolic levels observed 1 week following acute dosing at a dose of 10 mg/kg Hippocampus 5-HIAA,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622970,,10152,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus 5-HT,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622971,,10153,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below level of detection,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622972,,10154,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DA; below the levels of detection,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622973,,10155,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below level of detection,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622974,,10156,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus DOPAC; below the levels of detection,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622975,,10157,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below level of detection,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622976,,10158,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus HVA; below the levels of detection,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622977,,10159,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 10 mg/kg Hippocampus NE,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624351,,10160,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HIAA,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624352,,10161,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex 5-HT,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624353,,10162,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622397,,10163,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DOPAC,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622398,,10164,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex HVA,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622399,,10165,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex NE,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622400,,10166,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Frontal cortex DA,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628428,,10167,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HIAA,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628590,,10168,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus 5-HT,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628591,,10169,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below level of detection,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628592,,10170,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DA; below the levels of detection,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628593,,10171,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL875333,,10172,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628594,,10173,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,11020,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL628595,,10174,,,Plasma half-life was determined in Sprague-Dawley rats after 0-8 hr of administration,4969,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL628596,,10175,,,Stability in rat plasma was determined,6737,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL628597,,10176,,,Stability in rat plasma was determined; ND= no data,6737,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL628598,,10177,,,Tested for plasma half life period in rat (0-8 hr),5089,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL628599,,10178,,,Tested for plasma half life period in rat (0-8 hr); Not determined,5089,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628600,,10179,,,Tested for t1/2 upon intravenous administration of 5.0 mg/Kg dose in rat,1466,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628601,,10180,,,Tested for t1/2 upon peroral administration of 10.0 mg/Kg dose in rat,1466,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628602,,10181,,,Tested for the half life in rat,4950,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vitro,CHEMBL628603,,10182,,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase,2412,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vitro,CHEMBL628604,,10183,,,Tested in vitro for the time for half reactivation against rat small intestinal glucoamylase; ND=Not determined,2412,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vitro,CHEMBL628605,,10184,,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase,2412,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vitro,CHEMBL628606,,10185,,,Tested in vitro for the time for half reactivation against rat small intestinal isomaltase; ND=Not determined,2412,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vitro,CHEMBL628607,,10186,,,Tested in vitro for the time for half reactivation against rat small intestinal sucrase,2412,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628608,,10187,,,The biological half life the compound was measured at the dose of 100 umol/kg,15022,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628609,,10188,,,The biological half life the compound was measured at the dose of 30 umol/kg,15022,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL628610,,10189,,,The compound was evaluated for plasma half life period in rat,406,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL873819,,10190,,,"The half life value in female wistar rat at 100 mg/kg, p.o. dose",15078,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628611,,10191,,,"The half life value in male wistar rat at 100 mg/kg, p.o. dose",15078,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628612,,10192,,,The pharmacokinetic parameter half-life period in vivo in rats,5247,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628613,,10193,,,"The pharmacokinetic property, Half-life was determined",5041,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628614,,10194,,,"The pharmacokinetic property, Half-life in rat in vivo",5041,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628615,,10195,,,"The pharmacokinetic property, Half-life was determined; ND denotes no data",5041,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628616,,10196,,,"The pharmacokinetic property, Half-life was determined; ND denotes not determined",5041,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL627924,,10197,,,The plasma half life period in rats,3918,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL627925,,10198,,,The release rate of the free drug from the substrate in rat liver lysosomal preparation by rat liver lysosomal assay,2906,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627926,,10199,,,half life in rats at the dose of 1.0 mpk by i.v. administration; ND= not determined,6467,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627927,,10200,,,t1/2 (apparent elimination)of the compound was determined,5510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627928,,10201,,,t1/2 value in rat,3788,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627539,,10202,,,Half life in rat,17796,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL876790,,10203,,,"Half life period calculated from Time-Course plasma concentrations in rats at a dose of 2.5 mg/kg, iv",12873,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL858186,,10204,,,Pharmacokinetic property (t1/2beta) was measured in rat at the dose of 0.32 mg/kg i.v.,5983,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627540,,10205,,,Half-life period in fasted rats,15765,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627541,,10206,,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to female wistar rats,2661,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627715,,10207,,,Compound was evaluated for maximum time to reach Cmax after treatment with oral dose of 2 mgkg to male wistar rats,2661,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627716,,10208,,,Evaluated for pharmacokinetic parameter tmax in rat at the dose 50 mg/kg,429,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627717,,10209,,,Maximum time required to achieve Cmax was determined in rat,17655,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627718,,10210,,,Time calculated to reach Cmax at a concentration of 15 mg/kg perorally in rats along with 100 mg/kg of compound 11,17717,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627719,,10211,,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with 100 mg/kg of compound 11,17717,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627720,,10212,,,Time calculated to reach Cmax at a concentration of 60 mg/kg perorally in rats along with control,17717,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627721,,10213,,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration,6570,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627722,,10214,,,Time to reach maximum concentration in rat after 2 mg/kg peroral administration; 4-6,6570,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627723,,10215,,,Tmax of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626058,,10216,,,Tmax of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626059,,10217,,,Tmax of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626060,,10218,,,Tmax of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626061,,10219,,,Tmax at a dose of 4 mg/kg in Rat Plasma after iv administration,17720,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL876791,,10220,,,Tmax determined after 0.3 mg/kg oral administration in potassium oxonate treated rats,4723,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626062,,10221,,,Tmax determined after 3 mg/kg oral administration in potassium oxonate treated rats,4723,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626063,,10222,,,Tmax at the dose of 2 mg/Kg administered perorally in rats,4756,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626064,,10223,,,Tmax at the dose of 5 mg/Kg administered perorally in rats,4756,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626065,,10224,,,tmax at a dose of 100 mg/kg in Rat Plasma after iv administration,17720,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626066,,10225,,,tmax at a dose of 50 mg/kg in Rat Plasma after iv administration,17720,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626067,,10226,,,tmax upon peroral administration of 10.0 mg/Kg dose in rat,1466,Rattus norvegicus,10116.0
50597,,F,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626068,,10227,,,Percent total excretion of 3-(thiomethyl)acetaminophen glucuronide,7449,Rattus norvegicus,10116.0
50597,,F,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626069,,10228,,,Percent total excretion of 3-(thiomethyl)acetaminophen sulfate,7449,Rattus norvegicus,10116.0
50597,,F,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626070,,10229,,,Percent total excretion of 3-methoxyacetaminophen glucuronide,7449,Rattus norvegicus,10116.0
50597,,F,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626071,,10230,,,Percent total excretion of N-methoxyacetaminophen glucuronide,7449,Rattus norvegicus,10116.0
50597,,F,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626072,,10231,,,Percent total excretion of N-methoxyacetaminophen sulfate,7449,Rattus norvegicus,10116.0
50597,,F,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626073,,10232,,,Percent total excretion of acetaminophen,7449,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL626741,,10233,,,"Distribution of radioactivity in thyroid tissue of rats at 5 mins after an intravenous injection; Value expressed as mean % injected dose, Range- 6.19-7.22",7768,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626742,,10234,,,"Percent instability was measured by Rat S9 liver slice metabolism assay, in vitro",17655,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626743,,10235,,,Plasma clearance following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats,17735,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL876792,,10236,,,Plasma concentration at 4 hr after 30 mg/kg post dosing in rat using HPLC/MS,5960,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626744,,10237,,,Volume of distribution following 10 mg/kg intravenous or 50 mg/kg oral dosing in rats was determined,17735,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626745,,10238,,,Compound was tested for antidiuretic activity in rats,7116,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626746,,10239,,,AUC in rat after 3mg/kg oral dose,4878,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626747,,10240,,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 10 mg/kg,5939,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626748,,10241,,,Ratio in brain to that of rat plasma for 2 hr after peroral administration at 5 mg/kg,5939,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626749,,10242,,,Bioavailability administered orally at a dose of 10 mg/kg to rats,16367,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626750,,10243,,,Oral Bioavailability was determined,16366,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626751,,10244,,,Oral bioavailability in rat,4426,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626913,,10245,,,Oral bioavailability in rat; Not performed.,4426,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626914,,10246,,,Bioavailability,5041,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626915,,10247,,,Bioavailability was determined; ND denotes no data,5041,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626916,,10248,,,Biliary excretion when administered intravenously at a dose of 2.5 mg/kg in rats,1500,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626917,,10249,,,Biliary excretion when administered intravenously at a dose of 5 mg/kg in rats,1500,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626918,,10250,,,Binding towards rat plasma protein at 10 uM,17409,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626919,,10251,,,Binding towards rat plasma protein at 100 uM,17409,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626920,,10252,,,Bioavailability in rat (dose 20 mg/kg p.o.),2959,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621976,,10253,,,Bioavailability was determined after oral administration of compound 18 at a dose of 4 mg/kg to rat,13501,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL877599,,10254,,,Bioavailability in rat after 5 mg/kg oral gavage,6567,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621977,,10255,,,Bioavailability in rat,6571,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621978,,10256,,,Bioavailability in rat (dose 1 mg/kg i.v.),6715,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621979,,10257,,,Bioavailability in rat (dose 3 mg/kg p.o.),6715,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621980,,10258,,,Oral bioavailability in rat,2932,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621981,,10259,,,Bioavailability of the compound in rats after administration of 30 mg/kg,4171,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621982,,10260,,,Bioavailability after administration of 10 mg/kg in rats,17509,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL882953,,10261,,,Bioavailability after administration of 2 mg/kg in rats,17509,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621983,,10262,,,Bioavailability by oral administration at a dose of 100 uM/kg in rat was determined,4527,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621984,,10263,,,Bioavailability in dogs was determined; high,4026,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621985,,10264,,,Bioavailability in monkey after intravenous administration at 1 mpk,6659,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621986,,10265,,,Bioavailability in monkey after peroral administration at 10 mpk,6659,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621987,,10266,,,Bioavailability in rat after intravenous administration at 1 mpk,6659,Rattus norvegicus,10116.0
50597,,F,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL877600,,10267,,,Bioavailability in rat after intravenous administration at 2 mpk,6659,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621988,,10268,,,Bioavailability in rat after peroral administration at 30 mpk,6659,Rattus norvegicus,10116.0
50597,,F,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621989,,10269,,,Bioavailability in rat after peroral administration at at 100 mpk,6659,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621990,,10270,,,Bioavailability in rats was evaluated,6597,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621991,,10271,,,Bioavailability was calculated after an intravenous dose of 0.3 mg/Kg in rats after 6 hr,1202,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621992,,10272,,,Bioavailability was calculated after an intravenous dose of 1 mg/Kg in rats after 6 hr,1202,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621993,,10273,,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 4 hr,1202,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621994,,10274,,,Bioavailability was calculated after peroral dose of 3.0 mg/Kg in rats after 6 hr,1202,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621995,,10275,,,Bioavailability in rat,5207,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621996,,10276,,,Bioavailability in rat,5970,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621997,,10277,,,Oral bioavailability in rat (dose 10 mg/kg),17538,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621998,,10278,,,Bioavailability in rat after po administration at a dose of 10 mg/kg; nd is not determined,17538,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621999,,10279,,,Bioavailability upon peroral administration of 10.0 mg/Kg dose in rat,1466,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622000,,10280,,,Oral bioavailability in rat,2879,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622001,,10281,,,Bioavailability was measured in rat after oral administration; 2-4,2879,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622002,,10282,,,Bioavailability was measured in rat after oral administration; 3-7,2879,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622003,,10283,,,Bioavailability in rat (intraduodenal administration),3777,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL877601,,10284,,,Bioavailability in rat (intraduodenal administration),3777,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624871,,10285,,,Oral bioavailability in rat,3777,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622004,,10286,,,Oral bioavailability in rat,3777,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL882954,,10287,,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg p.o.),5423,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622005,,10288,,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally,16365,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622006,,10289,,,Bioavailability was evaluated when a dose of 3 mg/kg was administered orally to a fasting rat,16365,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622007,,10290,,,Bioavailability was measured in rat,4239,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622008,,10291,,,Bioavailability was reported,5438,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622009,,10292,,,Bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),5334,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622010,,10293,,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),5334,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622011,,10294,,,Bioavailability was determined upon 10 mg/kg in 1% methylcellulose peroral administration in rats,4199,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622012,,10295,,,Bioavailability in rat (dose 2 mg/kg in 1% methylcellulose p.o.),4199,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622013,,10296,,,Bioavailability in rat (dose 3 mg/kg in 1% methylcellulose ),4199,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622014,,10297,,,Bioavailability was determined after intravenous administration at a dose 5 mg/kg to male Sprague-Dawley rats,4890,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624749,,10298,,,Bioavailability was determined at 3 mg/kg po dose in rats,2792,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624750,,10299,,,Oral bioavailability in rat (dose 2 mg/kg),5529,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624751,,10300,,,"Bioavailability was determined in rats at 10 mg/kg, p.o. dose",6685,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624752,,10301,,,"Bioavailability was determined in rats at 20 mg/kg, i.p. dose; n/a: not applicable",6685,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624753,,10302,,,"Bioavailability was determined in rats at 2 mg/kg, i.v. dose; n/a: not applicable",6685,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624754,,10303,,,Bioavailability was evaluated in rat after peroral administration at a dose of 1 mg/kg,6005,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624755,,10304,,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,6410,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624756,,10305,,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,6410,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624757,,10306,,,Bioavailability in rat,6103,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624758,,10307,,,Bioavailability was evaluated in rats at an intravenous dose of 3 mg/kg; Not applicable,6410,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622270,,10308,,,Bioavailability was evaluated in rats at an oral dose of 30 mg/kg,6410,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622271,,10309,,,Bioavailability in rat (Sprague-Dawley),5353,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622272,,10310,,,Bioavailability in rat at the dose of 2 mg/kg,4727,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622273,,10311,,,Oral bioavailability in rat,17804,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622274,,10312,,,Bioavailability in rat (cannulated) (dose 2 mg/kg),5809,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622275,,10313,,,Bioavailability value of compound in rats was determined after peroral administration,17804,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622276,,10314,,,Oral bioavailability in rat (dose 20 mg/kg),3634,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622277,,10315,,,Oral bioavailability in rat,3341,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622278,,10316,,,Oral bioavailability in rat (dose 5 mg/kg),2690,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622279,,10317,,,Oral bioavailability in rat,3184,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622280,,10318,,,Oral bioavailability in rat,740,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624083,,10319,,,Compound was evaluated for oral bioavailability in rats; 15-27 %,1806,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624084,,10320,,,Compound was evaluated for pharmacokinetic parameter percent bioavailability at 18 h,4891,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624085,,10321,,,Compound was evaluated for pharmacokinetic property in rats after an oral dose of 10 mg/kg and the value was reported as oral bioavailability (F),3634,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624086,,10322,,,Compound was tested for bioavailability in rats,64,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624087,,10323,,,Bioavailability in rat,4839,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624088,,10324,,,Oral bioavailability in rat,1094,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Intermediate,0,U,,1,,,In vivo,CHEMBL624089,,10325,,,Compound was tested for oral bioavailability in rhesus monkey at a dose of 0.75 mg/kg iv/ 1.5 mg/kg po.,5005,Macaca mulatta,9544.0
22224,,A,,,BAO_0000218,Intermediate,0,U,,1,,,In vivo,CHEMBL624090,,10326,,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v. and 2 mg/kg p.o.),5005,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624091,,10327,,,Evaluated for the bioavailability in rat (in vivo),4687,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624092,,10328,,,F value of compound in rats was determined after peroral administration,17804,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624093,,10329,,,In vivo Oral bioavailability (F)was determined after intravenous administration of compound (9.13+/-0.85 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624094,,10330,,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (158.5+/-2 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624095,,10331,,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (19.01+/-0.31 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624096,,10332,,,In vivo Oral bioavailability (F)was determined after peroral administration of compound (76.4+/-2.6 mg/kg) in male Sprague-Dawley rat,5974,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624097,,10333,,,"In vivo percent of absolute bioavailability obtained from blood plasma levels analyzed by means of GC/MS (dose 5 uM/kg i.v. and 40 uM/kg, p.o.)",1088,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624098,,10334,,,Maximum fall in carotid flow in rat,1742,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL874392,,10335,,,Oral Bioavailability after intravenous administration (1 mg/kg) in rat,4689,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624099,,10336,,,Oral bioavailability in rat (dose 5 mg/kg),2463,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624100,,10337,,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 16 mg/kg peroral administration,5654,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624101,,10338,,,Oral bioavailability (F%) of compound was determined as average of four rats at each dose of 5 mg/kg intravenous and 20 mg/kg peroral administration,5654,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624102,,10339,,,Oral bioavailability in rat (male Wistar),6874,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624103,,10340,,,Oral bioavailability after administration (30 mg/kg) in rat; good,5633,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624104,,10341,,,Oral bioavailability at the dose of 2 mg/kg in rat,5496,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624105,,10342,,,Oral bioavailability determined in rats,2358,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624106,,10343,,,Oral bioavailability in rat (Sprague-Dawley) (male) (dose 50 mg/kg p.o.),16456,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624107,,10344,,,Oral bioavailability in rat (dose single 10 mg/kg),5302,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623943,,10345,,,Oral bioavailability in rat (dose single 10 mg/kg),5302,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623944,,10346,,,Oral bioavailability in rat (dose 5 mg/kg,5302,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623945,,10347,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623946,,10348,,,Momoamine and metabolic levels observed 1 week following acute dosing against at a dose of 20 mg/kg Hippocampus NE,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623947,,10349,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HIAA,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623948,,10350,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex 5-HT,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623949,,10351,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DA,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623950,,10352,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex DOPAC,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL874398,,10353,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex HVA,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623951,,10354,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Frontal cortex NE,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623952,,10355,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HIAA,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623953,,10356,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus 5-HT,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623954,,10357,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below level of detection,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623955,,10358,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DA; below the levels of detection,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623956,,10359,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below level of detection,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627807,,10360,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus DOPAC; below the levels of detection,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627808,,10361,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below level of detection,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627809,,10362,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus HVA; below the levels of detection,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627810,,10363,,,Momoamine and metabolic levels observed 2 weeks following sub-acute dosing against Hippocampus NE,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627811,,10364,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HIAA",11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627812,,10365,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex 5-HT",11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627813,,10366,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DA",11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627814,,10367,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex DOPAC",11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL875336,,10368,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex HVA",11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627815,,10369,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Frontal cortex NE",11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627816,,10370,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus 5-HIAA",11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627817,,10371,,,"Momoamine and metabolic levels observed at 3 h postdrug against, at a dose of 20 mg/kg Hippocampus 5-HT",11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627818,,10372,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DA; below the levels of detection",11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627819,,10373,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus DOPAC; below the levels of detection",11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627820,,10374,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus HVA; below the levels of detection",11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627821,,10375,,,"Momoamine and metabolic levels observed at 3 hr postdrug against, at a dose of 20 mg/kg Hippocampus NE",11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628464,,10376,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HIAA,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626239,,10377,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex 5-HT,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626240,,10378,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex DA,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626241,,10379,,,Momoamine and metabolic levels observed at 3 h postdrug against at a dose of 20 mg/kg Frontal cortex DOPAC,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626242,,10380,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex HVA,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626243,,10381,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Frontal cortex NE,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626244,,10382,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HIAA,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626907,,10383,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus 5-HT; below level of detection,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626908,,10384,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DA; below level of detection,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626909,,10385,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus DOPAC; below level of detection,11020,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626910,,10386,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus HVA; below level of detection,11020,Rattus norvegicus,10116.0
50597,,F,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL875342,,10387,,,Percent total excretion of acetaminophen cysteine conjugate,7449,Rattus norvegicus,10116.0
50597,,F,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626911,,10388,,,Percent total excretion of acetaminophen glucuronide,7449,Rattus norvegicus,10116.0
50597,,F,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626912,,10389,,,Percent total excretion of acetaminophen sulfate,7449,Rattus norvegicus,10116.0
50597,,F,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627065,,10390,,,Percent total excretion of acetaminophen-mercapturic acid,7449,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627066,,10391,,,Amount of urine output was measured in rat at a dose of 10 mg/kg administered orally,3172,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627067,,10392,,,Volume of distribution in Male Sprague-Dawley rats after intravenous administration at a dose of 10 mg/kg,16456,Rattus norvegicus,10116.0
22224,Muscle tissue,A,,,BAO_0000218,Autocuration,0,U,2385.0,1,,,In vivo,CHEMBL627068,,10393,,,Biodistribution of compound in rat muscle after 5 min of administration,10839,ratrat,8656.0
22224,Muscle tissue,A,,,BAO_0000218,Autocuration,0,U,2385.0,1,,,In vivo,CHEMBL627069,,10394,,,Biodistribution of compound in rat muscle after 5 min of administration.,10839,ratrat,8656.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL627070,,10395,,,Plasma clearance was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),5334,Ovis aries,9940.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL627071,,10396,,,Plasma clearance was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),5334,Ovis aries,9940.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL627072,,10397,,,Bioavailability was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),5334,Ovis aries,9940.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL627073,,10398,,,Bioavailability was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),5334,Ovis aries,9940.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625387,,10399,,,Volume of distribution was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),5334,Ovis aries,9940.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625388,,10400,,,Volume of distribution was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),5334,Ovis aries,9940.0
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL625389,,10401,,,Plasma half-life period (0-8 h) was reported after intravenous administration at a dose of 1 mg/kg in Abraham sheep (female),5334,Ovis aries,9940.0
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL875343,,10402,,,Plasma half-life period (0-8 h) was reported after oral administration at a dose of 2 mg/kg in Abraham sheep (female),5334,Ovis aries,9940.0
50497,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL876795,,10403,,,Biological half life period of compound was measured against snake venom phosphodiesterase (SVPDE),1735,Serpentes,8570.0
50497,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626552,,10404,,,Half life (t) of enzymatic phosphodiester hydrolysis of compound towards snake venom (SV-PDE) at a concentration of 4 microg,1469,Serpentes,8570.0
50497,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626553,,10405,,,Enzymatic stability was assessed with snake venom phosphodiesterase (SV PDE) exonuclase,1336,Serpentes,8570.0
22224,Plasma,A,,,BAO_0000366,Autocuration,0,U,1969.0,1,,,,CHEMBL626554,,10406,,,The human biological plasma half life of the compound,12403,Homo sapiens,9606.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL626555,,10407,,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,8151,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626556,,10408,,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 120 min after iv administration compound,8004,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626557,,10409,,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 15 after iv administration of compound,8004,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626558,,10410,,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 240 min after iv administration compound,8004,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626559,,10411,,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 30 min after iv administration of compound,8004,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626560,,10412,,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 5 min after iv administration of compound,8004,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL876803,,10413,,,Distribution of Se-75 activity in Adrenal of female Sprague-Dawley Rat 60 min after iv administration of compound,8004,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627964,,10414,,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 120 min after iv administration compound,8004,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627965,,10415,,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 15 min after iv administration of compound,8004,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627966,,10416,,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 240 min after iv administration compound,8004,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627967,,10417,,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 30 min after iv administration of compound,8004,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627968,,10418,,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 5 min after iv administration of compound,8004,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627969,,10419,,,Distribution of Se-75 activity in Heart of female Sprague-Dawley Rat 60 min after iv administration of compound,8004,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627970,,10420,,,Distribution of Se-75 activity in Liver of female Sprague-Dawley Rat 5 min after iv administration of compound,8004,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL627971,,10421,,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 120 min after iv administration of compound,8004,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL627972,,10422,,,Distribution of Se-75 activity in blood of female Sprague-Dawley Rat 240 min after iv administration of compound,8004,Rattus norvegicus,10116.0
180,,B,,,BAO_0000357,Expert,9,D,,1,,,,CHEMBL856029,,10423,,,Dissociation constant against binding to human cyclophilin A,15917,Homo sapiens,9606.0
11591,,B,,,BAO_0000019,Expert,8,H,,1,,,,CHEMBL627973,,10424,,,Michaelis-Menten constant for inhibitory activity against bovine liver glyoxalase II,12396,Bos taurus,9913.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627974,,10425,,,-Log C was determined by performing the electroshock minimum test,7065,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627975,,10426,,,-Log C was determined by performing the foot shock test,7065,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627976,,10427,,,-Log C was determined by performing the incl screen test,7065,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627977,,10428,,,-Log C was determined by performing the maximum electroshock test,7065,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627978,,10429,,,-Log C was determined by performing the pentylenetetrazole test,7065,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627979,,10430,,,Tested for experimental arotinoid inhibitory dose,12415,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL876804,,10431,,,Negative log transformed activity,10256,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627980,,10432,,,"Negative log of Langmuir's alpha constant (-log alpha), which is inversely proportional to the effective binding constant (protein binding)",7991,,
50512,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627981,,10433,,,Dissociation constant was evaluated on guinea pig bladder at M3 muscarinic receptor,14342,Cavia porcellus,10141.0
50512,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627982,,10434,,,Dissociation constant was evaluated on guinea pig heart (force) at M2 muscarinic receptor,14342,Cavia porcellus,10141.0
50512,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627983,,10435,,,Dissociation constant was evaluated on guinea pig heart (rate) at M2 muscarinic receptor,14342,Cavia porcellus,10141.0
50512,Ileum,A,,,BAO_0000218,Intermediate,1,N,2116.0,1,,,,CHEMBL627984,,10436,,,Dissociation constant was evaluated on guinea pig ileum at M3 muscarinic receptor,14342,Cavia porcellus,10141.0
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL627985,,10437,,,Solubility in water was determined; values expressed as -log,6047,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627986,,10438,,,Ratio of Kcat to that of Km was determined,17269,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627987,,10439,,,Observed first order rate constant,10026,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627988,,10440,,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours,14583,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627989,,10441,,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to female wistar rats,2661,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627990,,10442,,,Compound was evaluated for bioavailability after treatment with oral dose of 2 mgkg to male wistar rats,2661,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL876805,,10443,,,Oral Bioavailability after administration of 10 mg/kg in male rat,4029,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627991,,10444,,,Oral bioavailability in rat (dose 10 mg/kg i.v. and 50 mg/kg p.o.),17735,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627992,,10445,,,Oral bioavailability in rat,4576,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627993,,10446,,,Oral bioavailability after oral (po) administration at a dose of 10 mg/kg was measured in rats,17582,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622817,,10447,,,Oral bioavailability at 1 mg/kg was determined in rat,17651,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622818,,10448,,,Oral bioavailability at 10 mg/kg was determined in rat,17651,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622819,,10449,,,"Oral bioavailability in fischer rats at 30 mg/kg dose, administered perorally",17670,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL872267,,10450,,,Oral bioavailability in rat,5045,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622820,,10451,,,Oral bioavailability in rat,1696,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622821,,10452,,,Oral bioavailability after intravenous administration in rats at 24 uM/kg,17764,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622822,,10453,,,Oral bioavailability in rat,6448,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622823,,10454,,,Oral bioavailability in rat,6596,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622824,,10455,,,Oral bioavailability in rat,17547,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622825,,10456,,,Oral bioavailability in rat at a dose of 3 mg/kg,17771,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622901,,10457,,,Oral bioavailability in rat after oral administration at 10 mg/kg,6495,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622902,,10458,,,Oral bioavailability in rat,4558,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621844,,10459,,,Oral bioavailability in rat,17596,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621845,,10460,,,Oral bioavailability in Dawley rats,6827,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621846,,10461,,,Oral bioavailability,4026,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621847,,10462,,,Oral bioavailability in rat (dose 30 mg/kg),10,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL877609,,10463,,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,17717,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621848,,10464,,,Bioavailability in rat (dose 3 mg/kg i.v.),17717,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL621849,,10465,,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,17717,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622030,,10466,,,Oral bioavailability in rat (dose 60 mg/kg p.o.),17717,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622031,,10467,,,Percent oral bioavailability determined in rats,4796,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622032,,10468,,,Tested for percent bioavailability after oral administration to Sprague-Dawley rat at dosage of 0.2 mg/kg,4883,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622033,,10469,,,The compound was evaluated for bioavailability in rats; 32-51,2137,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622034,,10470,,,Bioavailability in rat (dose 20 mg/kg p.o.),2959,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622035,,10471,,,Oral bioavailability in rat,1361,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL882966,,10472,,,Bioavailability percent in rat at the dose of 2 mg/kg,4727,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622036,,10473,,,Bioavailability was evaluated after 20 uM/kg of peroral administration,16423,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622037,,10474,,,Oral bioavailability in rat,5206,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622038,,10475,,,Oral bioavailability in rat,6448,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622039,,10476,,,Bioavailability in rats,17723,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL622040,,10477,,,Biodistribution of radiolabeled compound in rat blood after 24 hr postinjection activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL622041,,10478,,,Biodistribution of radiolabeled compound in rat blood after 24 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL622042,,10479,,,Biodistribution of radiolabeled compound in rat blood after 2 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL622043,,10480,,,Biodistribution of radiolabeled compound in rat blood after 30 min activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL622044,,10481,,,Biodistribution of radiolabeled compound in rat blood after 5 min activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL622045,,10482,,,Biodistribution of radiolabeled compound in rat bone after 24 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL622046,,10483,,,Biodistribution of radiolabeled compound in rat bone after 2 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL622047,,10484,,,Biodistribution of radiolabeled compound in rat bone after 30 min activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL877610,,10485,,,Biodistribution of radiolabeled compound in rat bone after 5 min activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL622048,,10486,,,Biodistribution of radiolabeled compound in rat brain after 24 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL622049,,10487,,,Biodistribution of radiolabeled compound in rat brain after 2 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL622050,,10488,,,Biodistribution of radiolabeled compound in rat brain after 30 min activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL622051,,10489,,,Biodistribution of radiolabeled compound in rat brain after 5 min activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622052,,10490,,,Biodistribution of radiolabeled compound in rat fat after 24 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622053,,10491,,,Biodistribution of radiolabeled compound in rat fat after 2 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622054,,10492,,,Biodistribution of radiolabeled compound in rat fat after 30 min activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622055,,10493,,,Biodistribution of radiolabeled compound in rat fat after 5 min activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622056,,10494,,,Oral bioavailability in rats was determined; High,5237,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622057,,10495,,,Oral bioavailability in the rat was determined,5503,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628008,,10496,,,Oral bioavailability measured by the ratio of intravenous to oral area under concentration.,15765,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622058,,10497,,,Oral bioavailability in rat (dose 10 mg/kg p.o. and 3 mg/kg i.v.),15660,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622059,,10498,,,Oral bioavailability of compound (19.2 mg/kg) after po administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622060,,10499,,,Oral bioavailability of compound (19.76 mg/kg) after po administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622061,,10500,,,Oral bioavailability of compound (20.73 mg/kg) after po administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622062,,10501,,,Oral bioavailability of compound (25 mg/kg) after po administration was determined in Sprague-Dawley rat,5978,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622063,,10502,,,Oral bioavailability of compound at a dose of 20 mg/kg was determined after oral administration in rat,5656,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Expert,1,N,,1,,,In vivo,CHEMBL877611,,10503,,,Oral bioavailability of compound determined in rat after iv administration at a dose of 10 mg/kg,3598,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622064,,10504,,,Oral bioavailability of compound in Sprague Dawley rats,4216,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622065,,10505,,,Oral bioavailability of compound in rat,17839,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622066,,10506,,,Oral bioavailability in rat (dose 2 mg/kg),6570,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622067,,10507,,,Oral bioavailability of compound in rat was determined,5334,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622068,,10508,,,Oral bioavailability of compound in rats,6886,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622069,,10509,,,Oral bioavailability of compound was determined in rats,5210,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624796,,10510,,,Oral bioavailability at a dose of 30 mg/kg in rats,4170,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624797,,10511,,,Oral bioavailability in rat (dose 10 mg/kg),6028,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623053,,10512,,,Oral bioavailability in rat (dose 10 mg/kg),6028,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623054,,10513,,,Oral bioavailability evaluated in rat,6078,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623055,,10514,,,Oral bioavailability in fasted rat,6168,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623056,,10515,,,Oral bioavailability in fed rat,6168,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623057,,10516,,,Oral bioavailability in rat (mature male) (dose 30 mg/kg),5160,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623058,,10517,,,Oral bioavailability in rat,6057,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623059,,10518,,,Oral bioavailability in rat (dose 10 mg/kg p.o.),6535,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623060,,10519,,,Oral bioavailability in rat after administration of 10 mg/kg po,6535,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623061,,10520,,,Oral bioavailability in rat,4194,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623062,,10521,,,Oral bioavailability in rat,6230,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623063,,10522,,,Oral bioavailability in rat,6619,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623064,,10523,,,Oral bioavailability in rat,17607,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623065,,10524,,,Oral bioavailability in ratrs,4942,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623066,,10525,,,Oral bioavailability in rat,4942,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623067,,10526,,,Oral bioavailability in rat,6646,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623068,,10527,,,Oral bioavailability in rats was determined; High,5237,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623069,,10528,,,Oral bioavailability in rat,6646,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623070,,10529,,,Oral bioavailability in rat,4449,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623071,,10530,,,Oral bioavailability was calculated in rat,6057,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623072,,10531,,,Oral bioavailability,2552,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623073,,10532,,,Oral bioavailability,5496,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623074,,10533,,,Oral bioavailability,6484,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623075,,10534,,,Oral bioavailability,6485,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623076,,10535,,,Oral bioavailability after i.v. administration,6616,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623077,,10536,,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),4969,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623078,,10537,,,Oral bioavailability in rat (Sprague-Dawley),5862,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623079,,10538,,,Oral bioavailability in Sprague-Dawley rats,4514,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623080,,10539,,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),4514,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623081,,10540,,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),4514,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623082,,10541,,,Oral bioavailability in Sprague-Dawley rats at a dose of 2 mg/kg by po administration,5546,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL874400,,10542,,,Oral bioavailability in fasted rat,6168,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623083,,10543,,,Oral bioavailability in fed rat,6168,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623084,,10544,,,Oral bioavailability in rat,3624,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623085,,10545,,,Oral bioavailability in rat,5213,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623086,,10546,,,Oral bioavailability in rat,5496,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623087,,10547,,,Oral bioavailability in rat,5553,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623088,,10548,,,Oral bioavailability in rat,5833,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623089,,10549,,,Oral bioavailability in rat,5836,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623090,,10550,,,Oral bioavailability in rat,5865,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623091,,10551,,,Oral bioavailability in rat,5960,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623092,,10552,,,Oral bioavailability in rat,6249,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623093,,10553,,,Oral bioavailability in rat,6448,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL874401,,10554,,,Oral bioavailability in rat,6453,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623094,,10555,,,Oral bioavailability in rat,6640,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623095,,10556,,,Oral bioavailability in rat,17607,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623096,,10557,,,Oral bioavailability in rat after peroral administration at 10 mg/kg,5939,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624913,,10558,,,Oral bioavailability in rat after peroral administration at 5 mg/kg,5939,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624914,,10559,,,Oral bioavailability in rat (dose 2.8 mg/kg p.o.),6281,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624915,,10560,,,Oral bioavailability in rat by po administration at a dose of 40 mg/kg,5874,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624916,,10561,,,Oral bioavailability in rat; Not measured,5213,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624917,,10562,,,Oral bioavailability in rat,4964,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625157,,10563,,,Momoamine and metabolic levels observed at 3 hr postdrug against at a dose of 20 mg/kg Hippocampus NE,11020,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625158,,10564,,,In vitro metabolic potential in rat liver microsomes,6251,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625159,,10565,,,"Oral availability was tested for plasma levels at a dose of 40 mg/kg, after 6 hr of in fed fisher rats.",1568,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625160,,10566,,,"In vivo percentage mean absolute bioavailability of compound in rat after an oral dose of 10 mg/kg (in water, N=4)",3032,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625161,,10567,,,Oral bioavailability of intravenously administered compound (3 mg/kg) was tested in rats,3748,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625162,,10568,,,Oral bioavailability in rat,401,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625163,,10569,,,Oral bioavailability in rat,6512,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625164,,10570,,,Oral bioavailability in rats at 10 mg/kg,17617,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625165,,10571,,,Oral bioavailability was determined after 1 mg/kg (i.v.) / 2 mg/kg (p.o.) of compound administration,6679,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625166,,10572,,,Oral bioavailability in rat,6742,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625167,,10573,,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis,589,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625168,,10574,,,Tested for effective permeability across the rat intestinal membrane using mass balance analysis at 0.01 mM concentration,589,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625169,,10575,,,Plasma clearance of the compound,3185,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626264,,10576,,,Plasma clearance at 10 mg/kg in rat upon intravenous administration,17596,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626265,,10577,,,Plasma clearance upon intravenous administration of 1 mg/Kg in rats,2713,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626266,,10578,,,The compound was tested for plasma clearance in rat,12500,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626267,,10579,,,The compound was tested for plasma clearance in rat at dose of 3-10 mgkg,12500,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626268,,10580,,,Plasma concentration upon oral administration of 1 mg/Kg in rats,2713,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626269,,10581,,,Peak plasma level between 0.5 and 1.0 hour in Dawley rats; value ranges from 1021-2551,1446,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626270,,10582,,,Plasma level after intravenous administration in rat model of FeCl3-induced carotid thrombosis,6227,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626271,,10583,,,Plasma protein binding was determined after intravenous administration of 1 mg/kg in rat,4709,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626272,,10584,,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1",5510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626273,,10585,,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",5510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL875346,,10586,,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not determined",5510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626274,,10587,,,"Rat plasma cleavage data expressed as percentage of compound remains at 24 hr in PEG400/Water, 1:1; Not stable",5510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626275,,10588,,,Compound was tested for protein binding in rat plasma,4514,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624646,,10589,,,Compound was evaluated for absorption of radioligand following oral administration to bile duct cannulated rat. ,2713,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624647,,10590,,,Compound was evaluated for absorption of radioligand upon oral administration to bile duct cannulated rats,2713,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL624648,,10591,,,In vitro metabolism in rat liver microsomes was evaluated to determine diminishing of glucuronidation rate,5340,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624649,,10592,,,Area under curve ratio was determined (po/iv) in rat,12058,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624650,,10593,,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 15 mins after i.v. administration,11195,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624651,,10594,,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 2 mins after i.v. administration,11195,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624652,,10595,,,Blood by brain ratio of the radiolabeled compound (2-5 uCi) in rat 65 mins after i.v. administration,11195,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624653,,10596,,,Compound was tested for brain/plasma ratio after oral administration at 10 mg/kg,6495,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624654,,10597,,,Ratio of AUCbrain to AUCplasma,6078,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624655,,10598,,,Ratio of brain to plasma,5656,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624656,,10599,,,Ratio of the AUC values of brain and plasma after intravenous administration (4.7 mg/kg) to male rats was evaluated,4910,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624657,,10600,,,Ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,4910,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624658,,10601,,,Ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats was evaluated,4910,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624659,,10602,,,Selectivity ratio for biodistribution in brain and blood of rats after 15 minutes; Expressed as percent dose/gram ratio,10130,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624660,,10603,,,Selectivity ratio for biodistribution in brain and blood of rats after 2 minutes; Expressed as percent dose/gram ratio,10130,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624661,,10604,,,Selectivity ratio for biodistribution in brain and blood of rats after 60 minutes; Expressed as percent dose/gram ratio,10130,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624662,,10605,,,Steady state brain :blood ratio was determined,5213,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625199,,10606,,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats,4910,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625200,,10607,,,Tested for ratio in brain and plasma after 0.25 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,4910,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625201,,10608,,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats,4910,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625202,,10609,,,Tested for ratio in brain and plasma after 2 hrs of intravenous administration (5 mg/kg) to male rats; ND = not determined,4910,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625203,,10610,,,Percentage recovery after 3h incubation with rat hapatocytes was determined,2083,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625204,,10611,,,Percentage recovery in rat hepatic microsomal fractions under oxidative conditions after 1 hour,2082,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625205,,10612,,,Percentage recovery in rhesus monkey hepatic microsomal fractions under oxidative conditions after 1 hour,2082,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625206,,10613,,,Recovery rate from urine and bile was determined after iv administration at 20 mg/kg in rats,6351,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625207,,10614,,,"Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured, No site available for protein conjugation.",14583,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625208,,10615,,,Fraction of 88Y (%) released from chelate after incubation in serum for 15 hours; not measured.,14583,,
50587,,A,,495.0,BAO_0000218,Intermediate,1,N,,1,,Caco-2,,CHEMBL625209,,10616,,,In vivo absorption in Caco-2 cell line monolayers was determined,4608,Homo sapiens,9606.0
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL625210,,10617,,,Calculated partition coefficient (clogP),13668,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625211,,10618,,,Area under curve was determine after peroral administration at 10 mpk in Rat,5669,Rattus norvegicus,10116.0
50797,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625212,,10619,,,Area under curve was determine after peroral administration at 10 mpk in Rhesus,5669,Macaca mulatta,9544.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625213,,10620,,,Area under curve was determine after peroral administration at 160 mpk in Rat,5669,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625214,,10621,,,Area under curve was determine after peroral administration at 20 mpk in Rat,5669,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL874542,,10622,,,Area under curve was determine after peroral administration at 50 mpk in Rat,5669,Rattus norvegicus,10116.0
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL625215,,10623,,,Calculated partition coefficient (clogP) (AlogP),6472,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625216,,10624,,,Activated partial thromboplastin time measured,15106,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL625217,,10625,,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4),15207,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL625218,,10626,,,Compound was evaluated for the aqueous solubility (AS) in mg/mL (Measured in 0.2 M phosphate buffer of pH 7.4); ND=Not determined (AS mg/mL),15207,,
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622864,,10627,,,AUC (Area under curve) was determined after intravenous administration at a dose 1 mg/kg in dog,13941,Canis lupus familiaris,9615.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622865,,10628,,,AUC (Area under curve) was determined after intravenous administration at a dose 2 mg/kg in rat.,13941,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622866,,10629,,,AUC (Area under curve) was determined after peroral administration at a dose 10 mg/kg in rat.,13941,Rattus norvegicus,10116.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622867,,10630,,,AUC (Area under curve) was determined after peroral administration at a dose 5 mg/kg in dog,13941,Canis lupus familiaris,9615.0
50512,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL876808,,10631,,,AUC (ng h/mL) value after oral administration of 10 mg/kg in guinea pig.,15240,Cavia porcellus,10141.0
22224,Brain,A,,,BAO_0000019,Autocuration,0,U,955.0,1,,,,CHEMBL627725,,10632,,,AUC in brain,10655,,
22224,Serum,A,,,BAO_0000019,Autocuration,0,U,1977.0,1,,,,CHEMBL627726,,10633,,,AUC in serum,10655,,
22224,Plasma,A,,,BAO_0000019,Autocuration,0,U,1969.0,1,,,,CHEMBL627727,,10634,,,AUC was determined,6504,,
22224,Plasma,A,,,BAO_0000019,Autocuration,0,U,1969.0,1,,,,CHEMBL627728,,10635,,,AUC of the compound.,10615,,
22224,Plasma,A,,,BAO_0000019,Autocuration,0,U,1969.0,1,,,,CHEMBL627729,,10636,,,AUC value (0-4 hr),10353,,
22224,Plasma,A,,,BAO_0000019,Autocuration,0,U,1969.0,1,,,,CHEMBL627730,,10637,,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 150 uMol/kg,",14907,,
22224,Plasma,A,,,BAO_0000019,Autocuration,0,U,1969.0,1,,,,CHEMBL627731,,10638,,,AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,14907,,
22224,Plasma,A,,,BAO_0000019,Autocuration,0,U,1969.0,1,,,,CHEMBL627732,,10639,,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 300 uMol/kg,",14907,,
22224,Plasma,A,,,BAO_0000019,Autocuration,0,U,1969.0,1,,,,CHEMBL627733,,10640,,,"AUC was measured from the graph plotted against blood plasma concentration and time at the dose of 700 uMol/kg,",14907,,
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL627734,,10641,,,AUC(area under curve) was determined after intravenous administration in rats,16359,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL627735,,10642,,,AUC(area under curve) was determined after oral administration in rats,16359,Rattus norvegicus,10116.0
50512,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL627736,,10643,,,AUC(ng h/mL)values after oral administration of 10 mg/kg in guinea pig.,15240,Cavia porcellus,10141.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL876809,,10644,,,AUC(ng h/mL)values after oral administration of 10 mg/kg in rat.,15240,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627737,,10645,,,Area Under Curve after oral dosing of 100 uM/Kg,15469,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627738,,10646,,,Area Under Curve after oral dosing of 30 uM/Kg,15469,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627739,,10647,,,Area Under Curve was measured by ploting the graph between concentration verses time,13520,,
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626143,,10648,,,Area under concentration-time curve of compound was determined in dog at 25 mg/kg orally,17025,Canis lupus familiaris,9615.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL626144,,10649,,,Area under concentration-time curve of compound was determined in monkey at 25 mg/kg orally,17025,Simiiformes,314293.0
50592,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626145,,10650,,,Area under concentration-time curve of compound was determined in rabbit at 25 mg/kg orally,17025,Oryctolagus cuniculus,9986.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626146,,10651,,,Area under concentration-time curve of compound was determined in rat at 25 mg/kg orally,17025,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL626147,,10652,,,Area under curve (AUC) is the drug concentrations in blood samples of rats with arterial catheters at 5 min and 12 hr plotted against time,12032,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL626148,,10653,,,Area under curve (AUC) was determined,10291,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL626149,,10654,,,Area under curve (AUC) following ip administration at 1 mg/kg,5767,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL626150,,10655,,,Area under curve (AUC) was determined; ND is Not determined,1434,,
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626151,,10656,,,Area under curve (AUC) was determined in dogs fed after intravenous administration of 25 mg/kg of the compound,14925,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626152,,10657,,,Area under curve (AUC) was determined in dogs fed after oral administration of 25 mg/kg of the compound,14925,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626153,,10658,,,Area under curve (AUC) was determined in fasted dogs after oral administration of 25 mg/kg of the compound,14925,Canis lupus familiaris,9615.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL626154,,10659,,,Area under curve (AUR) was determined,1434,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL626155,,10660,,,Area under curve at 1 uM/dg administered intravenously,11883,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL626156,,10661,,,Area under curve at 10 uM/dg administered perorally,11883,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL626157,,10662,,,Area under curve at 2 uM/dg administered intravenously,11883,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL626158,,10663,,,Area under curve at 20 uM/dg administered perorally,11883,,
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626159,,10664,,,Area under curve at a peroral dose of 3 mg/kg in dog,15233,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626160,,10665,,,Area under curve at a peroral dose of 3 mg/kg in rat,15233,Rattus norvegicus,10116.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626161,,10666,,,Area under curve at an iv dose of 1 mg/kg in dog,15233,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626162,,10667,,,Area under curve at an iv dose of 1 mg/kg in rat,15233,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL626163,,10668,,,Area under curve gives the effective duration for the angiotensin II antagonist effect of the compound.,12978,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL626164,,10669,,,Area under curve gives the effective duration for the angiotensin II antagonist effect.,12978,,
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626165,,10670,,,Area under curve measured as conc vs time after intravenous administration to mice.,11355,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626166,,10671,,,Area under curve measured as conc vs time after peroral administration to mice.,11355,Mus musculus,10090.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626167,,10672,,,Area under curve of acid 2a was determined by HPLC at a dosage of 2.27 mg/kg administered intravenously by bolus method in dog,12923,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626168,,10673,,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by capsule method in dog,12923,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL877463,,10674,,,Area under curve of acid 2a was determined by HPLC at a dosage of 5.45 mg/kg administered intragastrically by gavage method in dog,12923,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626169,,10675,,,Area under curve of acid 2a was determined by HPLC at a dosage of 54.5 mg/kg administered intragastrically by capsule method in dog,12923,Canis lupus familiaris,9615.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL626170,,10676,,,Biodistribution of radiolabeled compound in rat heart after 24 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL626171,,10677,,,Biodistribution of radiolabeled compound in rat heart after 2 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL626172,,10678,,,Biodistribution of radiolabeled compound in rat heart after 30 min activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL626173,,10679,,,Biodistribution of radiolabeled compound in rat heart after 5 min activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL626174,,10680,,,Biodistribution of radiolabeled compound in rat kidney after 24 hr postinjection activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL626175,,10681,,,Biodistribution of radiolabeled compound in rat kidney after 24 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL626176,,10682,,,Biodistribution of radiolabeled compound in rat kidney after 2 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL626177,,10683,,,Biodistribution of radiolabeled compound in rat kidney after 30 min activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL622499,,10684,,,Biodistribution of radiolabeled compound in rat kidney after 5 min activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL622500,,10685,,,Biodistribution of radiolabeled compound in rat liver after 24 hr postinjection activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL622501,,10686,,,Biodistribution of radiolabeled compound in rat liver after 24 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL622502,,10687,,,Biodistribution of radiolabeled compound in rat liver after 2 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL622503,,10688,,,Biodistribution of radiolabeled compound in rat liver after 30 min activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL877614,,10689,,,Biodistribution of radiolabeled compound in rat liver after 5 min activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL624839,,10690,,,Biodistribution of radiolabeled compound in rat lung after 24 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL624840,,10691,,,Biodistribution of radiolabeled compound in rat lung after 2 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL624841,,10692,,,Biodistribution of radiolabeled compound in rat lung after 30 min activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL624842,,10693,,,Biodistribution of radiolabeled compound in rat lung after 5 min activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL624843,,10694,,,Biodistribution of radiolabeled compound in rat muscle after 24 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL624844,,10695,,,Biodistribution of radiolabeled compound in rat muscle after 2 hr activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL624845,,10696,,,Biodistribution of radiolabeled compound in rat muscle after 30 min activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL621904,,10697,,,Biodistribution of radiolabeled compound in rat muscle after 5 min activity expressed as %ID/Organ,17738,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL621905,,10698,,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 15 mins after i.v. administration,11195,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL874382,,10699,,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 2 mins after i.v. administration,11195,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL621906,,10700,,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat blood 65 mins after i.v. administration,11195,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL621907,,10701,,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 15 mins after i.v. administration,11195,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL622096,,10702,,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 2 mins after i.v. administration,11195,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL622097,,10703,,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat brain 65 mins after i.v. administration,11195,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL622098,,10704,,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 15 mins after i.v. administration,11195,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL622099,,10705,,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 2 mins after i.v. administration,11195,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL622100,,10706,,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat heart 65 mins after i.v. administration,11195,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL622101,,10707,,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 15 mins after i.v. administration,11195,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL622102,,10708,,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 2 mins after i.v. administration,11195,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL622103,,10709,,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat kidney 65 mins after i.v. administration,11195,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL622104,,10710,,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 15 mins after i.v. administration,11195,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL622105,,10711,,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 2 mins after i.v. administration,11195,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL622106,,10712,,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat liver 65 mins after i.v. administration,11195,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL622107,,10713,,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 15 mins after i.v. administration,11195,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL622108,,10714,,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 2 mins after i.v. administration,11195,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL622109,,10715,,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat lung 65 mins after i.v. administration,11195,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL622110,,10716,,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 15 mins after i.v. administration,11195,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL622111,,10717,,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 2 mins after i.v. administration,11195,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL874383,,10718,,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat muscle 65 mins after i.v. administration,11195,Rattus norvegicus,10116.0
50597,Zone of skin,A,,,BAO_0000218,Intermediate,1,N,14.0,1,,,In vivo,CHEMBL622112,,10719,,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 15 mins after i.v. administration,11195,Rattus norvegicus,10116.0
50597,Zone of skin,A,,,BAO_0000218,Intermediate,1,N,14.0,1,,,In vivo,CHEMBL622113,,10720,,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 2 mins after i.v. administration,11195,Rattus norvegicus,10116.0
50597,Zone of skin,A,,,BAO_0000218,Intermediate,1,N,14.0,1,,,In vivo,CHEMBL622114,,10721,,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat skin 65 mins after i.v. administration,11195,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL622115,,10722,,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 15 mins after i.v. administration,11195,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL622116,,10723,,,Biodistribution of the radiolabeled compound (2-5 uCi) in rat spleen 2 mins after i.v. administration,11195,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622117,,10724,,,Oral bioavailability in rat,6193,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622118,,10725,,,Oral bioavailability in rat,6803,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622119,,10726,,,Oral bioavailability in rats at 6 mg/kg,6647,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622120,,10727,,,Oral bioavailability in rat (dose 6 mg/kg),6647,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622121,,10728,,,Oral bioavailability in rats at 6 mg/kg dose; Not tested,6647,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622122,,10729,,,Oral bioavailability in rat,6640,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622123,,10730,,,Oral bioavailability in rat,6641,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622124,,10731,,,Oral bioavailability in rat,6641,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622125,,10732,,,Bioavailability in rat,6642,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622126,,10733,,,Oral bioavailability,5472,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620455,,10734,,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),6141,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620456,,10735,,,Oral bioavailability in rat,4390,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620457,,10736,,,Oral bioavailability in rat,5472,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620458,,10737,,,Oral bioavailability was evaluated; Not tested,5472,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620459,,10738,,,Oral bioavailability,5438,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620460,,10739,,,Oral bioavailability in rat by oral dosing,4883,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620461,,10740,,,Oral bioavailability in rat (dose 10 mg/kg p.o.),1908,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620462,,10741,,,Oral bioavailability in rat (Sprague-Dawley),4853,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620463,,10742,,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),4853,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620464,,10743,,,Oral bioavailability in rat (Sprague-Dawley) (dose 1 mg/kg i.v.),4853,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620465,,10744,,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg),4853,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620466,,10745,,,Oral bioavailability in rat (Sprague-Dawley) (dose 2 mg/kg p.o.),4853,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620467,,10746,,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 1 mg/kg,4853,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620468,,10747,,,Oral bioavailability was calculated in Spragun Dawley rat at oral dosage of 2 mg/kg,4853,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620469,,10748,,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in solution form,12873,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620470,,10749,,,Oral bioavailability was calculated in rats using an average of the intravenous AUC at peroral dose of 5 mgkg in suspension form,12873,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620471,,10750,,,Oral bioavailability in rat,3169,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620472,,10751,,,Oral bioavailability in rat,6305,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620473,,10752,,,Oral bioavailability of compound at 5 mg/kg after po administration was determined in rat,4762,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620474,,10753,,,Oral bioavailability in rat,17847,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620475,,10754,,,Oral bioavailability in rat (Sprague-Dawley) (fasted male) (dose 10 mg/kg),6211,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620476,,10755,,,Oral bioavailability in rat,6011,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620477,,10756,,,Oral bioavailability in rat,6317,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620478,,10757,,,Oral bioavailability in rat after oral administration at 10.5 mg/kg dose,6644,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618768,,10758,,,Oral bioavailability in rat after oral administration at 11.2 mg/kg dose,6644,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618769,,10759,,,Oral bioavailability in rat after oral administration at 13 mg/kg dose,6644,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618770,,10760,,,Oral bioavailability in rat after oral administration at 9.7 mg/kg dose,6644,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618771,,10761,,,Oral bioavailability (dose 20 mg/kg p.o.),6113,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618772,,10762,,,Oral bioavailability was determined in rat after oral administration at a concentration 1 mg/kg,5937,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618773,,10763,,,Oral bioavailability in rat at 10 mg/kg of the compound,5711,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL875842,,10764,,,Bioavailability in rat at a concentration of 15 mg/kg perorally in rat along with 100 mg/kg 11,17717,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618774,,10765,,,Bioavailability in rat (dose 3 mg/kg i.v.),17717,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618775,,10766,,,Bioavailability in rat at a concentration of 60 mg/kg perorally in rat along with 100 mg/kg 11,17717,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618776,,10767,,,Oral bioavailability in rat (dose 60 mg/kg p.o.),17717,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618777,,10768,,,Percent bioavailability (F) in rats after iv administration,4722,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618778,,10769,,,Percent bioavailability (F) in rats after oral dose of 10 mg/kg,4722,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618779,,10770,,,Bioavailability in rat (dose 5 uM/kg p.o.),4353,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618780,,10771,,,Oral bioavailability,15662,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618781,,10772,,,Bioavailability in rat (dose 2 mg/kg p.o.),4756,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618782,,10773,,,Percent bioavailability at the dose of 5 mg/Kg administered perorally in rats,4756,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618783,,10774,,,Oral bioavailability in rat (dose 20 mg/kg),3436,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618784,,10775,,,Oral bioavailability in rat,17800,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618785,,10776,,,Percent oral bioavailability evaluated in rat,15762,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618786,,10777,,,Oral bioavailability in rat,5089,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618787,,10778,,,Percent oral bioavailability in rat; Not determined,5089,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618788,,10779,,,Oral bioavailability in rat,3185,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618789,,10780,,,Bioavailability in rat,5145,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618790,,10781,,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a solution),3457,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618791,,10782,,,Pharmacokinetic property (oral bioavailability) in rat (dose given as a suspension),3457,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL875843,,10783,,,Pharmacokinetic property (F) was measured in rat at the dose of 0.32 mg/kg,5983,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618792,,10784,,,Oral bioavailability in rat (dose 20 mg/kg p.o.),5739,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623395,,10785,,,Cmax at a dose of 30 mg/kg in rat,3579,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL623396,,10786,,,Cmax in monkeys at a dose of 1 mg/kg,17788,Simiiformes,314293.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623397,,10787,,,Cmax in rat,14956,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623398,,10788,,,Cmax in rats at a dose of 1 mg/kg,17788,Rattus norvegicus,10116.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623399,,10789,,,Cmax was measured in mice after an oral dose of 50 mg/kg.,9750,Mus musculus,10090.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL623400,,10790,,,"Cmax value at a dose of 12.7 uM/kg, po",12767,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL623401,,10791,,,"Cmax value at a dose of 6.3 uM/kg, iv",12767,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL623402,,10792,,,"Cmax value at a dose of 7.1 uM/kg, iv",12767,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL623403,,10793,,,Cmax value of compound was determined after 1 hr,12703,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL623404,,10794,,,Cmax value of the compound,15778,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625997,,10795,,,Cmax value administered intraintestinal in rats.,12818,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625998,,10796,,,Cmax value administered perorally was determined in rat; Not determined,14964,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625999,,10797,,,Cmax value at the dose of 2.3 mg/kg,15808,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626000,,10798,,,Cmax value at the dose of 5 mg/kg,15808,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626001,,10799,,,Cmax value in the period of 8 hr after dosing. ,15778,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626002,,10800,,,Cmax value at a oral dose of 20 mg/kg; Not tested,3715,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626003,,10801,,,Cmax value at a oral dose of 20 mg/kg,3715,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626004,,10802,,,Cmax value was determined between 15 and 30 minutes post administration in fisher rats; value ranges from 200-500,1446,Rattus norvegicus,10116.0
50512,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626005,,10803,,,Cmax(ng /mL)values after oral administration of 10 mg/kg in guinea pig.,15240,Cavia porcellus,10141.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626006,,10804,,,Cmax(ng /mL)values after oral administration of 10 mg/kg in rat.,15240,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626007,,10805,,,Compound at a dose of 10 mg/kg was orally administered to rats and maximum plasma concentration was reported,14810,Rattus norvegicus,10116.0
50594,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626008,,10806,,,Compound was evaluated for maximum plasma concentration by administering orally at 25 mg/kg in mice,14239,Mus musculus,10090.0
50588,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL626009,,10807,,,Compound was evaluated for maximum plasma concentration levels in dogs for the orally delivered compound in 0.05 M citric acid,12555,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626010,,10808,,,Compound was evaluated in vivo for its concentration after a peroral administration 40 mg/kg in dogs.,10754,Canis lupus familiaris,9615.0
50594,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL626011,,10809,,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a intramuscular administration 40 mg/kg in mice,10754,Mus musculus,10090.0
50594,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL626012,,10810,,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration 40 mg/kg in mice,10754,Mus musculus,10090.0
50594,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL626013,,10811,,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after a peroral administration of 40 mg/kg in mice,10754,Mus musculus,10090.0
50594,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL626014,,10812,,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice,10754,Mus musculus,10090.0
50594,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL877496,,10813,,,Compound was evaluated in vivo in blood samples from the orbital sinus for its concentration after an intramuscular administration of 40 mg/kg in mice.,10754,Mus musculus,10090.0
50588,,F,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626015,,10814,,,Compound was tested Growth Hormone(GH) release after 0.5 mg/kg administration (Po) in Beagle dogs,14600,Canis lupus familiaris,9615.0
50588,,F,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626016,,10815,,,Compound was tested Growth Hormone(GH) release after 10 mg/kg administration (Po) in Beagle dogs,14600,Canis lupus familiaris,9615.0
50588,,F,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626017,,10816,,,Compound was tested Growth Hormone(GH) release after 2.5 mg/kg administration (Po) in Beagle dogs,14600,Canis lupus familiaris,9615.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626018,,10817,,,Bioavailability as maximal plasma concentration in dogs,13543,Canis lupus familiaris,9615.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626692,,10818,,,Bioavailability as maximal plasma concentration in dogs,13543,Canis lupus familiaris,9615.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626693,,10819,,,Bioavailability as maximal plasma concentration in rats,13543,Rattus norvegicus,10116.0
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL626694,,10820,,,Bioavailability as maximal plasma concentration in rats,13543,Rattus norvegicus,10116.0
50588,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL626695,,10821,,,Compound was tested for maximum blood concentration after 0.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,14600,Canis lupus familiaris,9615.0
50588,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL626696,,10822,,,Compound was tested for maximum blood concentration after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,14600,Canis lupus familiaris,9615.0
50588,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL626697,,10823,,,Compound was tested for maximum blood concentration after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,14600,Canis lupus familiaris,9615.0
50588,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL626859,,10824,,,Compound was tested for maximum concentration in blood after 0.5 mg/kg administration (Po) in Beagle dogs; nd = Not Detectable,14600,Canis lupus familiaris,9615.0
50588,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL626860,,10825,,,Compound was tested for maximum concentration in blood after 10 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,14600,Canis lupus familiaris,9615.0
50588,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL626861,,10826,,,Compound was tested for maximum concentration in blood after 2.5 mg/kg administration (Po) in Beagle dogs; nM/L maximum blood concentration,14600,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626296,,10827,,,Compound was tested for maximum observed concentration in three male Wistar rats at a single 5 mg/kg oral gavage dose,14681,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626297,,10828,,,Compound was tested for the max. conc. when administered perorally(po) 30 mg/kg,15905,,
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL626298,,10829,,,Compound was tested for the max. plasma conc. when administered intraperitoneally (ip) 30 mg/kg.,15905,,
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626299,,10830,,,"Drug plasma level in rat was determined on the last day of dosing at 1,2,4.8 and 24 hr and ED50 was evaluated",13304,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626300,,10831,,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats after 30 min.,15137,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626301,,10832,,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats after 30 min.,15137,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626962,,10833,,,Effect of ip administration of compound on plasma concentration of corticosterone (CTS) in rats after 30 min.,15137,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626963,,10834,,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats after 30 min.,15137,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626964,,10835,,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats after 30 min.,15137,Rattus norvegicus,10116.0
100710,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626965,,10836,,,In vivo antitumor efficacy expressed as maximum plasma concentration 0.4 hr after a peroral dose of 25 mg/kg in cynomolgus monkeys,14839,Macaca fascicularis,9541.0
50594,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626966,,10837,,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,14839,Mus musculus,10090.0
50594,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626967,,10838,,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,14839,Mus musculus,10090.0
100710,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626968,,10839,,,In vivo antitumor efficacy expressed as maximum plasma concentration after a peroral dose of 10 mg/kg in cynomolgus monkeys,14839,Macaca fascicularis,9541.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL626969,,10840,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.89-1.24,8418,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL627126,,10841,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-2.58,8418,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL631276,,10842,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.24-0.28,8418,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL631277,,10843,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.52-0.62,8418,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL631278,,10844,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.68-0.84,8418,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL874457,,10845,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.75-1.03,8418,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL631279,,10846,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.96-2.46,8418,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL631280,,10847,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.36-0.42,8418,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL631281,,10848,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.82,8418,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL631968,,10849,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.24-1.46,8418,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL631969,,10850,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.36-3.96,8418,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL631970,,10851,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.24-0.29,8418,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL631971,,10852,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.39-0.74,8418,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL631972,,10853,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.79-0.85,8418,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL630435,,10854,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.64-0.86,8418,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL630436,,10855,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.68-2.23,8418,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL630437,,10856,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.19-0.23,8418,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL630438,,10857,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.22-0.29,8418,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL630439,,10858,,,Distribution of radioactivity in heart tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.75,8418,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL630440,,10859,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.42-1.82,8418,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL630441,,10860,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.24-3.12,8418,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL630442,,10861,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.62-0.92,8418,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL625234,,10862,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.12-2.04,8418,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL625235,,10863,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.59-2.03,8418,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL625236,,10864,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.14-1.4,8418,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL625237,,10865,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.56-1.83,8418,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL626125,,10866,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.58-0.73,8418,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL626126,,10867,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.67-2.11,8418,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL626127,,10868,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.64-3.43,8418,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL626128,,10869,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.18-4.74,8418,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL626129,,10870,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.62-1.13,8418,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL626130,,10871,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.73-2.64,8418,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL626131,,10872,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 13.02-19.07,8418,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL626132,,10873,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.89-1.19,8418,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL626752,,10874,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.17-1.48,8418,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL626753,,10875,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.48-0.72,8418,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL626754,,10876,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.57,8418,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL626755,,10877,,,Distribution of radioactivity in kidney tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.99-1.24,8418,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL626756,,10878,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.23-1.78,8418,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL626757,,10879,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 2.43-2.92,8418,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL626758,,10880,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.81-1.18,8418,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL626759,,10881,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 1.37-1.74,8418,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL626760,,10882,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 4.01-4.81,8418,Rattus norvegicus,10116.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626394,,10883,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626395,,10884,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration,6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626396,,10885,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration (0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626397,,10886,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626398,,10887,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626399,,10888,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL874653,,10889,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration,6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626400,,10890,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626401,,10891,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626402,,10892,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626403,,10893,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626404,,10894,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626405,,10895,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration,6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625529,,10896,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625530,,10897,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625531,,10898,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625532,,10899,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625533,,10900,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL875474,,10901,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration,6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625534,,10902,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625535,,10903,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625536,,10904,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625537,,10905,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625538,,10906,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625539,,10907,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration,6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625540,,10908,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625541,,10909,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625542,,10910,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625543,,10911,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625544,,10912,,,Oral diuretic activity was evaluated by measuring K+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,10116.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625545,,10913,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.312 mg/kg after ip administration,6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625546,,10914,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625547,,10915,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.625 mg/kg after ip administration,6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625548,,10916,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625549,,10917,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625550,,10918,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625551,,10919,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL875475,,10920,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625552,,10921,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625553,,10922,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625554,,10923,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625555,,10924,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625556,,10925,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624986,,10926,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration,6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624987,,10927,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624988,,10928,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),6996,Canis lupus familiaris,9615.0
50588,Artery,A,,,BAO_0000218,Intermediate,1,N,1637.0,1,,,In vivo,CHEMBL624989,,10929,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -2/-14,9025,Canis lupus familiaris,9615.0
50588,Artery,A,,,BAO_0000218,Intermediate,1,N,1637.0,1,,,In vivo,CHEMBL624990,,10930,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; -4/-4,9025,Canis lupus familiaris,9615.0
50588,Artery,A,,,BAO_0000218,Intermediate,1,N,1637.0,1,,,In vivo,CHEMBL874391,,10931,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3 range; 4/7,9025,Canis lupus familiaris,9615.0
50588,Artery,A,,,BAO_0000218,Intermediate,1,N,1637.0,1,,,In vivo,CHEMBL624991,,10932,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 1/3/10 range; -3/0/4,9025,Canis lupus familiaris,9615.0
50588,Artery,A,,,BAO_0000218,Intermediate,1,N,1637.0,1,,,In vivo,CHEMBL624992,,10933,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; -6/0,9025,Canis lupus familiaris,9615.0
50588,Artery,A,,,BAO_0000218,Intermediate,1,N,1637.0,1,,,In vivo,CHEMBL624993,,10934,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 10/31,9025,Canis lupus familiaris,9615.0
50588,Artery,A,,,BAO_0000218,Intermediate,1,N,1637.0,1,,,In vivo,CHEMBL624994,,10935,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 11/-19,9025,Canis lupus familiaris,9615.0
50588,Artery,A,,,BAO_0000218,Intermediate,1,N,1637.0,1,,,In vivo,CHEMBL624995,,10936,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 14/6,9025,Canis lupus familiaris,9615.0
50588,Artery,A,,,BAO_0000218,Intermediate,1,N,1637.0,1,,,In vivo,CHEMBL624996,,10937,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/25,9025,Canis lupus familiaris,9615.0
50588,Artery,A,,,BAO_0000218,Intermediate,1,N,1637.0,1,,,In vivo,CHEMBL624997,,10938,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 19/3,9025,Canis lupus familiaris,9615.0
50588,Artery,A,,,BAO_0000218,Intermediate,1,N,1637.0,1,,,In vivo,CHEMBL624998,,10939,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 2/16,9025,Canis lupus familiaris,9615.0
50588,Artery,A,,,BAO_0000218,Intermediate,1,N,1637.0,1,,,In vivo,CHEMBL624999,,10940,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 6/2,9025,Canis lupus familiaris,9615.0
50588,Artery,A,,,BAO_0000218,Intermediate,1,N,1637.0,1,,,In vivo,CHEMBL882955,,10941,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 7/26,9025,Canis lupus familiaris,9615.0
50588,Artery,A,,,BAO_0000218,Intermediate,1,N,1637.0,1,,,In vivo,CHEMBL625000,,10942,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/49,9025,Canis lupus familiaris,9615.0
50588,Artery,A,,,BAO_0000218,Intermediate,1,N,1637.0,1,,,In vivo,CHEMBL625001,,10943,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 8/8,9025,Canis lupus familiaris,9615.0
50588,Artery,A,,,BAO_0000218,Intermediate,1,N,1637.0,1,,,In vivo,CHEMBL625089,,10944,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/30 range; 9/-18,9025,Canis lupus familiaris,9615.0
50588,Artery,A,,,BAO_0000218,Intermediate,1,N,1637.0,1,,,In vivo,CHEMBL625090,,10945,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 10/60 range; 13/23,9025,Canis lupus familiaris,9615.0
50588,Artery,A,,,BAO_0000218,Intermediate,1,N,1637.0,1,,,In vivo,CHEMBL625091,,10946,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3 range,9025,Canis lupus familiaris,9615.0
50588,Artery,A,,,BAO_0000218,Intermediate,1,N,1637.0,1,,,In vivo,CHEMBL625092,,10947,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a dose of 3/10 range; -7/-11,9025,Canis lupus familiaris,9615.0
50588,Artery,A,,,BAO_0000218,Intermediate,1,N,1637.0,1,,,In vivo,CHEMBL625093,,10948,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 1/3 dose range; 6/-7,9025,Canis lupus familiaris,9615.0
50588,Artery,A,,,BAO_0000218,Intermediate,1,N,1637.0,1,,,In vivo,CHEMBL625094,,10949,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 10/30 dose range; -13/19,9025,Canis lupus familiaris,9615.0
50588,Artery,A,,,BAO_0000218,Intermediate,1,N,1637.0,1,,,In vivo,CHEMBL625095,,10950,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a of 3/10 dose range; 30/47,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625096,,10951,,,Compound was evaluated for its bioavailability in the dogs,2249,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625097,,10952,,,Compound was evaluated for its bioavailability in the rats,2249,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL882956,,10953,,,Compound was evaluated for oral bioavailability,17515,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625098,,10954,,,Compound was evaluated for percentage of Oral bioavailability in rats,14541,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625099,,10955,,,Bioavailability in guinea pig,12797,Cavia porcellus,10141.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625100,,10956,,,Compound was evaluated for the oral bioavailability in rat,12797,Rattus norvegicus,10116.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625101,,10957,,,Compound was evaluated for the oral bioavailability in dog,12797,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL874396,,10958,,,Compound was evaluated for the oral bioavailability in rat,12797,Rattus norvegicus,10116.0
22224,,F,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625102,,10959,,,Bioavailability in dog (dosed i.v.),11727,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625103,,10960,,,Compound was tested for in vivo bioavailability in dog,13249,Canis lupus familiaris,9615.0
100712,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625104,,10961,,,Compound was tested for in vivo bioavailability in hamsters,13249,Cricetinae,10026.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625105,,10962,,,Compound was tested for in vivo bioavailability in monkey,13249,Simiiformes,314293.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625106,,10963,,,Compound was tested for in vivo bioavailability in rat,13249,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625107,,10964,,,Oral bioavailability in mouse,9552,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625108,,10965,,,Compound was tested for percent of oral bioavailability in mice; 56-74,9552,Mus musculus,10090.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625109,,10966,,,Oral bioavailability in mouse (nude) (dose of 25 mg/kg),14839,Mus musculus,10090.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625110,,10967,,,Bioavailability in cynomolgus monkey (dose 25 mg/kg i.v.),14839,Macaca fascicularis,9541.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625111,,10968,,,Bioavailability in cynomolgus monkey (dose 5 mg/kg i.v.),14839,Macaca fascicularis,9541.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625112,,10969,,,Oral bioavailability in mouse (nude) (dose 25 mg/kg i.v.),14839,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL875334,,10970,,,Oral bioavailability in nude mice,14839,Mus musculus,10090.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL628617,,10971,,,Bioavailability in monkey (i.d. dosing),11219,Primates,9443.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL628618,,10972,,,Bioavailability in rat,9552,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL628619,,10973,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 10%,11732,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL628620,,10974,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 20%,11732,,
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628621,,10975,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 10 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",14839,Macaca fascicularis,9541.0
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628622,,10976,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 25 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",14839,Macaca fascicularis,9541.0
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628623,,10977,,,"In vivo antitumor efficacy in cynomolgus monkeys by injecting a dose of 5 mg/kg, as HCl salt in saline solution, perorally and the maximum drug concentration was determined",14839,Macaca fascicularis,9541.0
100710,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL628624,,10978,,,Maximal plasma concentration in cynomolgus monkeys after 10 mg/kg oral dose,14839,Macaca fascicularis,9541.0
50594,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL628625,,10979,,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,14839,Mus musculus,10090.0
100710,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL628626,,10980,,,Maximal plasma concentration in cynomolgus monkeys after 5 mg/kg oral dose,14839,Macaca fascicularis,9541.0
50594,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL627041,,10981,,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,14839,Mus musculus,10090.0
50594,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL627042,,10982,,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,14839,Mus musculus,10090.0
50594,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL627043,,10983,,,Maximal plasma concentration in nude mice after 25 mg/kg oral dose,14839,Mus musculus,10090.0
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL627044,,10984,,,In vivo evaluation of maximum plasma concentration at a dose of 10 mg/kg,13932,,
50594,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL627045,,10985,,,Cmax in mouse plasma,11637,Mus musculus,10090.0
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL627046,,10986,,,Max plasma concentration was measured by 40 mg/kg dose of peroral administration.,11637,,
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL627047,,10987,,,Maximal plasma concentration in rat,13960,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL627048,,10988,,,Maximal plasma level when administered 1 mg/kg perorally (po) in rat,15905,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627049,,10989,,,Maximum concentration at an intraduodenal dose of 5.2 mg/kg in rat,14062,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627050,,10990,,,Maximum concentration at an intraduodenal dose of 6.6 mg/kg in rat,14062,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627051,,10991,,,Maximum concentration at an intravenous dose of 5.5 mg/kg in rat,14062,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627052,,10992,,,Maximum concentration at an intravenous dose of 6.5 mg/kg in rat,14062,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627053,,10993,,,Maximum concentration at an peroral dose of 6.2 mg/kg in rat,14062,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627054,,10994,,,Maximum concentration at an peroral dose of 6.3 mg/kg in rat,14062,Rattus norvegicus,10116.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627055,,10995,,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,15011,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627056,,10996,,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,15011,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627057,,10997,,,Maximum concentration (Cmax) using 0.4% Methyl cellulose (MC) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg (micronized sample),15011,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627058,,10998,,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered intravenously to nude mice at a dose of 25 mg/kg,15011,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626211,,10999,,,Maximum concentration (Cmax) using 20%aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle. compound was administered orally to nude mice at a dose of 25 mg/kg,15011,Mus musculus,10090.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626212,,11000,,,Maximum Concentration of the compound.,10291,,
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626213,,11001,,,Maximum Concentration was measured after iv administration into Beagle dog,14599,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626214,,11002,,,Maximum Concentration was measured after iv administration into Beagle dog.,14599,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626215,,11003,,,Maximum Concentration was measured after po administration into Beagle dog,14599,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626216,,11004,,,Maximum Concentration was measured after po administration into Beagle dog.,14599,Canis lupus familiaris,9615.0
22224,Blood,A,,,BAO_0000218,Autocuration,0,U,178.0,1,,,In vivo,CHEMBL626217,,11005,,,Maximum blood level reached after an dose of 10.6 uM/kg intravenously,12767,,
22224,Blood,A,,,BAO_0000218,Autocuration,0,U,178.0,1,,,In vivo,CHEMBL626218,,11006,,,Maximum blood level reached after an iv dose of 12.2 uM/kg,12767,,
22224,Blood,A,,,BAO_0000218,Autocuration,0,U,178.0,1,,,In vivo,CHEMBL626219,,11007,,,Maximum blood level reached after an oral dose 14.7 uM/kg oral route,12767,,
22224,Blood,A,,,BAO_0000218,Autocuration,0,U,178.0,1,,,In vivo,CHEMBL626220,,11008,,,Maximum blood level reached after an oral dose of 14.7 uM/kg intravenous route,12767,,
22224,Blood,A,,,BAO_0000218,Autocuration,0,U,178.0,1,,,In vivo,CHEMBL626221,,11009,,,Maximum blood level reached after an oral dose of 5.0 mg/kg,12767,,
22224,Blood,A,,,BAO_0000218,Autocuration,0,U,178.0,1,,,In vivo,CHEMBL626222,,11010,,,Maximum blood level reached at dose of 10.6 uM/kg orally,12767,,
50512,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626223,,11011,,,Maximum concentration (Cmax) in guinea pigs at 2 mg/kg after oral administration,14706,Cavia porcellus,10141.0
50512,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626224,,11012,,,Maximum concentration (Cmax) in guinea pigs at 3 mg/kg after oral administration,14706,Cavia porcellus,10141.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL626225,,11013,,,Maximum concentration achieved in rat brain when administered intraperitoneally at a dose of 10 mg/kg,14793,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL626226,,11014,,,Maximum concentration achieved in rat brain when administered intravenously at a dose of 10 mg/kg,14793,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL626227,,11015,,,Maximum concentration achieved in rat brain when administered perorally at a dose of 100 mg/kg,14793,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL626228,,11016,,,Maximum concentration achieved in rat brain when administered perorally at a dose of 10 mg/kg,14793,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626229,,11017,,,Maximum concentration achieved in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,14793,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626921,,11018,,,Maximum concentration achieved in rat plasma when administered intravenously at a dose of 10 mg/kg,14793,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL876793,,11019,,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 100 mg/kg,14793,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625309,,11020,,,Maximum concentration achieved in rat plasma when administered perorally at a dose of 10 mg/kg,14793,Rattus norvegicus,10116.0
50278,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625310,,11021,,,Maximum concentration determined against Bacillus subtilis ATCC 6633 after oral administration in dog(25 mg/kg),10524,Bacillus subtilis,1423.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625311,,11022,,,Maximum concentration determined in monkeys dosed intravenously with 30 mg/kg,11871,Simiiformes,314293.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625312,,11023,,,Maximum concentration determined in rats dosed intravenously with 20 mg/kg,11871,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625313,,11024,,,Maximum concentration for the bioavailability at a dose of 20 mg/kg administered orally,3437,,
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625314,,11025,,,Maximum concentration in male CD-1 mice after sc administration of 20 mg/kg,12038,Mus musculus,10090.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625315,,11026,,,Maximum concentration in male rats after iv administration of 20 mg/kg,12038,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625316,,11027,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.06-1.29,8418,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625317,,11028,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 1.77-2.08,8418,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625318,,11029,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.89,8418,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625319,,11030,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 1.57-1.66,8418,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625320,,11031,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.06-2.71,8418,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625321,,11032,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 2.98-3.22,8418,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625322,,11033,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.73-1.45,8418,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL876801,,11034,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.03-1.31,8418,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625323,,11035,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 6.76-10.44,8418,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625324,,11036,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.47-1.17,8418,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625325,,11037,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 1.12-1.44,8418,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625326,,11038,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.38-0.57,8418,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625327,,11039,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.75-1.14,8418,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625328,,11040,,,Distribution of radioactivity in liver tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 1.36-1.74,8418,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL625329,,11041,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.5,8418,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL625330,,11042,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 3.10-3.77,8418,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL627774,,11043,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.4-0.54,8418,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL627775,,11044,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.58-0.86,8418,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL627949,,11045,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.77-0.86,8418,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL627950,,11046,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.86-1.13,8418,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL627951,,11047,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 2.26-2.89,8418,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL627952,,11048,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.54-0.7,8418,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL627953,,11049,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.6-0.66,8418,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL627954,,11050,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.35-1.74,8418,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL627955,,11051,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 3.62-7.08,8418,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL627956,,11052,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.47-0.56,8418,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL876802,,11053,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.54-1.07,8418,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL627957,,11054,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.76-0.91,8418,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL627958,,11055,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.61-0.86,8418,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL627959,,11056,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 2.11-3.79,8418,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL627960,,11057,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.3-0.36,8418,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL627961,,11058,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.36-0.44,8418,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL627962,,11059,,,Distribution of radioactivity in lung tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.5-0.65,8418,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627963,,11060,,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,9796,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624759,,11061,,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,9796,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624760,,11062,,,Distribution of radiolabeled compound in intestinal contents of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,9796,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624761,,11063,,,Distribution of radiolabeled compound in intestinal contents of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,9796,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL877607,,11064,,,Distribution of radiolabeled compound in intestinal contents of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,9796,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL624762,,11065,,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,9796,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL624763,,11066,,,Distribution of radiolabeled compound in liver of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,9796,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL624764,,11067,,,Distribution of radiolabeled compound in liver of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,9796,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL624765,,11068,,,Distribution of radiolabeled compound in liver of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,9796,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL624766,,11069,,,Distribution of radiolabeled compound in liver of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,9796,Rattus norvegicus,10116.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624767,,11070,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624768,,11071,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration,6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624769,,11072,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624770,,11073,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624771,,11074,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624772,,11075,,,Oral diuretic activity was evaluated by measuring K+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624773,,11076,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration,6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624774,,11077,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624775,,11078,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration (0-5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624776,,11079,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624777,,11080,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624778,,11081,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624779,,11082,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration,6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624780,,11083,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624781,,11084,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL877608,,11085,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624782,,11086,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration (0-5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624783,,11087,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624784,,11088,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration,6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624785,,11089,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624786,,11090,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration (0-5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624787,,11091,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628676,,11092,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621842,,11093,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration,6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL621843,,11094,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623873,,11095,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623874,,11096,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623875,,11097,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623876,,11098,,,Oral diuretic activity was evaluated by measuring Na+ excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,10116.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623877,,11099,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.312 mg/kg after ip administration,6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623878,,11100,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623879,,11101,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.625 mg/kg after ip administration,6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623880,,11102,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623881,,11103,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623957,,11104,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration (0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623958,,11105,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623959,,11106,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623960,,11107,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623961,,11108,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration (0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623962,,11109,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624676,,11110,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624677,,11111,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624678,,11112,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration,6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624679,,11113,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration (0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624680,,11114,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),6996,Canis lupus familiaris,9615.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL624849,,11115,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 27%,11732,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL624850,,11116,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 4%,11732,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL874399,,11117,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 54%,11732,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL624851,,11118,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 72%,11732,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL624852,,11119,,,Measure of AUCpo/AUCiv x 100% of the parent compound before (free) and after (total) beta-glucuronidase treatment; total 76%,11732,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL624853,,11120,,,Oral bioavailability in rat (dose 10 mg/kg),13359,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL624854,,11121,,,Oral bioavailability in rat (Sprague-Dawley),16618,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL624855,,11122,,,Oral bioavailability in rat,13960,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL624856,,11123,,,Oral bioavailability in rats was determined in vivo,13917,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL882957,,11124,,,Oral bioavailability in dog,14266,Canis lupus familiaris,9615.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL624857,,11125,,,Oral bioavailability of compound in monkey,12359,Simiiformes,314293.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622202,,11126,,,Oral bioavailability of compound in rat,12359,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL622203,,11127,,,Bioavailability in rat of PMEA prodrug,12359,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625522,,11128,,,Oral bioavailability of compound was evaluated relative to that of PMEA in rat; Not determined due to lack of solubility,12359,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL622868,,11129,,,Serum conc at 3 hours following 25 mg/kg dose,10791,Macaca mulatta,9544.0
22224,Urine,A,,,BAO_0000218,Autocuration,0,U,1088.0,1,,,In vivo,CHEMBL622869,,11130,,,Urine conc 0-5 hours following 25 mg/kg dose,10791,Macaca mulatta,9544.0
22224,Urine,A,,,BAO_0000218,Autocuration,0,U,1088.0,1,,,In vivo,CHEMBL622870,,11131,,,Urine conc 0-24 hours following 25 mg/kg dose,10791,Macaca mulatta,9544.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL622871,,11132,,,Oral bioavailability in African green monkeys; 20-25,138,Chlorocebus aethiops,9534.0
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620560,,11133,,,Oral bioavailability in cynomolgus monkey.,14521,Macaca fascicularis,9541.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL620561,,11134,,,Oral bioavailability in dog,13953,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620562,,11135,,,Oral bioavailability in dog at 10 mg/kg oral dose,12836,Canis lupus familiaris,9615.0
100712,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620563,,11136,,,Oral bioavailability in hamster at 10 mg/kg oral dose,12836,Cricetinae,10026.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620564,,11137,,,Oral bioavailability in rat at 10 mg/kg oral dose,12836,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL872265,,11138,,,Oral bioavailability in rat,14521,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL620565,,11139,,,Oral bioavailability in rat,13953,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL620566,,11140,,,Oral bioavailability,6799,Eutheria,9347.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL620567,,11141,,,Oral bioavailability was determined; range 49-102%,11311,,
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620568,,11142,,,Oral bioavailability was determined in dogs,4013,Canis lupus familiaris,9615.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL620569,,11143,,,Oral bioavailability in rat,4013,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL620570,,11144,,,Oral bioavailability,17591,Eutheria,9347.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL620571,,11145,,,Oral bioavailability was determined; Not orally available,17591,,
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL620572,,11146,,,Percent bioavailability was administered by using 0.4% Methyl cellulose (MC) as vehicle to nude mice at a dose of 25 mg/kg (micronized sample),15011,Mus musculus,10090.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL620573,,11147,,,Bioavailability in mouse (nude) (dose 0.4% Methylcellulose (MC) as vehicle 25 mg/kg),15011,Mus musculus,10090.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL620574,,11148,,,Bioavailability in mouse (nude) using 20% aqueous hydroxypropyl-beta-cyclodextrin (HPbetaCD) as vehicle 25 mg/kg,15011,Mus musculus,10090.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL620575,,11149,,,Oral bioavailability in Rhesus monkey,9552,Macaca mulatta,9544.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL620576,,11150,,,Oral bioavailability in dog (female mongrel),9552,Canis lupus familiaris,9615.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL875846,,11151,,,Percent oral bioavailability of perorally administered compound (30 mg/kg) was tested,3639,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL620577,,11152,,,Oral bioavailability in dog,13397,Canis lupus familiaris,9615.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL620578,,11153,,,Percentage Bioavailability was evaluated.,3031,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL620579,,11154,,,Bioavailability in rat administered i.d.,12818,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL621248,,11155,,,Bioavailability,4847,Eutheria,9347.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625390,,11156,,,Bioavailability in dog (male Beagle) i.v. administration,12421,Canis lupus familiaris,9615.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625391,,11157,,,"Bioavailability in rat (dose 20 mg/kg p.o. in 1% methocel, and 5 mg/kg i.v. in PEG400)",11966,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL872266,,11158,,,Bioavailability in monkey (dose 10 mg/kg i.d. or 0.3 mg/kg i.v.),11218,Primates,9443.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625392,,11159,,,Oral bioavailability in rat (Sprague-Dawley) (male),13129,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625393,,11160,,,The oral bioavailability was measured on rats after oral administration,12350,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625394,,11161,,,Bioavailability was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,2231,Rattus norvegicus,10116.0
50797,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625395,,11162,,,Bioavailability was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,2231,Macaca mulatta,9544.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625396,,11163,,,Bioavailability in rat (dose 10 mg/kg i.d.),12187,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625397,,11164,,,Bioavailability in dog (male Beagle) i.v. administration,12421,Canis lupus familiaris,9615.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625398,,11165,,,Biodistribution in CD-1 mice was determined after 1 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,10090.0
50594,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL625399,,11166,,,Biodistribution in CD-1 mice was determined after 1 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,10090.0
50594,Cerebellum,A,,,BAO_0000218,Intermediate,1,N,2037.0,1,,,In vivo,CHEMBL626074,,11167,,,Biodistribution in CD-1 mice was determined after 1 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626075,,11168,,,Biodistribution in CD-1 mice was determined after 1 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,10090.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626076,,11169,,,Maximum concentration in plasma (Cmax) was evaluated in rat at an intravenous dose of 3 mg/kg and peroral dose of 5 mg/kg,2231,Rattus norvegicus,10116.0
50797,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626077,,11170,,,Maximum concentration in plasma (Cmax) was evaluated in rhesus monkey at an intravenous dose of 1 mg/kg and peroral dose of 1 mg/kg,2231,Macaca mulatta,9544.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL626078,,11171,,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 1 mg/kg in rat (normalized to a 1 mg/kg dose),12178,Rattus norvegicus,10116.0
22224,Blood,A,,,BAO_0000218,Autocuration,0,U,178.0,1,,,In vivo,CHEMBL625846,,11172,,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 2.5 mg/kg in rat (normalized to a 1 mg/kg dose),12178,,
22224,Blood,A,,,BAO_0000218,Autocuration,0,U,178.0,1,,,In vivo,CHEMBL625847,,11173,,,Maximum concentration in whole blood recorded in the period 0-24 hr postdose of 5.0 mg/kg GP (normalized to a 1 mg/kg dose),12178,,
50597,,A,,,BAO_0000218,Expert,1,N,,1,,,In vivo,CHEMBL625848,,11174,,,Maximum concentration observed in rats at an oral dose of 50 mg/kg,15633,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL625849,,11175,,,Maximum concentration of compound in plasma administered orally to rats,14258,Rattus norvegicus,10116.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626023,,11176,,,"Maximum concentration (10 mg/kg, orally) in plasma of dogs",14224,Canis lupus familiaris,9615.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626024,,11177,,,"Maximum concentration (10 mg/kg, perorally) in plasma of dogs",14224,Canis lupus familiaris,9615.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626025,,11178,,,"Maximum concentration (5 mg/kg, intravenously) in plasma of dogs",14224,Canis lupus familiaris,9615.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626026,,11179,,,Maximum concentration after 10 mg/kg by oral administration,5566,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626027,,11180,,,Maximum concentration at a dose of 1.5 mg/kg,16935,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626028,,11181,,,Maximum concentration at a dose of 2.0 mg/kg,16935,,
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626029,,11182,,,Maximum concentration in dog plasma,14224,Canis lupus familiaris,9615.0
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL626030,,11183,,,Maximum concentration in plasma after administration of 10 umol/kg dose perorally,12536,,
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL626031,,11184,,,Maximum concentration in plasma after administration of 2 umol/kg dose intravenously,12536,,
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL626032,,11185,,,Maximum concentration in plasma after administration of 4 umol/kg dose intravenously,12536,,
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL626033,,11186,,,Maximum concentration in plasma after administration of 40 umol/kg dose perorally,12536,,
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL626034,,11187,,,Maximum concentration in plasma after administration of 5 umol/kg dose intravenously,12536,,
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626035,,11188,,,Maximum concentration in plasma after oral administration in dog (25 mg/kg),9994,Canis lupus familiaris,9615.0
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL626036,,11189,,,Maximum concentration in plasma at Tmax,1434,,
50588,Plasma,A,,,BAO_0000218,Expert,1,N,1969.0,1,,,In vivo,CHEMBL626037,,11190,,,Maximum concentration in plasma recorded 0-6 hr post dose in dog at 10 mg/kg oral dose,12836,Canis lupus familiaris,9615.0
100712,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626038,,11191,,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in hamster at 10 mg/kg oral dose,12836,Cricetinae,10026.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626039,,11192,,,Maximum concentration in plasma recorded in the period 0-6 hr post dose in rat at 10 mg/kg oral dose,12836,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626040,,11193,,,Maximum concentration in plasma was determined by oral administration to rats at 20 mg/kg,12545,Rattus norvegicus,10116.0
50592,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626041,,11194,,,Maximum concentration present in the rabbit plasma following peroral administration of 10 mg/kg,13856,Oryctolagus cuniculus,9986.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626042,,11195,,,Maximum concentration was calculated,3550,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626043,,11196,,,Maximum concentration was calculated.,2632,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626044,,11197,,,Maximum concentration at a peroral dose of 10 mg/kg,5566,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626045,,11198,,,Maximum concentration of the drug at 10 uM/dg administered perorally,11883,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626046,,11199,,,Maximum concentration of the drug at 2 uM/dg administered intravenously,11883,,
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626047,,11200,,,"Maximum concentration of the unchanged compound in dog plasma, recorded in the period 0-6 hr post dose.",14122,Canis lupus familiaris,9615.0
100712,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626048,,11201,,,"Maximum concentration of the unchanged compound in hamster plasma, recorded in the period 0-6 hr post dose.",14122,Cricetinae,10026.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626049,,11202,,,"Maximum concentration of the unchanged compound in rat plasma, recorded in the period 0-6 hr post dose.",14122,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626050,,11203,,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 60 mg/kg oral dose,12542,Rattus norvegicus,10116.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL874541,,11204,,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in dog at 5 mg/kg oral dose,12542,Canis lupus familiaris,9615.0
100712,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622826,,11205,,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in hamster at 40 mg/kg oral dose,12542,Cricetinae,10026.0
100712,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622827,,11206,,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose to hamster at 40 mg/kg oral dose,12542,Cricetinae,10026.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622828,,11207,,,Maximum concentration of unchanged drug in plasma recorded in the period 0-6 hr of postdose in anesthetized rat at 25 mg/kg oral dose,12542,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622829,,11208,,,Maximum concentration of unchanged drug in rat plasma in the period 0-24 hr after dosing,14080,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL876806,,11209,,,Maximum concentration reached following intravenous administration in male rat,11911,Rattus norvegicus,10116.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622830,,11210,,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 10 mg/kg dosage administered perorally in dog,13204,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622831,,11211,,,Maximum concentration was determined in an aqueous sodium hydroxide solution adjusted to pH 10 at 5 mg/kg dosage administered perorally in rats,13204,Rattus norvegicus,10116.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626794,,11212,,,Maximum concentration was measured after peroral administration of 10 mg/kg of drug in male Beagle dogs,14346,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626795,,11213,,,Maximum concentration was measured after peroral administration of 5.0 mg/kg of drug in male Dawley rats,14346,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626796,,11214,,,Maximum concentration was measured after peroral administration of 5.1 mg/kg of drug in male Dawley rats,14346,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626797,,11215,,,Maximum concentration was measured after peroral administration of 5.2 mg/kg of drug in male Dawley rats,14346,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626798,,11216,,,Maximum drug concentration is determined after oral dosing in rats.,14127,Rattus norvegicus,10116.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626799,,11217,,,Maximum observed concentration in oral (5 mg/kg) fasted dogs,14339,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626800,,11218,,,Maximum observed concentration in oral (5 mg/kg) fed dogs,14339,Canis lupus familiaris,9615.0
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL626801,,11219,,,Maximum plasma concentration,13494,,
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL876816,,11220,,,Maximum plasma concentration (Cmax) was determined in rats after intraduodenal administration of the drug,14925,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626802,,11221,,,Maximum plasma concentration following oral administration of 26.3 mg/kg in rats,14474,Rattus norvegicus,10116.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626803,,11222,,,Maximum plasma concentration following oral administration of 3.8 mg/kg in Beagle dog,14474,Canis lupus familiaris,9615.0
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL626804,,11223,,,Maximum plasma concentration following oral administration of 30 umol/kg,13917,,
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626805,,11224,,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose,9796,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626309,,11225,,,Distribution of radiolabeled compound in plasma of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,9796,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626310,,11226,,,Distribution of radiolabeled compound in plasma of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,9796,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626311,,11227,,,Distribution of radiolabeled compound in plasma of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,9796,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626312,,11228,,,Distribution of radiolabeled compound in plasma of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,9796,Rattus norvegicus,10116.0
50597,Uterus,A,,,BAO_0000218,Intermediate,1,N,995.0,1,,,,CHEMBL626313,,11229,,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose; fmol equivalents per 100 mg,9796,Rattus norvegicus,10116.0
50597,Uterus,A,,,BAO_0000218,Intermediate,1,N,995.0,1,,,,CHEMBL626314,,11230,,,Distribution of radiolabeled compound in uterus of rat 1 hr after ip administration of dose and excess 8 microg of estradiol; fmol equivalents per 100 mg,9796,Rattus norvegicus,10116.0
50597,Uterus,A,,,BAO_0000218,Intermediate,1,N,995.0,1,,,,CHEMBL626315,,11231,,,Distribution of radiolabeled compound in uterus of rat 1 hr after iv administration of dose; fmol equivalents per 100 mg,9796,Rattus norvegicus,10116.0
50597,Uterus,A,,,BAO_0000218,Intermediate,1,N,995.0,1,,,,CHEMBL626316,,11232,,,Distribution of radiolabeled compound in uterus of rat 4 hr after ip administration of dose; fmol equivalents per 100 mg,9796,Rattus norvegicus,10116.0
50597,Uterus,A,,,BAO_0000218,Intermediate,1,N,995.0,1,,,,CHEMBL626317,,11233,,,Distribution of radiolabeled compound in uterus of rat 8 hr after ip administration of dose; fmol equivalents per 100 mg,9796,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626318,,11234,,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Minus (-),8363,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626319,,11235,,,Distribution of rat erythrocytes for tube 2 on rate of aging in 2 mL of cell suspension; Plus (+),8363,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626320,,11236,,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Minus (-),8363,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL875053,,11237,,,Distribution of rat erythrocytes for tube 3 on rate of aging in 2 mL of cell suspension; Plus (+),8363,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626321,,11238,,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Minus (-),8363,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626322,,11239,,,Distribution of rat erythrocytes for tube 4 on rate of aging in 2 mL of cell suspension; Plus (+),8363,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626323,,11240,,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Minus (-),8363,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626324,,11241,,,Distribution of rat erythrocytes for tube 5 on rate of aging in 2 mL of cell suspension; Plus (+),8363,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626325,,11242,,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Minus (-),8363,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626326,,11243,,,Distribution of rat erythrocytes for tube 6 on rate of aging in 2 mL of cell suspension; Plus (+),8363,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626327,,11244,,,Distribution of rat erythrocytes for tube 7 on rate of aging in 2 mL of cell suspension; Plus (+),8363,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626328,,11245,,,Distribution of rat erythrocytes for tube 1 on rate of aging in 2 mL of cell suspension; Minus (-),8363,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL626329,,11246,,,"Distribution in blood of rat 5 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL626330,,11247,,,"Distribution in blood of rat, 15 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL626331,,11248,,,"Distribution in blood of rat, 1 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL626332,,11249,,,"Distribution in blood of rat, 2 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL626333,,11250,,,"Distribution in blood of rat, 30 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL626334,,11251,,,"Distribution in blood of rat, 4 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL626335,,11252,,,"Distribution in blood of rat, 6 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL624798,,11253,,,"Distribution in blood of rat, 8 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL624799,,11254,,,"Distribution in brain of rat, 15 min after intravenous administered, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL624800,,11255,,,"Distribution in brain of rat, 1 hr after intravenous administered, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL624801,,11256,,,"Distribution in brain of rat, 2 hr after intravenous administered, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL624802,,11257,,,"Distribution in brain of rat, 30 min after intravenous administered, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL624803,,11258,,,"Distribution in brain of rat, 4 hr after intravenous administered, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL624804,,11259,,,"Distribution in brain of rat, 5 min after intravenous administered, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL624805,,11260,,,"Distribution in brain of rat, 6 hr after intravenous administered, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL624806,,11261,,,"Distribution in brain of rat, 8 hr after intravenous administered, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624807,,11262,,,"Distribution in rat fat 15 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624808,,11263,,,"Distribution in rat fat 1 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624809,,11264,,,"Distribution in rat fat 2 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624810,,11265,,,"Distribution in rat fat 30 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL877618,,11266,,,"Distribution in rat fat 4 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624811,,11267,,,"Distribution in rat fat 5 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624812,,11268,,,"Distribution in rat fat 6 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624813,,11269,,,"Distribution in rat fat 8 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624814,,11270,,,"Distribution in rat heart 15 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624815,,11271,,,"Distribution in rat heart 1 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624816,,11272,,,"Distribution in rat heart 2 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624817,,11273,,,"Distribution in rat heart 30 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624818,,11274,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5.4 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624819,,11275,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration,6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624820,,11276,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration (0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624821,,11277,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0 - 6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624822,,11278,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr ),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624823,,11279,,,Oral diuretic activity was evaluated by measuring Na+ excretion in dog at 5 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,9615.0
50212,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624824,,11280,,,Observed diffusion coefficient in organic solvent for Escherichia coli,15599,Escherichia coli,562.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL624825,,11281,,,"Concentration of compound in blood of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",9614,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL624826,,11282,,,"Concentration of compound in blood of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",9614,Rattus norvegicus,10116.0
50597,Cardiac atrium,A,,,BAO_0000218,Intermediate,1,N,2081.0,1,,,,CHEMBL876817,,11283,,,"Concentration of compound in left atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",9614,Rattus norvegicus,10116.0
50597,Cardiac atrium,A,,,BAO_0000218,Intermediate,1,N,2081.0,1,,,,CHEMBL624827,,11284,,,"Concentration of compound in left atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",9614,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624828,,11285,,,"Concentration of compound in left ventricle of of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",9614,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624829,,11286,,,"Concentration of compound in left ventricle of of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",9614,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL624830,,11287,,,"Concentration of compound in liver of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",9614,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL624831,,11288,,,"Concentration of compound in liver of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",9614,Rattus norvegicus,10116.0
50597,Cardiac atrium,A,,,BAO_0000218,Intermediate,1,N,2081.0,1,,,,CHEMBL624832,,11289,,,"Concentration of compound in right atrium of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",9614,Rattus norvegicus,10116.0
50597,Cardiac atrium,A,,,BAO_0000218,Intermediate,1,N,2081.0,1,,,,CHEMBL624833,,11290,,,"Concentration of compound in right atrium of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",9614,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624834,,11291,,,"Concentration of compound in right ventricle of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",9614,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624835,,11292,,,"Concentration of compound in right ventricle of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",9614,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL624836,,11293,,,"Concentration of compound in spleen of rats, pretreated with 6-Hydroxydopamine assessed using [18F]- as radiotracer",9614,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL624837,,11294,,,"Concentration of compound in spleen of rats, pretreated with desmethylimipramine, assessed using [18F]- as radiotracer;Dose/g",9614,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL624838,,11295,,,Distribution of radioactivity of radiolabeled compound in blood of female rats 30 minutes after intravenous administration,9071,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL622188,,11296,,,Distribution of radioactivity of radiolabeled compound in blood of female rats 5 minutes after intravenous administration,9071,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL622189,,11297,,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration,9071,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL622190,,11298,,,Distribution of radioactivity of radiolabeled compound in heart of female rats 30 minutes after intravenous administration at,9071,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL625170,,11299,,,Distribution of radioactivity of radiolabeled compound in heart of female rats 5 minutes after intravenous administration,9071,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL625171,,11300,,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,9071,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL625172,,11301,,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 30 minutes after intravenous administration,9071,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL625173,,11302,,,Distribution of radioactivity of radiolabeled compound in kidney of female rats 5 minutes after intravenous administration,9071,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625174,,11303,,,Distribution of radioactivity of radiolabeled compound in liver of female rats 30 minutes after intravenous administration,9071,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625175,,11304,,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration,9071,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625176,,11305,,,Distribution of radioactivity of radiolabeled compound in liver of female rats 5 minutes after intravenous administration at,9071,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL625177,,11306,,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,9071,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL625178,,11307,,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration,9071,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL625179,,11308,,,Distribution of radioactivity of radiolabeled compound in lung of female rats 5 minutes after intravenous administration at,9071,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL625180,,11309,,,Distribution of radioactivity of radiolabeled compound in lung of female rats 30 minutes after intravenous administration,9071,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL625181,,11310,,,"Original dose appeared in the bile as unchanged compound, which was eliminated at a fairly constant rate over the first 4 hr following the iv administration",10677,,
50594,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL625182,,11311,,,Percentage of dose recovered after 0-6 hr in the urine of mice was measured.,9750,Mus musculus,10090.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625183,,11312,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL875848,,11313,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,8319,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622260,,11314,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622261,,11315,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,8319,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622262,,11316,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL622263,,11317,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,8319,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL622418,,11318,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL622419,,11319,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,8319,Rattus norvegicus,10116.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623388,,11320,,,Biodistribution in CD-1 mice was determined after 1 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,10090.0
50594,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL623389,,11321,,,Biodistribution in CD-1 mice was determined after 1 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623390,,11322,,,Biodistribution in CD-1 mice was determined after 1 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623391,,11323,,,Biodistribution in CD-1 mice was determined after 120 minutes in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,10090.0
50594,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL623392,,11324,,,Biodistribution in CD-1 mice was determined after 120 minutes in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,10090.0
50594,Cerebellum,A,,,BAO_0000218,Intermediate,1,N,2037.0,1,,,In vivo,CHEMBL623393,,11325,,,Biodistribution in CD-1 mice was determined after 120 minutes in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623394,,11326,,,Biodistribution in CD-1 mice was determined after 120 minutes in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618885,,11327,,,Biodistribution in CD-1 mice was determined after 120 minutes in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,10090.0
50594,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL618886,,11328,,,Biodistribution in CD-1 mice was determined after 120 minutes in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL618887,,11329,,,Biodistribution in CD-1 mice was determined after 120 minutes in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL619535,,11330,,,Biodistribution in CD-1 mice was determined after 30 minutes in Striatum (expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,10090.0
50594,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL619536,,11331,,,Biodistribution in CD-1 mice was determined after 30 minutes in blood (expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,10090.0
50594,Cerebellum,A,,,BAO_0000218,Intermediate,1,N,2037.0,1,,,In vivo,CHEMBL619537,,11332,,,Biodistribution in CD-1 mice was determined after 30 minutes in cerebellum (expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL619705,,11333,,,Biodistribution in CD-1 mice was determined after 30 minutes in cortex (expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL619706,,11334,,,Biodistribution in CD-1 mice was determined after 30 minutes in femur (expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,10090.0
50594,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL619707,,11335,,,Biodistribution in CD-1 mice was determined after 30 minutes in liver (expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL619708,,11336,,,Biodistribution in CD-1 mice was determined after 30 minutes in lung (expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625219,,11337,,,Biodistribution in CD-1 mice was determined after 5 minute in Striatum(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,10090.0
50594,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL625220,,11338,,,Biodistribution in CD-1 mice was determined after 5 minute in blood(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,10090.0
50594,Cerebellum,A,,,BAO_0000218,Intermediate,1,N,2037.0,1,,,In vivo,CHEMBL625221,,11339,,,Biodistribution in CD-1 mice was determined after 5 minute in cerebellum(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625222,,11340,,,Biodistribution in CD-1 mice was determined after 5 minute in cortex(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625223,,11341,,,Biodistribution in CD-1 mice was determined after 5 minute in femur(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,10090.0
50594,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL625224,,11342,,,Biodistribution in CD-1 mice was determined after 5 minute in liver(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625225,,11343,,,Biodistribution in CD-1 mice was determined after 5 minute in lung(expressed as percent injected dose per gram normalized to a 25 g mouse),13256,Mus musculus,10090.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL625226,,11344,,,Biodistribution in Rat blood after 24 hours of iv administration,8829,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL625227,,11345,,,Biodistribution in Rat blood after 24 hours of iv administration; per g of tissue,8829,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL625228,,11346,,,Biodistribution in Rat blood after 30 minutes of iv administration,8829,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL875354,,11347,,,Biodistribution in Rat blood after 30 minutes of iv administration; per g of tissue,8829,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL625229,,11348,,,Biodistribution in Rat blood after 5 minutes of iv administration,8829,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL625230,,11349,,,Biodistribution in Rat blood after 5 minutes of iv administration; per g of tissue,8829,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL625231,,11350,,,Biodistribution in Rat heart after 24 hours of iv administration,8829,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL625900,,11351,,,Biodistribution in Rat heart after 24 hours of iv administration; per g of tissue,8829,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL625901,,11352,,,Biodistribution in Rat heart after 30 minutes of iv administration,8829,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL625902,,11353,,,Biodistribution in Rat heart after 30 minutes of iv administration; per g of tissue,8829,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL625903,,11354,,,Biodistribution in Rat heart after 5 minutes of iv administration,8829,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL625904,,11355,,,Biodistribution in Rat heart after 5 minutes of iv administration; per g of tissue,8829,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL625905,,11356,,,Biodistribution in Rat liver after 24 hours of iv administration,8829,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL627861,,11357,,,Biodistribution in Rat liver after 24 hours of iv administration; per g of tissue,8829,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL627862,,11358,,,Biodistribution in Rat liver after 30 minutes of iv administration,8829,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL627863,,11359,,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,8829,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL627769,,11360,,,Biodistribution in Rat liver after 30 minutes of iv administration,8829,Rattus norvegicus,10116.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL627770,,11361,,,Maximum plasma concentration in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,13249,Canis lupus familiaris,9615.0
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627771,,11362,,,Cmax in cynomolgus monkey (PO dose),13622,Macaca fascicularis,9541.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627772,,11363,,,Cmax in rat (PO dose),13622,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627773,,11364,,,Cmax in rat (PO dose),13622,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL621922,,11365,,,Maximum plasma concentration in rats after an oral dose of 5 mg/kg,13494,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL621923,,11366,,,Cmax in rat plasma after oral dose (10 mg/kg),12170,Rattus norvegicus,10116.0
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL621924,,11367,,,Cmax in plasma after oral dose (10 mg/kg),12170,,
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL621925,,11368,,,Maximum plasma concentration of compound was determined in dog at 25 mg/kg orally,17025,Canis lupus familiaris,9615.0
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL621926,,11369,,,Maximum plasma concentration of compound was determined in monkey at 25 mg/kg orally,17025,Simiiformes,314293.0
50592,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL621927,,11370,,,Maximum plasma concentration of compound was determined in rabbit at 25 mg/kg orally,17025,Oryctolagus cuniculus,9986.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL621928,,11371,,,Maximum plasma concentration of compound was determined in rat at 25 mg/kg orally,17025,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL621929,,11372,,,Maximum plasma concentration after p.o. (10 mpk) administration in rats.,14187,Rattus norvegicus,10116.0
50594,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL621930,,11373,,,Maximum plasma concentration (Cmax) after p.o. administration of 200 mg/kg in mice,14816,Mus musculus,10090.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL621931,,11374,,,Maximum plasma concentration after oral dosing in rat,17820,Rattus norvegicus,10116.0
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL621932,,11375,,,Maximum plasma concentration evaluated in 100% PEG solution at a dose of 20 mg/kg orally,14380,,
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL621933,,11376,,,Maximum plasma concentration evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,14380,,
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL621934,,11377,,,Maximum plasma concentration in dogs at 0.5 mg/kg dose upon oral administration,14691,Canis lupus familiaris,9615.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL621935,,11378,,,Maximum plasma concentration in dogs at 1 mg/kg dose upon oral administration,14691,Canis lupus familiaris,9615.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL621936,,11379,,,Maximum plasma concentration in rat upon oral administration of 40 mg/kg,13375,Rattus norvegicus,10116.0
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL621937,,11380,,,Maximum plasma concentration was determined,6236,,
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL621938,,11381,,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,14380,,
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL621939,,11382,,,Maximum plasma concentration was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,14380,,
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL621940,,11383,,,Maximum plasma concentration was evaluated in 10% of PEG suspension at a dose of 20 mg/kg orally,14380,,
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL621941,,11384,,,Maximum plasma concentration was evaluated in 100% of PEG solution at a dose of 20 mg/kg orally,14380,,
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL621942,,11385,,,Maximum plasma concentration was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,14380,,
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL626178,,11386,,,Maximum plasma concentration was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,14380,,
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL626179,,11387,,,Maximum plasma concentration was evaluated in Hp-beta-CD solution at a dose of 20 mg/kg orally,14380,,
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL626180,,11388,,,Maximum plasma concentration was evaluated in saline solution at a dose of 20 mg/kg orally,14380,,
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626181,,11389,,,Plasma Cmax in rat (PO dose),13622,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626182,,11390,,,Maximum serum concentration after po dose of 5.22 mg/kg in rats,15372,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626183,,11391,,,Maximum serum concentration after po dose of 5.46 mg/kg in rats,15372,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626184,,11392,,,Maximum serum concentration was determined for the compound after po dose of 5.01 mg/kg in rats,15372,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626185,,11393,,,Maximum serum concentration was determined for the compound after po dose of 5.03 mg/kg in rats,15372,Rattus norvegicus,10116.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626186,,11394,,,Maximum plasma concentration (Cmax) was determined in dogs fed after oral administration of 25 mg/kg of the compound.,14925,Canis lupus familiaris,9615.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL877589,,11395,,,Maximum plasma concentration (Cmax) was determined in fasted dogs after oral administration of 25 mg/kg of the compound.,14925,Canis lupus familiaris,9615.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626187,,11396,,,Maximum concentration of the drug at 1 uM/dg administered intravenously,11883,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626188,,11397,,,Maximum concentration of the drug at 20 uM/dg administered perorally,11883,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626189,,11398,,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg,13391,,
22224,Blood,A,,,BAO_0000218,Autocuration,0,U,178.0,1,,,In vivo,CHEMBL626855,,11399,,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,13391,,
22224,Blood,A,,,BAO_0000218,Autocuration,0,U,178.0,1,,,In vivo,CHEMBL623781,,11400,,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,13391,,
22224,Blood,A,,,BAO_0000218,Autocuration,0,U,178.0,1,,,In vivo,CHEMBL623782,,11401,,,Oral Bioavailability was measured as Maximal observed concentration (Cmax) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,13391,,
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623783,,11402,,,Oral absorption expressed as peak plasma conc (Cmax) after oral dosing of 50 mg/kg in rat,16360,Rattus norvegicus,10116.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623784,,11403,,,Cmax in dog plasma after 1mg/kg oral dose,3673,Canis lupus familiaris,9615.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623785,,11404,,,Bioavailability as maximal plasma concentration in dogs after 2.5 mg/kg oral dose,14431,Canis lupus familiaris,9615.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623786,,11405,,,Bioavailability as maximal plasma concentration in rats after 10 mg/kg oral dose,14431,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623787,,11406,,,Oral maximum concentration in rat,14964,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623788,,11407,,,Oral maximum concentration in rat,14964,Rattus norvegicus,10116.0
50594,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623789,,11408,,,Oral plasma concentration in mice at 100 mg/kg dosage within 4-hr time frame.,14209,Mus musculus,10090.0
50594,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL623790,,11409,,,Peak concentration in blood after intravenous administration to mice,11355,Mus musculus,10090.0
50594,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL623791,,11410,,,Peak concentration in blood after peroral administration to mice,11355,Mus musculus,10090.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623792,,11411,,,Peak concentration in rat plasma was determined,11966,Rattus norvegicus,10116.0
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL623793,,11412,,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of monkey after oral administration of 0.05 mmol/kg,8918,Simiiformes,314293.0
50594,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623794,,11413,,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of mouse after oral administration of 0.05 mmol/kg,8918,Mus musculus,10090.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623795,,11414,,,Peak plasma concentration expresses the ability of compound for the release of L-Dopa in the plasma of rat after oral administration of 0.05 mmol/kg,8918,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623796,,11415,,,"Distribution in rat heart 4 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623797,,11416,,,"Distribution in rat heart 5 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623798,,11417,,,"Distribution in rat heart 6 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623799,,11418,,,"Distribution in rat heart 8 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Intestine,A,,,BAO_0000218,Intermediate,1,N,160.0,1,,,,CHEMBL624490,,11419,,,"Distribution in rat intestine 15 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Intestine,A,,,BAO_0000218,Intermediate,1,N,160.0,1,,,,CHEMBL624491,,11420,,,"Distribution in rat intestine 1 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Intestine,A,,,BAO_0000218,Intermediate,1,N,160.0,1,,,,CHEMBL624492,,11421,,,"Distribution in rat intestine 2 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Intestine,A,,,BAO_0000218,Intermediate,1,N,160.0,1,,,,CHEMBL624493,,11422,,,"Distribution in rat intestine 30 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Intestine,A,,,BAO_0000218,Intermediate,1,N,160.0,1,,,,CHEMBL877595,,11423,,,"Distribution in rat intestine 4 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Intestine,A,,,BAO_0000218,Intermediate,1,N,160.0,1,,,,CHEMBL624494,,11424,,,"Distribution in rat intestine 5 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Intestine,A,,,BAO_0000218,Intermediate,1,N,160.0,1,,,,CHEMBL624495,,11425,,,"Distribution in rat intestine 6 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Intestine,A,,,BAO_0000218,Intermediate,1,N,160.0,1,,,,CHEMBL624681,,11426,,,"Distribution in rat intestine 8 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624682,,11427,,,"Distribution in rat kidney, 15 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624683,,11428,,,"Distribution in rat kidney, 1 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624684,,11429,,,"Distribution in rat kidney, 2 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624685,,11430,,,"Distribution in rat kidney, 30 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624686,,11431,,,"Distribution in rat kidney, 4 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624687,,11432,,,"Distribution in rat kidney, 5 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624688,,11433,,,"Distribution in rat kidney, 6 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627161,,11434,,,"Distribution in rat kidney, 8 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622127,,11435,,,"Distribution in rat liver 15 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622128,,11436,,,"Distribution in rat liver 1 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL874384,,11437,,,"Distribution in rat liver 2 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624898,,11438,,,"Distribution in rat liver 30 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624899,,11439,,,"Distribution in rat liver 4 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624900,,11440,,,"Distribution in rat liver 5 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624901,,11441,,,"Distribution in rat liver 6 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624902,,11442,,,"Distribution in rat liver 8 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624903,,11443,,,"Distribution in rat lungs 15 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624904,,11444,,,"Distribution in rat lungs 1 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624905,,11445,,,"Distribution in rat lungs 2 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624906,,11446,,,"Distribution in rat lungs 30 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624907,,11447,,,"Distribution in rat lungs 4 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624908,,11448,,,"Distribution in rat lungs 5 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624909,,11449,,,"Distribution in rat lungs 6 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624910,,11450,,,"Distribution in rat lungs 8 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL624911,,11451,,,"Distribution in rat muscle 15 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL874388,,11452,,,"Distribution in rat muscle 1 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL624912,,11453,,,"Distribution in rat muscle 2 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL622930,,11454,,,"Distribution in rat muscle 30 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL623121,,11455,,,"Distribution in rat muscle 4 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL623122,,11456,,,"Distribution in rat muscle 5 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL623123,,11457,,,"Distribution in rat muscle 6 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL623124,,11458,,,"Distribution in rat muscle 8 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623125,,11459,,,"Distribution in rat pancreas 15 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623126,,11460,,,"Distribution in rat pancreas 1 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623127,,11461,,,"Distribution in rat pancreas 2 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623128,,11462,,,"Distribution in rat pancreas 30 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623129,,11463,,,"Distribution in rat pancreas 4 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623130,,11464,,,"Distribution in rat pancreas 5 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623131,,11465,,,"Distribution in rat pancreas 6 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623132,,11466,,,"Distribution in rat pancreas 8 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL623133,,11467,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623134,,11468,,,The distribution of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL874389,,11469,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623135,,11470,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,8319,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623136,,11471,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623137,,11472,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,8319,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623138,,11473,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL623139,,11474,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,8319,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL623140,,11475,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL623141,,11476,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,8319,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL623142,,11477,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623143,,11478,,,The distribution of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,10116.0
50594,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623144,,11479,,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in mouse.,14571,Mus musculus,10090.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623405,,11480,,,The total amount of penciclovir recovered in the urine over a 48-h period was determined by HPLC using a C18 reversed-phase column in rat.,14571,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624074,,11481,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat blood as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624075,,11482,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose in the total organ,8319,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624076,,11483,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat brain as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624077,,11484,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose in the total organ,8319,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624078,,11485,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat heart as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL624079,,11486,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose in the total organ,8319,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL624261,,11487,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624262,,11488,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose in the total organ,8319,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624263,,11489,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat liver as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624264,,11490,,,The uptake of the 131 I-labeled compound at 30 min was evaluated in rat lung as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624265,,11491,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat blood as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624266,,11492,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose in the total organ,8319,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624267,,11493,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat brain as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624268,,11494,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose in the total organ,8319,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL875227,,11495,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat heart as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL624269,,11496,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose in the total organ,8319,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL624270,,11497,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat kidney as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624271,,11498,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose in the total organ,8319,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624272,,11499,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat liver as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624273,,11500,,,The uptake of the 131 I-labeled compound at 5 min was evaluated in rat lung as Percent of injected dose per gram in the organ,8319,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL624274,,11501,,,Urinary excretion in rat after 0-4 hours of oral administration at 50 mg/kg,12064,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL624275,,11502,,,Urinary excretion in rat after 4-8 hours of oral administration at 50 mg/kg,12064,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL624276,,11503,,,Urinary excretion in rat after 8-24 hours of oral administration at 50 mg/kg,12064,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL624277,,11504,,,Urinary recovery expressed as percentage dose in male rats after iv administration of 20 mg/kg,12038,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL624278,,11505,,,% dose converted to 2-amino-5-chlorophenyl sulfate,14314,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL624279,,11506,,,% dose converted to 4-(S-amino-N-{[(4-chlorophenyl)amino]carbonyl}sulfonimidoyl)benzoic acid (compound 41),14314,,
50597,Feces,A,,,BAO_0000218,Intermediate,1,N,1988.0,1,,,,CHEMBL624280,,11507,,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",11488,Rattus norvegicus,10116.0
50597,Feces,A,,,BAO_0000218,Intermediate,1,N,1988.0,1,,,,CHEMBL624281,,11508,,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",11488,Rattus norvegicus,10116.0
50597,Feces,A,,,BAO_0000218,Intermediate,1,N,1988.0,1,,,,CHEMBL622933,,11509,,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",11488,Rattus norvegicus,10116.0
50597,Feces,A,,,BAO_0000218,Intermediate,1,N,1988.0,1,,,,CHEMBL622934,,11510,,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",11488,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL622935,,11511,,,Biodistribution in Rat liver after 30 minutes of iv administration; per g of tissue,8829,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL622936,,11512,,,Biodistribution in Rat liver after 5 minutes of iv administration,8829,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL875228,,11513,,,Biodistribution in Rat liver after 5 minutes of iv administration; per g of tissue,8829,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL622937,,11514,,,Biodistribution in Rat lung after 24 hours of iv administration,8829,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL622938,,11515,,,Biodistribution in Rat lung after 24 hours of iv administration; per g of tissue,8829,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL619736,,11516,,,Biodistribution in Rat lung after 30 minutes of iv administration,8829,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL625117,,11517,,,Biodistribution in Rat lung after 30 minutes of iv administration; per g of tissue,8829,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL625118,,11518,,,Biodistribution in Rat lung after 5 minutes of iv administration,8829,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL625119,,11519,,,Biodistribution in Rat lung after 5 minutes of iv administration; per g of tissue,8829,Rattus norvegicus,10116.0
50597,Cerebellum,A,,,BAO_0000218,Intermediate,1,N,2037.0,1,,,In vivo,CHEMBL625120,,11520,,,"Biodistribution in rat cerebellum, expressed as percent I.D./g tissue",14972,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625121,,11521,,,"Biodistribution in rat superior coliculus, expressed as percent I.D./g tissue",14972,Rattus norvegicus,10116.0
50597,Thalamus,A,,,BAO_0000218,Intermediate,1,N,10000006.0,1,,,In vivo,CHEMBL625122,,11522,,,"Biodistribution in rat thalamus, expressed as percent I.D./g tissue",14972,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL622204,,11523,,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 2 min,14608,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL877503,,11524,,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 30 min,14608,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL627127,,11525,,,Biodistribution was measured in blood of rat by injecting the radiolabeled compound intravenously and the value measured after 60 min,14608,Rattus norvegicus,10116.0
22224,Hippocampus,A,,,BAO_0000218,Autocuration,0,U,10000000.0,1,,,In vivo,CHEMBL627128,,11526,,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 2 min,14608,,
22224,Hippocampus,A,,,BAO_0000218,Autocuration,0,U,10000000.0,1,,,In vivo,CHEMBL627129,,11527,,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 30 min,14608,,
22224,Hippocampus,A,,,BAO_0000218,Autocuration,0,U,10000000.0,1,,,In vivo,CHEMBL627130,,11528,,,Biodistribution was measured in hippocampus region(HP/CB) by injecting the radiolabeled compound intravenously and the value measured after 60 min,14608,,
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL627131,,11529,,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 2 min,14608,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL627132,,11530,,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 30 min,14608,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL627133,,11531,,,Biodistribution was measured in rat brain by injecting the radiolabeled compound intravenously and the value measured after 60 min,14608,Rattus norvegicus,10116.0
50597,Cerebellum,A,,,BAO_0000218,Intermediate,1,N,2037.0,1,,,In vivo,CHEMBL627134,,11532,,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 2 min,14608,Rattus norvegicus,10116.0
50597,Cerebellum,A,,,BAO_0000218,Intermediate,1,N,2037.0,1,,,In vivo,CHEMBL627135,,11533,,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 30 min,14608,Rattus norvegicus,10116.0
50597,Cerebellum,A,,,BAO_0000218,Intermediate,1,N,2037.0,1,,,In vivo,CHEMBL627136,,11534,,,Biodistribution was measured in rat cerebellum by injecting the radiolabeled compound intravenously and the value measured after 60 min,14608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628435,,11535,,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 2 min,14608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628436,,11536,,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 30 min,14608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628437,,11537,,,Biodistribution was measured in rat cortex by injecting the radiolabeled compound intravenously and the value measured after 60 min,14608,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL628438,,11538,,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 2 min,14608,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL628439,,11539,,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 30 min,14608,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL628440,,11540,,,Biodistribution was measured in rat heart by injecting the radiolabeled compound intravenously and the value measured after 60 min,14608,Rattus norvegicus,10116.0
50597,Hippocampus,A,,,BAO_0000218,Intermediate,1,N,10000000.0,1,,,In vivo,CHEMBL628441,,11541,,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 2 min,14608,Rattus norvegicus,10116.0
50597,Hippocampus,A,,,BAO_0000218,Intermediate,1,N,10000000.0,1,,,In vivo,CHEMBL628442,,11542,,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 30 min,14608,Rattus norvegicus,10116.0
50597,Hippocampus,A,,,BAO_0000218,Intermediate,1,N,10000000.0,1,,,In vivo,CHEMBL628443,,11543,,,Biodistribution was measured in rat hippocampus by injecting the radiolabeled compound intravenously and the value measured after 60 min,14608,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL628444,,11544,,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 2 min,14608,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL628445,,11545,,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 30 min,14608,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL877504,,11546,,,Biodistribution was measured in rat kidney by injecting the radiolabeled compound intravenously and the value measured after 60 min,14608,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL628446,,11547,,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 2 min,14608,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL626874,,11548,,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 30 min,14608,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL626875,,11549,,,Biodistribution was measured in rat liver by injecting the radiolabeled compound intravenously and the value measured after 60 min,14608,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL626876,,11550,,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 2 min,14608,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL626877,,11551,,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 30 min,14608,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL626878,,11552,,,Biodistribution was measured in rat lung by injecting the radiolabeled compound intravenously and the value measured after 60 min,14608,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL626879,,11553,,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 2 min,14608,Rattus norvegicus,10116.0
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL626880,,11554,,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of monkey after oral administration of 0.05 mmol/kg,8918,Simiiformes,314293.0
50594,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626881,,11555,,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of mouse after oral administration of 0.05 mmol/kg,8918,Mus musculus,10090.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626882,,11556,,,Peak plasma concentration expresses the ability of compound for the release of dopamine in the plasma of rat after oral administration of 0.05 mmol/kg,8918,Rattus norvegicus,10116.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626883,,11557,,,Peak plasma concentration was measured in dogs,14470,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626884,,11558,,,Pharmacokinetic Parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,14393,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626885,,11559,,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,14886,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626886,,11560,,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,14886,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626887,,11561,,,Pharmacokinetic parameter (Cmax ) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,14886,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626888,,11562,,,Pharmacokinetic parameter (Cmax) was evaluated at 10 mg/kg (p.o.) in Wistar rats,14393,Rattus norvegicus,10116.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626889,,11563,,,Pharmacokinetic parameter Cmax determined after intravenous administration of 15 mg/kg to dog,13465,Canis lupus familiaris,9615.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626761,,11564,,,Pharmacokinetic parameter Cmax determined after intravenous administration of 25 mg/kg to monkey,13465,Simiiformes,314293.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626762,,11565,,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg abd antacid (CaCO3 dosed orally 10 min prior to and 60 min postdosing) to dog,13465,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626763,,11566,,,Pharmacokinetic parameter Cmax determined after intravenous administration of 30 mg/kg to dog,13465,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626764,,11567,,,Pharmacokinetic parameter Cmax determined after intravenous administration of 50 mg/kg to rat,13465,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626765,,11568,,,Pharmacokinetic parameter Cmax determined after intravenous administration of 60 mg/kg to rat,13465,Rattus norvegicus,10116.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626766,,11569,,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to dog,13465,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626767,,11570,,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat,13465,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626768,,11571,,,Pharmacokinetic parameter Cmax determined after oral administration of 50 mg/kg to rat; No levels,13465,Rattus norvegicus,10116.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626769,,11572,,,Pharmacokinetic parameter Cmax determined after peroral administration of 15 mg/kg to dog,13465,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL874463,,11573,,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to dog,13465,Canis lupus familiaris,9615.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626770,,11574,,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey,13465,Simiiformes,314293.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626771,,11575,,,Pharmacokinetic parameter Cmax determined after peroral administration of 25 mg/kg to monkey; No levels,13465,Simiiformes,314293.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626772,,11576,,,Pharmacokinetic parameter Cmax determined after peroral administration of 50 mg/kg to rat,13465,Rattus norvegicus,10116.0
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626773,,11577,,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,14731,Macaca fascicularis,9541.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626774,,11578,,,Pharmacokinetic parameter Cmax for the compound was evaluated in nude mice after oral administration. ,14731,Mus musculus,10090.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626775,,11579,,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 375 mg/kg,13376,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626776,,11580,,,Pharmacokinetic parameter Cmax has been determined in fed Beagle dogs at a dose of 500 mg/kg,13376,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626777,,11581,,,Maximum concentration (Cmax) in rat when administered orally,14443,Rattus norvegicus,10116.0
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL626778,,11582,,,Maximal concentration in monkey plasma after 25 mg/kg oral dose,13465,Simiiformes,314293.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626779,,11583,,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.17-0.20)",16359,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626780,,11584,,,"Mean Cmax in rats after 5 mg/kg oral dose, range (0.4-0.8)",16359,Rattus norvegicus,10116.0
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL626781,,11585,,,Cmax in rat plasma after single 5 mg/kg oral cassette gavage dose,15618,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL632164,,11586,,,Pharmacokinetic profile Cmax was evaluated in rats,14554,Rattus norvegicus,10116.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL632165,,11587,,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in dog (25 mg/kg),11537,Canis lupus familiaris,9615.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL632166,,11588,,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration in mice (50 mg/kg),11537,Mus musculus,10090.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL632167,,11589,,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to dog (25 mg/kg),11537,Canis lupus familiaris,9615.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL632168,,11590,,,Pharmacokinetic property(Cmax- maximum concentration) after oral administration to mice (50 mg/kg),11537,Mus musculus,10090.0
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL632169,,11591,,,Cmax in rat plasma,2021,Rattus norvegicus,10116.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL632170,,11592,,,Cmax in dog plasma after 30mg/kg oral dose,5932,Canis lupus familiaris,9615.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL632171,,11593,,,Cmax in rat plasma after 30mg/kg oral dose,5932,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL632172,,11594,,,Plasma level in rats at 30 mg/kg,17320,Rattus norvegicus,10116.0
50594,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL632173,,11595,,,Tested for maximum plasma concentration in mice,15831,Mus musculus,10090.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL632174,,11596,,,"The Cmax value in female wistar rat at 100 mg/kg, p.o. dose",15078,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL632175,,11597,,,The Cmax values in female wistar rats.,14941,Rattus norvegicus,10116.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL632176,,11598,,,The Peak plasma concentration was measured in dogs after oral administration of 1 mg/kg dose,15343,Canis lupus familiaris,9615.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL632177,,11599,,,The Peak plasma concentration was measured in rats after oral administration of 1 mg/kg dose,15343,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL632178,,11600,,,The compound tested for maximum observed plasma concentration in rats and is expressed in microgram/mL.,14856,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL632179,,11601,,,The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat.,13129,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL632180,,11602,,,The compound was tested for maximum blood level reached in rats at 15.9 uM/kg after peroral administration.,13098,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL632181,,11603,,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after intravenous administration.,13098,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL632182,,11604,,,The compound was tested for maximum blood level reached in rats at 15.9 uM/Kg after peroral administration.,13098,Rattus norvegicus,10116.0
22224,Blood,A,,,BAO_0000218,Autocuration,0,U,178.0,1,,,In vivo,CHEMBL632183,,11605,,,The maximum concentration observed (Cmax) in the blood sample at indicated time point (tmax) at a dose 50 mg/Kg administered orally in mice.,15478,Mus musculus,10090.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL632184,,11606,,,The maximum concentration of the compound was measured in dog at dose 5 mg/kg after peroral administration.,15341,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL874470,,11607,,,The maximum concentration of the compound was measured in rat at dose 1 mg/kg after peroral administration.,15341,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631302,,11608,,,"Distribution in rat skin 15 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631303,,11609,,,"Distribution in rat skin 1 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631304,,11610,,,"Distribution in rat skin 2 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631305,,11611,,,"Distribution in rat skin 30 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631306,,11612,,,"Distribution in rat skin 4 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631307,,11613,,,"Distribution in rat skin 5 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631308,,11614,,,"Distribution in rat skin 6 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625557,,11615,,,"Distribution in rat skin 8 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL625558,,11616,,,"Distribution in rat spleen 15 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL625559,,11617,,,"Distribution in rat spleen 1 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL625560,,11618,,,"Distribution in rat spleen 2 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL625561,,11619,,,"Distribution in rat spleen 30 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL625562,,11620,,,"Distribution in rat spleen 4 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL875320,,11621,,,"Distribution in rat spleen 5 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL625563,,11622,,,"Distribution in rat spleen 6 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL625564,,11623,,,"Distribution in rat spleen 8 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Uterus,A,,,BAO_0000218,Intermediate,1,N,995.0,1,,,,CHEMBL625565,,11624,,,"Distribution in rat uterus 15 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Uterus,A,,,BAO_0000218,Intermediate,1,N,995.0,1,,,,CHEMBL625566,,11625,,,"Distribution in rat uterus 1 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Uterus,A,,,BAO_0000218,Intermediate,1,N,995.0,1,,,,CHEMBL625567,,11626,,,"Distribution in rat uterus 2 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Uterus,A,,,BAO_0000218,Intermediate,1,N,995.0,1,,,,CHEMBL625568,,11627,,,"Distribution in rat uterus 30 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Uterus,A,,,BAO_0000218,Intermediate,1,N,995.0,1,,,,CHEMBL628217,,11628,,,"Distribution in rat uterus 4 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Uterus,A,,,BAO_0000218,Intermediate,1,N,995.0,1,,,,CHEMBL628218,,11629,,,"Distribution in rat uterus 5 min after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Uterus,A,,,BAO_0000218,Intermediate,1,N,995.0,1,,,,CHEMBL628219,,11630,,,"Distribution in rat uterus 6 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
50597,Uterus,A,,,BAO_0000218,Intermediate,1,N,995.0,1,,,,CHEMBL628220,,11631,,,"Distribution in rat uterus 8 hr after intravenous administration, injected dose/gm",8684,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628221,,11632,,,Distribution in the blood after 120 min of intravenous administration,8926,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628222,,11633,,,Distribution in the blood after 15 min of intravenous administration,8926,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628223,,11634,,,Distribution in the blood after 30 min of intravenous administration,8926,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628224,,11635,,,Distribution in the blood after 5 min of intravenous administration,8926,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628225,,11636,,,Distribution in the blood after 60 min of intravenous administration,8926,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628226,,11637,,,Distribution in the blood after 90 min of intravenous administration,8926,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628227,,11638,,,Distribution in the bone after 120 min of intravenous administration,8926,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL875481,,11639,,,Distribution in the bone after 15 min of intravenous administration,8926,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628228,,11640,,,Distribution in the bone after 30 min of intravenous administration,8926,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628229,,11641,,,Distribution in the bone after 5 min of intravenous administration,8926,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628230,,11642,,,Distribution in the bone after 60 min of intravenous administration,8926,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628231,,11643,,,Distribution in the bone after 90 min of intravenous administration,8926,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628232,,11644,,,Distribution in the heart after 120 min of intravenous administration,8926,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628233,,11645,,,Distribution in the heart after 15 min of intravenous administration,8926,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628234,,11646,,,Distribution in the heart after 30 min of intravenous administration,8926,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628235,,11647,,,Distribution in the heart after 5 min of intravenous administration,8926,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628236,,11648,,,Distribution in the heart after 60 min of intravenous administration,8926,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628237,,11649,,,Distribution in the heart after 90 min of intravenous administration,8926,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628238,,11650,,,Distribution in the kidneys after 120 min of intravenous administration,8926,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628239,,11651,,,Distribution in the kidneys after 15 min of intravenous administration,8926,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628240,,11652,,,Distribution in the kidneys after 30 min of intravenous administration,8926,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628241,,11653,,,Distribution in the kidneys after 5 min of intravenous administration,8926,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628242,,11654,,,Distribution in the kidneys after 60 min of intravenous administration,8926,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL875482,,11655,,,Distribution in the kidneys after 90 min of intravenous administration,8926,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628243,,11656,,,Distribution in the liver after 120 min of intravenous administration,8926,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628244,,11657,,,Distribution in the liver after 15 min of intravenous administration,8926,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628245,,11658,,,Distribution in the liver after 30 min of intravenous administration,8926,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628246,,11659,,,Distribution in the liver after 5 min of intravenous administration,8926,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628247,,11660,,,Distribution in the liver after 60 min of intravenous administration,8926,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628248,,11661,,,Distribution in the liver after 90 min of intravenous administration,8926,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628249,,11662,,,Distribution in the lung after 120 min of intravenous administration,8926,,
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625452,,11663,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, iv and the total drug exposure was determined. (0-24hr)",14839,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625453,,11664,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, as HCl salt in solution, perorally and the total drug exposure was determined (0-24hr)",14839,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625454,,11665,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, iv and the total drug exposure was determined. (0-24hr)",14839,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623844,,11666,,,"In vivo antitumor efficacy in nude mice by injecting a dose of 25 mg/kg, micronized free base in 20% HPbetaCD, perorally and the total drug exposure was determined (0-24hr)",14839,Mus musculus,10090.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623845,,11667,,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 1 mg/kg (normalized to a 1 mg/kg dose) in rat,12178,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623846,,11668,,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 2.5 mg/kg (normalized to a 1 mg/kg dose) in rat,12178,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL623847,,11669,,,Integrated area under the blood concentration vs time curve for the period 0-24 hr postdose of 5.0 mg/kg (normalized to a 1 mg/kg dose) GP,12178,,
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623848,,11670,,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,12186,Macaca fascicularis,9541.0
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623849,,11671,,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,12186,Macaca fascicularis,9541.0
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623850,,11672,,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,12186,Macaca fascicularis,9541.0
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623851,,11673,,,Integrated area under the plasma drug level-time curve after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,12186,Macaca fascicularis,9541.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL623852,,11674,,,Integrated area under the plasma drug level-time curve was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,12187,Simiiformes,314293.0
50506,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624551,,11675,,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,12187,Mustela putorius furo,9669.0
50506,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624552,,11676,,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",12187,Mustela putorius furo,9669.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL624553,,11677,,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,12187,Simiiformes,314293.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL624554,,11678,,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey determined by renin inhibition assay,12187,Simiiformes,314293.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624555,,11679,,,Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,12187,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624741,,11680,,,"Integrated area under the plasma drug level-time curve was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",12187,Rattus norvegicus,10116.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624742,,11681,,,"Intravenous integrated area under the concentration vs time curve, for compound in dog plasma",14122,Canis lupus familiaris,9615.0
100712,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624743,,11682,,,"Intravenous integrated area under the concentration vs time curve, for compound in hamster plasma",14122,Cricetinae,10026.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL877606,,11683,,,"Intravenous integrated area under the concentration vs time curve, for compound in rat plasma",14122,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL624744,,11684,,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg,13391,,
22224,Blood,A,,,BAO_0000218,Autocuration,0,U,178.0,1,,,,CHEMBL624745,,11685,,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b = No compound detectable in blood above the detection limit of 0.1 uM,13391,,
22224,Blood,A,,,BAO_0000218,Autocuration,0,U,178.0,1,,,,CHEMBL624746,,11686,,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg; b denotes No compound detectable in blood above the detection limit of 0.1 uM,13391,,
22224,Blood,A,,,BAO_0000218,Autocuration,0,U,178.0,1,,,,CHEMBL624747,,11687,,,Oral Bioavailability was measured as area-under-curve(AUC) value at dose 125 mg/kg;b = No compound detectable in blood above the detection limit of 0.1 uM,13391,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL624748,,11688,,,Oral absorption expressed as Area under curve was determined,16360,,
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622504,,11689,,,Oral absorption kinetics (AUC) was determined after administration of compound orally at 1 mg/kg in dogs,3673,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622505,,11690,,,"Oral integrated area under the concentration vs time curve, for compound in dog plasma",14122,Canis lupus familiaris,9615.0
100712,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622506,,11691,,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",14122,Cricetinae,10026.0
100712,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622507,,11692,,,"Oral integrated area under the concentration vs time curve, for compound in hamster plasma",14122,Cricetinae,10026.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622508,,11693,,,"Oral integrated area under the concentration vs time curve, for compound in rat plasma",14122,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL622509,,11694,,,Pharmacokinetic parameter AUC in mice following a single dose intravenous administration of the compound,13889,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622510,,11695,,,Pharmacokinetic Parameter [Area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,14393,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622511,,11696,,,Pharmacokinetic parameter (AUC) was determined after administering 1 mg/kg of compound intravenously in rat no.3 belonging to phenotype EM (extensive metabolizer),17279,Rattus norvegicus,10116.0
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622512,,11697,,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,14548,Macaca fascicularis,9541.0
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622513,,11698,,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,14548,Macaca fascicularis,9541.0
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622514,,11699,,,Pharmacokinetic parameter AUC calculated in cynomolgus monkey when the compound was administered po at 5 mg/kg concentration,14548,Macaca fascicularis,9541.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622515,,11700,,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,14548,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622516,,11701,,,Pharmacokinetic parameter AUC calculated in dog when the compound was administered po at 5 mg/kg concentration,14548,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622517,,11702,,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,14548,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622518,,11703,,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 12 mg/kg concentration,14548,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622519,,11704,,,Pharmacokinetic parameter AUC calculated in rat when the compound was administered po at 20 mg/kg concentration,14548,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL622520,,11705,,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 30 min,14608,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL622521,,11706,,,Biodistribution was measured in rat muscle by injecting the radiolabeled compound intravenously and the value measured after 60 min,14608,Rattus norvegicus,10116.0
50594,Zone of skin,A,,,BAO_0000218,Intermediate,1,N,14.0,1,,,In vivo,CHEMBL625113,,11707,,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 2 min,14608,Mus musculus,10090.0
50597,Zone of skin,A,,,BAO_0000218,Intermediate,1,N,14.0,1,,,In vivo,CHEMBL625114,,11708,,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 30 min,14608,Rattus norvegicus,10116.0
50597,Zone of skin,A,,,BAO_0000218,Intermediate,1,N,14.0,1,,,In vivo,CHEMBL874397,,11709,,,Biodistribution was measured in rat skin by injecting the radiolabeled compound intravenously and the value measured after 60 min,14608,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL625115,,11710,,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 2 min,14608,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL625116,,11711,,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 30 min,14608,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL623932,,11712,,,Biodistribution was measured in rat spleen by injecting the radiolabeled compound intravenously and the value measured after 60 min,14608,Rattus norvegicus,10116.0
50597,Striatum,A,,,BAO_0000218,Intermediate,1,N,2435.0,1,,,In vivo,CHEMBL623933,,11713,,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 2 min,14608,Rattus norvegicus,10116.0
50597,Striatum,A,,,BAO_0000218,Intermediate,1,N,2435.0,1,,,In vivo,CHEMBL623934,,11714,,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 30 min,14608,Rattus norvegicus,10116.0
50597,Striatum,A,,,BAO_0000218,Intermediate,1,N,2435.0,1,,,In vivo,CHEMBL623935,,11715,,,Biodistribution was measured in rat striatum by injecting the radiolabeled compound intravenously and the value measured after 60 min,14608,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,In vivo,CHEMBL623936,,11716,,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 2 min,14608,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,In vivo,CHEMBL623937,,11717,,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 30 min,14608,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,In vivo,CHEMBL623938,,11718,,,Biodistribution was measured in rat thyroid by injecting the radiolabeled compound intravenously and the value measured after 60 min,14608,Rattus norvegicus,10116.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623939,,11719,,,In vivo biodistribution in mice blood bearing intracerebral GL261 gliomas at the dose of 30 ug/day,15383,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623940,,11720,,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 10 ug/g,15383,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623941,,11721,,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 20 ug/g,15383,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627216,,11722,,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 30 ug/g,15383,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623942,,11723,,,In vivo biodistribution in mice blood bearing subcutaneous B16 melanomas at the dose of 40 ug/g,15383,Mus musculus,10090.0
50594,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL618793,,11724,,,In vivo biodistribution in mice brain bearing intracerebral GL261 gliomas at the dose of 30 ug/day,15383,Mus musculus,10090.0
50594,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL618794,,11725,,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 30 ug/g,15383,Mus musculus,10090.0
50594,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL618795,,11726,,,In vivo biodistribution in mice brain bearing subcutaneous B16 melanomas at the dose of 40 ug/g,15383,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618796,,11727,,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 30 ug/g,15383,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618797,,11728,,,In vivo biodistribution in mice eyes bearing subcutaneous B16 melanomas at the dose of 40 ug/g,15383,Mus musculus,10090.0
50594,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL618798,,11729,,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,15383,Mus musculus,10090.0
50594,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL618799,,11730,,,In vivo biodistribution in mice kidney bearing intracerebral GL261 gliomas at the dose of 30 ug/day,15383,Mus musculus,10090.0
50594,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL618800,,11731,,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 10 ug/g,15383,Mus musculus,10090.0
50594,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL618801,,11732,,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 20 ug/g,15383,Mus musculus,10090.0
50594,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL618802,,11733,,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 30 ug/g,15383,Mus musculus,10090.0
50594,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL618803,,11734,,,In vivo biodistribution in mice kidney bearing subcutaneous B16 melanomas at the dose of 40 ug/g,15383,Mus musculus,10090.0
50594,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL618804,,11735,,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 10 microg of boron/g/day,15383,Mus musculus,10090.0
50594,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL618805,,11736,,,In vivo biodistribution in mice liver bearing intracerebral GL261 gliomas at the dose of 30 ug/day,15383,Mus musculus,10090.0
50594,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL618806,,11737,,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 10 ug/g,15383,Mus musculus,10090.0
50594,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL618807,,11738,,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 20 ug/g,15383,Mus musculus,10090.0
50594,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL618808,,11739,,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 30 ug/g,15383,Mus musculus,10090.0
50594,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL618809,,11740,,,In vivo biodistribution in mice liver bearing subcutaneous B16 melanomas at the dose of 40 ug/g,15383,Mus musculus,10090.0
50594,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL618810,,11741,,,In vivo biodistribution in mice muscle bearing intracerebral GL261 gliomas at the dose of 30 ug/day,15383,Mus musculus,10090.0
50594,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL618811,,11742,,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 10 ug/g,15383,Mus musculus,10090.0
50594,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL875844,,11743,,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 20 ug/g,15383,Mus musculus,10090.0
50594,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL618812,,11744,,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 30 ug/g,15383,Mus musculus,10090.0
50594,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL618813,,11745,,,In vivo biodistribution in mice muscle bearing subcutaneous B16 melanomas at the dose of 40 ug/g,15383,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618814,,11746,,,In vivo biodistribution in mice skin bearing intracerebral GL261 gliomas at the dose of 30 ug/day,15383,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618815,,11747,,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 30 ug/g,15383,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618816,,11748,,,In vivo biodistribution in mice skin bearing subcutaneous B16 melanomas at the dose of 40 ug/g,15383,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL618817,,11749,,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 30 ug/g,15383,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL620544,,11750,,,In vivo biodistribution in mice skin by pump bearing subcutaneous B16 melanomas at the dose of 40 ug/g,15383,Mus musculus,10090.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626230,,11751,,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intraperitoneal administration.,15341,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626231,,11752,,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after intravenous administration.,15341,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626232,,11753,,,The maximum concentration of the compound was measured in rat at dose 30 mg/kg after peroral administration.,15341,Rattus norvegicus,10116.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626233,,11754,,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on dog.,14906,Canis lupus familiaris,9615.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626234,,11755,,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat,14906,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL875341,,11756,,,The maximum plasma concentration (Cmax) is the observed peak plasma concentration after an oral dose on rat.,14906,Rattus norvegicus,10116.0
50587,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626235,,11757,,,The maximum plasma concentration (100 mg/kg) administered orally in human,14215,Homo sapiens,9606.0
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL626236,,11758,,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in marmoset,14215,Callithrix,9481.0
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL626237,,11759,,,The maximum plasma concentration (12.5 mg/kg) administered intravenously in monkey,14215,Simiiformes,314293.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626238,,11760,,,The maximum plasma concentration (15 mg/kg) administered intravenously in dog,14215,Canis lupus familiaris,9615.0
50587,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622412,,11761,,,The maximum plasma concentration (200 mg/kg) administered orally in human,14215,Homo sapiens,9606.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623114,,11762,,,The maximum plasma concentration (25 mg/kg) administered intravenously in rat,14215,Rattus norvegicus,10116.0
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL623115,,11763,,,The maximum plasma concentration (25 mg/kg) administered orally in marmoset,14215,Callithrix,9481.0
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL623116,,11764,,,The maximum plasma concentration (25 mg/kg) administered orally in monkey,14215,Simiiformes,314293.0
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL623117,,11765,,,The maximum plasma concentration (30 mg/kg) administered orally in dog,14215,Canis lupus familiaris,9615.0
50587,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623118,,11766,,,The maximum plasma concentration (400 mg/kg) administered orally in human,14215,Homo sapiens,9606.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623119,,11767,,,The maximum plasma concentration (50 mg/kg) administered orally in fasted rat,14215,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623120,,11768,,,The maximum plasma concentration (50 mg/kg) administered orally in rat,14215,Rattus norvegicus,10116.0
50587,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623286,,11769,,,The maximum plasma concentration (800 mg/kg) administered orally in human,14215,Homo sapiens,9606.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623287,,11770,,,The maximum plasma concentration was measured on rats,14067,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623288,,11771,,,The maximum plasma concentration was measured on rats after oral administration,12350,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623289,,11772,,,Plasma drug Cmax in rat (PO dose),14813,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL623290,,11773,,,Time taken to reach maximum concentration after administration of 2 umol/kg dose intravenously,12536,,
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623291,,11774,,,maximum Plasma concentration in Dog was determined after Peroral administration,14169,Canis lupus familiaris,9615.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623292,,11775,,,maximum Plasma concentration in Rats was determined after Peroral administration,14169,Rattus norvegicus,10116.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623293,,11776,,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,15604,Canis lupus familiaris,9615.0
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL623294,,11777,,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,15604,Simiiformes,314293.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL623295,,11778,,,maximum concentration in plasma in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,15604,Rattus norvegicus,10116.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623296,,11779,,,maximum concentration was measured when administered through oral route in mice,14387,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL875349,,11780,,,Compound was evaluated for Cmax/Tmax when administered through oral route in mouse; Value is 0.93/1,15115,Mus musculus,10090.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL623297,,11781,,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.34/1,15115,Simiiformes,314293.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL623298,,11782,,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 0.81/1.6,15115,Simiiformes,314293.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL623299,,11783,,,Compound was evaluated for Cmax/Tmax when administered through oral route to mouse; Value is 1.1/1.3,15115,Simiiformes,314293.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623300,,11784,,,Pharmacokinetic parameter was evaluated in rats,16359,Rattus norvegicus,10116.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623301,,11785,,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,12829,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623302,,11786,,,Plasma concentration at time-0 was measured in mice at 100 mg/kg after intraperitoneal administration with saline(pH=11.4) as vehicle,12829,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623303,,11787,,,Plasma concentration at time-0 was measured in mice at 120 mg/kg after intraperitoneal administration with 90% DMSO as vehicle,12829,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623304,,11788,,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with saline(pH=11.4) as vehicle,12829,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623305,,11789,,,Plasma concentration at time-0 was measured in mice at 40 mg/kg after intravenous administration with 90% DMSO as vehicle,12829,Mus musculus,10090.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL623306,,11790,,,Effect of ip administration of compound on plasma concentration of allo-pregnanolone (AP) in rats(Cerebral Cortex) after 30 min.,15137,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL623307,,11791,,,Effect of ip administration of compound on plasma concentration of allotetrahydrodeoxy corticosterone(THDOC) in rats(Cerebral Cortex) after 30 min.,15137,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL623308,,11792,,,Effect of ip administration of compound on plasma concentration of pregnenolone (PRE) in rats(Cerebral Cortex) after 30 min.,15137,Rattus norvegicus,10116.0
50594,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL623309,,11793,,,Effect of ip administration of compound on plasma concentration of progesterone (PRO) in rats(Cerebral Cortex) after 30 min.,15137,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623310,,11794,,,Plasma Concentration after 120 min of oral administration to mice,13509,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623311,,11795,,,Plasma Concentration after 30 min of oral administration to mice,13509,Mus musculus,10090.0
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623312,,11796,,,Plasma Concentration after 60 min of oral administration to mice,13509,Macaca fascicularis,9541.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL875350,,11797,,,Plasma Concentration after 60 min of oral administration to mice; Not determined,13509,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628635,,11798,,,Plasma Concentration after 90 min of oral administration to mice,13509,Mus musculus,10090.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628636,,11799,,,Plasma concentration level in rat after 1 hour of oral administration at 50 mg/kg,12064,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628637,,11800,,,Plasma concentration level in rat after 15 hours of oral administration at 50 mg/kg,12064,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628058,,11801,,,Plasma concentration level in rat after 4 hours of oral administration at 50 mg/kg,12064,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628059,,11802,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 0-1 hr time,10677,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628060,,11803,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 1-2 hr time,10677,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628061,,11804,,,Distribution in the lung after 15 min of intravenous administration,8926,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628062,,11805,,,Distribution in the lung after 30 min of intravenous administration,8926,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628063,,11806,,,Distribution in the lung after 5 min of intravenous administration,8926,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628064,,11807,,,Distribution in the lung after 60 min of intravenous administration,8926,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628065,,11808,,,Distribution in the lung after 90 min of intravenous administration,8926,,
22224,Muscle tissue,A,,,BAO_0000019,Autocuration,0,U,2385.0,1,,,,CHEMBL628066,,11809,,,Distribution in the muscle after 120 min of intravenous administration,8926,,
22224,Muscle tissue,A,,,BAO_0000019,Autocuration,0,U,2385.0,1,,,,CHEMBL628067,,11810,,,Distribution in the muscle after 15 min of intravenous administration,8926,,
50594,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL874646,,11811,,,Distribution in the muscle after 30 min of intravenous administration,8926,Mus musculus,10090.0
22224,Muscle tissue,A,,,BAO_0000019,Autocuration,0,U,2385.0,1,,,,CHEMBL628068,,11812,,,Distribution in the muscle after 5 min of intravenous administration,8926,,
22224,Muscle tissue,A,,,BAO_0000019,Autocuration,0,U,2385.0,1,,,,CHEMBL628069,,11813,,,Distribution in the muscle after 60 min of intravenous administration,8926,,
22224,Muscle tissue,A,,,BAO_0000019,Autocuration,0,U,2385.0,1,,,,CHEMBL628070,,11814,,,Distribution in the muscle after 90 min of intravenous administration,8926,,
22224,Spleen,A,,,BAO_0000019,Autocuration,0,U,2106.0,1,,,,CHEMBL628071,,11815,,,Distribution in the spleen after 120 min of intravenous administration,8926,,
22224,Spleen,A,,,BAO_0000019,Autocuration,0,U,2106.0,1,,,,CHEMBL628072,,11816,,,Distribution in the spleen after 15 min of intravenous administration,8926,,
22224,Spleen,A,,,BAO_0000019,Autocuration,0,U,2106.0,1,,,,CHEMBL628073,,11817,,,Distribution in the spleen after 30 min of intravenous administration,8926,,
22224,Spleen,A,,,BAO_0000019,Autocuration,0,U,2106.0,1,,,,CHEMBL628074,,11818,,,Distribution in the spleen after 5 min of intravenous administration,8926,,
22224,Spleen,A,,,BAO_0000019,Autocuration,0,U,2106.0,1,,,,CHEMBL628075,,11819,,,Distribution in the spleen after 60 min of intravenous administration,8926,,
22224,Spleen,A,,,BAO_0000019,Autocuration,0,U,2106.0,1,,,,CHEMBL628076,,11820,,,Distribution in the spleen after 90 min of intravenous administration,8926,,
50597,Adrenal cortex,A,,,BAO_0000218,Intermediate,1,N,1235.0,1,,,,CHEMBL628077,,11821,,,Evaluated for distribution at 0.5 hr after intravenous administration in adrenal cortex of female Sprague Dawley rats,7570,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL628078,,11822,,,Evaluated for distribution at 0.5 hr after intravenous administration in blood of female Sprague Dawley rats,7570,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL628079,,11823,,,Evaluated for distribution at 0.5 hr after intravenous administration in liver of female Sprague Dawley rats,7570,Rattus norvegicus,10116.0
50597,Female gonad,A,,,BAO_0000218,Intermediate,1,N,992.0,1,,,,CHEMBL628080,,11824,,,Evaluated for distribution at 0.5 hr after intravenous administration in ovary of female Sprague Dawley rats,7570,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL628081,,11825,,,Evaluated for distribution at 0.5 hr after intravenous administration in thyroid of female Sprague Dawley rats,7570,Rattus norvegicus,10116.0
50597,Adrenal cortex,A,,,BAO_0000218,Intermediate,1,N,1235.0,1,,,,CHEMBL628082,,11826,,,Evaluated for distribution at 24 hours after intravenous administration in adrenal cortex of female Sprague Dawley rats,7570,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL874647,,11827,,,Evaluated for distribution at 24 hours after intravenous administration in blood of female Sprague Dawley rats,7570,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL626406,,11828,,,Evaluated for distribution at 24 hours after intravenous administration in liver of female Sprague Dawley rats,7570,Rattus norvegicus,10116.0
50597,Female gonad,A,,,BAO_0000218,Intermediate,1,N,992.0,1,,,,CHEMBL626407,,11829,,,Evaluated for distribution at 24 hours after intravenous administration in ovary of female Sprague Dawley rats,7570,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL626408,,11830,,,Evaluated for distribution at 24 hours after intravenous administration in thyroid of female Sprague Dawley rats,7570,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL626409,,11831,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.07-0.09",8608,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL626410,,11832,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.10-0.13",8608,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL626411,,11833,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.18-0.24",8608,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL626412,,11834,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.19-0.24",8608,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL626413,,11835,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.22-0.32",8608,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL626414,,11836,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 30 minutes intravenous administration; dose/g, range 0.25-0.32",8608,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL626415,,11837,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.10-0.14",8608,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL626416,,11838,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.25-0.34",8608,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL627062,,11839,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.27-0.33",8608,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL627063,,11840,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.32-0.46",8608,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL627064,,11841,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.40-0.45",8608,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL627227,,11842,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 5 minutes intravenous administration; dose/g, range 0.44-0.52",8608,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL627228,,11843,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.08-0.09",8608,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL627229,,11844,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.12-0.14",8608,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL625792,,11845,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.13-0.15",8608,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL625793,,11846,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.20",8608,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL625794,,11847,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.15-0.23",8608,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL625795,,11848,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats blood after 60 minutes intravenous administration; dose/g, range 0.16-0.21",8608,Rattus norvegicus,10116.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625796,,11849,,,Pharmacokinetic parameter AUC for the compound after intravenous administration into BALB/c Mice in plasma samples.,13792,Mus musculus,10090.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625797,,11850,,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 375 mg/kg,13376,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625798,,11851,,,Pharmacokinetic parameter AUC has been determined in fed Beagle dogs at a dose of 500 mg/kg,13376,Canis lupus familiaris,9615.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL875613,,11852,,,Pharmacokinetic parameter AUC evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,14380,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL625799,,11853,,,Pharmacokinetic parameter AUC was evaluated in 0.5% methylcellulose suspension at a dose of 20 mg/kg orally,14380,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL625800,,11854,,,Pharmacokinetic parameter AUC was evaluated in 10% PEG suspension at a dose of 20 mg/kg orally,14380,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL625801,,11855,,,Pharmacokinetic parameter AUC was evaluated in 100% PEG solution at a dose of 20 mg/kg orally,14380,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL625802,,11856,,,Pharmacokinetic parameter AUC was evaluated in DMA:H2O solution at a dose of 20 mg/kg orally,14380,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL625803,,11857,,,Pharmacokinetic parameter AUC was evaluated in HP-beta-CD solution at a dose of 20 mg/kg orally,14380,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625804,,11858,,,Pharmacokinetic parameter AUC was evaluated in Hp-beta-CD solution,14380,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL622530,,11859,,,Pharmacokinetic parameter AUC was evaluated in saline solution at a dose of 20 mg/kg orally,14380,,
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622531,,11860,,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h); not detected,13701,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622532,,11861,,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),13701,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623176,,11862,,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),13701,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623177,,11863,,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),13701,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623178,,11864,,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),13701,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623179,,11865,,,Pharmacokinetic parameter AUC was measured at 112 mg/kg dose by intravenous administration using FMAddA as substrate in mice brain; AUC 0-r (mM.h); not detected,13701,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623180,,11866,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC (mM.h),13701,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623181,,11867,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),13701,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624131,,11868,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),13701,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624132,,11869,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration using 2`-F-ara-ddI as substrate in mice serum; AUC (mM.h),13701,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624133,,11870,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),13701,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624846,,11871,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h).,13701,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624847,,11872,,,Pharmacokinetic parameter AUC was measured at 20 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),13701,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624848,,11873,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),13701,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625012,,11874,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC (mM.h),13701,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625013,,11875,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice serum; AUC 0-r (mM.h),13701,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625014,,11876,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain; AUC 0-r (mM.h); not detected,13701,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625015,,11877,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC (mM.h),13701,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625016,,11878,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum; AUC 0-r (mM.h),13701,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625017,,11879,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral in mice brain; AUC (mM.h); not detected,13701,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625018,,11880,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration in mice brain; AUC 0-r (mM.h),13701,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625019,,11881,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by intravenous administration mice serum.; AUC 0-r (mM.h),13701,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625020,,11882,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice brain.; AUC 0-r (mM.h),13701,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625021,,11883,,,Pharmacokinetic parameter AUC was measured at 55 mg/kg dose by oral administration in mice serum.,13701,Mus musculus,10090.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625022,,11884,,,Pharmacokinetic parameter [area under curve (AUC)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,14393,Rattus norvegicus,10116.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625023,,11885,,,Pharmacokinetic parameter area under the curve (0-24 hr) for the compound was evaluated in nude mice after oral administration. ,14731,Mus musculus,10090.0
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625024,,11886,,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration,14731,Macaca fascicularis,9541.0
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627626,,11887,,,Pharmacokinetic parameter area under the curve (0-48 h) for the compound was evaluated in nude cynomolgus monkeys after oral administration. ,14731,Macaca fascicularis,9541.0
22224,Brain,A,,,BAO_0000218,Autocuration,0,U,955.0,1,,,,CHEMBL627627,,11888,,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,13758,,
22224,Serum,A,,,BAO_0000218,Autocuration,0,U,1977.0,1,,,,CHEMBL627628,,11889,,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in serum,13758,,
22224,Brain,A,,,BAO_0000218,Autocuration,0,U,955.0,1,,,,CHEMBL627629,,11890,,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,13758,,
22224,Serum,A,,,BAO_0000218,Autocuration,0,U,1977.0,1,,,,CHEMBL627630,,11891,,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in serum,13758,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627631,,11892,,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/Kg orally; range (0.19-0.35),16359,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL629515,,11893,,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered 5 mg/kg intravenously; range (2.1-2.3),16359,,
50594,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL629516,,11894,,,In vivo biodistribution in mice spleen bearing intracerebral GL261 gliomas at the dose of 30 ug/day,15383,Mus musculus,10090.0
50594,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL629517,,11895,,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 30 ug/g,15383,Mus musculus,10090.0
50594,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL629518,,11896,,,In vivo biodistribution in mice spleen bearing subcutaneous B16 melanomas at the dose of 40 ug/g,15383,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL877499,,11897,,,In vivo biodistribution in mice tumor bearing intracerebral GL261 gliomas at the dose of 30 ug/day,15383,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629519,,11898,,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 20 ug/g,15383,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629520,,11899,,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 30 ug/g,15383,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629521,,11900,,,In vivo biodistribution in mice tumor bearing subcutaneous B16 melanomas at the dose of 40 ug/g,15383,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629522,,11901,,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Blood (B),14439,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629523,,11902,,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Heart (H) and Lung (L),14439,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629524,,11903,,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and Muscle (M),14439,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629525,,11904,,,Ratio of biodistributions in Athymic mice bearing human Tumor (KB) xenografts in Tumor (T) and blood (B),14439,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629526,,11905,,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Blood (B),14439,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629527,,11906,,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Heart (H) and Lung (L),14439,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629528,,11907,,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and Muscle (M),14439,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629529,,11908,,,Ratio of biodistributions in Athymic mice bearing human Tumor (LS174T) xenografts in Tumor (T) and blood (B),14439,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629530,,11909,,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Blood (B),14439,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629531,,11910,,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Heart (H) and Lung (L),14439,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628656,,11911,,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and Muscle (M),14439,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628657,,11912,,,Ratio of biodistributions in Athymic mice bearing human Tumor (TE671) xenografts in Tumor (T) and blood (B),14439,Mus musculus,10090.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628658,,11913,,,"Biodistribution in abdominal Dawley rat after 30min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628659,,11914,,,"Biodistribution in abdominal of mature female Dawley rat after 10min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL877500,,11915,,,"Biodistribution in abdominal of mature female Dawley rat after 15min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628660,,11916,,,"Biodistribution in abdominal of mature female Dawley rat after 1h, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628661,,11917,,,"Biodistribution in abdominal of mature female Dawley rat after 3 h, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628662,,11918,,,"Biodistribution in abdominal of mature female Dawley rat after 30min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628663,,11919,,,"Biodistribution in abdominal of mature female Dawley rat after 45min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628664,,11920,,,"Biodistribution in abdominal of mature female Dawley rat after 5min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL628665,,11921,,,"Biodistribution in blood of mature female Dawley rat after 10min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL628666,,11922,,,"Biodistribution in blood of mature female Dawley rat after 15min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL628667,,11923,,,"Biodistribution in blood of mature female Dawley rat after 1h, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL628668,,11924,,,"Biodistribution in blood of mature female Dawley rat after 3 h, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL628669,,11925,,,"Biodistribution in blood of mature female Dawley rat after 30min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL628670,,11926,,,"Biodistribution in blood of mature female Dawley rat after 45min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL628671,,11927,,,"Biodistribution in blood of mature female Dawley rat after 5min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL628672,,11928,,,"Biodistribution in bone of mature female Dawley rat after 10min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL630300,,11929,,,"Biodistribution in bone of mature female Dawley rat after 1h, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL629787,,11930,,,"Biodistribution in bone of mature female Dawley rat after 3 h, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL629788,,11931,,,"Biodistribution in bone of mature female Dawley rat after 30min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL629789,,11932,,,"Biodistribution in brain of mature female Dawley rat after 10min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL629790,,11933,,,"Biodistribution in brain of mature female Dawley rat after 15min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL629791,,11934,,,"Biodistribution in brain of mature female Dawley rat after 1h, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL629792,,11935,,,"Biodistribution in brain of mature female Dawley rat after 3 h, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL629793,,11936,,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL629794,,11937,,,"Biodistribution in brain of mature female Dawley rat after 45min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL874459,,11938,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 2-3 hr time,10677,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629795,,11939,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 3-4 hr time,10677,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629796,,11940,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 4-5 hr time,10677,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629797,,11941,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 5-6 hr time,10677,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629798,,11942,,,Biliary excretion after dosing at 10 mg/kg intravenously to conscious rats with Indwelling bile duct cannulae for 6-24 h time,10677,Rattus norvegicus,10116.0
50597,Adrenal gland,A,,,BAO_0000218,Intermediate,1,N,2369.0,1,,,In vivo,CHEMBL629799,,11943,,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Adrenal gland,A,,,BAO_0000218,Intermediate,1,N,2369.0,1,,,In vivo,CHEMBL629800,,11944,,,Biodistribution studied in the adrenals of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Adrenal gland,A,,,BAO_0000218,Intermediate,1,N,2369.0,1,,,In vivo,CHEMBL629801,,11945,,,Biodistribution studied in the adrenals of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Adrenal gland,A,,,BAO_0000218,Intermediate,1,N,2369.0,1,,,In vivo,CHEMBL629802,,11946,,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour,10911,Rattus norvegicus,10116.0
50597,Adrenal gland,A,,,BAO_0000218,Intermediate,1,N,2369.0,1,,,In vivo,CHEMBL629803,,11947,,,Biodistribution studied in the adrenals of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL629804,,11948,,,Biodistribution studied in the blood of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL629805,,11949,,,Biodistribution studied in the blood of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL629806,,11950,,,Biodistribution studied in the blood of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL629807,,11951,,,Biodistribution studied in the blood of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL629808,,11952,,,Biodistribution studied in the blood of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL629809,,11953,,,Biodistribution studied in the brain of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL629810,,11954,,,Biodistribution studied in the brain of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL629811,,11955,,,Biodistribution studied in the brain of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL629812,,11956,,,Biodistribution studied in the brain of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL629813,,11957,,,Biodistribution studied in the brain of immature Fischer female rats at 5 hou; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL874460,,11958,,,Biodistribution studied in the brain of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL629814,,11959,,,Biodistribution studied in the fat of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL629815,,11960,,,Biodistribution studied in the fat of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL629816,,11961,,,Biodistribution studied in the fat of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL629817,,11962,,,Biodistribution studied in the fat of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL626643,,11963,,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL626644,,11964,,,Biodistribution studied in the kidneys of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL626806,,11965,,,Biodistribution studied in the kidneys of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL626807,,11966,,,Biodistribution studied in the kidneys of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL627261,,11967,,,Biodistribution studied in the liver of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL627262,,11968,,,Biodistribution studied in the liver of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL627263,,11969,,,Biodistribution studied in the liver of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL627264,,11970,,,Biodistribution studied in the liver of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL627265,,11971,,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL627266,,11972,,,Biodistribution studied in the lungs of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL627267,,11973,,,Biodistribution studied in the lungs of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL627268,,11974,,,Biodistribution studied in the lungs of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL627269,,11975,,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL627270,,11976,,,Biodistribution studied in the muscle of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627271,,11977,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 0.95-1.44",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627946,,11978,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 1.39-2.43",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL875472,,11979,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.47-2.96",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627947,,11980,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-3.69",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627948,,11981,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 2.67-4.31",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628113,,11982,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 30 minutes intravenous administration; dose/g, range 3.17-4.70",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628114,,11983,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration.; dose/g, range 2.20-2.97",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628115,,11984,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 0.90-1.46",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628116,,11985,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.72-3.52",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628117,,11986,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.78-3.62",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628118,,11987,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 2.82-3.86",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628119,,11988,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 5 minutes intravenous administration; dose/g, range 3.80-5.74",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628120,,11989,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.05-1.57",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628121,,11990,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 1.93-3.58",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628122,,11991,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 2.88-4.32",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627297,,11992,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3-3.70",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627298,,11993,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.21-3.92",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627299,,11994,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats heart after 60 minutes intravenous administration; dose/g, range 3.51-5.44",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627300,,11995,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 0.24-0.31",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627301,,11996,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 10.5-14.4",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627302,,11997,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.28-7.41",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627303,,11998,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 6.47-10.2",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627304,,11999,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 7.21-7.95",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627305,,12000,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 30 minutes intravenous administration; dose/g, range 8.28-10.72",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627306,,12001,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 1.04-2.56",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623982,,12002,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 10.7-16.9",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623983,,12003,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 11.7-14.6",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623984,,12004,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 14.4-20.1",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623985,,12005,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 4.78-9.72",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623986,,12006,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 5 minutes intravenous administration; dose/g, range 9.87-11.9",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623987,,12007,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 0.17-0.25",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623988,,12008,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 3.33-4.68",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623989,,12009,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.59-8.81",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622215,,12010,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 4.62-5.60",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622216,,12011,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.02-6.57",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL877481,,12012,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats kidneys after 60 minutes intravenous administration; dose/g, range 5.67-8.41",8608,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL622217,,12013,,,Pharmacokinetic parameter was evaluated which is represented as AUC when administered orally a dose of 5 mg/kg; range (4.2-8.8),16359,,
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622218,,12014,,,Pharmacokinetic parameters was measured at 55 mg/kg dose by oral administration in mice serum.; AUC 0-r (mM.h),13701,Mus musculus,10090.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622219,,12015,,,Pharmacokinetic profile AUC was evaluated in rats,14554,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL622220,,12016,,,Pharmacokinetic property (Area under curve),6241,,
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622221,,12017,,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in dog (25 mg/kg).",11537,Canis lupus familiaris,9615.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622222,,12018,,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration in mice (50 mg/kg).",11537,Mus musculus,10090.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622223,,12019,,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to dog (25 mg/kg).",11537,Canis lupus familiaris,9615.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622224,,12020,,,"Pharmacokinetic property(AUC- area under curve, (micro g/mL/h)) after oral administration to mice (50 mg/kg).",11537,Mus musculus,10090.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL622225,,12021,,,Plasma concentration (AUC) was determined,13118,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL622226,,12022,,,Plasma concentration (AUC) was determined; Not detectable,13118,,
50512,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624154,,12023,,,Prolongation of time to collapse in guinea pig treated with aerosolized histamine was measured in vivo as area under curve (AUC),9562,Cavia porcellus,10141.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624155,,12024,,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg,10363,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624156,,12025,,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 30 mg/kg; Not significant,10363,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624157,,12026,,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 60 mg/kg,10363,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624158,,12027,,,Suppressor cell activity was measured as area under curve(AUC) in normal rats by a splenic cell coculture assay at a dose of 7.5 mg/kg,10363,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624159,,12028,,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 1,12504,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624160,,12029,,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 2,12504,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624161,,12030,,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 3,12504,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624162,,12031,,,Tested for area under the curve (AUC) after intravenous bolus administration of 100 mg/kg in rat 4,12504,Rattus norvegicus,10116.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624163,,12032,,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Area Under Curve value) iv administration.,13317,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624164,,12033,,,"The AUC(0-infinitive) value in female wistar rat at 100 mg/kg, p.o. dose",15078,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624165,,12034,,,The AUC(0-infinity) values in female wistar rats.,14941,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624166,,12035,,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose",15078,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624167,,12036,,,"The AUC(0-t)value in female wistar rat at 100 mg/kg, p.o. dose in mice",15078,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624168,,12037,,,The AUC(0-t)values in female wistar rats.,14941,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624169,,12038,,,The Area under the concentration time curve of compound was measured on rats,14067,Rattus norvegicus,10116.0
50587,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624170,,12039,,,The area under curve (100 mg/kg) administered orally in humans,14215,Homo sapiens,9606.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL624171,,12040,,,The area under curve (12.5 mg/kg) administered intravenously in marmoset,14215,Callithrix,9481.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL624172,,12041,,,The area under curve (12.5 mg/kg) administered intravenously in monkey,14215,Simiiformes,314293.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624173,,12042,,,The area under curve (15 mg/kg) administered intravenously in dog,14215,Canis lupus familiaris,9615.0
50587,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL877488,,12043,,,The area under curve (200 mg/kg) administered orally in humans,14215,Homo sapiens,9606.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624174,,12044,,,The area under curve (25 mg/kg) administered intravenously in rat,14215,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL624175,,12045,,,The area under curve (25 mg/kg) administered orally in marmoset,14215,Callithrix,9481.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL624176,,12046,,,The area under curve (25 mg/kg) administered orally in monkey,14215,Simiiformes,314293.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624177,,12047,,,The area under curve (30 mg/kg) administered orally in dog,14215,Canis lupus familiaris,9615.0
50587,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624178,,12048,,,The area under curve (400 mg/kg) administered orally in humans,14215,Homo sapiens,9606.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624179,,12049,,,The area under curve (50 mg/kg) administered orally in fasted rat,14215,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627689,,12050,,,The area under curve (50 mg/kg) administered orally in rat,14215,Rattus norvegicus,10116.0
50587,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627690,,12051,,,The area under curve (800 mg/kg) administered orally in humans,14215,Homo sapiens,9606.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627691,,12052,,,The compound was evaluated for area under the curve,11324,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627692,,12053,,,The compound was evaluated for area under the curve in marmosets,11324,Callithrix,9481.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627693,,12054,,,The compound was evaluated for area under the curve in marmosets,11324,Callithrix,9481.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627694,,12055,,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,13875,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627695,,12056,,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po) in conscious spontaneously hypertensive rat,13875,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL627696,,12057,,,The compound was tested for the area of the change in MABP versus time curve at dose 10 mg/kg (po),13875,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627697,,12058,,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,13875,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627698,,12059,,,The compound was tested for the area of the change in MABP versus time curve at dose 30 mg/kg (po) in conscious spontaneously hypertensive rat,13875,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627699,,12060,,,The compound was tested for the area of the change in MABP versus time curve at dose 5 mg/kg (po) in conscious spontaneously hypertensive rat,13875,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627700,,12061,,,Total absorption was estimated by area under curve (AUC) after intravenous administration in rat,13807,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627701,,12062,,,Total drug exposure is determined after oral dosing in rats.,14127,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL627702,,12063,,,Total drug exposure (5 mg/kg) when administered intravenously,15116,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL627703,,12064,,,Total drug exposure (5 mg/kg) when administered orally,15116,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL626873,,12065,,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,15604,Simiiformes,314293.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629583,,12066,,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,15604,Rattus norvegicus,10116.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629584,,12067,,,area under curve in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,15604,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629585,,12068,,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in dog,15604,Canis lupus familiaris,9615.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL629586,,12069,,,"Biodistribution in brain of mature female Dawley rat after 5min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL629587,,12070,,,"Biodistribution in brain of mature female Dawley rat after 30min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL629588,,12071,,,"Biodistribution in fat of mature female Dawley rat after 10min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL629589,,12072,,,"Biodistribution in fat of mature female Dawley rat after 15min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL629590,,12073,,,"Biodistribution in fat of mature female Dawley rat after 1h, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL629591,,12074,,,"Biodistribution in fat of mature female Dawley rat after 3 h, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL629592,,12075,,,"Biodistribution in fat of mature female Dawley rat after 30min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL629593,,12076,,,"Biodistribution in fat of mature female Dawley rat after 45min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL629594,,12077,,,"Biodistribution in fat of mature female Dawley rat after 5min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL629595,,12078,,,"Biodistribution in heart of mature female Dawley rat after 10min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL630290,,12079,,,"Biodistribution in heart of mature female Dawley rat after 15min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL627137,,12080,,,"Biodistribution in heart of mature female Dawley rat after 1h, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL627138,,12081,,,"Biodistribution in heart of mature female Dawley rat after 3 h, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL627139,,12082,,,"Biodistribution in heart of mature female Dawley rat after 30min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL627140,,12083,,,"Biodistribution in heart of mature female Dawley rat after 45min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL627141,,12084,,,"Biodistribution in heart of mature female Dawley rat after 5min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL627142,,12085,,,"Biodistribution in kidney of mature female Dawley rat after 10min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL627143,,12086,,,"Biodistribution in kidney of mature female Dawley rat after 15min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL874449,,12087,,,"Biodistribution in kidney of mature female Dawley rat after 1h, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL627144,,12088,,,"Biodistribution in kidney of mature female Dawley rat after 3 h, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL627145,,12089,,,"Biodistribution in kidney of mature female Dawley rat after 30min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL627146,,12090,,,"Biodistribution in kidney of mature female Dawley rat after 45min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL627147,,12091,,,"Biodistribution in kidney of mature female Dawley rat after 5min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL627148,,12092,,,"Biodistribution in liver of mature female Dawley rat after 10min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL627149,,12093,,,"Biodistribution in lung of mature female Dawley rat after 10min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL632160,,12094,,,"Biodistribution in lung of mature female Dawley rat after 15min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL632161,,12095,,,"Biodistribution in lung of mature female Dawley rat after 1h, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL632162,,12096,,,"Biodistribution in lung of mature female Dawley rat after 3 h, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL632163,,12097,,,"Biodistribution in lung of mature female Dawley rat after 30min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL874469,,12098,,,"Biodistribution in lung of mature female Dawley rat after 45min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL627182,,12099,,,"Biodistribution in lung of mature female Dawley rat after 5min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL627183,,12100,,,"Biodistribution in muscle of mature female Dawley rat after 10min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL627184,,12101,,,"Biodistribution in muscle of mature female Dawley rat after 15min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL627185,,12102,,,"Biodistribution in muscle of mature female Dawley rat after 1h, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL627186,,12103,,,"Biodistribution in muscle of mature female Dawley rat after 3 h, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL627187,,12104,,,"Biodistribution in muscle of mature female Dawley rat after 30min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL627188,,12105,,,"Biodistribution in muscle of mature female Dawley rat after 45min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL627189,,12106,,,"Biodistribution in muscle of mature female Dawley rat after 5min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627190,,12107,,,"Biodistribution inl ilver of mature female Dawley rat after 30min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL627191,,12108,,,"Biodistribution inl iver of mature female Dawley rat after 15min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL627192,,12109,,,"Biodistribution inl iver of mature female Dawley rat after 3 h, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL627193,,12110,,,"Biodistribution inl iver of mature female Dawley rat after 5min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL874590,,12111,,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hou; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL627194,,12112,,,Biodistribution studied in the muscle of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL627195,,12113,,,Biodistribution studied in the muscle of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Female gonad,A,,,BAO_0000218,Intermediate,1,N,992.0,1,,,In vivo,CHEMBL627196,,12114,,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Female gonad,A,,,BAO_0000218,Intermediate,1,N,992.0,1,,,In vivo,CHEMBL627197,,12115,,,Biodistribution studied in the ovaries of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Female gonad,A,,,BAO_0000218,Intermediate,1,N,992.0,1,,,In vivo,CHEMBL627198,,12116,,,Biodistribution studied in the ovaries of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Female gonad,A,,,BAO_0000218,Intermediate,1,N,992.0,1,,,In vivo,CHEMBL627199,,12117,,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour,10911,Rattus norvegicus,10116.0
50597,Female gonad,A,,,BAO_0000218,Intermediate,1,N,992.0,1,,,In vivo,CHEMBL627200,,12118,,,Biodistribution studied in the ovaries of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL627201,,12119,,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL627202,,12120,,,Biodistribution studied in the plasma of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL627203,,12121,,,Biodistribution studied in the plasma of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL627204,,12122,,,Biodistribution studied in the plasma of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL627205,,12123,,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL627206,,12124,,,Biodistribution studied in the spleen of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL627207,,12125,,,Biodistribution studied in the spleen of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL627208,,12126,,,Biodistribution studied in the spleen of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,In vivo,CHEMBL627209,,12127,,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,In vivo,CHEMBL627210,,12128,,,Biodistribution studied in the thyroid of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,In vivo,CHEMBL627211,,12129,,,Biodistribution studied in the thyroid of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,In vivo,CHEMBL627212,,12130,,,Biodistribution studied in the thyroid of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Uterus,A,,,BAO_0000218,Intermediate,1,N,995.0,1,,,In vivo,CHEMBL627213,,12131,,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hr +E2; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Uterus,A,,,BAO_0000218,Intermediate,1,N,995.0,1,,,In vivo,CHEMBL626599,,12132,,,Biodistribution studied in the uterus of immature Fischer female rats at 1 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Uterus,A,,,BAO_0000218,Intermediate,1,N,995.0,1,,,In vivo,CHEMBL626600,,12133,,,Biodistribution studied in the uterus of immature Fischer female rats at 2 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
50597,Uterus,A,,,BAO_0000218,Intermediate,1,N,995.0,1,,,In vivo,CHEMBL626601,,12134,,,Biodistribution studied in the uterus of immature Fischer female rats at 5 hour; activity is expressed as inductive dose / gram,10911,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627484,,12135,,,C(f=2) is the concentration at which the half life (t1/2) in the time course of inhibition of BChE by DFP increased by twofold in the presence of compound,8081,,
100710,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL627485,,12136,,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg),17248,Macaca fascicularis,9541.0
100710,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL628147,,12137,,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not applicable,17248,Macaca fascicularis,9541.0
100710,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL628148,,12138,,,Compound was tested for plasma concentration in CM-monkeys 7 hours after oral administration (50 mg/kg); Not determined,17248,Macaca fascicularis,9541.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL628149,,12139,,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg),17248,Canis lupus familiaris,9615.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL628150,,12140,,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 1,17248,Canis lupus familiaris,9615.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL628318,,12141,,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg) in experiment 2,17248,Canis lupus familiaris,9615.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL628319,,12142,,,Compound was tested for plasma concentration in dogs 7 hours after oral administration (30 mg/kg); Not applicable,17248,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL875609,,12143,,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",15592,Canis lupus familiaris,9615.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628320,,12144,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10,7040,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628321,,12145,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 10.5,7040,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628322,,12146,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 6.8,7040,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628323,,12147,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.2,7040,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628324,,12148,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 7.6,7040,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628325,,12149,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 8.2,7040,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628326,,12150,,,Concentration distributed until decomposition of N-acetyl-N-hydroxy-p-aminophenol at pH 9.6,7040,,
50588,Adrenal medulla,A,,,BAO_0000218,Intermediate,1,N,1236.0,1,,,,CHEMBL628327,,12151,,,"Concentration of compound in adrenal medulla of dog 2, after administering intravenously",9614,Canis lupus familiaris,9615.0
50588,Adrenal medulla,A,,,BAO_0000218,Intermediate,1,N,1236.0,1,,,,CHEMBL628328,,12152,,,"Concentration of compound in adrenal medulla of dog1, after administering intravenously",9614,Canis lupus familiaris,9615.0
50588,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL628329,,12153,,,"Concentration of compound in blood of dog 1, after administering intravenously",9614,Canis lupus familiaris,9615.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL628330,,12154,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration.; dose/g, range 0.23-0.29",8608,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL628331,,12155,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.22-0.30",8608,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL628332,,12156,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.55-0.71",8608,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL628333,,12157,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 0.57-0.72",8608,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL628334,,12158,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 1.51-2.23",8608,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL628335,,12159,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 30 minutes intravenous administration; dose/g, range 2.30-3.12",8608,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL628336,,12160,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 0.93-1.20",8608,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL628337,,12161,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.04-2.56",8608,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL628338,,12162,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.06-1.70",8608,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL875610,,12163,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 1.26-2.45",8608,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL628339,,12164,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 3.12-4.56",8608,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL628340,,12165,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 5 minutes intravenous administration; dose/g, range 4.12-6.30",8608,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL628341,,12166,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.14-0.19",8608,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL622214,,12167,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.15-0.19",8608,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL623167,,12168,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.24-0.30",8608,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL623168,,12169,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.44-0.54",8608,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL623169,,12170,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 0.73-1.19",8608,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL623170,,12171,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats liver after 60 minutes intravenous administration; dose/g, range 1.08-2.31",8608,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL627224,,12172,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration.; dose/g, range 0.34-0.47",8608,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL875634,,12173,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.83-1.21",8608,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL627225,,12174,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.91-1.74",8608,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL627226,,12175,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 0.99-1.23",8608,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL626083,,12176,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.07-1.30",8608,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL626084,,12177,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 30 minutes intravenous administration; dose/g, range 1.12-1.39",8608,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL626085,,12178,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.51-0.66",8608,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL626086,,12179,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.95-1.49",8608,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL626087,,12180,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 0.96-1.35",8608,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL626088,,12181,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.18-1.44",8608,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL626089,,12182,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.20-1.52",8608,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL626090,,12183,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 5 minutes intravenous administration; dose/g, range 1.41-2.17",8608,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL626091,,12184,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.28-0.33",8608,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL626092,,12185,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.81-1.13",8608,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL626093,,12186,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.83-2.11",8608,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL626094,,12187,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.94-1.36",8608,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL626095,,12188,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 0.97-1.54",8608,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL626096,,12189,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats lungs after 60 minutes intravenous administration; dose/g, range 1.07-1.26",8608,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL626097,,12190,,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in monkey,15604,Simiiformes,314293.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626098,,12191,,,area under curve in preclinical species was measured after oral administration at the given dose (0.5 mg/kg) in rat,15604,Rattus norvegicus,10116.0
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,,CHEMBL626099,,12192,,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 27.5 mg/kg DMP323 equiv,1806,,
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,,CHEMBL626100,,12193,,,compound was evaluated for area under the plasma concentration vs. time curve at different dose 7.7 mg/kg DMP323 equiv,1806,,
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626101,,12194,,,AUC 0-inf in dog,17237,Canis lupus familiaris,9615.0
50512,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626102,,12195,,,AUC 0-inf in guinea pig,17237,Cavia porcellus,10141.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626103,,12196,,,AUC 0-t in dog,17237,Canis lupus familiaris,9615.0
50512,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL628391,,12197,,,AUC 0-t in guinea pig,17237,Cavia porcellus,10141.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628392,,12198,,,The compound was tested for brain to plasma partition in rat,15194,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628393,,12199,,,The compound was tested for brain to plasma partition in rat.,15194,Rattus norvegicus,10116.0
22224,Blood,A,,,BAO_0000019,Autocuration,0,U,178.0,1,,,,CHEMBL628394,,12200,,,Area under curve was determined for 0-6 hr duration using dihydralazine as reference drug for the peak blood pressure,8787,,
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628395,,12201,,,Area under concentration-time curve of compound was determined in dog at 5 mg/kg intravenously admn.,17025,Canis lupus familiaris,9615.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL628396,,12202,,,Area under concentration-time curve of compound was determined in monkey at 5 mg/kg intravenously admn.,17025,Simiiformes,314293.0
50592,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628397,,12203,,,Area under concentration-time curve of compound was determined in rabbit at 5 mg/kg intravenously admn.,17025,Oryctolagus cuniculus,9986.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628398,,12204,,,Area under concentration-time curve of compound was determined in rat at 5 mg/kg intravenously admn.,17025,Rattus norvegicus,10116.0
50797,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628399,,12205,,,Area under curve obtained at a dose of 10 mg/kg when administered orally to rhesus monkey,4236,Macaca mulatta,9544.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628400,,12206,,,The Plasma area under the compound concentration -time curve was measured in dogs after oral administration of 1 mg/kg dose,15343,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL874907,,12207,,,The Plasma area under the compound concentration -time curve was measured in rats after oral administration of 1 mg/kg dose,15343,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628401,,12208,,,Area under curve of the compound was determined,17720,,
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,,CHEMBL628402,,12209,,,AUC in monkeys at a dose of 1 mg/kg,17788,Simiiformes,314293.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL628403,,12210,,,AUC in rats at a dose of 1 mg/kg,17788,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628404,,12211,,,Compound was evaluated for the overall absorbance loss at pH of 2,8778,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628405,,12212,,,Compound was evaluated for the overall absorbance loss at pH of 4,8778,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628406,,12213,,,Compound was evaluated for the overall absorbance loss at pH of 7,8778,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628407,,12214,,,Compound was evaluated for its absorption in the rats,2249,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628408,,12215,,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,8881,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL629171,,12216,,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight.,8881,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL629172,,12217,,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of 0.1 mmol/kg of body weight per mole of pro drug,8881,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL629173,,12218,,,Compound was evaluated for percent tranexamic acid recovered in rat urine within 24 hr after oral administration of per moiety tranexamic acid,8881,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629174,,12219,,,In vitro percent permeability into rat ileum,15286,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629175,,12220,,,In vitro percent permeability into rat ileum; Range is 10-17,15286,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629176,,12221,,,In vitro percent permeability into rat ileum; Range is 10-18,15286,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629177,,12222,,,In vitro percent permeability into rat ileum; Range is 10-19,15286,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629178,,12223,,,In vitro percent permeability into rat ileum; Range is 12-15,15286,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631869,,12224,,,In vitro percent permeability into rat ileum; Range is 13-19,15286,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631870,,12225,,,In vitro percent permeability into rat ileum; Range is 14-17,15286,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631871,,12226,,,In vitro percent permeability into rat ileum; Range is 15-18,15286,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631872,,12227,,,In vitro percent permeability into rat ileum; Range is 2-5,15286,Rattus norvegicus,10116.0
22224,Ileum,A,,,BAO_0000221,Autocuration,0,U,2116.0,1,,,,CHEMBL875775,,12228,,,In vitro percent permeability into rat ileum; Range is 23-42,15286,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631873,,12229,,,In vitro percent permeability into rat ileum; Range is 28-36,15286,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631874,,12230,,,In vitro percent permeability into rat ileum; Range is 29-35,15286,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631875,,12231,,,In vitro percent permeability into rat ileum; Range is 46-66,15286,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631876,,12232,,,In vitro percent permeability into rat ileum; Range is 50-68,15286,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631877,,12233,,,In vitro percent permeability into rat ileum; Range is 78-81,15286,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631878,,12234,,,In vitro percent permeability into rat ileum; insol indicates not soluble in aqueous buffer,15286,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631879,,12235,,,In vitro percent permeability into rat ileum; nd indicates not detected,15286,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631880,,12236,,,In vitro percent permeability into rat ileum; nt indicates not detected,15286,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631881,,12237,,,In vitro percent permeability into rat ileum; nt indicates not tested,15286,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631882,,12238,,,Compound was tested for oral absorption in bile-duct cannulated rats,13770,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630749,,12239,,,Compound was tested for oral absorption in bile-duct cannulated rats.,13770,Rattus norvegicus,10116.0
50587,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630750,,12240,,,Oral absorption using Caco-2 cell monolayers.,5202,Homo sapiens,9606.0
50587,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630253,,12241,,,Percent of the drug absorbed after administration to humans was determined,14920,Homo sapiens,9606.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL630254,,12242,,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 120 minutes.,14103,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL630255,,12243,,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 15 minutes.,14103,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL630256,,12244,,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 180 minutes.,14103,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL875781,,12245,,,"Biodistribution inl liver of mature female Dawley rat after 1h, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL630257,,12246,,,"Biodistribution inl liver of mature female Dawley rat after 30min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL630258,,12247,,,"Biodistribution inl liver of mature female Dawley rat after 45min, expressed as percent injected dose/g",13751,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630259,,12248,,,"Distribution of radioactivity in rat blood after 2 minutes of iv administration at the dose of 10.05-0.07 gram of tissue, expressed as percent injected dose per gram of tissue",15807,Rattus norvegicus,10116.0
50597,Striatum,A,,,BAO_0000218,Intermediate,1,N,2435.0,1,,,,CHEMBL630260,,12249,,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 1.89-3.73 g of tissue, expressed as percent injected dose per gram of tissue",15807,Rattus norvegicus,10116.0
50597,Striatum,A,,,BAO_0000218,Intermediate,1,N,2435.0,1,,,,CHEMBL630261,,12250,,,"Distribution of radioactivity in rat striatum after 5 minutes of iv administration at the dose of 3.44-4.80 g of tissue, expressed as percent injected dose per gram of tissue",15807,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630262,,12251,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat and 5-alpha-DHT was reported,14950,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630263,,12252,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 1 hour time,14950,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630264,,12253,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat blood at 2 hours time,14950,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630265,,12254,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 0.5 hours time,14950,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630266,,12255,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat fat at 4 hours time,14950,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL630267,,12256,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 0.5 hours time,14950,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL630268,,12257,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat kidney at 4 hours time,14950,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630269,,12258,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 1 hour time,14950,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630270,,12259,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat liver at 2 hours time,14950,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL630141,,12260,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 1 hour time,14950,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL630142,,12261,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat lung at 2 hours time,14950,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL630143,,12262,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 0.5 hours time,14950,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL630144,,12263,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat muscle at 4 hours time,14950,Rattus norvegicus,10116.0
50597,Prostate gland,A,,,BAO_0000218,Intermediate,1,N,2367.0,1,,,,CHEMBL630145,,12264,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 0.5 hours time,14950,Rattus norvegicus,10116.0
50597,Prostate gland,A,,,BAO_0000218,Intermediate,1,N,2367.0,1,,,,CHEMBL630146,,12265,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate at 4 hours time,14950,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630147,,12266,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood,14950,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630148,,12267,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 1 hours time,14950,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630149,,12268,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat prostate/blood at 2 hours time,14950,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL630150,,12269,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 1 hour time,14950,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL630151,,12270,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat spleen at 2 hours time,14950,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL632031,,12271,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 0.5 hours time,14950,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL632032,,12272,,,Distribution of tissue Radioactivity following Intravenous injection into castarted male rat thyroid at 4 hours time,14950,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL632033,,12273,,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat fat at 1 hour time,14950,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL632034,,12274,,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat kidney at 1 hour time,14950,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL632035,,12275,,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat muscle at 1 hour time,14950,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL632036,,12276,,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat prostrateat 1 hour time,14950,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL632037,,12277,,,Distribution of tissue Radioactivity following subcutaneous injection of 500 mg of 5-alpha-DHT 15 min before the administration of the [125I]- tracer castarted male rat thyroid at 1 hour time,14950,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL632038,,12278,,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,8631,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL632039,,12279,,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,8631,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL632040,,12280,,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,8631,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL632041,,12281,,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,8631,Rattus norvegicus,10116.0
50588,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL632042,,12282,,,"Concentration of compound in blood of dog 2, after administering intravenously",9614,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL632043,,12283,,,"Concentration of compound in left ventricle of dog 1, after administering intravenously",9614,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL632044,,12284,,,"Concentration of compound in left ventricle of dog 2, after administering intravenously",9614,Canis lupus familiaris,9615.0
50588,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL632045,,12285,,,"Concentration of compound in liver of dog 1, after administering intravenously",9614,Canis lupus familiaris,9615.0
50588,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL632046,,12286,,,"Concentration of compound in liver of dog 2, after administering intravenously",9614,Canis lupus familiaris,9615.0
50588,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL632047,,12287,,,"Concentration of compound in lung of dog 1, after administering intravenously",9614,Canis lupus familiaris,9615.0
50588,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL632048,,12288,,,"Concentration of compound in lung of dog 2, after administering intravenously",9614,Canis lupus familiaris,9615.0
50588,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL632049,,12289,,,"Concentration of compound in muscle of dog 1, after administering intravenously",9614,Canis lupus familiaris,9615.0
50588,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL876418,,12290,,,"Concentration of compound in muscle of dog 2, after administering intravenously",9614,Canis lupus familiaris,9615.0
50588,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL632050,,12291,,,"Concentration of compound in spleen of dog 1,after administering intravenously",9614,Canis lupus familiaris,9615.0
50588,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL632051,,12292,,,"Concentration of compound in spleen of dog 2, after administering intravenously",9614,Canis lupus familiaris,9615.0
22224,,F,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL632052,,12293,,,Concentration of liberated compound in serum after 120 min at the dose of 50 mg/kg (po).,10353,,
22224,,F,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL632053,,12294,,,Concentration of liberated compound in serum after 240 min at the dose of 50 mg/kg (po).,10353,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL632054,,12295,,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,10353,,
22224,,F,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL632055,,12296,,,Concentration of liberated compound in serum after 30 min at the dose of 50 mg/kg (po).,10353,,
22224,,F,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL631181,,12297,,,Concentration of liberated compound in serum after 60 min at the dose of 50 mg/kg (po).,10353,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL631182,,12298,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous after 1.5 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL631183,,12299,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL631184,,12300,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL629774,,12301,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL629775,,12302,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL876549,,12303,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL628172,,12304,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL628173,,12305,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL628174,,12306,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous after 1.5 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL628175,,12307,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 4.0 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL628176,,12308,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL628177,,12309,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL628178,,12310,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL628179,,12311,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL628180,,12312,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg i intravenous dosage after 1.0 hr; insufficient gastric juice produced,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL628181,,12313,,,Concentration of radioactivity in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage a after 2.5 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL628182,,12314,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL628183,,12315,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL628184,,12316,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr; ND means not determined,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL628185,,12317,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL875617,,12318,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL628186,,12319,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr; ND means not determined,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL628187,,12320,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL628188,,12321,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL628189,,12322,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL628190,,12323,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr; ND means not determined,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL628191,,12324,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL626513,,12325,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr; ND means not determined,9196,,
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL626514,,12326,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 19-24",8608,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL626515,,12327,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 26-40",8608,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL626516,,12328,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 29-44",8608,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL626517,,12329,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 32-42",8608,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL626518,,12330,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 33-60",8608,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL626519,,12331,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 30 minutes intravenous administration; dose/g, range 4-7",8608,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL626520,,12332,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 13-18",8608,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL626521,,12333,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 16-32",8608,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL626522,,12334,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 22-25",8608,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL626523,,12335,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 26-49",8608,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL626524,,12336,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 29-36",8608,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL626688,,12337,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 5 minutes intravenous administration; dose/g, range 5-8",8608,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL626689,,12338,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 26-42",8608,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL626690,,12339,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 30-53",8608,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL626691,,12340,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 32-43",8608,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL627319,,12341,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 35-53",8608,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL624052,,12342,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 5-12",8608,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL624053,,12343,,,"Evaluated for the distribution of radioactivity in tissues of female Fischer rats thyroid after 60 minutes intravenous administration; dose/g, range 55-102",8608,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624054,,12344,,,In vivo distribution of the drug in plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,8085,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624055,,12345,,,In vivo distribution of the drug in plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,8085,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624056,,12346,,,In vivo distribution of the drug in plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,8085,Rattus norvegicus,10116.0
50597,Uterus,A,,,BAO_0000218,Intermediate,1,N,995.0,1,,,,CHEMBL624057,,12347,,,In vivo distribution of the drug in uterus was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,8085,Rattus norvegicus,10116.0
50597,Uterus,A,,,BAO_0000218,Intermediate,1,N,995.0,1,,,,CHEMBL622281,,12348,,,In vivo distribution of the drug in uterus was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,8085,Rattus norvegicus,10116.0
50597,Uterus,A,,,BAO_0000218,Intermediate,1,N,995.0,1,,,,CHEMBL622282,,12349,,,In vivo distribution of the drug in uterus was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,8085,Rattus norvegicus,10116.0
50597,Uterus,A,,,BAO_0000218,Intermediate,1,N,995.0,1,,,,CHEMBL622283,,12350,,,In vivo distribution of the drug in uterus/plasma was determined at 1 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,8085,Rattus norvegicus,10116.0
50597,Uterus,A,,,BAO_0000218,Intermediate,1,N,995.0,1,,,,CHEMBL622284,,12351,,,In vivo distribution of the drug in uterus/plasma was determined at 2 hr following injection of five microcurics of the radiolabeled [125 I] compound in rats,8085,Rattus norvegicus,10116.0
50597,Uterus,A,,,BAO_0000218,Intermediate,1,N,995.0,1,,,,CHEMBL622285,,12352,,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,8085,Rattus norvegicus,10116.0
50597,Uterus,A,,,BAO_0000218,Intermediate,1,N,995.0,1,,,,CHEMBL622286,,12353,,,In vivo distribution of the drug in uterus/plasma was determined at 3h following injection of five microcurics of the radiolabeled [125 I] compound in rats,8085,Rattus norvegicus,10116.0
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL622287,,12354,,,Distribution coefficient (D %) between octanol and buffer of pH 7.4,7657,,
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622288,,12355,,,Partition coefficient (logD7.4),8935,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622289,,12356,,,"Percentage of radioactivity in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",13792,Mus musculus,10090.0
50594,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL622290,,12357,,,"Percentage of radioactivity in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",13792,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622291,,12358,,,Percentage of radioactivity in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,13792,Mus musculus,10090.0
50594,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL622292,,12359,,,Percentage of radioactivity in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,13792,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622293,,12360,,,"Percentage of total protein recovered in P1 subregion in mouse brain that contains nuclei and cell debris, after Jugular Vein Injection",13792,Mus musculus,10090.0
50594,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL622294,,12361,,,"Percentage of total protein recovered in P2 subregion in mouse brain that contains myelin fragments, synaptosomes (pinched-nerve endings), and mitochondria after Jugular Vein Injection",13792,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622295,,12362,,,Percentage of total protein recovered in P3 subregion in mouse brain that contains microsomal fraction after Jugular Vein Injection,13792,Mus musculus,10090.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL622296,,12363,,,Percentage of total protein recovered in S3 which is the soluble fraction in mouse brain after Jugular Vein Injection,13792,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL874409,,12364,,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 2 minutes.,14103,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622297,,12365,,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 240 minutes.,14103,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622298,,12366,,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 30 minutes.,14103,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622299,,12367,,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 45 minutes.,14103,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622300,,12368,,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 5 minutes.,14103,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622301,,12369,,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 60 minutes.,14103,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622302,,12370,,,1 mg/kg was administered intravenously in anesthetized rats and the concentration in plasma was determined after 90 minutes.,14103,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622303,,12371,,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 120 minutes.,14103,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622304,,12372,,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes.,14103,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622305,,12373,,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 15 minutes;nd=not determined,14103,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL622306,,12374,,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 180 minutes.,14103,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626864,,12375,,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 2 minutes;nd=not determined,14103,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626865,,12376,,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes.,14103,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626866,,12377,,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 240 minutes;nd=not determined,14103,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626867,,12378,,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 30 minutes.,14103,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626868,,12379,,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes.,14103,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626869,,12380,,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 45 minutes;nd=not determined,14103,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626870,,12381,,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes.,14103,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626871,,12382,,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 5 minutes;nd=not determined,14103,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626872,,12383,,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 60 minutes.,14103,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL632185,,12384,,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes.,14103,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL632186,,12385,,,50 mg/kg was administered orally in anesthetized rats and the concentration in plasma was determined after 90 minutes;nd=not determined,14103,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629310,,12386,,,Amount of acetic acid produced by the compound,12904,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629311,,12387,,,Apparent first-order rate of solvolysis for the bipinnatin-A(A4) was determined,12904,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629312,,12388,,,Log of (Cbrain/Cblood) in rats,9663,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000221,Autocuration,0,U,,1,,,,CHEMBL629313,,12389,,,Compound in absence of MPM cell homogenate at pH 3 to isolate compound 4 (ng),7652,,
22224,,A,,,BAO_0000221,Autocuration,0,U,,1,,,,CHEMBL629314,,12390,,,Compound in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),7652,,
22224,,A,,,BAO_0000221,Autocuration,0,U,,1,,,,CHEMBL629315,,12391,,,Compound in absence of MPM cell homogenate at pH 7 to isolate compound 4 (ng),7652,,
22224,,B,,,BAO_0000219,Autocuration,0,U,,1,,,,CHEMBL629316,,12392,,,Compound in presence of MPM cells and in absence of inactivator at pH 8 to isolate compound 4 (ng),7652,,
22224,,A,,,BAO_0000221,Autocuration,0,U,,1,,,,CHEMBL629317,,12393,,,Compound treated in absence of MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),7652,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629318,,12394,,,Compound treated with MPM cell homogenate at pH 3 to isolate compound 4 (ng),7652,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL877497,,12395,,,Compound treated with MPM cell homogenate at pH 3.5 to isolate compound 4 (ng),7652,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629319,,12396,,,Compound treated with MPM cell homogenate at pH 4 to isolate compound 4 (ng),7652,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629320,,12397,,,Compound treated with MPM cell homogenate at pH 4.5 to isolate compound 4 (ng),7652,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629496,,12398,,,Compound treated with MPM cell homogenate at pH 5 to isolate compound 4 (ng),7652,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629497,,12399,,,Compound treated with MPM cell homogenate at pH 5.5 to isolate compound 4 (ng),7652,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629498,,12400,,,Compound treated with MPM cell homogenate at pH 6 to isolate compound 4 (ng),7652,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629499,,12401,,,Compound treated with MPM cell homogenate at pH 6.5 to isolate compound 4 (ng),7652,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629500,,12402,,,Compound treated with MPM cell homogenate at pH 7 to isolate compound 4 (ng),7652,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629501,,12403,,,Compound treated with MPM cell homogenate at pH 7.5 to isolate compound 4 (ng),7652,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629502,,12404,,,Compound treated with MPM cell homogenate at pH 8 to isolate compound 4 (ng),7652,,
22224,,F,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL629503,,12405,,,Compound was evaluated for its urinary recovery after oral administration (100 mg) to Beagle dogs,8267,,
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629504,,12406,,,Compound was evaluated for its urinary recovery after oral administration (200 mg) to Beagle dogs,8267,Canis lupus familiaris,9615.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629505,,12407,,,Compound was evaluated for the rate of degradation by Carboxypeptidase A.,14479,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629506,,12408,,,Compound was evaluated for total body clearance,17515,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629507,,12409,,,Compound was evaluated for volume of distribution at steady state,17515,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL877498,,12410,,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant KOH- was reported.,8142,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629508,,12411,,,Percentage of the diamine which is monoprotonated at pH 7.4,14849,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629509,,12412,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells,7653,,
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL629510,,12413,,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,8631,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL629511,,12414,,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,8631,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL629512,,12415,,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,8631,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL629513,,12416,,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,8631,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL629514,,12417,,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,8631,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL628447,,12418,,,Amount of compound present in blood of rat 1 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,8631,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL628448,,12419,,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 10 minutes,8631,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL628449,,12420,,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 15 minutes,8631,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL631119,,12421,,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 20 minutes,8631,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL631120,,12422,,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 30 minutes,8631,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL631121,,12423,,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 microCi and activity calculated after 5 minutes,8631,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL874458,,12424,,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 min,8631,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL631122,,12425,,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,8631,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL631123,,12426,,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,8631,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL631124,,12427,,,Amount of compound present in blood of rat 2 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,8631,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL631125,,12428,,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,8631,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL631290,,12429,,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,8631,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL631291,,12430,,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,8631,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL631292,,12431,,,Amount of compound present in blood of rat 3 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,8631,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL631293,,12432,,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 10 minutes,8631,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL631294,,12433,,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 15 minutes,8631,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL631295,,12434,,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 20 minutes,8631,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL631296,,12435,,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 30 minutes,8631,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL631297,,12436,,,Amount of compound present in blood of rat 4 when administered intravenously at a dose of 2 mg containing approximately 3 uCi and activity calculated after 5 minutes,8631,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL631298,,12437,,,Maximum biodistribution (Bmax) was determined.,10263,,
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631299,,12438,,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 1.5625 (mg/kg) intravenous dose in 6 mice,12364,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631300,,12439,,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 10 (mg/kg) intravenous dose in 6 mice,12364,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631301,,12440,,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 3.125 (mg/kg) intravenous dose in 6 mice,12364,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630291,,12441,,,Mean difference between rectal temperature measured at time zero and rectal temperature measured at 10 min at 6.25 (mg/kg) intravenous dose in 6 mice,12364,Mus musculus,10090.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL630292,,12442,,,Brain concentration after 0.25 hr at a dose of 10 mg/kg when administered intraperitoneally,14793,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL630293,,12443,,,Brain concentration after 0.25 h at a dose of 10 mg/kg when administered intravenously,14793,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL630294,,12444,,,Brain concentration after 0.5 h at a dose of 100 mg/kg when administered perorally,14793,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL630295,,12445,,,Brain concentration after 0.5 h at a dose of 10 mg/kg when administered intraperitoneally,14793,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL630296,,12446,,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered intravenously,14793,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL626782,,12447,,,Brain concentration after 0.5 hr at a dose of 10 mg/kg when administered perorally,14793,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL626783,,12448,,,Brain concentration after 1 hr at a dose of 100 mg/kg when administered perorally,14793,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL626784,,12449,,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intraperitoneally,14793,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL626785,,12450,,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered intravenously,14793,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL626786,,12451,,,Brain concentration after 1 hr at a dose of 10 mg/kg when administered perorally,14793,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL626787,,12452,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL626788,,12453,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr; ND means not determined,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL625927,,12454,,,Concentration of radioactivity in plasma for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,9196,,
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL625928,,12455,,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL625929,,12456,,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,8374,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL625930,,12457,,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected.,8374,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL625931,,12458,,,"Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound, Compound was found to be in trace amount.",8374,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL627230,,12459,,,Concentration 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected.,8374,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL627231,,12460,,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL627232,,12461,,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,8374,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL627233,,12462,,,Concentration 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected.,8374,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL875470,,12463,,,Concentration 5a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL627234,,12464,,,Concentration 5a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL627235,,12465,,,Concentration 5b detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL627236,,12466,,,Concentration 5b detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL627237,,12467,,,Concentration 5c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL627238,,12468,,,Concentration 5c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL627239,,12469,,,Concentration 5d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL627240,,12470,,,Concentration 5d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL627241,,12471,,,Concentration 5e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL627242,,12472,,,Concentration 5e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL627243,,12473,,,Concentration 5f detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound; ND is Not Detected,8374,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL627244,,12474,,,Concentration 5f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,8374,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL627245,,12475,,,Concentration 6a detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL627246,,12476,,,Concentration 6a detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL627247,,12477,,,Concentration 6c detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL627248,,12478,,,Concentration 6c detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL627249,,12479,,,Concentration 6d detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL625569,,12480,,,Concentration 6d detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL625570,,12481,,,Concentration 6e detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL625571,,12482,,,Concentration 6e detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL625572,,12483,,,Concentration 6f detected in blood of rat 1 hr after an oral dose of 200 mg/kg; ND is Not Detected,8374,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL625573,,12484,,,Concentration 6f detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,8374,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL625574,,12485,,,Concentration detected in blood of rat 1 hr after an oral dose of 200 mg/kg,8374,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL626245,,12486,,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg; ND is Not Detected,8374,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL626246,,12487,,,Concentration detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL626247,,12488,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL626248,,12489,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL626249,,12490,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL626420,,12491,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL626421,,12492,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL626422,,12493,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL626423,,12494,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL626424,,12495,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,9196,,
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626425,,12496,,,Volume of distribution in Beagles dog at a dose of 1 mg/kg given intravenously,12023,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL875476,,12497,,,Volume of distribution in CD rat at a dose of 5 mg/kg given intravenously,12023,Rattus norvegicus,10116.0
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626426,,12498,,,Volume of distribution in Cynomolgus monkey at a dose of 5 mg/kg given intravenously,12023,Macaca fascicularis,9541.0
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL626427,,12499,,,Distribution coefficient and iron(III) complex was measured at an aqueous phase buffered at pH 7.4 and octanol,10580,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL626428,,12500,,,Distribution coefficient was measured at an aqueous phase buffered at pH 7.4 and octanol,10580,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL626429,,12501,,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in bile by subcutaneous dose of 150 umol/kg,16032,,
22224,Urine,A,,,BAO_0000019,Autocuration,0,U,1088.0,1,,,,CHEMBL625025,,12502,,,Iron clearance was stimulated by the compound was expressed as % distribution of excreted Fe in urine by subcutaneous dose of 150 umol/kg,16032,,
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL625026,,12503,,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL625027,,12504,,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL874410,,12505,,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL625028,,12506,,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,8594,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL625029,,12507,,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL625030,,12508,,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL625031,,12509,,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL625032,,12510,,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL625033,,12511,,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL625034,,12512,,,Concentration was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624872,,12513,,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624873,,12514,,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624874,,12515,,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624875,,12516,,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,8594,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624876,,12517,,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624877,,12518,,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624878,,12519,,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624879,,12520,,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624880,,12521,,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624881,,12522,,,Concentration was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 10 min (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL624882,,12523,,,"Concentration was measured in heart tissue of unfasted Fischer 344 rats, administered intravenous, after 5 minute (radiolabeled with [125I]-",8594,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL624883,,12524,,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL624884,,12525,,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL624885,,12526,,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL624886,,12527,,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,8594,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL624887,,12528,,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL624888,,12529,,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL624889,,12530,,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL624890,,12531,,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL621964,,12532,,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL621965,,12533,,,Concentration was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL621966,,12534,,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL621967,,12535,,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL622164,,12536,,,Concentration was measured in liver tissue f unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL623097,,12537,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (nucleic acids),7653,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL623098,,12538,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid insoluble (protein),7653,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL623099,,12539,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; acid soluble,7653,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL623100,,12540,,,Distribution of radioactivity derived form [C14]-labeled compound taken up by 7800C1 cells; total uptake,7653,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628673,,12541,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated Number of new tumors observed",9104,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628674,,12542,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated complete percent remission indicates tumor not palpable.",9104,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628675,,12543,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated number of tumors at the beginning of the test.",9104,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627644,,12544,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated of percent static tumors indicates size of tumor 51-150% of the initial size",9104,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627645,,12545,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated partial percent remission indicates reduction of initial tumor size <=50%.",9104,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627646,,12546,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent progress in tumor size indicates >150% of the initial size",9104,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627647,,12547,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent static tumors indicates size of tumor 51-150% of the initial size",9104,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627648,,12548,,,"Effect was evaluated on the (DMBA)-induced carcinoma of the 8 Sprague-Dawley Rat, calculated percent tumor area measured as the average on the 28th day of therapy.",9104,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627649,,12549,,,Free level in rat plasma,12902,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628313,,12550,,,Level reaching in blood plasma of rat or human was determined,6614,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628314,,12551,,,Log (Cbrain/Cblood) in rats,9663,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628315,,12552,,,Mean percentage of compound transport through P-glycoprotein; expressed as p-glycoprotein affinity,17658,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628316,,12553,,,Mean percentage of compound transport through membrane; expressed as membrane transport,17658,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL628317,,12554,,,Metabolic breakdown to the o-sulfate of p-chloroaniline (2-amino-5-chlorophenyl sulfate) by giving 100 mg/kg oral doses of the compound,14314,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628473,,12555,,,Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5,7385,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628474,,12556,,,"Michaelis-Menten constant was measured in the inactivation of HPK; Km x 10 e5, ND=Not determined",7385,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628475,,12557,,,Michaelis-Menten constant was measured in the inactivation of trypsin; Km x 10 e5,7385,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628476,,12558,,,Net water uptake by a carrier mediated transport (%cm) mechanism,1329,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL628477,,12559,,,Peak concentration was determined in portal circulation after intraduodenal dose of 10 mg/kg in monkey,12187,Simiiformes,314293.0
50506,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628478,,12560,,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret,12187,Mustela putorius furo,9669.0
50506,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628479,,12561,,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in ferret, determined by renin inhibition assay",12187,Mustela putorius furo,9669.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL628480,,12562,,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey,12187,Simiiformes,314293.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL628481,,12563,,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in monkey, determined by renin inhibition assay",12187,Simiiformes,314293.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628482,,12564,,,Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat,12187,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628483,,12565,,,"Peak concentration was determined in systemic circulation after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",12187,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL628484,,12566,,,"Peak plasma concentration at a dose of 10 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",9278,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL628485,,12567,,,"Peak plasma concentration at a dose of 100 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",9278,Rattus norvegicus,10116.0
100710,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL628486,,12568,,,"Peak plasma concentration at a dose of 20 mg/kg, oral route in monkey (Macaca fascicularis) suspended in carboxymethyl cellulose (CMC);Range is between (5.5-6)",9278,Macaca fascicularis,9541.0
50587,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL628487,,12569,,,"Peak plasma concentration at a dose of 200 mg/kg, oral route in human",9278,Homo sapiens,9606.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL628488,,12570,,,"Peak plasma concentration at a dose of 25 mg/kg, ip route in rat suspended in carboxymethyl cellulose (CMC);ND is defined as no-data.",9278,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL628489,,12571,,,"Peak plasma concentration at a dose of 25 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",9278,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL628490,,12572,,,"Peak plasma concentration at a dose of 50 mg/kg, os route in rat suspended in carboxymethyl cellulose (CMC)",9278,Rattus norvegicus,10116.0
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628491,,12573,,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from portal circulation in salt-depleted cynomolgus monkeys using HPLC assay,12186,Macaca fascicularis,9541.0
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL877507,,12574,,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using HPLC assay,12186,Macaca fascicularis,9541.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL628492,,12575,,,Peak plasma drug level after intraduodenal administration at a dose 10 mg/kg from systemic circulation in salt-depleted cynomolgus monkeys using renin inhibition assay,12186,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628493,,12576,,,% metabolized in monkey S-9 after 2 hours (10 ug/mL),12041,Simiiformes,314293.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628494,,12577,,,% metabolized in monkey S-9 after 2 hours (1 ug/ml),12041,Simiiformes,314293.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628495,,12578,,,% metabolized in monkey S-9 after 2 hours (10 ug/ml),12041,Simiiformes,314293.0
50587,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628496,,12579,,,Permeability in Caco-2 assay at 10E-6,6737,Homo sapiens,9606.0
22224,Brain,A,,,BAO_0000218,Autocuration,0,U,955.0,1,,,,CHEMBL628497,,12580,,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered intravenously in brain,13758,,
22224,Brain,A,,,BAO_0000218,Autocuration,0,U,955.0,1,,,,CHEMBL628498,,12581,,,Pharmacokinetic parameter after dosing of 100 mg/kg of compound administered orally in brain,13758,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628499,,12582,,,Plasma protein binding was determined,5676,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL627656,,12583,,,Brain concentration after 2 hr at a dose of 100 mg/kg when administered perorally,14793,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL627657,,12584,,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intraperitoneally,14793,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL626808,,12585,,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered intravenously,14793,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL626809,,12586,,,Brain concentration after 2 hr at a dose of 10 mg/kg when administered perorally,14793,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL626810,,12587,,,Brain concentration after 4 hr at a dose of 100 mg/kg when administered perorally,14793,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL626811,,12588,,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intraperitoneally,14793,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL874465,,12589,,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered intravenously,14793,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL626812,,12590,,,Brain concentration after 4 hr at a dose of 10 mg/kg when administered perorally,14793,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL626813,,12591,,,Brain concentration after 6 hr at a dose of 100 mg/kg when administered perorally,14793,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL626814,,12592,,,Brain concentration after 6 hr at a dose of 10 mg/kg when administered perorally,14793,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL626815,,12593,,,Bullaticin index relates the IC50 values by normalizing to the value of bullatacin for easy comparison.,14000,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628566,,12594,,,Partition coefficient (logP),5948,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL628567,,12595,,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),13824,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL628568,,12596,,,Calculated partition coefficient (clogP),10778,,
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628569,,12597,,,C max in dog,17237,Canis lupus familiaris,9615.0
50512,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628570,,12598,,,C max in guinea pig,17237,Cavia porcellus,10141.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL628571,,12599,,,C max value was evaluated,2809,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL628572,,12600,,,Cmax value after oral dose of 0.1 mg//kg,11954,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL628573,,12601,,,Cmax value after oral dose of 0.3 mg/kg,11954,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL628574,,12602,,,Cmax value after oral dose of 1 mg/kg,11954,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL628575,,12603,,,Cmax value after oral dose of 10 mg/kg,11954,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL628576,,12604,,,Cmax value after oral dose of 23.4 mg/kg,11954,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL628577,,12605,,,Cmax value after oral dose of 3 mg/kg,11954,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL628578,,12606,,,Cmax value after oral dose of 3.87 mg/kg,11954,,
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL874466,,12607,,,Cmax value in female Beagle dogs,12768,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628579,,12608,,,Cmax value in male rats,12768,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL628580,,12609,,,Cmax value in rat plasma when administered 20 mg/kg perorally,12780,Rattus norvegicus,10116.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL628581,,12610,,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,15592,Canis lupus familiaris,9615.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL628582,,12611,,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,15592,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628583,,12612,,,Peak concentration of compound at Time = 0 was determined in dog at 5 mg/kg intravenously admn.,17025,Canis lupus familiaris,9615.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL625782,,12613,,,Peak concentration of compound at Time = 0 was determined in monkey at 5 mg/kg intravenously admn.,17025,Simiiformes,314293.0
50592,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625783,,12614,,,Peak concentration of compound at Time = 0 was determined in rabbit at 5 mg/kg intravenously admn.,17025,Oryctolagus cuniculus,9986.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625784,,12615,,,Peak concentration of compound at Time = 0 was determined in rat at 5 mg/kg intravenously admn.,17025,Rattus norvegicus,10116.0
50797,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL625785,,12616,,,Total plasma concentration at 24 hr at a dose of 10 mg/kg when administered orally to rhesus monkey,4236,Macaca mulatta,9544.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625786,,12617,,,C5min (nM) value was determined in rats after intravenous dose of 5 mg/kg,15791,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL874467,,12618,,,C6h was measured as concentration obtained after 6 hr of oral administration in air pouch exudate,11149,,
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625787,,12619,,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 )",15592,Canis lupus familiaris,9615.0
50677,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625964,,12620,,,cytotoxicity against HIV protease enzyme.,15778,Human immunodeficiency virus,12721.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625965,,12621,,,Apparent clearance in mice after intravenous administration of 105.1 mg/kg of dose,12745,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625966,,12622,,,Apparent clearance in mice after oral administration of 100 mg/kg of dose,12745,Mus musculus,10090.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL625967,,12623,,,The plasma clearance in dog.,13941,Canis lupus familiaris,9615.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL625968,,12624,,,The plasma clearance in rat.,13941,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL625969,,12625,,,Clearance from plasma in male Sprague-Dawley rats,16449,Rattus norvegicus,10116.0
100710,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL625970,,12626,,,Clearance from plasma in male cynomolgus monkeys,16449,Macaca fascicularis,9541.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL625971,,12627,,,"Clearance of compound (5 mg/kg, intravenously), in dog plasma",14224,Canis lupus familiaris,9615.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL625972,,12628,,,Clearance of compound in dog plasma,14224,Canis lupus familiaris,9615.0
50587,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL625973,,12629,,,Clearance of compound in human plasma,14224,Homo sapiens,9606.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625974,,12630,,,Clearance of compound when administered intravenously as a mixture (five-in-one dose) to a single dog.,14317,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625975,,12631,,,Clearance of compound when administered intravenously as an individual dose to a single dog.,14317,Canis lupus familiaris,9615.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL625976,,12632,,,"Clearance (10 mg/kg, intravenously) in dog plasma",14224,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625977,,12633,,,Clearance value in dog,17237,Canis lupus familiaris,9615.0
50512,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625978,,12634,,,Clearance value in guinea pig,17237,Cavia porcellus,10141.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL874468,,12635,,,Clearance values in rats after iv administration.,14187,Rattus norvegicus,10116.0
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL625421,,12636,,,Compound was tested for plasma clearance on administered orally as aqueous solutions at 1 mpk and by iv at 0.2 mpk,4806,,
50592,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625422,,12637,,,In vivo clearance (5 mg/kg) was determined in rabbits,15025,Oryctolagus cuniculus,9986.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625423,,12638,,,Plasma Clearance rate was determined for the compound in rats,13197,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625424,,12639,,,Plasma Clearance rate was determined for the compound in squirrel monkeys,13197,Saimiri,9520.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625425,,12640,,,Plasma clearance in rat,13960,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625426,,12641,,,Plasma clearance of the compound,17820,,
50512,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625427,,12642,,,Plasma clearance in guinea pigs at 2 mg/kg after iv administration,14706,Cavia porcellus,10141.0
50512,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625428,,12643,,,Plasma clearance in guinea pigs at 3 mg/kg after iv administration,14706,Cavia porcellus,10141.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625429,,12644,,,Plasma clearance was determined,6504,,
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625430,,12645,,,Plasma clearance rate (CL) was determined in dogs after intravenous administration of 25 mg/kg of the compound.,14925,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625431,,12646,,,Plasma clearance rate was determined for the compound in rats,13197,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL627307,,12647,,,Plasma clearance rate was determined for the compound in squirrel monkeys,13197,Saimiri,9520.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL627308,,12648,,,Slow clearance (CL) was determined,3437,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL627309,,12649,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 0.5 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL627310,,12650,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr; insufficient gastric juice produced,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL627311,,12651,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL627312,,12652,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.0 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL627313,,12653,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL627314,,12654,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL627315,,12655,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL627316,,12656,,,Concentration of thiocyanates in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL627317,,12657,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 0.5 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL627318,,12658,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.0 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL627999,,12659,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 1.5 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL628000,,12660,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.0 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL628001,,12661,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 2.5 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL628002,,12662,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.0 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL625610,,12663,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 3.5 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL625611,,12664,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 0.2 mg/kg intravenous dosage after 4.0 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL625612,,12665,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.0 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL625613,,12666,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 1.5 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL875479,,12667,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.0 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL625614,,12668,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 3.5 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL625615,,12669,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 4.0 hr,9196,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL626302,,12670,,,Concentration of unlabelled compound in gastric juices for the C14 radiolabeled compound was determined at 4 mg/kg intravenous dosage after 2.5 hr,9196,,
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL626303,,12671,,,Cumulative concentration 6b and compound 1 detected in blood of rat 1 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL627420,,12672,,,Cumulative concentration 6b and compound 1 detected in blood of rat 3 hr after an oral dose of 200 mg/kg of the compound,8374,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627421,,12673,,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 1 hour relative to initial concentration of 1 uM,13477,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625695,,12674,,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 24 hour relative to initial concentration of 1 uM,13477,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625696,,12675,,,Degradation of compound in incubations at 25 uM with normal rat liver microsomes after 4 hour relative to initial concentration of 1 uM,13477,Rattus norvegicus,10116.0
50594,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL875606,,12676,,,Distribution of compound in mice brain was measured after 1 hr,10009,Mus musculus,10090.0
50594,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL625697,,12677,,,Distribution of compound in mice brain was measured after 24 hr r,10009,Mus musculus,10090.0
50594,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL625698,,12678,,,Distribution of compound in mice brain was measured after 2 hr,10009,Mus musculus,10090.0
50594,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL625699,,12679,,,Distribution of compound in mice brain was measured after 3 hr,10009,Mus musculus,10090.0
50594,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL625700,,12680,,,Distribution of compound in mice brain was measured after 6 hr,10009,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625701,,12681,,,Distribution of compound in mice liver was measured after 1 hr,10009,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625702,,12682,,,Distribution of compound in mice liver was measured after 24 hr; b=Undetected,10009,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625703,,12683,,,Distribution of compound in mice liver was measured after 2 hr,10009,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625704,,12684,,,Distribution of compound in mice liver was measured after 3 hr,10009,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625705,,12685,,,Distribution of compound in mice liver was measured after 6 hr,10009,Mus musculus,10090.0
50588,Adrenal medulla,A,,,BAO_0000218,Intermediate,1,N,1236.0,1,,,,CHEMBL625706,,12686,,,Distribution in dog adrenal medulla 30 min after administration.,8170,Canis lupus familiaris,9615.0
50588,Adrenal medulla,A,,,BAO_0000218,Intermediate,1,N,1236.0,1,,,,CHEMBL625707,,12687,,,Distribution in dog adrenal medulla 72 hours after administration.,8170,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625708,,12688,,,Distribution in female dog Ovary 24 hours after administration.,8170,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625709,,12689,,,Distribution in female dog Ovary 72 hours after administration.,8170,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624180,,12690,,,Distribution in female dog adipose 24 hours after administration.,8170,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624181,,12691,,,Distribution in female dog adipose 72 hours after administration.,8170,Canis lupus familiaris,9615.0
50588,Adrenal cortex,A,,,BAO_0000218,Intermediate,1,N,1235.0,1,,,,CHEMBL624182,,12692,,,Distribution in female dog adrenal cortex 72 hours after administration.,8170,Canis lupus familiaris,9615.0
50588,Adrenal cortex,A,,,BAO_0000218,Intermediate,1,N,1235.0,1,,,,CHEMBL624183,,12693,,,Distribution in female dog adrenal cortex 72 hours after administration.,8170,Canis lupus familiaris,9615.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL624184,,12694,,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,8594,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL877489,,12695,,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL624185,,12696,,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL624186,,12697,,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL624187,,12698,,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL624188,,12699,,,Concentration was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL624189,,12700,,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL624190,,12701,,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL624191,,12702,,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL624192,,12703,,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL624193,,12704,,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,8594,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL624194,,12705,,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL624891,,12706,,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL624892,,12707,,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL624893,,12708,,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL627632,,12709,,,Concentration was measured in lungs tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627633,,12710,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627634,,12711,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627635,,12712,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627636,,12713,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626816,,12714,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,8594,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626817,,12715,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626818,,12716,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626819,,12717,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626820,,12718,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626821,,12719,,,Concentration was measured in mean heart/blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL626822,,12720,,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 10 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL626823,,12721,,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL626824,,12722,,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL626825,,12723,,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL626826,,12724,,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [123I]-,8594,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL626827,,12725,,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 4 hr (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL626828,,12726,,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL626829,,12727,,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL626830,,12728,,,Concentration was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627150,,12729,,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627151,,12730,,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627152,,12731,,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [123I]-,8594,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627153,,12732,,,Concentration was measured in tissue of unfasted Fischer 344 rats administered intravenously after 60 minute (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627154,,12733,,,Rate of acetate production by the compound was determined,12904,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627155,,12734,,,Rate of acetate production by the compound was determined; Not determined,12904,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627156,,12735,,,Rate of hydrolysis of nitrocefin by compound was evaluated in water,3730,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627157,,12736,,,Reductive elimination of leaving group was determined at pH 7.4; expressed as loss of parent,3627,,
50592,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627158,,12737,,,Relative concentration of compound (70 mg/Kg) in brain compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,13799,Oryctolagus cuniculus,9986.0
50592,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL627159,,12738,,,Relative concentration of compound (70 mg/Kg) in lung compared to concentration in plasma (160 ug/mL) at the time of tissue collection from rabbit; relative concentration,13799,Oryctolagus cuniculus,9986.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627160,,12739,,,Relative concentration of compound in brain compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,13799,Mus musculus,10090.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628540,,12740,,,Relative concentration of compound in brain compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,13799,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL628541,,12741,,,Relative concentration of compound in lung compared to concentration in plasma (0.4 ug/mL) at the time of tissue collection from mice; relative concentration,13799,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL628542,,12742,,,Relative concentration of compound in lung compared to concentration in plasma (3.5 ug/mL) at the time of tissue collection from mice; relative concentration,13799,Rattus norvegicus,10116.0
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL628543,,12743,,,Solubility after at a pH 1.2,6629,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL628544,,12744,,,Solubility after at pH 1.2,6629,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL628545,,12745,,,Solubility after injection of water,6629,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628546,,12746,,,Statistical significance of IC 50 values; Expressed as R value,14000,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL874455,,12747,,,Systemic availability with respect to methyldopa was determined,8267,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628547,,12748,,,Tissue distribution of the in rat brain relative to plasma concentration of 1 ug/kg; relative concentration,13799,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL628548,,12749,,,Tissue distribution of the in rat lung relative to plasma concentration of 1 ug/kg; relative concentration,13799,Rattus norvegicus,10116.0
50592,Feces,A,,,BAO_0000218,Intermediate,1,N,1988.0,1,,,,CHEMBL628549,,12750,,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated",7132,Oryctolagus cuniculus,9986.0
50592,Feces,A,,,BAO_0000218,Intermediate,1,N,1988.0,1,,,,CHEMBL628550,,12751,,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit 1 liver, and radioactivity content in feces was estimated",7132,Oryctolagus cuniculus,9986.0
50592,Feces,A,,,BAO_0000218,Intermediate,1,N,1988.0,1,,,,CHEMBL628551,,12752,,,"100 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit3, and radioactivity content in feces was estimated at total hours",7132,Oryctolagus cuniculus,9986.0
50592,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628552,,12753,,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit1, and radioactivity content in urine was estimated at 0-2 hr",7132,Oryctolagus cuniculus,9986.0
50592,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628553,,12754,,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-24 hr",7132,Oryctolagus cuniculus,9986.0
50592,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628554,,12755,,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 0-48 hr",7132,Oryctolagus cuniculus,9986.0
50592,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628555,,12756,,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 24-48 h",7132,Oryctolagus cuniculus,9986.0
50592,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628556,,12757,,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at 48-72 h",7132,Oryctolagus cuniculus,9986.0
50592,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL628557,,12758,,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit kidney, and radioactivity content in feces was estimated",7132,Oryctolagus cuniculus,9986.0
50592,Feces,A,,,BAO_0000218,Intermediate,1,N,1988.0,1,,,,CHEMBL628558,,12759,,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated",7132,Oryctolagus cuniculus,9986.0
50592,Feces,A,,,BAO_0000218,Intermediate,1,N,1988.0,1,,,,CHEMBL628559,,12760,,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 1 lung, and radioactivity content in feces was estimated at",7132,Oryctolagus cuniculus,9986.0
50592,Feces,A,,,BAO_0000218,Intermediate,1,N,1988.0,1,,,,CHEMBL628560,,12761,,,"100 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit1plasma, and radioactivity content in feces was estimated",7132,Oryctolagus cuniculus,9986.0
50592,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL874456,,12762,,,"100 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit3, and radioactivity content in urine was estimated at total hours",7132,Oryctolagus cuniculus,9986.0
50592,Feces,A,,,BAO_0000218,Intermediate,1,N,1988.0,1,,,,CHEMBL628561,,12763,,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at 0-48 hr",7132,Oryctolagus cuniculus,9986.0
50592,Feces,A,,,BAO_0000218,Intermediate,1,N,1988.0,1,,,,CHEMBL628562,,12764,,,"200 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit4, and radioactivity content in feces was estimated at total hours",7132,Oryctolagus cuniculus,9986.0
50592,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628563,,12765,,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit2, and radioactivity content in urine was estimated at 0-4 hr",7132,Oryctolagus cuniculus,9986.0
50592,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628564,,12766,,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at",7132,Oryctolagus cuniculus,9986.0
50592,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628565,,12767,,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 24-48 h",7132,Oryctolagus cuniculus,9986.0
50592,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631248,,12768,,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at 48-72 h",7132,Oryctolagus cuniculus,9986.0
50592,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631249,,12769,,,"200 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit4, and radioactivity content in urine was estimated at total hours",7132,Oryctolagus cuniculus,9986.0
50592,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL627214,,12770,,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 kidney, and radioactivity content in feces was estimated",7132,Oryctolagus cuniculus,9986.0
50592,Feces,A,,,BAO_0000218,Intermediate,1,N,1988.0,1,,,,CHEMBL874591,,12771,,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 liver, and radioactivity content in feces was estimated",7132,Oryctolagus cuniculus,9986.0
50592,Feces,A,,,BAO_0000218,Intermediate,1,N,1988.0,1,,,,CHEMBL627215,,12772,,,"200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 lung, and radioactivity content in feces was estimated",7132,Oryctolagus cuniculus,9986.0
50592,Feces,A,,,BAO_0000218,Intermediate,1,N,1988.0,1,,,,CHEMBL625471,,12773,,,200 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit 2 plasma and radioactivity content in feces was estimated,7132,Oryctolagus cuniculus,9986.0
50592,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625472,,12774,,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 1,7132,Oryctolagus cuniculus,9986.0
50592,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625473,,12775,,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 3 by Gas-liquid chromatographic analysis,7132,Oryctolagus cuniculus,9986.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625474,,12776,,,Tested for pharmacokinetic parameter in fasted Beagle dogs (Clearance value of the compound) iv administration.,13317,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625475,,12777,,,The clearance was measured in dog at dose 5 mg/kg after intravenous administration.,15341,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625476,,12778,,,The clearance was measured in rat at dose 12 mg/kg after intravenous administration.,15341,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625477,,12779,,,The clearance was measured in rat at dose 1 mg/kg after intravenous administration.,15341,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625478,,12780,,,The clearance was measured in rat at dose 30 mg/kg after intravenous administration.,15341,Rattus norvegicus,10116.0
50597,esophageal tunica muscularis mucosae,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vitro,CHEMBL625479,,12781,,,The compound was evaluated for clearance value in rat isolated esophageal tunica muscularis mucose,12801,Rattus norvegicus,10116.0
50597,esophageal tunica muscularis mucosae,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vitro,CHEMBL625480,,12782,,,The compound was evaluated for the value in rat isolated esophageal tunica muscularis mucose,12801,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL625481,,12783,,,The compound was tested for systemic plasma clearance(CL) in rats and is expressed in mL/min/kg.,14856,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625482,,12784,,,Total body clearance at an intravenous dose of 5.2 mg/kg in rat,14062,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625483,,12785,,,Total body clearance at an intravenous dose of 5.5 mg/kg in rat,14062,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625484,,12786,,,Total body clearance at an intravenous dose of 6.3 mg/kg in rat,14062,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625485,,12787,,,Total body clearance at an intravenous dose of 6.5 mg/kg in rat,14062,Rattus norvegicus,10116.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL625486,,12788,,,Total plasma clearance value was obtained after intravenous administration of 1.8 mg/kg of drug in male Beagle dogs,14346,Canis lupus familiaris,9615.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL625487,,12789,,,Total plasma clearance value was obtained after intravenous administration of 2.5 mg/kg of drug in male Dawley rats,14346,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL625488,,12790,,,Total plasma clearance value was obtained after intravenous administration of 2.6 mg/kg of drug in male Dawley rats,14346,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL625489,,12791,,,Total plasma clearance value was obtained after intravenous administration of 2.7 mg/kg of drug in male Dawley rats,14346,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL625490,,12792,,,Total plasma clearance value was obtained after intravenous administration of 2.8 mg/kg of drug in male Dawley rats,14346,Rattus norvegicus,10116.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL625491,,12793,,,Total plasma clearance value was obtained after intravenous administration of 4.9 mg/kg of drug in male Beagle dogs,14346,Canis lupus familiaris,9615.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL625492,,12794,,,Total plasma clearance value was obtained after intravenous administration of 5.1 mg/kg of drug in male Dawley rats,14346,Rattus norvegicus,10116.0
50587,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL625493,,12795,,,plasma clearance in human,15711,Homo sapiens,9606.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625494,,12796,,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given intravenously at dose 15 mg/kg,14886,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625495,,12797,,,Pharmacokinetic parameter (CL/F ) was evaluated in Spargue-Dawley rat when given peroral at dose 30 mg/kg,14886,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625496,,12798,,,Pharmacokinetic parameter (CL/F) was evaluated in Spargue-Dawley rat when given peroral at dose 80 mg/kg,14886,Rattus norvegicus,10116.0
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL625497,,12799,,,1-Octanol/water partition coefficient measured at 7.4,4115,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL625498,,12800,,,Calculated partition coefficient (clogP),13733,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625499,,12801,,,Partition coefficient (logP),12102,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL625500,,12802,,,Calculated partition coefficient (clogP),12676,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL625501,,12803,,,Calculated partition coefficient (clogP),13733,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL625502,,12804,,,Calculated partition coefficient (clogP),13740,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL625503,,12805,,,Calculated partition coefficient (clogP) (relative to BAY K 8644),12766,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL625504,,12806,,,Calculated partition coefficient (clogP),2764,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL625505,,12807,,,Calculated partition coefficient (clogP),12355,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL625506,,12808,,,Calculated partition coefficient of the compound,11314,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625507,,12809,,,Partition coefficient (logP),12706,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL625508,,12810,,,Calculated partition coefficient (clogP),12645,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL625509,,12811,,,Calculated partition coefficient (clogP),13668,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL625510,,12812,,,Calculated partition coefficient (clogP),12819,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL883125,,12813,,,Calculated partition coefficient (clogP),13668,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL625511,,12814,,,Calculated partition coefficient (clogP),13017,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL874650,,12815,,,Partition coefficient of the compound,2448,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625512,,12816,,,Partition coefficient of the compound,11526,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625513,,12817,,,Partition coefficient of compound was determined,12426,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625514,,12818,,,Partition coefficient was determined,2448,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL625515,,12819,,,Calculated partition coefficient (clogP),12001,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL625516,,12820,,,partition coefficient of compound was determined,12426,,
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625517,,12821,,,The total body administered intravenously in dog,13204,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625518,,12822,,,The total body administered intravenously in rats,13204,Rattus norvegicus,10116.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625519,,12823,,,Time taken for the administration to female NIH mice weighing 25-30 g.,13889,Mus musculus,10090.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625520,,12824,,,Time taken for the administration,13889,,
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL874651,,12825,,,Total clearance of compound was determined in dog at 5 mg/kg intravenously admn.,17025,Canis lupus familiaris,9615.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625521,,12826,,,Total clearance of compound was determined in monkey at 5 mg/kg intravenously admn.,17025,Simiiformes,314293.0
50592,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623171,,12827,,,Total clearance of compound was determined in rabbit at 5 mg/kg intravenously admn.,17025,Oryctolagus cuniculus,9986.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623853,,12828,,,Total clearance of compound was determined in rat at 5 mg/kg intravenously admn.,17025,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL623854,,12829,,,Plasma clearance for the compound was determined.,15067,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL874405,,12830,,,CLog P value of the compound,3091,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL623855,,12831,,,Calculated partition coefficient (clogP),15592,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL623856,,12832,,,Calculated partition coefficient (clogP),14738,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL623857,,12833,,,ClogP value of the compound; nd ='no data',14738,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL623858,,12834,,,ClogP value of the compound; nd ='not determined',14738,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL623859,,12835,,,CLog P was determined,6076,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL839829,,12836,,,Calculated partition coefficient (clogP),17840,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL623860,,12837,,,CLogP was calculated,13589,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL623861,,12838,,,CLogP value was determined,17655,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL623862,,12839,,,CLogP value was evaluated using http://esc.syrres.com/interkow/kowdemo.htm.,5867,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL874406,,12840,,,Calculated partition coefficient (clogP),5867,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL623863,,12841,,,Calculated partition coefficient (clogP),10783,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL624021,,12842,,,Calculated partition coefficient (clogP),14849,,
50588,Adrenal medulla,A,,,BAO_0000218,Intermediate,1,N,1236.0,1,,,,CHEMBL624022,,12843,,,Distribution in female dog adrenal medulla 24 hours after administration.,8170,Canis lupus familiaris,9615.0
50588,Adrenal medulla,A,,,BAO_0000218,Intermediate,1,N,1236.0,1,,,,CHEMBL624023,,12844,,,Distribution in female dog adrenal medulla 72 hours after administration.,8170,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624024,,12845,,,Distribution in female dog bile 24 hours after administration.,8170,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624025,,12846,,,Distribution in female dog bile 72 hr after administration.,8170,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624026,,12847,,,Distribution in female dog blood 24 hours after administration.,8170,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624027,,12848,,,Distribution in female dog blood 72 hours after administration.,8170,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624028,,12849,,,Distribution in female dog heart 24 hours after administration.,8170,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624029,,12850,,,Distribution in female dog heart 72 hours after administration.,8170,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624030,,12851,,,Distribution in female dog kidney 24 hours after administration.,8170,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624031,,12852,,,Distribution in female dog kidney 72 hours after administration.,8170,Canis lupus familiaris,9615.0
50588,Intestine,A,,,BAO_0000218,Intermediate,1,N,160.0,1,,,,CHEMBL624032,,12853,,,Distribution in female dog large intestine 24 hours after administration.,8170,Canis lupus familiaris,9615.0
50588,Intestine,A,,,BAO_0000218,Intermediate,1,N,160.0,1,,,,CHEMBL874407,,12854,,,Distribution in female dog large intestine 72 hours after administration.,8170,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624033,,12855,,,Distribution in female dog liver 24 hours after administration.,8170,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624034,,12856,,,Distribution in female dog liver 72 hours after administration.,8170,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624035,,12857,,,Distribution in female dog lung 24 hours after administration.,8170,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624036,,12858,,,Distribution in female dog lung 72 hours after administration.,8170,Canis lupus familiaris,9615.0
50588,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL624037,,12859,,,Distribution in female dog muscle 24 hours after administration.,8170,Canis lupus familiaris,9615.0
50588,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL624038,,12860,,,Distribution in female dog muscle 72 hours after administration.,8170,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624039,,12861,,,Distribution in female dog pancreas 24 hours after administration.,8170,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624040,,12862,,,Distribution in female dog pancreas 72 hours after administration.,8170,Canis lupus familiaris,9615.0
50588,Intestine,A,,,BAO_0000218,Intermediate,1,N,160.0,1,,,,CHEMBL624041,,12863,,,Distribution in female dog small intestine 24 hours after administration.,8170,Canis lupus familiaris,9615.0
50588,Intestine,A,,,BAO_0000218,Intermediate,1,N,160.0,1,,,,CHEMBL624042,,12864,,,Distribution in female dog small intestine 72 hours after administration.,8170,Canis lupus familiaris,9615.0
50588,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL624043,,12865,,,Distribution in female dog spleen 24 hours after administration.,8170,Canis lupus familiaris,9615.0
50588,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL624044,,12866,,,Distribution in female dog spleen 72 hours after administration.,8170,Canis lupus familiaris,9615.0
50588,Stomach,A,,,BAO_0000218,Intermediate,1,N,945.0,1,,,,CHEMBL624045,,12867,,,Distribution in female dog stomach 24 hours after administration.,8170,Canis lupus familiaris,9615.0
50588,Stomach,A,,,BAO_0000218,Intermediate,1,N,945.0,1,,,,CHEMBL624046,,12868,,,Distribution in female dog stomach 72 hours after administration.,8170,Canis lupus familiaris,9615.0
50588,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL624047,,12869,,,Distribution in female dog thyroid 24 hours after administration.,8170,Canis lupus familiaris,9615.0
50588,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL624048,,12870,,,Distribution in female dog thyroid 72 hours after administration.,8170,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL874408,,12871,,,Distribution in female dog urine 24 hours after administration.,8170,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL624049,,12872,,,Distribution in female dog urine 72 hr after administration.,8170,Canis lupus familiaris,9615.0
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,,CHEMBL624050,,12873,,,Mean plasma concentration measured 1 h following an oral dose of 30 mg/kg,14283,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL624051,,12874,,,Plasma concentration at 7 hr after intravenous dosing,5623,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623278,,12875,,,Plasma concentration of 3 mg/kg iv after 0.25 hr in rats,13477,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623279,,12876,,,Plasma concentration of 3 mg/kg iv after 0.5 hr in rats,13477,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623280,,12877,,,Plasma concentration of 3 mg/kg iv after 1 hr in rats,13477,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623963,,12878,,,Plasma concentration of 3 mg/kg iv after 2 hr in rats,13477,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623964,,12879,,,Plasma concentration of 3 mg/kg iv after 4 hr in rats,13477,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623965,,12880,,,Plasma concentration of 3 mg/kg iv after 6 hr in rats,13477,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623966,,12881,,,Plasma concentration of 3 mg/kg po after 0.083 hr in rats,13477,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL874415,,12882,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.083 h,13477,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623967,,12883,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.25 hr,13477,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623968,,12884,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 0.5 hr,13477,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623969,,12885,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 1 hr,13477,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628409,,12886,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 2 hr,13477,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628410,,12887,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 4 hr,13477,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628411,,12888,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 6 hr,13477,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628412,,12889,,,Plasma concentration after 3 mg/kg peroral dosing in rat at 8 hr,13477,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628413,,12890,,,Tested for the highest concentration at which toxicity was not observed or the concentration which provided the highest number of net grain counts,12553,,
22224,Plasma,A,,,BAO_0000019,Autocuration,0,U,1969.0,1,,,,CHEMBL628414,,12891,,,The concentration in plasmat; Not determined,14548,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628415,,12892,,,Tissue level at 10 mg/kg/po in wistar rats in blood,14393,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628416,,12893,,,Tissue level at 10 mg/kg/po in wistar rats in brown fat,14393,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628417,,12894,,,Tissue level at 10 mg/kg/po in wistar rats in heart,14393,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL874908,,12895,,,Tissue level at 10 mg/kg/po in wistar rats in liver,14393,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628418,,12896,,,Tissue level at 10 mg/kg/po in wistar rats in plasma,14393,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL628419,,12897,,,Tissue level at 10 mg/kg/po in wistar rats in skeletal muscle,14393,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628420,,12898,,,Tissue level at 10 mg/kg/po in wistar rats in subcutaneous fat,14393,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628421,,12899,,,Water solubility at 37 degree C.,1629,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL626726,,12900,,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,8194,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL626727,,12901,,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,8194,,
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL626728,,12902,,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL626729,,12903,,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL626730,,12904,,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL626731,,12905,,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL626732,,12906,,,Distribution of radioactivity was measured in blood tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL626733,,12907,,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL626734,,12908,,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL626735,,12909,,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL874909,,12910,,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,,CHEMBL626736,,12911,,,Distribution of radioactivity was measured in heart tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL626737,,12912,,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL630999,,12913,,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL631000,,12914,,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL631001,,12915,,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL631002,,12916,,,Distribution of radioactivity was measured in kidney tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL631003,,12917,,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL631004,,12918,,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL631005,,12919,,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL631006,,12920,,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL631007,,12921,,,Distribution of radioactivity was measured in liver tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL631008,,12922,,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL631009,,12923,,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL631010,,12924,,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL631011,,12925,,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,,CHEMBL631012,,12926,,,Distribution of radioactivity was measured in lung tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL630271,,12927,,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 15 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL630272,,12928,,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 2 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL630273,,12929,,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 30 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL630274,,12930,,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 5 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,,CHEMBL630275,,12931,,,Distribution of radioactivity was measured in thyroid tissue of unfasted Fischer 344 rats administered intravenously after 60 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL875782,,12932,,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 15 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630276,,12933,,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 2 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630277,,12934,,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 30 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630278,,12935,,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 5 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630279,,12936,,,Mean heart/blood tissue of unfasted Fischer 344 rats administered intravenous after 60 minutes (radiolabeled with [125I]-,8594,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630280,,12937,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg,8151,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630281,,12938,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,8151,,
50592,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630282,,12939,,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 4 by Gas-liquid chromatographic analysis,7132,Oryctolagus cuniculus,9986.0
50592,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630283,,12940,,,Percent of 3-Methyl-thiazolidin-2-ylideneamine as administered dose was reported in rabbit 2,7132,Oryctolagus cuniculus,9986.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630284,,12941,,,Alkylating activity (0.1 mM) was determined at pH 7.4; expressed as OD (540n m)/mM of drug),5797,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630285,,12942,,,Alkylating activity was determined,7849,,
22224,,A,,,BAO_0000251,Autocuration,0,U,,1,,,,CHEMBL630286,,12943,Microsomes,,Amount of metabolites in the microsomal medium after 90 min incubation of BTCP (500 uM),14220,,
50592,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630069,,12944,,,"Formation of metabolite by rabbit liver microsomal preparation in absence of NADPH, at 2 hours",8650,Oryctolagus cuniculus,9986.0
50592,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630070,,12945,,,"Formation of metabolite by rabbit liver microsomal preparation in presence of Co-O2 (90:10),at 2 hour",8650,Oryctolagus cuniculus,9986.0
50592,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630071,,12946,,,"Formation of metabolite by rabbit liver microsomal preparation in presence of N2,at 2 hour",8650,Oryctolagus cuniculus,9986.0
50592,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630072,,12947,,,"Formation of metabolite by rabbit liver microsomal preparation in presence of NADPH, at 2 hours",8650,Oryctolagus cuniculus,9986.0
50592,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL875110,,12948,,,"Formation of metabolite by rabbit liver microsomal preparation in presence of SKF525A,at 2 hour",8650,Oryctolagus cuniculus,9986.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630073,,12949,,,Compound was tested for antidiuretic activity in rats,7116,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630074,,12950,,,Compound was tested for inactivation kinetic values,14131,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL630075,,12951,,,Compound was evaluated for the average apparent volume of distribution when administered through intravenous route,7415,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630076,,12952,,,Dissociation rate calculated from the first-order equation using the t1/2 value,13178,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL630077,,12953,,,Compound was evaluated for pKa by titration of the compounds in 1:2 methyl alcohol and water,8815,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL630078,,12954,,,Aqueous solubility was measured,1450,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL630079,,12955,,,Aqueous solubility was measured at a pH 4,1450,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL630080,,12956,,,Aqueous solubility (pH 7),1450,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL630081,,12957,,,Aqueous solubility was measured at a pH 9,1450,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630082,,12958,,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents",12711,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630083,,12959,,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",12711,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630084,,12960,,,"Aqueous solubilities were determined by dissolving an crystalline hemisulfate and dichloride salts, respectively in water and adding acetate to pH 5.0, concentrations are expressed in free base equivalents.",12711,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL629198,,12961,,,Aqueous solubility of the compound,15032,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL629199,,12962,,,Aqueous solubility at 37 degree Celsius at pH 7.38,9964,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL629200,,12963,,,Aqueous solubility in pH 7.4 phosphate buffer,14962,,
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629201,,12964,,,Mean arterial pressure response following 10 mg/kg intraduodenal administration to salt depleted dog,12487,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629202,,12965,,,Mean arterial pressure response following 1 mg/kg intravenous administration to salt depleted dog,12487,Canis lupus familiaris,9615.0
50587,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL875111,,12966,,,Percentage of aspirin formed during hydrolysis in 10% human plasma at pH 7.4 at 37 degrees celsius,10026,Homo sapiens,9606.0
50587,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629203,,12967,,,Percentage of aspirin formed during hydrolysis in undiluted human plasma at pH 7.4 at 37 degrees celsius,10026,Homo sapiens,9606.0
50587,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629204,,12968,,,The percentage of aspirin formed during hydrolysis in 100% human plasma at pH 7.4 at 37 degrees celsius,10026,Homo sapiens,9606.0
50587,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629205,,12969,,,The percentage of aspirin formed during hydrolysis in 20% human plasma at pH 7.4 at 37 degrees celsius,10026,Homo sapiens,9606.0
50587,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629206,,12970,,,The percentage of aspirin formed during hydrolysis in 60% human plasma at pH 7.4 at 37 degrees celsius,10026,Homo sapiens,9606.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631185,,12971,,,The percentage of aspirin formed during hydrolysis in 80% human plasma at pH 7.4 at 37 degrees celsius,10026,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631186,,12972,,,Compound was evaluated for the average bile flow rat in rats,7415,Rattus norvegicus,10116.0
50592,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631187,,12973,,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 15 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",17025,Oryctolagus cuniculus,9986.0
50592,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631188,,12974,,,"Effect of compound on cartilage in surgically induced osteoarthritis (OA) model in rabbit at 25 mg/kg, value are relative to activity of RS-130830 (7.9+/-1.5) at 25 mg/kg",17025,Oryctolagus cuniculus,9986.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL876419,,12975,,,Average half life period was determined,10184,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631189,,12976,,,Average half life period was determined,10184,,
50602,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631190,,12977,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,8613,Human herpesvirus 1,10298.0
50602,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631191,,12978,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 0.8 mg/kg per day.,8613,Human herpesvirus 1,10298.0
50602,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631192,,12979,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day.,8613,Human herpesvirus 1,10298.0
50602,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL632400,,12980,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day.,8613,Human herpesvirus 1,10298.0
50602,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630564,,12981,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,8613,Human herpesvirus 1,10298.0
50602,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630565,,12982,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day.,8613,Human herpesvirus 1,10298.0
50602,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630566,,12983,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day.,8613,Human herpesvirus 1,10298.0
50602,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631229,,12984,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day.,8613,Human herpesvirus 1,10298.0
50602,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631230,,12985,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day.,8613,Human herpesvirus 1,10298.0
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL876428,,12986,,,Calculated partition coefficient (clogP),6030,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL631231,,12987,,,Calculated partition coefficient (clogP),6147,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL631232,,12988,,,Calculated partition coefficient (clogP) (MacLogP),14556,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631233,,12989,,,Hydrophilicity was determined,768,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL631234,,12990,,,Calculated partition coefficient (clogP),14452,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL883126,,12991,,,Increased absorption was determined,5237,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL631235,,12992,,,Lipophilicity value was evaluated,14378,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL631236,,12993,,,Log P value of the compound.,14418,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631237,,12994,,,Partition coefficient of compound was determined,5249,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL631238,,12995,,,Calculated partition coefficient (clogP),14621,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL876429,,12996,,,Calculated partition coefficient (clogP),12542,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631414,,12997,,,Partition coefficient was measured by medchem software; Not calculated,12542,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL631415,,12998,,,Partition coefficient was measured by octanol-water using standard shake-flask method,12542,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL631416,,12999,,,Calculated partition coefficient (clogP),15462,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631417,,13000,,,Partition coefficient (logP),14884,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL631418,,13001,,,Calculated partition coefficient (clogP),16526,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL631419,,13002,,,The Octanol/Water partition coefficient CLogP,13693,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631420,,13003,,,The pharmacokinetic parameter C Log p was reported,13693,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL631421,,13004,,,Calculated partition coefficient (clogP),13779,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL631422,,13005,,,Calculated partition coefficient (clogP),14772,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL631423,,13006,,,Calculated partition coefficient (clogP),14393,,
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL876430,,13007,,,Clearance rate in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,14793,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL631424,,13008,,,Clearance rate in rat plasma when administered intravenously at a dose of 10 mg/kg,14793,Rattus norvegicus,10116.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL631425,,13009,,,Compound was administered intravenously in dog to evaluate plasma clearance values,13744,Canis lupus familiaris,9615.0
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL631426,,13010,,,Compound was administered intravenously in monkey to evaluate plasma clearance values,13744,Simiiformes,314293.0
50594,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL631427,,13011,,,Compound was administered intravenously in mouse to evaluate plasma clearance values,13744,Mus musculus,10090.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL631428,,13012,,,Compound was evaluated in vivo for plasma clearance in dog after intravenous dose at 2 mg/Kg,13207,Canis lupus familiaris,9615.0
50797,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vitro,CHEMBL631429,,13013,Microsomes,,Intrinsic clearance in Rhesus liver microsome,5669,Macaca mulatta,9544.0
50588,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vitro,CHEMBL631430,,13014,Microsomes,,Intrinsic clearance in dog liver microsome,5669,Canis lupus familiaris,9615.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vitro,CHEMBL631431,,13015,Microsomes,,Intrinsic clearance in rat liver microsome,5669,Rattus norvegicus,10116.0
50797,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL631432,,13016,,,Low plasma clearance was calculated in rhesus monkey,4853,Macaca mulatta,9544.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL631433,,13017,,,Pharmacokinetic data at 0.5 mg/kg dose given to dogs intravenously.,16452,Canis lupus familiaris,9615.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL631434,,13018,,,Plasma clearance after intravenous dose of 0.3 mg/kg,11954,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL631435,,13019,,,Plasma clearance after intravenous dose of 1 mg/kg,11954,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL631436,,13020,,,Plasma clearance after intravenous dose of 3 mg/kg,11954,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL631437,,13021,,,Plasma clearance after intravenous dose of 3.87 mg/kg,11954,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL631438,,13022,,,Plasma clearance after peroral administration at 10 mpk in Rat,5669,Rattus norvegicus,10116.0
50797,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL876431,,13023,,,Plasma clearance after peroral administration at 10 mpk in Rhesus,5669,Macaca mulatta,9544.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL631439,,13024,,,Plasma clearance after peroral administration at 10 mpk in dog,5669,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL631440,,13025,,,Totla clearance of compound reported after 5 mg/kg i.v. dose in rat,13662,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631441,,13026,,,Compound was evaluated for physico-chemical property of Critical micellar concentration (CMC),8272,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631442,,13027,,,Critical Micellar concentration was determined,13410,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL626525,,13028,,,Critical Micellar concentration of the compound. was determined,13410,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627168,,13029,,,Critical micelle concentration determined from the plots of the fluorescence intensity as a function of compound concentration,12628,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL875618,,13030,,,Critical micellar concentration was measured in water by the dye solubilization method,9675,,
22224,,B,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL626612,,13031,,,Hydrolysis turn over determined from the plots of the fluorescence assay quantified by HPLC,12628,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL626613,,13032,,,CMR value (relative to BAY K 8644),12766,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL626614,,13033,,,Carbamoylating activity was determined,7849,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL626615,,13034,,,Hypotension peak is percentage change from predose baseline pressure observed after intraduodenal dose of 10 mg/kg in monkey,12187,Simiiformes,314293.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL626616,,13035,,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:10 at 0.1 to 0.2 degrees Centigrade.,2040,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL626617,,13036,,,Compound was evaluated for induced thermal stabilization for compound: DNA ratio of 1:5 at 0.1 to 0.2 degrees Centigrade.,2040,,
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626618,,13037,,,Clearance from dog plasma after intravenous injection of 1 mg/kg of compound,14180,Canis lupus familiaris,9615.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626619,,13038,,,Clearance from rat plasma after intravenous injection of 1 mg/kg of compound,14180,Rattus norvegicus,10116.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626620,,13039,,,"Clearance rate at 0.46 mg/kg, iv, in dogs",14474,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626621,,13040,,,"Clearance rate at 5.5 mg/kg, iv, in rat",14474,Rattus norvegicus,10116.0
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626622,,13041,,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 1 mg/kg concentration,14548,Macaca fascicularis,9541.0
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626623,,13042,,,Pharmacokinetic parameter Cl calculated in cynomolgus monkey when the compound was administered intravenously at 0.5 mg/kg concentration,14548,Macaca fascicularis,9541.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626624,,13043,,,Pharmacokinetic parameter Cl calculated in dog when the compound was administered intravenously at 2 mg/kg concentration,14548,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626625,,13044,,,Pharmacokinetic parameter Cl calculated in rat when the compound was administered intravenously at 5 mg/kg concentration,14548,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,Ex vivo,CHEMBL626626,,13045,,,Clearance rate constant using isolated perfused rat liver (IPRL) assay,6125,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626627,,13046,,,Tested for the total clearance of the compound,6874,,
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626628,,13047,,,The clearance was measured in dogs after intravenous administration of 1 mg/kg dose,15343,Canis lupus familiaris,9615.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626629,,13048,,,Total body clearance was determined,6236,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626630,,13049,,,Mean Chlorine excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626631,,13050,,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,11510,Rattus norvegicus,10116.0
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL626632,,13051,,,Solubility of 10 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,8194,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL626633,,13052,,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,8194,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL626634,,13053,,,Solubility of 150 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 8.0 hr,8194,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL626635,,13054,,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 13.5 hr,8194,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL626636,,13055,,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Celsius after 4.0 hr,8194,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL626637,,13056,,,Solubility of 20 mg compound in aqueous buffer at pH 7.3 and 37 degree Centigrade after 8.0 hr,8194,,
50339,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626638,,13057,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 10.9 uM/Kg/day),13273,Pneumocystis carinii,4754.0
50339,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626639,,13058,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.3 uM/Kg/day,13273,Pneumocystis carinii,4754.0
50339,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626640,,13059,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 23.3 uM/Kg/day,13273,Pneumocystis carinii,4754.0
50339,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626641,,13060,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 4.8 uM/Kg/day,13273,Pneumocystis carinii,4754.0
50339,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627272,,13061,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 9.2 uM/Kg/day,13273,Pneumocystis carinii,4754.0
50339,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627273,,13062,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted uM/Kg/day,13273,Pneumocystis carinii,4754.0
50339,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627441,,13063,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.027 (uM/kg/day),13273,Pneumocystis carinii,4754.0
50339,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628355,,13064,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 0.27 (uM/kg/day),13273,Pneumocystis carinii,4754.0
50339,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628356,,13065,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 13.3 (uM/kg/day),13273,Pneumocystis carinii,4754.0
50339,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628357,,13066,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 2.7 (uM/kg/day),13273,Pneumocystis carinii,4754.0
50339,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628358,,13067,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 22.1 (uM/kg/day),13273,Pneumocystis carinii,4754.0
50339,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622307,,13068,,,In vivo activity against pneumocystis carinii was determined as toxicity which indicates the death of animals and counted cysts in a blinding protocol in lung tissue reported as % of saline treated control at a dose of 66.3 (uM/kg/day),13273,Pneumocystis carinii,4754.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL622527,,13069,,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0,13118,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL622528,,13070,,,Conversion rate by hydrolysis of compound in plasma after 2 hr at a pH of 1.0; Not detectable,13118,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL622529,,13071,,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4,13118,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL622992,,13072,,,Conversion rate by hydrolysis of compound in plasma after 4 hr at a pH of 7.4; Not detectable,13118,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL622993,,13073,,,Conversion rate by hydrolysis of compound in plasma after 6 hr. ,13118,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL622994,,13074,,,Conversion rate by hydrolysis of compound in plasma after 6 h; Not detectable,13118,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622995,,13075,,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in rat liver homogenate",10633,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622996,,13076,,,"In vitro rate constant, correlation coefficient for the conversion to progesterone in whole rat blood.",10633,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622997,,13077,,,"In vitro rate constant, correlation coefficient for the disappearance in rat liver homogenate",10633,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622998,,13078,,,"In vitro rate constant, correlation coefficient for the disappearance in rat brain homogenate",10633,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL622999,,13079,,,Cp max following ip administration at 1 mg/kg,5767,,
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL623000,,13080,,,Maximum concentration in plasma was reported at 0.5 hour,3302,,
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL623001,,13081,,,Maximum concentration in plasma was reported at 2 hour,3302,,
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623002,,13082,,,Cellular uptake kinetics of Porphycenes saturation cell level (cs) in SSK3 murine fibrosarcoma cells,12467,Mus musculus,10090.0
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL623003,,13083,,,Aqueous solubility in 25 mM N-glycyl-glycine and 10 mM MgSO4 (pH 7.8),11778,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL623004,,13084,,,Steady state concentration was evaluated,4321,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL623005,,13085,,,Partition coefficient (logP),14884,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL623006,,13086,,,Partition coefficient (logD7.4),15234,,
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL623007,,13087,,,Biodistribution of {18]Fluoro-CGP 12388 (60 minutes post injection) in liver of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL623008,,13088,,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in bone of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Cerebellum,A,,,BAO_0000218,Intermediate,1,N,2037.0,1,,,In vivo,CHEMBL876654,,13089,,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cerebellum of male wistar rats,14198,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623009,,13090,,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in cortex of male wistar rats,14198,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623010,,13091,,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in fat of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL623011,,13092,,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in heart of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Intestine,A,,,BAO_0000218,Intermediate,1,N,160.0,1,,,In vivo,CHEMBL623012,,13093,,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in intestine of male wistar rats,14198,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL623013,,13094,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,8151,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL623014,,13095,,,Antidiuretic activity was determined expressed as Na+(sodium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,8151,,
22224,Urine,A,,,BAO_0000019,Autocuration,0,U,1088.0,1,,,,CHEMBL623015,,13096,,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 10 mg/Kg,8151,,
22224,Urine,A,,,BAO_0000019,Autocuration,0,U,1088.0,1,,,,CHEMBL623016,,13097,,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 100 mg/Kg,8151,,
22224,Urine,A,,,BAO_0000019,Autocuration,0,U,1088.0,1,,,,CHEMBL624858,,13098,,,Antidiuretic activity was determined expressed as volume of urine excreted in mL was reported at a dose of 25 mg/Kg,8151,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624859,,13099,,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 10 mg/Kg.,8151,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624860,,13100,,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg,8151,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624861,,13101,,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,8151,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624862,,13102,,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg,8151,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624863,,13103,,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli equivalents was reported for a duration of 5 hours after administration of a dose of 25 mg/Kg.,8151,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL876655,,13104,,,Antidiuretic activity was determined in SH rats expressed as K(+) (potassium) excreted in milli euivalents was reported for a duration of 5 hours after administration of a dose of 100 mg/Kg.,8151,Rattus norvegicus,10116.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624864,,13105,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624865,,13106,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624866,,13107,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,6996,Canis lupus familiaris,9615.0
50588,,F,,,BAO_0000218,Expert,1,N,,1,,,,CHEMBL624867,,13108,,,Salidiuretic activity in dog following i.v. dosing at 5 mg/kg,6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624868,,13109,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628450,,13110,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600- 799,6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628451,,13111,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628452,,13112,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628453,,13113,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628454,,13114,,,Compound administered intravenously at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; act above 5 mg/kg,6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628455,,13115,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog,6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628456,,13116,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 0-99,6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628457,,13117,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-249,6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL877505,,13118,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 100-299,6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628458,,13119,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 250-399,6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628459,,13120,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 400-599,6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628460,,13121,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 600-799,6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628461,,13122,,,Compound administered intravenously was evaluated for salidiuretic activity measured as sodium ion excretion in Dog; Value ranges from 800-899,6996,Canis lupus familiaris,9615.0
22224,,B,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL628462,,13123,,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 16.5 mg/kg",6996,,
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628463,,13124,,,Compound administered orally at a dose of 1 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,6996,Canis lupus familiaris,9615.0
50597,,F,,,BAO_0000218,Expert,1,N,,1,,,,CHEMBL625666,,13125,,,"Evaluated for salidiuretic activity measured as sodium ion excretion in Rat, administered orally at a dose of 50 mg/kg",6996,Rattus norvegicus,10116.0
22224,,B,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL625667,,13126,,,Compound administered orally at a dose of 5 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,6996,,
50597,,A,,,BAO_0000218,Expert,1,N,,1,,,,CHEMBL625668,,13127,,,Compound administered orally at a dose of 81 mg/kg was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625669,,13128,,,Compound administered orally was evaluated for salidiuretic activity measured as sodium ion excretion in Rat,6996,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625670,,13129,,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry,7114,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625671,,13130,,,Compound was tested for diuretic activity in potassium content of the 3-h sample was measured by flame photometry in rat,7114,Rattus norvegicus,10116.0
50602,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625672,,13131,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day.,8613,Human herpesvirus 1,10298.0
50602,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625673,,13132,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously,8613,Human herpesvirus 1,10298.0
50602,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625674,,13133,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 0.8 mg/kg administered subcutaneously.,8613,Human herpesvirus 1,10298.0
50602,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625675,,13134,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously,8613,Human herpesvirus 1,10298.0
50602,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627637,,13135,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,8613,Human herpesvirus 1,10298.0
50602,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627638,,13136,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered orally.,8613,Human herpesvirus 1,10298.0
50602,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627639,,13137,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously,8613,Human herpesvirus 1,10298.0
50602,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627640,,13138,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered subcutaneously.,8613,Human herpesvirus 1,10298.0
50602,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627641,,13139,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 3.1 mg/kg administered orally.,8613,Human herpesvirus 1,10298.0
50602,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627642,,13140,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,8613,Human herpesvirus 1,10298.0
50602,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL877506,,13141,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 50 mg/kg administered orally.,8613,Human herpesvirus 1,10298.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627275,,13142,,,Efficacy was evaluated against Systemic HSV-1 infection in mice at a daily dose of 12.5 mg/kg administered subcutaneously.,8613,Mus musculus,10090.0
50506,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627643,,13143,,,"Average area under curve value dosed at 0.3 mg/kg, iv in ferrets.",11219,Mustela putorius furo,9669.0
50506,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631246,,13144,,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",11219,Mustela putorius furo,9669.0
50506,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631247,,13145,,,"Average area under curve value dosed at 10 mg/kg, id in ferrets.",11219,Mustela putorius furo,9669.0
50506,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629532,,13146,,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,11219,Mustela putorius furo,9669.0
50506,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629533,,13147,,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from arterial blood).,11219,Mustela putorius furo,9669.0
50506,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629534,,13148,,,Average peak plasma drug concentration after id dose of 10 mg/kg in ferrets(Plasma samples collected from portal blood).,11219,Mustela putorius furo,9669.0
50506,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629535,,13149,,,Average peak plasma drug concentration after iv dose of 0.3 mg/kg in ferrets.,11219,Mustela putorius furo,9669.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625932,,13150,,,Pharmacokinetic parameter :drug bound to plasma was reported,14837,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625933,,13151,,,compound was evaluated for drug bound in plasma,14837,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625934,,13152,,,The Brain concentration compared to plasma concentration in rats after oral administration of 1 mg/kg dose,15343,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL625935,,13153,,,Bioavailability,13761,Eutheria,9347.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625936,,13154,,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported,14810,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625937,,13155,,,Compound at a dose of 10 mg/kg was orally administered to rats and Bioavailability was reported; Not tested,14810,Rattus norvegicus,10116.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625938,,13156,,,Oral bioavailability in Beagle dogs at oral dose of 20 mg/kg and an intravenous dose of 5 mg/kg was administered,13249,Canis lupus familiaris,9615.0
50597,Bile,A,,,BAO_0000218,Intermediate,1,N,1970.0,1,,,,CHEMBL625939,,13157,,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-1 hr after the treatment.,9267,Rattus norvegicus,10116.0
50597,Bile,A,,,BAO_0000218,Intermediate,1,N,1970.0,1,,,,CHEMBL625940,,13158,,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-2 hr after the treatment.,9267,Rattus norvegicus,10116.0
50597,Bile,A,,,BAO_0000218,Intermediate,1,N,1970.0,1,,,,CHEMBL874464,,13159,,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-3 hr after the treatment.,9267,Rattus norvegicus,10116.0
50597,Bile,A,,,BAO_0000218,Intermediate,1,N,1970.0,1,,,,CHEMBL625941,,13160,,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-4 hr after the treatment.,9267,Rattus norvegicus,10116.0
50597,Bile,A,,,BAO_0000218,Intermediate,1,N,1970.0,1,,,,CHEMBL625942,,13161,,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-5 hr after the treatment.,9267,Rattus norvegicus,10116.0
50597,Bile,A,,,BAO_0000218,Intermediate,1,N,1970.0,1,,,,CHEMBL625943,,13162,,,Percent biliary excretion property by administering intravenously to rats was reported as amount of unchanged form of compound detected in bile samples collected at 0-6 hr after the treatment.,9267,Rattus norvegicus,10116.0
50587,Serum,A,,,BAO_0000218,Intermediate,1,N,1977.0,1,,,,CHEMBL625944,,13163,,,In vitro protein binding in human serum at 5 ug/ml,15549,Homo sapiens,9606.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625945,,13164,,,Serum protein binding ability was measured,10929,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625946,,13165,,,The ability binding to plasma (Binding classified based on injection of compound at 80 concentration.),15444,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625947,,13166,,,Oral bioavailability in dog,12860,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625948,,13167,,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,12170,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625949,,13168,,,Absolute oral bioavailability at an iv dose of 14 mg/kg,15173,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625950,,13169,,,Absolute oral bioavailability at an iv dose of 15.2 mg/kg,15173,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625951,,13170,,,Oral bioavailability (dose 15 mg/kg i.v.),15173,Eutheria,9347.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625952,,13171,,,Absolute oral bioavailability at an peroral dose of 15 mg/kg orally.,15173,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625953,,13172,,,Absolute oral bioavailability at an peroral dose of 30 mg/kg orally,15173,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625954,,13173,,,Absolute oral bioavailability at an peroral dose of 30.2 mg/kg orally.,15173,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL882959,,13174,,,Absolute oral bioavailability at an peroral dose of 30.3 mg/kg orally.,15173,,
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625955,,13175,,,Apparent bioavailability in dogs at 15 mg/kg in an iv vs po dosing regimen,11767,Canis lupus familiaris,9615.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625956,,13176,,,Bioavailability in ferret,11219,Mustela putorius furo,9669.0
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625957,,13177,,,Bioavailability after intraduodenal administration at a dose 10 mg/kg in cynomolgus monkeys using renin inhibition assay,12186,Macaca fascicularis,9541.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625958,,13178,,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625959,,13179,,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626642,,13180,,,Mean Chlorine excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631330,,13181,,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631331,,13182,,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631332,,13183,,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631333,,13184,,,Mean Chlorine excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL632018,,13185,,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL632019,,13186,,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL632020,,13187,,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL632021,,13188,,,Mean Chlorine excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL632022,,13189,,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL632023,,13190,,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL632024,,13191,,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL874472,,13192,,,Mean Chlorine excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL632025,,13193,,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL632026,,13194,,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL632027,,13195,,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL632028,,13196,,,Mean Chlorine excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626430,,13197,,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626431,,13198,,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626432,,13199,,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626433,,13200,,,Mean Chlorine excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626434,,13201,,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627280,,13202,,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627281,,13203,,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627282,,13204,,,Mean Chlorine excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,11510,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627283,,13205,,,Total body clearance was measured at given dose,7199,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,,CHEMBL627284,,13206,,,Total body clearance was measured at given dose.,7199,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627285,,13207,,,Metabolic clearance from the body in rat,7095,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL627286,,13208,,,Renal clearance from the body,7095,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL875477,,13209,,,Renal clearance from the body in rat,7095,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627287,,13210,,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 12 mg/kg in rat,12528,Rattus norvegicus,10116.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627288,,13211,,,Tested for pharmacokinetic parameter to calculate the total body clearance at a dosage of 2.5 mg/kg in dog,12528,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627289,,13212,,,Total clearance from the body in rat,7095,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL627290,,13213,,,Clearance into cortex from rat plasma or PBS,14223,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL627291,,13214,,,Clearance at an iv dose of 15 mg/Kg and po dose of 120 mg/Kg,13569,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL627292,,13215,,,Clearance at an iv dose of 15 mg/Kg and po dose of 240 mg/Kg,13569,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL627293,,13216,,,Clearance at an iv dose of 15 mg/Kg and po dose of 29.1 mg/Kg,13569,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL627294,,13217,,,Clearance at an iv dose of 15 mg/Kg and po dose of 30 mg/Kg,13569,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL875478,,13218,,,Clearance at an iv dose of 15 mg/Kg and po dose of 60 mg/Kg,13569,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL627295,,13219,,,Clearance was determined,13979,,
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627296,,13220,,,Clearance was measured in mouse after administration of compound 20 mg/kg intravenously,14315,Mus musculus,10090.0
50592,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626119,,13221,,,Clearance was measured in rabbit after administration of compound 20 mg/kg intravenously,14315,Oryctolagus cuniculus,9986.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626120,,13222,,,Clearance was measured in rat after administration of compound 20 mg/kg intravenously,14315,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626121,,13223,,,Clearance in rat after iv dose (100 ug/kg),12174,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626122,,13224,,,Clearance in guinea pig,12797,Cavia porcellus,10141.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626123,,13225,,,Compound was evaluated for clearance in rat,12797,Rattus norvegicus,10116.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623456,,13226,,,Compound was evaluated for the clearance in dog,12797,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623457,,13227,,,Compound was evaluated for the clearance in rat,12797,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623458,,13228,,,Compound was tested in vivo for clearance after iv administration in the rat,11500,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL623459,,13229,,,IV clearance determined at an iv dose of 14 mg/kg,15173,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL875484,,13230,,,IV clearance determined at an iv dose of 15.2 mg/kg,15173,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL623460,,13231,,,IV clearance determined at an iv dose of 15 mg/kg,15173,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL623461,,13232,,,IV clearance determined at an peroral dose of 30 mg/kg.,15173,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL623462,,13233,,,IV clearance determined at an peroral dose of 30.2 mg/kg.,15173,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL627386,,13234,,,IV clearance determined at an peroral dose of 30.3 mg/kg.,15173,,
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL627387,,13235,,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in kidney of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL627388,,13236,,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in liver of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL627389,,13237,,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in lung of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL627390,,13238,,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in muscle of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL627391,,13239,,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in plasma of male wistar rats,14198,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627392,,13240,,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in red blood cells of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL627393,,13241,,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in spleen of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Trachea,A,,,BAO_0000218,Intermediate,1,N,3126.0,1,,,In vivo,CHEMBL627394,,13242,,,Biodistribution of [11C]-CGP- 12388 (10 minutes post injection) in trachea of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL627395,,13243,,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in bone of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Cerebellum,A,,,BAO_0000218,Intermediate,1,N,2037.0,1,,,In vivo,CHEMBL875485,,13244,,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cerebellum of male wistar rats,14198,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627396,,13245,,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in cortex of male wistar rats,14198,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627397,,13246,,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in fat of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL627398,,13247,,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in heart of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL627399,,13248,,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in intestine bone of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL627400,,13249,,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in kidney of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL627401,,13250,,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in liver of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL627402,,13251,,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in lung of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL627403,,13252,,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in muscle of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL627404,,13253,,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in plasma of male wistar rats,14198,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623101,,13254,,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in red blood cells of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL877480,,13255,,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in spleen of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Trachea,A,,,BAO_0000218,Intermediate,1,N,3126.0,1,,,In vivo,CHEMBL623102,,13256,,,Biodistribution of [11C]-CGP- 12388 (60 minutes post injection) in trachea of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL623103,,13257,,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in bone of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Cerebellum,A,,,BAO_0000218,Intermediate,1,N,2037.0,1,,,In vivo,CHEMBL623104,,13258,,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cerebellum of male wistar rats,14198,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623105,,13259,,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in cortex of male wistar rats,14198,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623106,,13260,,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in fat of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL623107,,13261,,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in heart of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Intestine,A,,,BAO_0000218,Intermediate,1,N,160.0,1,,,In vivo,CHEMBL623108,,13262,,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in intestine of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL623109,,13263,,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in kidney of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL623110,,13264,,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in liver of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL623111,,13265,,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in lung of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL625060,,13266,,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in muscle of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL625061,,13267,,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in plasma of male wistar rats,14198,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625062,,13268,,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in red blood cells of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL625063,,13269,,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in spleen of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Trachea,A,,,BAO_0000218,Intermediate,1,N,3126.0,1,,,In vivo,CHEMBL625064,,13270,,,Biodistribution of [18]Fluoro-CGP 12388 (10 minutes post injection) in trachea of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL625065,,13271,,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in bone of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Cerebellum,A,,,BAO_0000218,Intermediate,1,N,2037.0,1,,,In vivo,CHEMBL625066,,13272,,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cerebellum of male wistar rats,14198,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625067,,13273,,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in cortex of male wistar rats,14198,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625068,,13274,,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in fat of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL622159,,13275,,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in heart of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Intestine,A,,,BAO_0000218,Intermediate,1,N,160.0,1,,,In vivo,CHEMBL622160,,13276,,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in intestine of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL622161,,13277,,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in kidney of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL622162,,13278,,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in lung of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL622163,,13279,,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in muscle of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622313,,13280,,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in plasma of male wistar rats,14198,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622314,,13281,,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in red blood cells of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL622315,,13282,,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in spleen of male wistar rats,14198,Rattus norvegicus,10116.0
50597,Trachea,A,,,BAO_0000218,Intermediate,1,N,3126.0,1,,,In vivo,CHEMBL622316,,13283,,,Biodistribution of [18]Fluoro-CGP 12388 (60 minutes post injection) in trachea of male wistar rats,14198,Rattus norvegicus,10116.0
50212,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL877486,,13284,,,Normal diffusion coefficient in water for Escherichia coli,15599,Escherichia coli,562.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL622317,,13285,,,Average max percent decrease in RVR (renal vascular resistance) was determined,8204,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL622318,,13286,,,Average max percent decrease in RVR (renal vascular resistance) was determined.,8204,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL622319,,13287,,,In vitro stability to pepsin promoting hydrolysis after 1 hr incubation time,6154,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL622320,,13288,,,In vitro stability to pepsin promoting hydrolysis after 2 hr incubation time,6154,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL622321,,13289,,,In vitro stability to pepsin promoting hydrolysis after 64h incubation time,6154,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL622322,,13290,,,In vitro stability to pepsin promoting hydrolysis after 84 hr incubation time,6154,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL622323,,13291,,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry,7114,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL622324,,13292,,,Compound was tested for diuretic activity in sodium content of the 3-h sample was measured by flame photometry in rat,7114,Rattus norvegicus,10116.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622325,,13293,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",8133,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622326,,13294,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",8133,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL877487,,13295,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 10.0 mg/kg, po",8133,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622327,,13296,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",8133,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622328,,13297,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3.0 mg/kg, po",8133,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622329,,13298,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",8133,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622330,,13299,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",8133,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622331,,13300,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 0.3mg/kg, po",8133,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622332,,13301,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",8133,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622333,,13302,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded dogs at 3 mg/kg, po",8133,Canis lupus familiaris,9615.0
22224,Urine,A,,,BAO_0000218,Autocuration,0,U,1088.0,1,,,,CHEMBL627658,,13303,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",8133,Simiiformes,314293.0
22224,Urine,A,,,BAO_0000218,Autocuration,0,U,1088.0,1,,,,CHEMBL630428,,13304,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 10mg/kg, po",8133,Simiiformes,314293.0
22224,Urine,A,,,BAO_0000218,Autocuration,0,U,1088.0,1,,,,CHEMBL630429,,13305,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",8133,Simiiformes,314293.0
22224,Urine,A,,,BAO_0000218,Autocuration,0,U,1088.0,1,,,,CHEMBL630430,,13306,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 30 mg/kg, po",8133,Simiiformes,314293.0
22224,Urine,A,,,BAO_0000218,Autocuration,0,U,1088.0,1,,,,CHEMBL630431,,13307,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded monkey at 3 mg/kg, po",8133,Simiiformes,314293.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL630432,,13308,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",8133,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL630433,,13309,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",8133,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL630434,,13310,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",8133,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL629372,,13311,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",8133,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL629553,,13312,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 100.0mg/kg, po",8133,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL629554,,13313,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",8133,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL874447,,13314,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",8133,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL629555,,13315,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",8133,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL629556,,13316,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",8133,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL629557,,13317,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 h in urine of normotensive saline loaded rats at 30.0 mg/kg, po",8133,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL629558,,13318,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",8133,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL629559,,13319,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",8133,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL629560,,13320,,,"Diuretic activity was evaluated by measuring amount of Cl- during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",8133,Rattus norvegicus,10116.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL629561,,13321,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.03mg/kg, po",8133,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL629562,,13322,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",8133,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL629563,,13323,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.3mg/kg, po",8133,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL629564,,13324,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",8133,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL629565,,13325,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10.0mg/kg, po",8133,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL629566,,13326,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",8133,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL629567,,13327,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded dogs at 1 mg/kg, po",8133,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL629568,,13328,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",8133,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL629569,,13329,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 30mg/kg, po",8133,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL629570,,13330,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",8133,Canis lupus familiaris,9615.0
22224,Urine,A,,,BAO_0000218,Autocuration,0,U,1088.0,1,,,,CHEMBL629571,,13331,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",8133,Simiiformes,314293.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL629572,,13332,,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,12170,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL629573,,13333,,,% bioavailability in rat after oral dose (10 mg/kg) 0 - 6 h.,12170,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL629574,,13334,,,Bioavailability (dose 20 mg/kg),4985,Eutheria,9347.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL629575,,13335,,,Bioavailability in dog,15145,Canis lupus familiaris,9615.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL874448,,13336,,,Bioavailability in rat (Sprague-Dawley) (male),14080,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL629576,,13337,,,Bioavailability in monkey (dose 10 mg/kg i.d.),11219,Primates,9443.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL629577,,13338,,,Bioavailability in rat,15145,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL629578,,13339,,,Bioavailability in rat,15145,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL629579,,13340,,,Bioavailability in dog (dose 3.0 mg/kg p.o.),1202,Canis lupus familiaris,9615.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL882958,,13341,,,Bioavailability in dog (dose of 1.0 mg/kg i.v.) 0.5 hr,1202,Canis lupus familiaris,9615.0
50505,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL629580,,13342,,,Bioavailability was calculated after peroral dose of 10 mg/Kg in chimp,1202,Pan troglodytes,9598.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL629581,,13343,,,Bioavailability,4026,Eutheria,9347.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL629582,,13344,,,Bioavailability in squirrel monkey,1492,Saimiri,9520.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628522,,13345,,,Bioavailability was evaluated in dog,12793,Canis lupus familiaris,9615.0
100712,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625432,,13346,,,Bioavailability was evaluated in hamster,12793,Cricetinae,10026.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625433,,13347,,,Bioavailability in rat,12793,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL625434,,13348,,,Bioavailability was evaluated in rat plasma when administered intraperitoneally at a dose of 10 mg/kg,14793,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL625435,,13349,,,Bioavailability was evaluated in rat plasma when administered intravenously at a dose of 10 mg/kg; <Tr>,14793,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625436,,13350,,,Bioavailability in rat (dose 10 mg/kg p.o.),14793,Rattus norvegicus,10116.0
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL874588,,13351,,,Bioavailability was measured in cynomolgus monkeys.,14731,Macaca fascicularis,9541.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625437,,13352,,,Bioavailability was measured in nude mice.,14731,Mus musculus,10090.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625438,,13353,,,Bioavailability in ferret (dose 10 mg/kg i.d.),12187,Mustela putorius furo,9669.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625439,,13354,,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose),12187,Simiiformes,314293.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625440,,13355,,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 0.3 mg/kg intravenous dose), determined by renin inhibition assay",12187,Simiiformes,314293.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625441,,13356,,,Bioavailability was determined after intraduodenal dose of 10 mg/kg in monkey (compared to 1 mg/kg intravenous dose),12187,Simiiformes,314293.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625442,,13357,,,Bioavailability in rat (dose 10 mg/kg i.d.),12187,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625443,,13358,,,"Bioavailability was determined after intraduodenal dose of 10 mg/kg in rat, determined by renin inhibition assay",12187,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625444,,13359,,,Bioavailability was determined; extremely poor,17431,,
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625445,,13360,,,% bioavailability in mice after oral administration of prodrug,13318,Mus musculus,10090.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625446,,13361,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose 10/30 range (low/high); -21/-5,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL882960,,13362,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -2/6,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625447,,13363,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -4/-14,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625448,,13364,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3 range (low/high); -5/-12,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625449,,13365,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 1/3/10 range (low/high); -1/-7/-11,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL874589,,13366,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high),9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625450,,13367,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -1/-9,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625451,,13368,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -11/-28,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626584,,13369,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/-29,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626585,,13370,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -13/30,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626586,,13371,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-18,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626587,,13372,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -16/-35,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626588,,13373,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -19/-50,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626589,,13374,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -21/-29,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626590,,13375,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -24/-56,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626591,,13376,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -25/-33,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627181,,13377,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -3/-13,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628083,,13378,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -5/-47,9025,Canis lupus familiaris,9615.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL628084,,13379,,,IV clearance determined at an peroral dose of 15 mg/kg.,15173,,
50064,,F,,,BAO_0000218,Expert,1,N,,1,,,In vivo,CHEMBL628085,,13380,,,Mouse oral clearance was measured against Hymenolepiasis nana.,7732,Hymenolepis nana,102285.0
50545,,F,,,BAO_0000218,Expert,1,N,,1,,,In vivo,CHEMBL628086,,13381,,,Mouse oral clearance was measured against Nematospiroides dubius,7732,Heligmosomoides polygyrus,6339.0
22224,,F,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL628087,,13382,,,Mouse oral clearance was measured against N. dubius; NT is Not Tested,7732,,
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628088,,13383,,,Mouse oral clearance was measured against N. nana; NT is Not Tested,7732,Mus musculus,10090.0
22224,,B,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL628089,,13384,,,Mouse oral clearance was measured against N. nana; NT is Not Tested,7732,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL628090,,13385,,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 10 J/cm e2 ultraviolet-A radiation,8328,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL628091,,13386,,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 6 J/cm e2 ultraviolet-A radiation,8328,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL628092,,13387,,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 8 J/cm e2 ultraviolet-A radiation,8328,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL628093,,13388,,,Percentage of clearance of psoriatic lesions by 8-methoxypsoralen (8-MOP) for comparison at dose of 9 J/cm e2 ultraviolet-A radiation,8328,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL875607,,13389,,,Percentage of clearance of psoriatic lesions by the compound at dose of 10 J/cm e2 ultraviolet-A radiation,8328,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625710,,13390,,,Percentage of clearance of psoriatic lesions by the compound at dose of 4 J/cm e2 ultraviolet-A radiation,8328,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625711,,13391,,,Percentage of clearance of psoriatic lesions by the compound at dose of 6 J/cm e2 ultraviolet-A radiation,8328,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625712,,13392,,,Percentage of clearance of psoriatic lesions by the compound at dose of 8 J/cm e2 ultraviolet-A radiation,8328,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625713,,13393,,,Percentage of clearance of psoriatic lesions by the compound at dose of 9 J/cm e2 ultraviolet-A radiation,8328,,
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625714,,13394,,,Pharmacokinetic parameter clearance was determined in fed Beagle dogs after iv administration of 1.5 mg/kg,13376,Canis lupus familiaris,9615.0
50797,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625715,,13395,,,Plasma clearance after intravenous administration dosing (30 mg/kg) in Rhesus monkey,13477,Macaca mulatta,9544.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625716,,13396,,,Plasma clearance after intravenous administration dosing (30 mg/kg) in rat,13477,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625717,,13397,,,Plasma clearance after intravenous administration iv dosing of 3 mg/kg in rat,13477,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625718,,13398,,,Plasma clearance was determined for the compound in rats,13313,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625719,,13399,,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 1,12504,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625720,,13400,,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 2,12504,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625721,,13401,,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 3,12504,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625722,,13402,,,Tested for total body clearance (CL) after intravenous bolus administration of 100 mg/kg in rat 4,12504,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625723,,13403,,,The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat.,13129,Rattus norvegicus,10116.0
50545,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625724,,13404,,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.0125 concentration of diet.,7732,Heligmosomoides polygyrus,6339.0
50545,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625725,,13405,,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.025 concentration of diet.,7732,Heligmosomoides polygyrus,6339.0
50545,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625726,,13406,,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.05 concentration of diet.,7732,Heligmosomoides polygyrus,6339.0
50545,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL875608,,13407,,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.1 concentration of diet.,7732,Heligmosomoides polygyrus,6339.0
50545,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625727,,13408,,,Titration of anthelmintic activity against Nematospiroides dubius in mice at 0.2 concentration of diet.,7732,Heligmosomoides polygyrus,6339.0
22224,Urine,A,,,BAO_0000218,Autocuration,0,U,1088.0,1,,,In vivo,CHEMBL625728,,13409,,,Urinary clearance was determined in rat at 100 mg/kg os dosage;ND is defined as no-data.,9278,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625729,,13410,,,Total clearance was determined in rat at 10 mg/kg intraperitoneal dosage,9278,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL625730,,13411,,,Total clearance was determined in rat at 25 mg/kg os dosage;ND is defined as no-data.,9278,Rattus norvegicus,10116.0
22224,Urine,A,,,BAO_0000218,Autocuration,0,U,1088.0,1,,,In vivo,CHEMBL625731,,13412,,,Urinary clearance was determined in rat at 10 mg/kg intraperitoneal dosage,9278,Rattus norvegicus,10116.0
22224,Urine,A,,,BAO_0000218,Autocuration,0,U,1088.0,1,,,In vivo,CHEMBL626417,,13413,,,Urinary clearance was determined in rat at 25 mg/kg os dosage,9278,Rattus norvegicus,10116.0
50587,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,In vivo,CHEMBL626418,,13414,,,Urinary clearance was determined at 100 mg/kg oral dosage in human,9278,Homo sapiens,9606.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,In vivo,CHEMBL626419,,13415,,,Urinary clearance was determined at 20 mg/kg oral dosage in dog(beagle);ND is defined as no-data.,9278,Canis lupus familiaris,9615.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626592,,13416,,,Plasma concentration in dogs after 2 hr at 30mg/kg oral dose,5932,Canis lupus familiaris,9615.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626593,,13417,,,Plasma concentration in rats after 7 hr at 30mg/kg oral dose,5932,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626594,,13418,,,Clearance was determined by administering the compound intravenously at a dose of 1 mg/kg in male wistar rat,5182,Rattus norvegicus,10116.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625035,,13419,,,Clearance rate in dogs,10499,Canis lupus familiaris,9615.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,In vitro,CHEMBL625036,,13420,,,Compound was measured for intrinsic clearance,6051,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL625037,,13421,,,Calculated partition coefficient (clogP),17508,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL625038,,13422,,,Calculated partition coefficient (clogP),6228,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL625039,,13423,,,Calculated partition coefficient (clogP),6231,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL625040,,13424,,,Calculated partition coefficient (clogP),17740,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL625041,,13425,,,Calculated partition coefficient (clogP),6495,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL625042,,13426,,,Calculated partition coefficient (clogP),2171,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL874411,,13427,,,Partition coefficient of the compound,3255,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625043,,13428,,,Permeability,6821,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL625044,,13429,,,Calculated partition coefficient (clogP),2685,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625045,,13430,,,Partition coefficient (logD),17584,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL625046,,13431,,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),13824,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL625047,,13432,,,Calculated partition coefficient (clogP) (CLOGP3 V3.4),13824,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL625048,,13433,,,Calculated partition coefficient (clogP),16479,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL625049,,13434,,,Calculated partition coefficient (clogP),11997,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL625050,,13435,,,Calculated logarithm of partition coefficient (P) was determined,2988,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL625051,,13436,,,Calculated partition coefficient (clogP),931,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL874412,,13437,,,Calculated partition coefficient (clogP),4381,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL625052,,13438,,,Calculated partition coefficient (clogP),4397,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL625053,,13439,,,Calculated partition coefficient (clogP),5889,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL623250,,13440,,,In vitro stability to pepsin promoting hydrolysis after 8 hr incubation time,6154,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL623251,,13441,,,In vitro stability to trypsin promoting hydrolysis after 1 hr incubation time,6154,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL623252,,13442,,,In vitro stability to trypsin promoting hydrolysis after 2 hr incubation time,6154,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL623253,,13443,,,In vitro stability to trypsin promoting hydrolysis after 64h incubation time,6154,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL623254,,13444,,,In vitro stability to trypsin promoting hydrolysis after 84 hr incubation time,6154,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL623255,,13445,,,In vitro stability to trypsin promoting hydrolysis after 8 hr incubation time,6154,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL626831,,13446,,,Percent degradation of compound at a pH of 1 over a 18 hr period,6887,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL877494,,13447,,,Percent degradation of compound at pH of 1 over an 18 hr period,6887,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL626832,,13448,,,Delta Logarithm of Partition Coefficient value was determined.,14116,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL626833,,13449,,,Delta logPoct-cyc,11137,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL626834,,13450,,,Lipophilicity estimated on reversed phase TLC,7230,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL626835,,13451,,,Delta Tm value ( Tmdrug-DNA )-TmDNA ) was obtained for the covalently cross-linked compound in the absence of formaldehyde using calf thymus DNA.,15741,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL626836,,13452,,,Delta logPoct-cyc,9663,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL626837,,13453,,,Change in logarithm of partition coefficient of the compound,9663,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL626838,,13454,,,Delta logD (pH 6.5),13807,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL626839,,13455,,,"Partition coefficient by standard shake-flask techniquesat 37 C, using octanol and cyclohexane",13807,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL626840,,13456,,,Oxygen pressure at which hemoglobin is 50% oxygenated; negative sign indicates that P50 of modified Hb is lower than that of unmodified Hb,17425,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL626841,,13457,,,Deoxyribose-damaging property as a measure of hydroxyl-radical formation (uM of malondialdehyde/mmol of deoxyribose released by 75 uM test compound),12143,,
22224,,A,,,BAO_0000219,Autocuration,0,U,,1,,,,CHEMBL626842,,13458,,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in nine cells,12608,,
22224,,A,,,BAO_0000219,Autocuration,0,U,,1,,,,CHEMBL626843,,13459,,,Peak depolarizations produced by injections of 100 micro M Ins p3 isomers in six cells,12608,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626844,,13460,,,Amount of deuterium retained was reported after normal workup in beta-naphthoflavone-treated male rats with the substrate rac 7-D,8649,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL877495,,13461,,,Amount of deuterium retained was reported after normal workup in rats,8649,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626845,,13462,,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats,8649,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626846,,13463,,,Amount of deuterium retained was reported after reincubation followed by normal workup in phenobarbital treated male rats with rac 8-D,8649,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626847,,13464,,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,8649,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628677,,13465,,,Compound incubated with microsomal preparations from beta-naphthoflavone-treated male rats with the substrate rac 7-D and the amount of deuterium retained was reported after reincubation followed by normal workup,8649,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628678,,13466,,,Compound incubated with microsomal preparations from phenobarbital treated male rats with the substrate rac 8-D and the amount of deuterium retained was reported after normal workup,8649,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628679,,13467,,,Compound was subjected to electrochemical oxidation,9659,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628680,,13468,,,Compound was subjected to photochemical oxidation,9659,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628681,,13469,,,Oxidation of compound by Chloroperoxidase in presence of ethylperoxide,9659,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628682,,13470,,,Oxidation of compound by horseradish peroxidase in presence of hydroperoxide,9659,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628683,,13471,,,Oxidation of compound by methemoglobin in presence of hydroperoxide,9659,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628684,,13472,,,Percent diffusion through fuzzy rat skin after 48 h of incubation,9607,Rattus norvegicus,10116.0
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL877501,,13473,,,Dissociation constant (pKa),7057,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL628685,,13474,,,Dissociation constant value of the compound; ND means not determined.,7057,,
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL628686,,13475,,,% distribution of the radioiron in blood of rat followed by intravenous injection of chelating agent,7911,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL628687,,13476,,,% distribution of the radioiron in blood of rats followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,7911,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628688,,13477,,,% distribution of the radioiron in rat kidney followed by intravenous injection of chelating agent,7911,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628689,,13478,,,% distribution of the radioiron in rat kidney followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,7911,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL628690,,13479,,,% distribution of the radioiron in rat liver followed by intravenous injection of chelating agent,7911,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL629363,,13480,,,% distribution of the radioiron in rat liver followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,7911,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL629364,,13481,,,% distribution of the radioiron in rat spleen followed by intravenous injection of chelating agent,7911,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL629365,,13482,,,% distribution of the radioiron in rat spleen followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,7911,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629366,,13483,,,% excretion of ferritin determined in faces of rat followed by intravenous injection of chelating agent,7911,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL629367,,13484,,,% excretion of ferritin determined in urine of rat followed by intravenous injection of chelating agent,7911,Rattus norvegicus,10116.0
50597,Feces,A,,,BAO_0000218,Intermediate,1,N,1988.0,1,,,,CHEMBL629368,,13485,,,% excretion of radioiron determined in feces of rat followed by intravenous injection of transferrin pre-incubated with 10 mg of chelating agent,7911,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL877502,,13486,,,% excretion of radioiron determined in urine of rat followed by intravenous injection of transferrin preincubated with 10 mg of chelating agent,7911,Rattus norvegicus,10116.0
50594,Cerebellum,A,,,BAO_0000218,Intermediate,1,N,2037.0,1,,,,CHEMBL629369,,13487,,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cerebellum,13792,Mus musculus,10090.0
50594,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL629370,,13488,,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into cortex,13792,Mus musculus,10090.0
22224,Urine,A,,,BAO_0000218,Autocuration,0,U,1088.0,1,,,,CHEMBL629371,,13489,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded monkey at 10 mg/kg, po",8133,Simiiformes,314293.0
22224,Urine,A,,,BAO_0000218,Autocuration,0,U,1088.0,1,,,,CHEMBL626276,,13490,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",8133,Simiiformes,314293.0
22224,Urine,A,,,BAO_0000218,Autocuration,0,U,1088.0,1,,,,CHEMBL626277,,13491,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",8133,Simiiformes,314293.0
22224,Urine,A,,,BAO_0000218,Autocuration,0,U,1088.0,1,,,,CHEMBL631250,,13492,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",8133,Simiiformes,314293.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631251,,13493,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",8133,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631252,,13494,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 0.3mg/kg, po",8133,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631253,,13495,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 1.0 mg/kg, po",8133,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631254,,13496,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 10.0mg/kg, po",8133,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631255,,13497,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",8133,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631256,,13498,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 2.1 mg/kg, po",8133,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631257,,13499,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 20.8mg/kg, po",8133,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628009,,13500,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 207.6 mg/kg, po",8133,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628010,,13501,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 3.0mg/kg, po",8133,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628011,,13502,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",8133,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628012,,13503,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 h in urine of normotensive saline loaded rats at 6.9 mg/kg, po",8133,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628013,,13504,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 69.2mg/kg, po",8133,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628014,,13505,,,"Diuretic activity was evaluated by measuring amount of K+ during 0-6 hr in urine of normotensive saline loaded rats at 691.9mg/kg, po",8133,Rattus norvegicus,10116.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628015,,13506,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.03 mg/kg, po",8133,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628016,,13507,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 0.1 mg/kg, po",8133,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL874461,,13508,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 0.3 mg/kg, po",8133,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628017,,13509,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 1.0 mg/kg, po",8133,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628018,,13510,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 10.0mg/kg, po",8133,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628019,,13511,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 10mg/kg, po",8133,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628020,,13512,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 1 mg/kg, po",8133,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628021,,13513,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded dogs at 30 mg/kg, po",8133,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628022,,13514,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3mg/kg, po",8133,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628023,,13515,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded dogs at 3.0mg/kg, po",8133,Canis lupus familiaris,9615.0
22224,Urine,A,,,BAO_0000218,Autocuration,0,U,1088.0,1,,,,CHEMBL628024,,13516,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 100 mg/kg, po",8133,Simiiformes,314293.0
22224,Urine,A,,,BAO_0000218,Autocuration,0,U,1088.0,1,,,,CHEMBL628025,,13517,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 10mg/kg, po",8133,Simiiformes,314293.0
22224,Urine,A,,,BAO_0000218,Autocuration,0,U,1088.0,1,,,,CHEMBL628026,,13518,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 1 mg/kg, po",8133,Simiiformes,314293.0
22224,Urine,A,,,BAO_0000218,Autocuration,0,U,1088.0,1,,,,CHEMBL628027,,13519,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 30mg/kg, po",8133,Simiiformes,314293.0
22224,Urine,A,,,BAO_0000218,Autocuration,0,U,1088.0,1,,,,CHEMBL628028,,13520,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded monkey at 3mg/kg, po",8133,Simiiformes,314293.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628029,,13521,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 0.1 mg/kg, po",8133,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628030,,13522,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 0.3 mg/kg, po",8133,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628031,,13523,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 1.0mg/kg, po",8133,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628032,,13524,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 10.0 mg/kg, po",8133,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628033,,13525,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 100.0 mg/kg, po",8133,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628034,,13526,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 2.08 mg/kg, po",8133,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628035,,13527,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 207.6mg/kg, po",8133,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628036,,13528,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 3.0 mg/kg, po",8133,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL874462,,13529,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 30.0mg/kg, po",8133,Rattus norvegicus,10116.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628037,,13530,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -8/-38,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628123,,13531,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 13/-25,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628124,,13532,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); 27/-15,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628125,,13533,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/30 range (low/high); -2/-19,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628126,,13534,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 10/60 range (low/high); -3/-4,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628127,,13535,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3 range (low/high),9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628128,,13536,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); -9/24,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628129,,13537,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as heart rate (HR) at a dose of 3/10 range (low/high); 3/-1,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628130,,13538,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/030 range (low/high); 12/23,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628131,,13539,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 1/3,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628132,,13540,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 6/16,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628133,,13541,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3 range (low/high); 7/14,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628134,,13542,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 1/3/10 range (low/high); 4/4/23,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628135,,13543,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 10/14,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628136,,13544,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/15,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628137,,13545,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 11/44,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628138,,13546,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 14/28,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628139,,13547,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 15-28,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628140,,13548,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 2/3,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628141,,13549,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 26/32,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628142,,13550,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/1,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628143,,13551,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 5/12,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628144,,13552,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 6/7,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628145,,13553,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 7/6,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628146,,13554,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/12,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625355,,13555,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 8/27,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625356,,13556,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/14,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625357,,13557,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/30 range (low/high); 9/16,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625527,,13558,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 10/60 range (low/high); 12/23,9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL875473,,13559,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3 range (low/high),9025,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625528,,13560,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 10/22,9025,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626304,,13561,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as left ventricular functional refractory period (LV-FRP) at a dose of 3/10 range (low/high); 4/12,9025,Rattus norvegicus,10116.0
50588,Artery,A,,,BAO_0000218,Intermediate,1,N,1637.0,1,,,In vivo,CHEMBL624138,,13562,,,Compound was evaluated for intraduodenal bioavailability in anesthetized dogs measured as mean blood pressure at a 10/30 dose range; 11/-11,9025,Canis lupus familiaris,9615.0
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL624139,,13563,,,Calculated partition coefficient (clogP),6448,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL624140,,13564,,,Calculated partition coefficient (clogP),17221,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL624141,,13565,,,Calculated partition coefficient (clogP),6545,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL624142,,13566,,,Calculated partition coefficient (clogP),577,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL624143,,13567,,,Calculated partition coefficient (clogP),6285,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL624144,,13568,,,Calculated partition coefficient (clogP),6500,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL624145,,13569,,,Calculated partition coefficient (clogP),6716,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL624146,,13570,,,Calculated partition coefficient (clogP),13658,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL624147,,13571,,,Calculated partition coefficient (clogP),6549,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL883123,,13572,,,Calculated partition coefficient (clogP) (MacLogP),14685,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL624148,,13573,,,Partition coefficient (logP),6893,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL874416,,13574,,,Kinetic parameter was determined,3687,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL624149,,13575,,,Calculated partition coefficient (clogP),4207,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL624150,,13576,,,Calculated partition coefficient (clogP),4626,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL624151,,13577,,,Lipophilicity was determined,1021,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL624152,,13578,,,Lipophilicity was determined,3777,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL622139,,13579,,,Lipophilicity was determined,17533,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL622140,,13580,,,Calculated partition coefficient (clogP),6524,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL622141,,13581,,,Lipophilicity was determined,17533,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL622142,,13582,,,Lipophilicity in octanol-water,6480,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL622143,,13583,,,Calculated partition coefficient (clogP),17606,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL622144,,13584,,,Octanol-water partition coefficient was determined,6863,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL877473,,13585,,,Partition coefficient (logP),1356,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL622145,,13586,,,Calculated partition coefficient (clogP),3326,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL622146,,13587,,,Partition coefficient was determined; ND means not determined,1356,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL622147,,13588,,,Calculated partition coefficient (clogP),12984,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL622148,,13589,,,Partition coefficient of the compound,17363,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL883124,,13590,,,Permeability was determined,6827,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL622149,,13591,,,The compound was evaluated for the partition coefficient,261,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL622150,,13592,,,Partition coefficient (logP),2685,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL622151,,13593,,,The lipophilicity was reported,414,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL622152,,13594,,,logarithm of the octanol-water partition coefficient for the compound,15769,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL622153,,13595,,,Clogp value was determined,17248,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL877474,,13596,,,Clp at a dose of 1.5 mg/kg,16935,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL622154,,13597,,,Clp at a dose of 2.0 mg/kg,16935,,
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL622155,,13598,,,"Clp, plasma clearance at a dose of 10 mg/kg",14832,,
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL622156,,13599,,,"Clp, plasma clearance at a dose of 50 mg/kg",14832,,
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622157,,13600,,,Compound was tested for plasma clearance in rat,2399,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622158,,13601,,,Compound was tested for plasma clearance in rat; Not determined,2399,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622807,,13602,,,Plasma clearance (pharmacokinetic parameter) in rat (in vivo) at a dose of 10 mg/kg,6227,Rattus norvegicus,10116.0
50797,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622808,,13603,,,Plasma clearance (pharmacokinetic parameter) in rhesus (in vivo) at a dose of 5 mg/kg,6227,Macaca mulatta,9544.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL622809,,13604,,,Plasma clearance by iv administration at a dose 0.003 ug/mL,5623,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL622810,,13605,,,Plasma clearance determined,4854,,
100712,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL876653,,13606,,,Plasma clearance after iv administration at 3 mg/kg in hamster,4493,Cricetinae,10026.0
100712,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622811,,13607,,,Plasma clearance after iv administration at 4 mg/kg in hamster,4493,Cricetinae,10026.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622986,,13608,,,Rate of clearance in rat was determined,14956,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622987,,13609,,,Total plasma clearance Clp was determined for the compound after iv dose of 5.06 mg/kg in rats,15372,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622988,,13610,,,Total plasma clearance after iv dose of 5.10 mg/kg in rats,15372,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622989,,13611,,,Total plasma clearance was determined for the compound after iv dose of 4.74 mg/kg in rats,15372,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622990,,13612,,,Total plasma clearance was determined for the compound after iv dose of 4.97 mg/kg in rats,15372,Rattus norvegicus,10116.0
22224,Plasma,A,,,BAO_0000218,Autocuration,0,U,1969.0,1,,,In vivo,CHEMBL622991,,13613,,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.01 mg/kg) in monkey,15604,Simiiformes,314293.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622227,,13614,,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.05 mg/kg) in rat,15604,Rattus norvegicus,10116.0
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL622228,,13615,,,plasma clearance in preclinical species was measured after Intravenous administration at the given dose (0.1 mg/kg) in dog,15604,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622229,,13616,,,Clpl value in rat,14964,Rattus norvegicus,10116.0
50512,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622230,,13617,,,Cmax (ng /mL) value after oral administration of 10 mg/kg in guinea pig.,15240,Cavia porcellus,10141.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622231,,13618,,,Cmax after an oral dose of 10 uM/Kg in male Sprague-Dawley rats,16449,Rattus norvegicus,10116.0
100710,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL622232,,13619,,,Cmax after an oral dose of 10 uM/Kg in male cynomolgus monkeys,16449,Macaca fascicularis,9541.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL622233,,13620,,,Cmax in minutes at a iv dose of 1.0(pmol/g/h).,12902,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL622234,,13621,,,Cmax in minutes at a iv dose of 2.0(pmol/g/h).,12902,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL622235,,13622,,,Cmax in minutes at a iv dose of 4.0(pmol/g/h).,12902,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL622236,,13623,,,Cmax in minutes at a iv dose of 5.0(pmol/g/h).,12902,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL622237,,13624,,,Cmax in minutes at a iv dose of 54.0(pmol/g/h).,12902,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL877482,,13625,,,Cmax in minutes at a po dose of 10.0(pmol/g/h).,12902,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL622238,,13626,,,Cmax in minutes at a po dose of 20.0(pmol/g/h).,12902,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL622239,,13627,,,Cmax in minutes at a po dose of 40.0(pmol/g/h).,12902,,
22224,Blood,A,,,BAO_0000218,Autocuration,0,U,178.0,1,,,In vivo,CHEMBL622240,,13628,,,Cmax was calculated as maximum concentration reached in the blood,11149,,
22224,Blood,A,,,BAO_0000218,Autocuration,0,U,178.0,1,,,In vivo,CHEMBL622241,,13629,,,Cmax was calculated as maximum concentration reached in the blood in air pouch exudate,11149,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL631013,,13630,,,Cmax was determine after peroral administration at 10 mpk in Rat,5669,Rattus norvegicus,10116.0
50797,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL631014,,13631,,,Cmax was determine after peroral administration at 10 mpk in Rhesus,5669,Macaca mulatta,9544.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL631015,,13632,,,Cmax was determine after peroral administration at 10 mpk in dog,5669,Canis lupus familiaris,9615.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL631016,,13633,,,Cmax was determine after peroral administration at 160 mpk in Rat,5669,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL631017,,13634,,,Cmax was determine after peroral administration at 20 mpk in Rat,5669,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL631018,,13635,,,Cmax was determine after peroral administration at 50 mpk in Rat,5669,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL631019,,13636,,,Cmax was determined,4236,,
50594,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL875761,,13637,,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hippocampus,13792,Mus musculus,10090.0
50594,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL631020,,13638,,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into hypothalamus,13792,Mus musculus,10090.0
50594,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL631669,,13639,,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into pons and medulla,13792,Mus musculus,10090.0
50594,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL631670,,13640,,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into rest of the brain,13792,Mus musculus,10090.0
50594,Striatum,A,,,BAO_0000218,Intermediate,1,N,2435.0,1,,,,CHEMBL631671,,13641,,,Distribution of analyte (pmol/mg) in mouse brain regions after Jugular Vein Injection into striatum,13792,Mus musculus,10090.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL631672,,13642,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.31-0.4,8418,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL631673,,13643,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.97-1.12,8418,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL631856,,13644,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.35-0.37,8418,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL631857,,13645,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.72-1.03,8418,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL631858,,13646,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.95-1.06,8418,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL631859,,13647,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.35-0.4,8418,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL631860,,13648,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.73-0.85,8418,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL631861,,13649,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.65-0.83,8418,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL631862,,13650,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.69-0.84,8418,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL631863,,13651,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.46,8418,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL631864,,13652,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 1.38-1.5,8418,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL631865,,13653,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.34-0.48,8418,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL631866,,13654,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.58-1.17,8418,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL629360,,13655,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 1.0-1.24,8418,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL629361,,13656,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.28-0.37,8418,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL629362,,13657,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.54-0.63,8418,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL630740,,13658,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.25-0.32,8418,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL630741,,13659,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.49-0.58,8418,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,,CHEMBL630742,,13660,,,Distribution of radioactivity in blood tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.58-0.77,8418,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630743,,13661,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 0.20-0.25,8418,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630744,,13662,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injection by intravenously; value ranges from 1.05-1.25,8418,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630745,,13663,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.03,8418,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630746,,13664,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.03-0.06,8418,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630747,,13665,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 15 min injecton by intravenously; 0.34-0.5,8418,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630748,,13666,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.17-0.20,8418,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL632056,,13667,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injection by intravenously; value ranges from 0.81-1.26,8418,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL632057,,13668,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.03-0.06,8418,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL632058,,13669,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 30 min injecton by intravenously; 0.18-0.36,8418,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL632059,,13670,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.28-0.37,8418,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL632060,,13671,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injection by intravenously; value ranges from 0.97-2.17,8418,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL632061,,13672,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.02-0.03,8418,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629207,,13673,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.05-0.07,8418,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629208,,13674,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 5 min injecton by intravenously; 0.35-0.72,8418,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629209,,13675,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.15-0.19,8418,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629210,,13676,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injection by intravenously; value ranges from 0.76-1.42,8418,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629211,,13677,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.02-0.03,8418,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629212,,13678,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.03-0.06,8418,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629213,,13679,,,Distribution of radioactivity in brain tissues of Sprague-Dawley rats after 60 min injecton by intravenously; 0.05-0.06,8418,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL629214,,13680,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 hr in urine of normotensive saline loaded rats at 6.9mg/kg, po",8133,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL629215,,13681,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 69.2 mg/kg, po",8133,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL635154,,13682,,,"Diuretic activity was evaluated by measuring amount of Na+ during 0-6 h in urine of normotensive saline loaded rats at 691.9 mg/kg, po",8133,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629216,,13683,,,Oral diuretic activity measured by Na+ excretion in Rat at 9 mg/kg after ip administration (0-5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629217,,13684,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration,6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629218,,13685,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629219,,13686,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration (0-5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629220,,13687,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0 - 5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629221,,13688,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr ),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631127,,13689,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 27 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631128,,13690,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration,6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631129,,13691,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631130,,13692,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration (0-5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631131,,13693,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0 - 5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631132,,13694,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr ),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631133,,13695,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 3 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631134,,13696,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration,6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL875120,,13697,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631135,,13698,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration (0-5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631136,,13699,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0 - 5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631137,,13700,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr ),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631138,,13701,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 81 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631139,,13702,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration,6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631140,,13703,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631141,,13704,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration (0-5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631142,,13705,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0 - 5 hr),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631143,,13706,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr ),6996,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631144,,13707,,,Oral diuretic activity was evaluated by measuring Cl- excretion in Rat at 9 mg/kg after ip administration ( 0-5 hr),6996,Rattus norvegicus,10116.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631145,,13708,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.312 mg/kg after ip administration,6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631146,,13709,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.3 mg/kg after ip administration (0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631147,,13710,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.625 mg/kg after ip administration,6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631148,,13711,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 0.6 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631149,,13712,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1.8 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631150,,13713,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration (0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631151,,13714,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 10 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631152,,13715,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 16.2 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631443,,13716,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631444,,13717,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration (0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631445,,13718,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0 - 6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631446,,13719,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg after ip administration ( 0-6 hr ),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631447,,13720,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 1 mg/kg g after ip administration (0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631448,,13721,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 20 mg/kg after ip administration ( 0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631449,,13722,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration,6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631450,,13723,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration (0-6 hr),6996,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629724,,13724,,,Oral diuretic activity was evaluated by measuring Cl- excretion in dog at 2 mg/kg after ip administration ( 0 - 6 hr),6996,Canis lupus familiaris,9615.0
50594,Zone of skin,A,,,BAO_0000218,Intermediate,1,N,14.0,1,,,In vivo,CHEMBL629725,,13725,,,"Biodistribution in mice skin, after 24 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",9716,Mus musculus,10090.0
50594,Zone of skin,A,,,BAO_0000218,Intermediate,1,N,14.0,1,,,In vivo,CHEMBL629726,,13726,,,"Biodistribution in mice skin, after 48 hr of intravenous administration of 1-2 ug ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",9716,Mus musculus,10090.0
50594,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL629727,,13727,,,"Biodistribution in mice spleen, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",9716,Mus musculus,10090.0
50594,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL630404,,13728,,,"Biodistribution in mice spleen, after 1 hr of intravenous aadministration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",9716,Mus musculus,10090.0
50594,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL630405,,13729,,,"Biodistribution in mice spleen, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",9716,Mus musculus,10090.0
50594,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL630406,,13730,,,"Biodistribution in mice spleen, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",9716,Mus musculus,10090.0
50594,Stomach,A,,,BAO_0000218,Intermediate,1,N,945.0,1,,,In vivo,CHEMBL630407,,13731,,,"Biodistribution in mice stomach, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",9716,Mus musculus,10090.0
50594,Stomach,A,,,BAO_0000218,Intermediate,1,N,945.0,1,,,In vivo,CHEMBL630573,,13732,,,"Biodistribution in mice stomach, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",9716,Mus musculus,10090.0
50594,Stomach,A,,,BAO_0000218,Intermediate,1,N,945.0,1,,,In vivo,CHEMBL630574,,13733,,,"Biodistribution in mice stomach, after 24 hr of intravenous administration of 1-2 ug of ofcompound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",9716,Mus musculus,10090.0
50594,Stomach,A,,,BAO_0000218,Intermediate,1,N,945.0,1,,,In vivo,CHEMBL630575,,13734,,,"Biodistribution in mice stomach, after 48 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",9716,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL630576,,13735,,,"Biodistribution in mice tail, after 12 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",9716,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL630577,,13736,,,"Biodistribution in mice tail, after 1 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",9716,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL630578,,13737,,,"Biodistribution in mice tail, after 24 hr of intravenous administration of 1-2 ug of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",9716,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL630579,,13738,,,"Biodistribution in mice tail, after 48 hr of intravenous administration of compound (entrapped in bovine brain sphingomyelin/ cholesterol multilamellar vehicles)",9716,Mus musculus,10090.0
50594,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL630580,,13739,,,Percent of injected 238-Plutonium(IV) in mice kidney at 24 hr (orally administered),12192,Mus musculus,10090.0
50594,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL630581,,13740,,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 h,12192,Mus musculus,10090.0
50594,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,,CHEMBL630582,,13741,,,Percent of injected 238-Plutonium(IV) in mice kidneys at 24 hr (orally administered),12192,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630583,,13742,,,Percent of injected 238-Plutonium(IV) in mice liver at 24 h,12192,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630584,,13743,,,Percent of injected 238-Plutonium(IV) in mice liver at 24 hr (orally administered),12192,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630585,,13744,,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 h,12192,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630586,,13745,,,Percent of injected 238-Plutonium(IV) in mice skeleton at 24 hr (orally administered),12192,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630587,,13746,,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 h,12192,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630588,,13747,,,Percent of injected 238-Plutonium(IV) in mice soft tissue at 24 hr (orally administered),12192,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630589,,13748,,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 h,12192,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630590,,13749,,,Percent of injected 238-Plutonium(IV) in mice whole body at 24 hr (orally administered),12192,Mus musculus,10090.0
22224,Feces,A,,,BAO_0000019,Autocuration,0,U,1988.0,1,,,,CHEMBL630591,,13750,,,Removal of 238-Plutonium(IV) in feces at 24 h,12192,,
22224,Feces,A,,,BAO_0000019,Autocuration,0,U,1988.0,1,,,,CHEMBL630592,,13751,,,Removal of 238-Plutonium(IV) in feces at 24 hr (orally administered),12192,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630593,,13752,,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 h,12192,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630594,,13753,,,Removal of 238-Plutonium(IV) in gastrointestinal (GI) contents at 24 hr (orally administered),12192,,
22224,Urine,A,,,BAO_0000019,Autocuration,0,U,1088.0,1,,,,CHEMBL630595,,13754,,,Removal of 238-Plutonium(IV) in urine 0-4 h (orally administered),12192,,
22224,Urine,A,,,BAO_0000019,Autocuration,0,U,1088.0,1,,,,CHEMBL630596,,13755,,,Removal of 238-Plutonium(IV) in urine 4-24 hr (orally administered),12192,,
22224,Urine,A,,,BAO_0000019,Autocuration,0,U,1088.0,1,,,,CHEMBL630597,,13756,,,Removal of 238-Plutonium(IV) in urine after 0-24 h,12192,,
22224,Urine,A,,,BAO_0000019,Autocuration,0,U,1088.0,1,,,,CHEMBL630598,,13757,,,Removal of 238-Plutonium(IV) in urine after 0-24 hr (orally administered),12192,,
22224,Urine,A,,,BAO_0000019,Autocuration,0,U,1088.0,1,,,,CHEMBL630599,,13758,,,Removal of 238-Plutonium(IV) in urine after 0-4 h,12192,,
22224,Urine,A,,,BAO_0000019,Autocuration,0,U,1088.0,1,,,,CHEMBL630600,,13759,,,Removal of 238-Plutonium(IV) in urine after 0-4 hr (orally administered),12192,,
22224,Urine,A,,,BAO_0000019,Autocuration,0,U,1088.0,1,,,,CHEMBL630601,,13760,,,Removal of 238-Plutonium(IV) in urine after 4-24 h,12192,,
22224,Urine,A,,,BAO_0000019,Autocuration,0,U,1088.0,1,,,,CHEMBL630602,,13761,,,Removal of 238-Plutonium(IV) in urine after 4-24 hr (orally administered),12192,,
22224,Urine,A,,,BAO_0000019,Autocuration,0,U,1088.0,1,,,,CHEMBL630603,,13762,,,Removal of 238-Plutonium(IV) in urine at 0-4 hr (orally administered),12192,,
22224,Urine,A,,,BAO_0000019,Autocuration,0,U,1088.0,1,,,,CHEMBL630604,,13763,,,Removal of 238-Plutonium(IV) in urine at 4-24 hr (orally administered),12192,,
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL624869,,13764,,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL624870,,13765,,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL623189,,13766,,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL623190,,13767,,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL623191,,13768,,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623192,,13769,,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623193,,13770,,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623194,,13771,,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623195,,13772,,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623196,,13773,,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623197,,13774,,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 15 microCi of the drug and 15 micro g of estradiol,11836,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623198,,13775,,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,11836,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623199,,13776,,,Tested in vivo for the biodistribution in rat uterus/blood at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,11836,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL623200,,13777,,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 100 microCi of drug in 10%ethanol saline,11836,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL623201,,13778,,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 120 microCi of drug in 10%ethanol saline,11836,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL623202,,13779,,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 15 microCi of drug in 10%ethanol saline,11836,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL623203,,13780,,,Tested in vivo for the biodistribution in rat uterus/muscle after 3 hours following an intravenous dose of 50 microCi of drug in 10%ethanol saline,11836,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL623204,,13781,,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of drug in 10%ethanol saline,11836,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL623205,,13782,,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 100 microCi of the drug and 15 ug of estradiol,11836,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL623206,,13783,,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,11836,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL623207,,13784,,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 120 microCi of the drug and 15 micro g of estradiol,11836,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL623208,,13785,,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 15 microCi of the drug and 15 ug of estradiol,11836,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL623209,,13786,,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,11836,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL623210,,13787,,,Tested in vivo for the biodistribution in rat uterus/muscle at 1 hour after intravenous dose of 50 microCi of the drug and 15 ug of estradiol,11836,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623211,,13788,,,Tested in vivo for the biodistribution in rat fat at 1 hour after intravenous dose of 50 microCi of drug in 10%ethanol saline,11836,Rattus norvegicus,10116.0
50597,Uterus,A,,,BAO_0000218,Intermediate,1,N,995.0,1,,,,CHEMBL623212,,13789,,,Tested in vivo for the biodistribution in rat uterus at 1 hour after intravenous dose of 120 microCi of drug in 10%ethanol saline,11836,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL623213,,13790,,,Tested in vitro for intrinsic activity relative to quinpirole,12640,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL623214,,13791,,,"Relative ion enhancement, determined in pulsed ultrafiltration",14218,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL623215,,13792,,,% ionization at the pH 7.4 at 37 degree Centigrade,11296,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL623216,,13793,,,Percentage ionization was measured,10929,,
50591,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL623217,,13794,,,Association constant of binding of compound with calf thymus DNA was determined by using equilibrium dialysis.,13841,Bos taurus,9913.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL623218,,13795,,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 Pseudo-first-order rate constant,10431,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL623913,,13796,,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer Pseudo-first-order rate constant,10431,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL623914,,13797,,,Compound was autooxidized for 2 hour at 37 degree Celsius in pH 7.4 phosphate buffer pseudo-first-order rate constant 0.1 mM EDTA,10431,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL623915,,13798,,,Compound was evaluated for the partition coefficient in octanol/water,8826,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL624080,,13799,,,Compound was evaluated for the partition coefficient in octanol/water (1-octanol / 10 mM phosphate buffer at pH 7.4),8826,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL624081,,13800,,,Equilibrium constant measured by the pulse radiolysis at pH 7,9884,,
50587,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL624082,,13801,,,In vitro hydrolytic rate constant determined in human blood,9827,Homo sapiens,9606.0
50587,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625054,,13802,,,In vitro oxidation of compound to its pyridinium salt (3) in presence of human plasma,10009,Homo sapiens,9606.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL877485,,13803,,,In vitro oxidation of compound to its pyridinium salt (3) in presence of hydrogen peroxide,10009,,
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625055,,13804,,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse brain homogenate,10009,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625056,,13805,,,In vitro oxidation of compound to its pyridinium salt (3) in presence of mouse liver homogenate,10009,Mus musculus,10090.0
50587,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625057,,13806,,,In vitro oxidation of compound in presence of human plasma,10009,Homo sapiens,9606.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625058,,13807,,,In vitro oxidation of compound in presence of hydrogen peroxide,10009,,
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625059,,13808,,,In vitro oxidation of compound in presence of mouse brain homogenate,10009,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629536,,13809,,,In vitro oxidation of compound in presence of mouse liver homogenate,10009,Mus musculus,10090.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629537,,13810,,,Mean potassium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629538,,13811,,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629539,,13812,,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL874445,,13813,,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629540,,13814,,,Mean potassium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629541,,13815,,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629542,,13816,,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630243,,13817,,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630244,,13818,,,Mean potassium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630245,,13819,,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630246,,13820,,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630247,,13821,,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630248,,13822,,,Mean potassium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,11510,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL630249,,13823,,,Biodistribution in rat blood at 240 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL630250,,13824,,,Biodistribution in rat blood at 30 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL630251,,13825,,,Biodistribution in rat blood at 360 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL630252,,13826,,,Biodistribution in rat blood at 3 hr after dose administration.,13100,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL630408,,13827,,,Biodistribution in rat blood at 60 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Cerebellum,A,,,BAO_0000218,Intermediate,1,N,2037.0,1,,,In vivo,CHEMBL630409,,13828,,,Biodistribution in rat cerebellum at 120 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Cerebellum,A,,,BAO_0000218,Intermediate,1,N,2037.0,1,,,In vivo,CHEMBL874446,,13829,,,Biodistribution in rat cerebellum at 1440 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Cerebellum,A,,,BAO_0000218,Intermediate,1,N,2037.0,1,,,In vivo,CHEMBL630410,,13830,,,Biodistribution in rat cerebellum at 15 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Cerebellum,A,,,BAO_0000218,Intermediate,1,N,2037.0,1,,,In vivo,CHEMBL630411,,13831,,,Biodistribution in rat cerebellum at 240 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Cerebellum,A,,,BAO_0000218,Intermediate,1,N,2037.0,1,,,In vivo,CHEMBL630412,,13832,,,Biodistribution in rat cerebellum at 30 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Cerebellum,A,,,BAO_0000218,Intermediate,1,N,2037.0,1,,,In vivo,CHEMBL630413,,13833,,,Biodistribution in rat cerebellum at 360 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Cerebellum,A,,,BAO_0000218,Intermediate,1,N,2037.0,1,,,In vivo,CHEMBL630414,,13834,,,Biodistribution in rat cerebellum at 3 hr after dose administration.,13100,Rattus norvegicus,10116.0
50597,Cerebellum,A,,,BAO_0000218,Intermediate,1,N,2037.0,1,,,In vivo,CHEMBL630415,,13835,,,Biodistribution in rat cerebellum at 60 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL630416,,13836,,,Biodistribution in rat cortex at 120 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL630417,,13837,,,Biodistribution in rat cortex at 1440 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL630418,,13838,,,Biodistribution in rat cortex at 15 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL630419,,13839,,,Biodistribution in rat cortex at 240 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL630420,,13840,,,Biodistribution in rat cortex at 30 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL630421,,13841,,,Biodistribution in rat cortex at 360 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL630422,,13842,,,Biodistribution in rat cortex at 3 hr after dose administration.,13100,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL630423,,13843,,,Biodistribution in rat cortex at 60 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL630424,,13844,,,Biodistribution in rat heart at 120 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL630425,,13845,,,Biodistribution in rat heart at 15 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL629462,,13846,,,Biodistribution in rat heart at 240 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL630426,,13847,,,Biodistribution in rat heart at 30 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL630427,,13848,,,Biodistribution in rat heart at 360 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL625877,,13849,,,Biodistribution in rat heart at 3 hr after dose administration.,13100,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL625878,,13850,,,Biodistribution in rat heart at 60 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Hippocampus,A,,,BAO_0000218,Intermediate,1,N,10000000.0,1,,,In vivo,CHEMBL625879,,13851,,,Biodistribution in rat hippocampus at 1440 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Hippocampus,A,,,BAO_0000218,Intermediate,1,N,10000000.0,1,,,In vivo,CHEMBL625880,,13852,,,Biodistribution in rat hippocampus at 240 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Hippocampus,A,,,BAO_0000218,Intermediate,1,N,10000000.0,1,,,In vivo,CHEMBL625881,,13853,,,Biodistribution in rat hippocampus at 30 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Hippocampus,A,,,BAO_0000218,Intermediate,1,N,10000000.0,1,,,In vivo,CHEMBL625882,,13854,,,Biodistribution in rat hippocampus at 360 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Hippocampus,A,,,BAO_0000218,Intermediate,1,N,10000000.0,1,,,In vivo,CHEMBL625883,,13855,,,Biodistribution in rat hippocampus at 15 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL625884,,13856,,,Biodistribution in rat kidney at 120 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL625885,,13857,,,Biodistribution in rat kidney at 1440 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL628649,,13858,,,Biodistribution in rat kidney at 15 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL628650,,13859,,,Biodistribution in rat kidney at 240 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL628651,,13860,,,Biodistribution in rat kidney at 30 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL628652,,13861,,,Biodistribution in rat kidney at 360 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL628653,,13862,,,Biodistribution in rat kidney at 60 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL628654,,13863,,,Biodistribution in rat liver at 120 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL628655,,13864,,,Biodistribution in rat liver at 1440 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL625238,,13865,,,Biodistribution in rat liver at 15 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL625239,,13866,,,Biodistribution in rat liver at 240 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL625240,,13867,,,Biodistribution in rat liver at 30 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL625241,,13868,,,Biodistribution in rat liver at 360 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL625242,,13869,,,Biodistribution in rat liver at 60 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL874587,,13870,,,Biodistribution in rat lung at 120 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL625405,,13871,,,Biodistribution in rat lung at 1440 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL625406,,13872,,,Biodistribution in rat lung at 15 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL625407,,13873,,,Biodistribution in rat lung at 240 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL625408,,13874,,,Biodistribution in rat lung at 30 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL625409,,13875,,,Biodistribution in rat lung at 360 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Thoracic aorta,A,,,BAO_0000218,Intermediate,1,N,1515.0,1,,,,CHEMBL625410,,13876,,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of calcium deficient buffer,12361,Rattus norvegicus,10116.0
50597,Thoracic aorta,A,,,BAO_0000218,Intermediate,1,N,1515.0,1,,,,CHEMBL625411,,13877,,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of nifedipine,12361,Rattus norvegicus,10116.0
50597,Thoracic aorta,A,,,BAO_0000218,Intermediate,1,N,1515.0,1,,,,CHEMBL625412,,13878,,,Percent of maximal contractile response to compound in rat thoracic aorta strips in the presence of verapamil,12361,Rattus norvegicus,10116.0
50597,Thoracic aorta,A,,,BAO_0000218,Intermediate,1,N,1515.0,1,,,,CHEMBL625413,,13879,,,Percent of maximal contractile response to compound in rat thoracic aorta strips presence of PBZ and CIR,12361,Rattus norvegicus,10116.0
50597,Thoracic aorta,A,,,BAO_0000218,Intermediate,1,N,1515.0,1,,,,CHEMBL625414,,13880,,,Percent of maximal contractile response to compound in rat thoracic aorta strips v,12361,Rattus norvegicus,10116.0
50597,Thoracic aorta,A,,,BAO_0000218,Intermediate,1,N,1515.0,1,,,,CHEMBL625415,,13881,,,Percent of maximal contractile response to compound with phenoxybenzamine pretreatment on rat thoracic aorta strips,12361,Rattus norvegicus,10116.0
50597,Thoracic aorta,A,,,BAO_0000218,Intermediate,1,N,1515.0,1,,,,CHEMBL625416,,13882,,,Percent of maximal contractile response to compound without phenoxybenzamine pretreatment on rat thoracic aorta strips,12361,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL625417,,13883,,,% of the total radioactive dose of compound present in the 0-24 hour urine after a single 5 mg/kg dose administered intravenously in rats,12712,Rattus norvegicus,10116.0
50597,Feces,A,,,BAO_0000218,Intermediate,1,N,1988.0,1,,,,CHEMBL625418,,13884,,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through feces,7415,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL625419,,13885,,,Compound at the dose 10 mg/kg administered intraperitoneally was evaluated for the excretion rate in rats in 7 days through urine,7415,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625420,,13886,,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 1 mg/kg,7415,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626996,,13887,,,Compound was evaluated for the biliary excretion in the anesthetized rats in 6 hours after intravenous doses 10 mg/kg,7415,Rattus norvegicus,10116.0
50597,Feces,A,,,BAO_0000218,Intermediate,1,N,1988.0,1,,,,CHEMBL626997,,13888,,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through feces",7415,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL626998,,13889,,,"Compound was evaluated for the cumulative excretion rate in rats at the dose 10 mg/kg, intraperitoneally for 18 days through urine",7415,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626999,,13890,,,"Compound was evaluated for the in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour biliary excretion",7415,Rattus norvegicus,10116.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627000,,13891,,,faecal levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-30h,8050,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627001,,13892,,,fecal levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-30h,8050,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627002,,13893,,,fecal levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-30h,8050,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627003,,13894,,,fecal levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-30h,8050,Mus musculus,10090.0
50594,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627004,,13895,,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-24 hr,8050,Mus musculus,10090.0
50594,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627005,,13896,,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 0-6 hr,8050,Mus musculus,10090.0
50594,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL874594,,13897,,,urine levels excreted after administration of 2-(3-bromophenyl)thiazolidine(500 mg/kg) to mice measured at 24-30 hr,8050,Mus musculus,10090.0
50594,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627006,,13898,,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-24 hr,8050,Mus musculus,10090.0
50594,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627007,,13899,,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 0-6 hr,8050,Mus musculus,10090.0
50594,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627884,,13900,,,urine levels excreted after administration of 2-phenylthiazolidine (500 mg/kg) to mice measured at 24-30 hr,8050,Mus musculus,10090.0
50594,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627885,,13901,,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-24 hr,8050,Mus musculus,10090.0
50594,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627886,,13902,,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 0-6 hr,8050,Mus musculus,10090.0
50594,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627887,,13903,,,urine levels excreted after administration of benzaldehyde (250 mg/kg) to mice measured at 24-30 hr,8050,Mus musculus,10090.0
50594,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627888,,13904,,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-24 hr,8050,Mus musculus,10090.0
50594,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628057,,13905,,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 0-6 hr,8050,Mus musculus,10090.0
50594,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627405,,13906,,,urine levels excreted after administration of cysteamine (175 mg/kg) to mice measured at 24-30 hr,8050,Mus musculus,10090.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627406,,13907,,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627407,,13908,,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627408,,13909,,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627409,,13910,,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL875486,,13911,,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627410,,13912,,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627411,,13913,,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627412,,13914,,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627413,,13915,,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627414,,13916,,,Total electrolytic excretion of chlorine in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627415,,13917,,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 10.1 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627416,,13918,,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 102 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627417,,13919,,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.40 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627418,,13920,,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 3.76 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627419,,13921,,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 34.1 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627320,,13922,,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 50.8 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627321,,13923,,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 68.1 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL627322,,13924,,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL627323,,13925,,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL627491,,13926,,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL627492,,13927,,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL627493,,13928,,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL627494,,13929,,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL627495,,13930,,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL627496,,13931,,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL627497,,13932,,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL627498,,13933,,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL627499,,13934,,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL627500,,13935,,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL627501,,13936,,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL625616,,13937,,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL625617,,13938,,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL625618,,13939,,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL625619,,13940,,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL625620,,13941,,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL625621,,13942,,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL625622,,13943,,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL625788,,13944,,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL625789,,13945,,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL625790,,13946,,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL625791,,13947,,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL622334,,13948,,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,In vivo,CHEMBL622335,,13949,,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,In vivo,CHEMBL622336,,13950,,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,In vivo,CHEMBL622337,,13951,,,Biodistribution in thyroid of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,In vivo,CHEMBL622338,,13952,,,Biodistribution in thyroid of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,In vivo,CHEMBL622339,,13953,,,Biodistribution in thyroid of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL624153,,13954,,,Biodistribution in uterus / blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628430,,13955,,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628431,,13956,,,Biodistribution in uterus / blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628432,,13957,,,Biodistribution in uterus / blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628433,,13958,,,Biodistribution in uterus / blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL628434,,13959,,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",12017,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL626789,,13960,,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",12017,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL626790,,13961,,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2)",12017,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL626791,,13962,,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",12017,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL626792,,13963,,,"Biodistribution in uterus / spleen, muscle, lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",12017,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL626793,,13964,,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",12017,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627436,,13965,,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627437,,13966,,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627438,,13967,,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627439,,13968,,,Mean potassium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627440,,13969,,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627602,,13970,,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627603,,13971,,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627604,,13972,,,Mean potassium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627605,,13973,,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627606,,13974,,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627607,,13975,,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627608,,13976,,,Mean potassium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627609,,13977,,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627610,,13978,,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627611,,13979,,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627612,,13980,,,Mean potassium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,11510,Rattus norvegicus,10116.0
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL627613,,13981,,,Octanol:water partition coefficient is evaluated,8362,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL627614,,13982,,,Partition coefficient in 1-octanol/water system,8257,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL627615,,13983,,,Partition coefficient in 1-octanol/water system measured using radio active compounds,8257,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL627616,,13984,,,Partition coefficient in octanol/water system was determined,9468,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL627617,,13985,,,Partition coefficient in octanol/water system was determined using [14C]-labeled compounds.,9468,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627618,,13986,,,Pseudo-first-order rate constant at pH 10 and 35 degrees Centigrade,10568,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627619,,13987,,,"Pseudo-first-order rate constant at pH 10, micro=0.5, 35 degrees Centigrade",10568,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627620,,13988,,,Pseudo-first-order rate constant of the compound,15359,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627621,,13989,,,Pseudo-first-order rate constant with 1-min time point,15359,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627622,,13990,,,Pseudo-first-order rate constant without 1-min time point,15359,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627623,,13991,,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 0.5 mM EDTA,10431,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627624,,13992,,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 50 mM EDTA,10431,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627625,,13993,,,Pseudo-first-order rate constant was determined in pH 7.4 phosphate buffer in presence 70 mM EDTA,10431,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628523,,13994,,,Rate constants determined using 31P NMR Kinetics experiments at 37 degrees Centigrade,15704,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628524,,13995,,,The alkaline hydrolysis second order rate constant(K OH) of the compound,15287,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628525,,13996,,,The efflux rate constant of the compound,7516,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625732,,13997,,,The reaction rate constant (K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,12973,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625733,,13998,,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,12973,,
22224,,F,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625734,,13999,,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine,12973,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625913,,14000,,,The reaction rate constant(K) by measuring competition with nitroblue tetrazolium of the superoxide radicals formed by xanthine oxidase/xanthine; ND= not determined,12973,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625914,,14001,,,Association constant was evaluated towards synthetic peptidoglycan analogue Ac2-Lys-D-Ala-D-Ala,8696,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625915,,14002,,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of electroneutral DMPC in PBSbuffer at pH 7.4 and 37 C,15052,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625916,,14003,,,Equilibrium association (binding) constant interacting with Unilamellar Vesicles of negatively charged DMPG in PBS buffer at pH 7.4 and 37 C,15052,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625917,,14004,,,Evaluated for the mustard reactivity by determining rate constant for hydrolysis of mustard in aqueous acetone (K H),10503,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625918,,14005,,,"Effective biomolecular rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625919,,14006,,,"Effective biomolecular rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625920,,14007,,,"Effective biomolecular rate constant at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL874453,,14008,,,"Effective biomolecular rate constant at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625921,,14009,,,"Effective biomolecular rate constant in the conditions of 25degreeC,pH 7.6",8354,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625922,,14010,,,Evaluated for the mustard reactivity by determining rate constant for alkylation of 4-(4-nitrobenzyl)pyridine using NBP alkylation assay,10503,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625923,,14011,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625924,,14012,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625925,,14013,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 0.790 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625926,,14014,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator at the concentration 1.00 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL627704,,14015,,,Biodistribution in rat lung at 60 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627705,,14016,,,Biodistribution in rat pons/medulla at 120 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627706,,14017,,,Biodistribution in rat pons/medulla at 15 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627707,,14018,,,Biodistribution in rat pons/medulla at 240 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627708,,14019,,,Biodistribution in rat pons/medulla at 30 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628361,,14020,,,Biodistribution in rat pons/medulla at 360 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628362,,14021,,,Biodistribution in rat pons/medulla at 60 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Striatum,A,,,BAO_0000218,Intermediate,1,N,2435.0,1,,,In vivo,CHEMBL628363,,14022,,,Biodistribution in rat striatum at 120 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Striatum,A,,,BAO_0000218,Intermediate,1,N,2435.0,1,,,In vivo,CHEMBL628364,,14023,,,Biodistribution in rat striatum at 1440 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Striatum,A,,,BAO_0000218,Intermediate,1,N,2435.0,1,,,In vivo,CHEMBL628365,,14024,,,Biodistribution in rat striatum at 15 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Striatum,A,,,BAO_0000218,Intermediate,1,N,2435.0,1,,,In vivo,CHEMBL874454,,14025,,,Biodistribution in rat striatum at 240 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Striatum,A,,,BAO_0000218,Intermediate,1,N,2435.0,1,,,In vivo,CHEMBL628531,,14026,,,Biodistribution in rat striatum at 30 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Striatum,A,,,BAO_0000218,Intermediate,1,N,2435.0,1,,,In vivo,CHEMBL628532,,14027,,,Biodistribution in rat striatum at 360 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Striatum,A,,,BAO_0000218,Intermediate,1,N,2435.0,1,,,In vivo,CHEMBL628533,,14028,,,Biodistribution in rat striatum at 3 hr after dose administration.,13100,Rattus norvegicus,10116.0
50597,Striatum,A,,,BAO_0000218,Intermediate,1,N,2435.0,1,,,In vivo,CHEMBL628534,,14029,,,Biodistribution in rat striatum at 60 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,In vivo,CHEMBL628535,,14030,,,Biodistribution in rat thyroid at 120 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,In vivo,CHEMBL628536,,14031,,,Biodistribution in rat thyroid at 1440 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,In vivo,CHEMBL628537,,14032,,,Biodistribution in rat thyroid at 15 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,In vivo,CHEMBL628538,,14033,,,Biodistribution in rat thyroid at 240 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,In vivo,CHEMBL628539,,14034,,,Biodistribution in rat thyroid at 30 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,In vivo,CHEMBL630297,,14035,,,Biodistribution in rat thyroid at 360 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,In vivo,CHEMBL630298,,14036,,,Biodistribution in rat thyroid at 60 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL630299,,14037,,,Biodistribution in rest of brain of rat 120 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL628094,,14038,,,Biodistribution in rest of brain of rat at 1440 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL628095,,14039,,,Biodistribution in rest of brain of rat at 15 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL874648,,14040,,,Biodistribution in rest of brain of rat at 240 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL628096,,14041,,,Biodistribution in rest of brain of rat at 30 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL628097,,14042,,,Biodistribution in rest of brain of rat at 360 minutes after dose administration.,13100,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL628098,,14043,,,Biodistribution in rest of brain of rat at 60 minutes after dose administration.,13100,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628099,,14044,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (10:1)",13331,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628100,,14045,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 6.5, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",13331,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628101,,14046,,,Mean rate constant for the hydrolysis of compound in buffers at pH 7.4 at 37 degrees Centigrade in incubation mixture - d(A)-d(T) (10:!),13331,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628102,,14047,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - 5'-GMP/5'-CMP (1:1)",13331,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628103,,14048,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(A)-d(T) (1:1)",13331,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628104,,14049,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (10:1)",13331,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628105,,14050,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(C) (1:1)",13331,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628106,,14051,,,"Mean rate constant for the hydrolysis of compound in buffers at pH 7.4, at 37 degrees Celsius in incubation mixture - d(G)-d(T) (10:1)",13331,,
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628107,,14052,,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,10086,Rattus norvegicus,10116.0
22224,Urine,F,,,BAO_0000218,Autocuration,0,U,1088.0,1,,,,CHEMBL628108,,14053,,,Mean urine volume excretion in conscious rats at a dose of 0.3 mg/kg given orally,10086,,
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628109,,14054,,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,10086,Rattus norvegicus,10116.0
22224,Urine,F,,,BAO_0000218,Autocuration,0,U,1088.0,1,,,,CHEMBL625299,,14055,,,Mean urine volume excretion in conscious rats at a dose of 1.0 mg/kg given orally,10086,,
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL625300,,14056,,,Mean urine volume excretion in conscious rats at a dose of 10 mg/kg given orally,10086,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL625301,,14057,,,Mean urine volume excretion in conscious rats at a dose of 100 mg/kg given orally,10086,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL625302,,14058,,,Mean urine volume excretion in conscious rats at a dose of 3.0 mg/kg given orally,10086,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL874649,,14059,,,Mean urine volume excretion in conscious rats at a dose of 30 mg/kg given orally,10086,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625303,,14060,,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes,13248,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625463,,14061,,,In vitro metabolic stability of the test compound was evaluated after incubation in the presence of freshly isolated rat hepatocytes; NA= Not tested,13248,Rattus norvegicus,10116.0
50587,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL625464,,14062,,,In vitro metabolism in human liver microsomes,14527,Homo sapiens,9606.0
50587,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625465,,14063,,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated.,3008,Homo sapiens,9606.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL625466,,14064,,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.06 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL625467,,14065,,,Total electrolytic excretion of chlorine in urine of dogs after peroral administration of 9.6 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL625468,,14066,,,Total electrolytic excretion of chlorine in urine of rats after intravenous administration of 7.94 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL625469,,14067,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 0 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL625470,,14068,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.01 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL632418,,14069,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 1.13 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627250,,14070,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 10.1 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627251,,14071,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 102 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627252,,14072,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 105 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627253,,14073,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 11.3 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627254,,14074,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 113 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL875471,,14075,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 19.5 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627255,,14076,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 195 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627256,,14077,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 21.7 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627257,,14078,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 217 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627258,,14079,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 23.9 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627259,,14080,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 239 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627260,,14081,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 24.9 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623256,,14082,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 249 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL874413,,14083,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 25.9 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623257,,14084,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 259 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623258,,14085,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 26.5 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623259,,14086,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 265 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623260,,14087,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623261,,14088,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 27.9 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623262,,14089,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 270 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623263,,14090,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 279 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623264,,14091,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.2 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623265,,14092,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.22 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623266,,14093,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 28.9 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623267,,14094,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 282 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623268,,14095,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 289 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623269,,14096,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.40 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623270,,14097,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 3.76 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623271,,14098,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 30.2 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623272,,14099,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 302 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623273,,14100,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 31.6 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623274,,14101,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 316 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL874414,,14102,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 32.4 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623275,,14103,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 324 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL629150,,14104,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.0 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623276,,14105,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.1 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623277,,14106,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 34.8 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623112,,14107,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 341 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623113,,14108,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 348 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623800,,14109,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 37.6 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623801,,14110,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 58.4 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL623802,,14111,,,"Biodistribution in uterus / spleen, muscle, lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol",12017,Rattus norvegicus,10116.0
50597,Uterus,A,,,BAO_0000218,Intermediate,1,N,995.0,1,,,In vivo,CHEMBL623803,,14112,,,Biodistribution in uterus of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Uterus,A,,,BAO_0000218,Intermediate,1,N,995.0,1,,,In vivo,CHEMBL623970,,14113,,,Biodistribution in uterus of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Uterus,A,,,BAO_0000218,Intermediate,1,N,995.0,1,,,In vivo,CHEMBL623971,,14114,,,Biodistribution in uterus of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL623972,,14115,,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 10 min post injection (Average of three to five animals),14045,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL623973,,14116,,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 30 min post injection (Average of three to five animals),14045,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL623974,,14117,,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 5 min post injection (Average of three to five animals),14045,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL623975,,14118,,,Biodistribution of 99m Tc complexes in rat and radio activity in blood at 60 min post injection (Average of three to five animals),14045,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL623976,,14119,,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 10 min post injection (Average of three to five animals),14045,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL623977,,14120,,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 30 min post injection (Average of three to five animals),14045,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL623978,,14121,,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 5 min post injection (Average of three to five animals),14045,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL623979,,14122,,,Biodistribution of 99m Tc complexes in rat and radio activity in brain at 60 min post injection (Average of three to five animals),14045,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623980,,14123,,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 10 min post injection (Average of three to five animals),14045,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL623981,,14124,,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 30 min post injection (Average of three to five animals),14045,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626278,,14125,,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 5 min post injection (Average of three to five animals),14045,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626279,,14126,,,Biodistribution of 99m Tc complexes in rat and radio activity in brain/blood at 60 min post injection (Average of three to five animals),14045,Rattus norvegicus,10116.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626280,,14127,,,Biodistribution in mice bladder plus excreted urine was determined,14045,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626281,,14128,,,"Percentage biodistribution in mouse blood, 10 minutes post injection",14045,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626282,,14129,,,"Percentage biodistribution in mouse blood, 30 minutes post injection",14045,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626283,,14130,,,"Percentage biodistribution in mouse blood, 5 minutes post injection",14045,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626284,,14131,,,"Percentage biodistribution in mouse blood, 60 minutes post injection",14045,Mus musculus,10090.0
50594,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL626285,,14132,,,"Percentage biodistribution in mouse brain, 10 minutes post injection",14045,Mus musculus,10090.0
50594,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL626286,,14133,,,"Percentage biodistribution in mouse brain, 30 minutes post injection",14045,Mus musculus,10090.0
50594,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL626287,,14134,,,"Percentage biodistribution in mouse brain, 5 minutes post injection",14045,Mus musculus,10090.0
50594,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,,CHEMBL626288,,14135,,,"Percentage biodistribution in mouse brain, 60 minutes post injection",14045,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626289,,14136,,,"Percentage biodistribution in mouse heart, 10 minutes post injection",14045,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626290,,14137,,,"Percentage biodistribution in mouse heart, 30 minutes post injection",14045,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626291,,14138,,,"Percentage biodistribution in mouse heart, 5 minutes post injection",14045,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL839888,,14139,,,"Percentage biodistribution in mouse heart, 60 minutes post injection",14045,Mus musculus,10090.0
50594,Intestine,A,,,BAO_0000218,Intermediate,1,N,160.0,1,,,,CHEMBL626292,,14140,,,"Percentage biodistribution in mouse intestine, 10 minutes post injection",14045,Mus musculus,10090.0
50594,Intestine,A,,,BAO_0000218,Intermediate,1,N,160.0,1,,,,CHEMBL626293,,14141,,,"Percentage biodistribution in mouse intestine, 30 minutes post injection",14045,Mus musculus,10090.0
50594,Intestine,A,,,BAO_0000218,Intermediate,1,N,160.0,1,,,,CHEMBL626294,,14142,,,"Percentage biodistribution in mouse intestine, 5 minutes post injection",14045,Mus musculus,10090.0
50594,Intestine,A,,,BAO_0000218,Intermediate,1,N,160.0,1,,,,CHEMBL626295,,14143,,,"Percentage biodistribution in mouse intestine, 60 minutes post injection",14045,Mus musculus,10090.0
50594,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL627659,,14144,,,"Percentage biodistribution in mouse liver, 10 minutes post injection",14045,Mus musculus,10090.0
50594,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL627660,,14145,,,"Percentage biodistribution in mouse liver, 30 minutes of post injection",14045,Mus musculus,10090.0
50594,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL627661,,14146,,,"Percentage biodistribution in mouse liver, 5 minutes post injection",14045,Mus musculus,10090.0
50594,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL627662,,14147,,,Biodistribution in mice liver at 60 minutes of post injection,14045,Mus musculus,10090.0
50594,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL627663,,14148,,,Biodistribution in mice lungs at 10 min of post injection,14045,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627664,,14149,,,"Percentage biodistribution in mouse lung, 30 minutes post injection",14045,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL627665,,14150,,,"Percentage biodistribution in mousee lung, 5 minutes post injection",14045,Mus musculus,10090.0
50594,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL627666,,14151,,,Biodistribution in mice lungs at 60 min of post injection,14045,Mus musculus,10090.0
50594,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,,CHEMBL627667,,14152,,,Percentage biodistribution in mouse spleen,14045,Mus musculus,10090.0
50594,Stomach,A,,,BAO_0000218,Intermediate,1,N,945.0,1,,,,CHEMBL627668,,14153,,,Percentage biodistribution in mouse stomach,14045,Mus musculus,10090.0
50594,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627669,,14154,,,Mean biodistribution and elimination data in urine was reported 24 h after administering compound intravenously in tumor-bearing female BALB-C mice.,11745,Mus musculus,10090.0
22224,Urinary bladder,A,,,BAO_0000218,Autocuration,0,U,1255.0,1,,,In vivo,CHEMBL627670,,14155,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bladder,13257,,
22224,Blood,A,,,BAO_0000218,Autocuration,0,U,178.0,1,,,In vivo,CHEMBL627671,,14156,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in blood,13257,,
22224,Bone element,A,,,BAO_0000218,Autocuration,0,U,1474.0,1,,,In vivo,CHEMBL627672,,14157,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in bone,13257,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL627673,,14158,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in fat,13257,,
22224,Kidney,A,,,BAO_0000218,Autocuration,0,U,2113.0,1,,,In vivo,CHEMBL627674,,14159,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in kidney,13257,,
22224,Liver,A,,,BAO_0000218,Autocuration,0,U,2107.0,1,,,In vivo,CHEMBL627675,,14160,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in liver,13257,,
22224,Lung,A,,,BAO_0000218,Autocuration,0,U,2048.0,1,,,In vivo,CHEMBL627676,,14161,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in lung,13257,,
22224,Muscle tissue,A,,,BAO_0000218,Autocuration,0,U,2385.0,1,,,In vivo,CHEMBL627677,,14162,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in muscle,13257,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627678,,14163,,,"Biomolecular rate constant for reactivation and measure of the inherent reactivity of the oximate form of the reactivator in the conditions of 25degreeC,pH 7.6",8354,,
50597,Serum,A,,,BAO_0000218,Intermediate,1,N,1977.0,1,,,,CHEMBL627679,,14164,,,Affinity for protein binding expressed as association constant in fresh rat serum,7095,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627680,,14165,,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,12185,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627681,,14166,,,Kinetic constant (Kcat) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,12185,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627682,,14167,,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation,12185,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627683,,14168,,,Inactivation constant (Kinact) was calculated by inhibition of monoamino oxidase B (MAO B) at saturation; Inactive,12185,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627684,,14169,,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4,12686,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL874441,,14170,,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 2.4; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",12686,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627685,,14171,,,The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; No cyclization detected over 4 h,12686,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627686,,14172,,,"The observed pseudo-first-order rate constants of compound for cyclization reaction at pH 6.8; Significant cyclization occurred during nitro reduction, precluding isolation of the pure amine and determination of rate constants",12686,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627687,,14173,,,Apparent rate constant Koff for inactivation of dTMP synthase.,8057,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627688,,14174,,,The irreversible inhibitor activity by second order rate equation.,15778,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628038,,14175,,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 1 mg/kg concentration,12375,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628039,,14176,,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at 5 mg/kg concentration,12375,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628040,,14177,,,Compound was tested for oral diuretic effect on spontaneously hypertensive rats by measuring the potassium excretion at vehicle concentration,12375,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628041,,14178,,,Dissociation rate calculated from the first-order equation using t1/2 value,13588,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630226,,14179,,,The compound was tested for Binding constant against DNA,15039,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628042,,14180,,,First order rate constant for cyclization of the compound,9500,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625232,,14181,,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,10014,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625233,,14182,,,First order rate constant of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,10014,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625979,,14183,,,Hydrolysis rate constant was determined,568,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625980,,14184,,,Observed first order rate constant,10026,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625981,,14185,,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,10281,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625982,,14186,,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,10281,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625983,,14187,,,Second-order rate constant for attack on PNPA at 25 degree Centigrade,9680,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625984,,14188,,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625985,,14189,,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625986,,14190,,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625987,,14191,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625988,,14192,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625989,,14193,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625990,,14194,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625991,,14195,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625992,,14196,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625993,,14197,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631973,,14198,,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL632143,,14199,,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL632144,,14200,,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL632145,,14201,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL632146,,14202,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL632147,,14203,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL632148,,14204,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL632149,,14205,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL632150,,14206,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL632151,,14207,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,
50587,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL632152,,14208,,,Metabolism (NADH oxidation) by recombinant human NAD(P)H: quinone oxidoreductase (NQO1) is evaluated; not detected,3008,Homo sapiens,9606.0
50587,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL632153,,14209,,,Metabolism after 30 min of incubation with human liver microsomes in the absence of cofactor NADH (2.0 mM) at a concentration of 25 uM,4509,Homo sapiens,9606.0
50587,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL632154,,14210,,,Metabolism after 30 min of incubation with human liver microsomes in the presence of cofactor NADH (2.0 mM) at a concentration of 25 uM,4509,Homo sapiens,9606.0
50602,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL632155,,14211,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Tested mice 10,8613,Human herpesvirus 1,10298.0
50602,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL632156,,14212,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 12.5 mg/kg per day; Total mice tested 10,8613,Human herpesvirus 1,10298.0
50602,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL632157,,14213,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 3.1 mg/kg per day; Tested mice 10,8613,Human herpesvirus 1,10298.0
50602,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL632158,,14214,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Tested mice 10,8613,Human herpesvirus 1,10298.0
50602,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL632159,,14215,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at a dose 50 mg/kg per day; Total mice tested 10,8613,Human herpesvirus 1,10298.0
50602,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626305,,14216,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 0.8 mg/kg per day; Tested mice 10,8613,Human herpesvirus 1,10298.0
50602,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626306,,14217,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered orally at dose 3.1 mg/kg per day; Total mice tested 10,8613,Human herpesvirus 1,10298.0
50602,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626307,,14218,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.02 mg/kg per day; Tested mice 10,8613,Human herpesvirus 1,10298.0
50602,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626308,,14219,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.06 mg/kg per day; Tested mice 10,8613,Human herpesvirus 1,10298.0
50602,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626479,,14220,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 0.25 mg/kg per day; Tested mice 10,8613,Human herpesvirus 1,10298.0
50602,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626480,,14221,,,Efficacy was evaluated against Oraficial HSV-1 infection in mice with lesions administered topically at a dose 1 mg/kg per day; Tested mice 10,8613,Human herpesvirus 1,10298.0
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL626481,,14222,,,Calculated partition coefficient (clogP) (MlogP),6021,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL626482,,14223,,,Equipotent potent ratio relative to carbachol (nicotinic activity),9348,,
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626483,,14224,,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 ); NA denotes not available",15592,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626484,,14225,,,"Concentration after 8 hour (bioavailability in dog, compound was delivered orally in 0.05 M citric acid at 10 mg/Kg. n=2 );NA denotes not available",15592,Canis lupus familiaris,9615.0
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL626485,,14226,,,Solubility at pH 7.4 in micro g/mL;NA denotes available,15592,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL626486,,14227,,,Solubility at pH 7.4 in micro g/mL;NA denotes not available,15592,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL626487,,14228,,,Solubility at pH 7.4 in ug/mL;NA denotes not available,15592,,
50588,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,In vivo,CHEMBL626488,,14229,,,Maximal plasma concentration in dogs at 10mg/kg oral dose 0.05M citric acid,15592,Canis lupus familiaris,9615.0
50597,Serum,A,,,BAO_0000218,Intermediate,1,N,1977.0,1,,,,CHEMBL626489,,14230,,,Affinity for protein binding expressed as association constant in fresh rat serum; ND is Not Determined.,7095,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL626490,,14231,,,Area under the MAP curve measured over 5 min; ND means Not determined,16618,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL626491,,14232,,,Lipophilicity expressed as the negative logarithm of the equilibrium constant; ND denotes no data.,16835,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL626492,,14233,,,The apparent partition coefficient(D) in cyclohexane-0.05 M phosphate buffer (pH 7.4) at 21 degree celsius; not determined,15284,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL626493,,14234,,,Half-life was measured in the presence of NADPH at 20 uM; No inhibition,15750,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626494,,14235,,,Half life after oral administration to Sprague-Dawley rats; NT is Not tested,16618,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626495,,14236,,,Half life after oral tested,16618,,
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626496,,14237,,,Half life was determined in plasma of rat; NT indicates not tested,15812,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL626497,,14238,,,Oral bioavailability after oral administration to Sprague-Dawley rats; NT is Not tested,16618,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL626498,,14239,,,Oral bioavailability after oral tested,16618,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626499,,14240,,,The bioavailability in rats at 15.9 uM/Kg after intravenous administration; NT=Not tested (F),13098,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626500,,14241,,,The compound was tested for volume of distribution in rat at 15.9 uM/Kg after peroral administration; NT=Not tested (Vd L/Kg),13098,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626501,,14242,,,half life was determined in plasma of rat; NT indicates not tested,15812,Rattus norvegicus,10116.0
50597,Plasma,A,,,BAO_0000218,Intermediate,1,N,1969.0,1,,,,CHEMBL626502,,14243,,,half life was determined in plasma of rat; NT means not tested,15812,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626503,,14244,,,Mean sodium excretion in rats (Control/Drug treatment value); Value 0.41/2.32,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626504,,14245,,,Mean sodium excretion in rats (Control/Drug treatment value); inactive,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626505,,14246,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.17/0.43,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626506,,14247,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.2/0.38,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626507,,14248,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.26/0.23,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626508,,14249,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.28/0.26,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626509,,14250,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.31/0.35,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL875480,,14251,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.35/2.88,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626510,,14252,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.29,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626511,,14253,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.47,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL626512,,14254,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.36/0.49,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628208,,14255,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.38/0.23,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628209,,14256,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.39/0.22,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628210,,14257,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/0.48,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628211,,14258,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/1.49,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628212,,14259,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.41/2.06,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628213,,14260,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.42/0.65,11510,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628214,,14261,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 65.2 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628215,,14262,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.6 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628216,,14263,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 71.8 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL626595,,14264,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 74.8 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL626596,,14265,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 77.5 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL626597,,14266,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 79.4 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL626598,,14267,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 80.9 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622242,,14268,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 83.8 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622243,,14269,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.5 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622244,,14270,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 84.7 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622245,,14271,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.7 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622246,,14272,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 86.9 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622247,,14273,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 9.06 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622248,,14274,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 90.6 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL877483,,14275,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 94.9 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622249,,14276,,,Total electrolytic excretion of chlorine in urine of rats after peroral administration of 97.1 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622250,,14277,,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622251,,14278,,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622252,,14279,,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622253,,14280,,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622254,,14281,,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622255,,14282,,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622256,,14283,,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622257,,14284,,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622258,,14285,,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622259,,14286,,,Total electrolytic excretion of potassium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622927,,14287,,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622928,,14288,,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL622929,,14289,,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623182,,14290,,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.06 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623183,,14291,,,Total electrolytic excretion of potassium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623184,,14292,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 0 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623185,,14293,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.01 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL877484,,14294,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 1.13 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627274,,14295,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 10.1 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623186,,14296,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 102 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623187,,14297,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 105 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL623188,,14298,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 11.3 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628055,,14299,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 113 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628056,,14300,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 19.5 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628200,,14301,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 195 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628201,,14302,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 21.7 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628202,,14303,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 217 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628203,,14304,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 23.9 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628204,,14305,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 239 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628205,,14306,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 24.9 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628206,,14307,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 249 uM/Kg of drug,12582,Rattus norvegicus,10116.0
22224,Prostate gland,A,,,BAO_0000218,Autocuration,0,U,2367.0,1,,,In vivo,CHEMBL628207,,14308,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d),13257,,
22224,Prostate gland,A,,,BAO_0000218,Autocuration,0,U,2367.0,1,,,In vivo,CHEMBL627220,,14309,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/biood,13257,,
22224,Muscle tissue,A,,,BAO_0000218,Autocuration,0,U,2385.0,1,,,In vivo,CHEMBL627221,,14310,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (d)/muscle,13257,,
22224,Prostate gland,A,,,BAO_0000218,Autocuration,0,U,2367.0,1,,,In vivo,CHEMBL627222,,14311,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v),13257,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL627223,,14312,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/blood,13257,,
22224,Muscle tissue,A,,,BAO_0000218,Autocuration,0,U,2385.0,1,,,In vivo,CHEMBL632062,,14313,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in prostate (v)/muscle,13257,,
22224,Spleen,A,,,BAO_0000218,Autocuration,0,U,2106.0,1,,,In vivo,CHEMBL632063,,14314,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 1 hour in spleen,13257,,
22224,Urinary bladder,A,,,BAO_0000218,Autocuration,0,U,1255.0,1,,,In vivo,CHEMBL632064,,14315,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bladder,13257,,
22224,Blood,A,,,BAO_0000218,Autocuration,0,U,178.0,1,,,In vivo,CHEMBL632065,,14316,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in blood,13257,,
22224,Bone element,A,,,BAO_0000218,Autocuration,0,U,1474.0,1,,,In vivo,CHEMBL632066,,14317,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in bone,13257,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL632067,,14318,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in fat,13257,,
22224,Kidney,A,,,BAO_0000218,Autocuration,0,U,2113.0,1,,,In vivo,CHEMBL629188,,14319,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in kidney,13257,,
22224,Liver,A,,,BAO_0000218,Autocuration,0,U,2107.0,1,,,In vivo,CHEMBL629189,,14320,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in liver,13257,,
22224,Lung,A,,,BAO_0000218,Autocuration,0,U,2048.0,1,,,In vivo,CHEMBL629190,,14321,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in lung,13257,,
22224,Muscle tissue,A,,,BAO_0000218,Autocuration,0,U,2385.0,1,,,In vivo,CHEMBL629191,,14322,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in muscle,13257,,
22224,Prostate gland,A,,,BAO_0000218,Autocuration,0,U,2367.0,1,,,In vivo,CHEMBL629192,,14323,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d),13257,,
22224,Muscle tissue,A,,,BAO_0000218,Autocuration,0,U,2385.0,1,,,In vivo,CHEMBL629193,,14324,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (d)/muscle,13257,,
22224,Prostate gland,A,,,BAO_0000218,Autocuration,0,U,2367.0,1,,,In vivo,CHEMBL629194,,14325,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v),13257,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL629195,,14326,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/blood,13257,,
22224,Muscle tissue,A,,,BAO_0000218,Autocuration,0,U,2385.0,1,,,In vivo,CHEMBL629373,,14327,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in prostate (v)/muscle,13257,,
22224,Spleen,A,,,BAO_0000218,Autocuration,0,U,2106.0,1,,,In vivo,CHEMBL629374,,14328,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked) in spleen,13257,,
22224,Prostate gland,A,,,BAO_0000218,Autocuration,0,U,2367.0,1,,,In vivo,CHEMBL629375,,14329,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (blocked)i n prostate (d)/biood,13257,,
22224,Urinary bladder,A,,,BAO_0000218,Autocuration,0,U,1255.0,1,,,In vivo,CHEMBL629376,,14330,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bladder,13257,,
22224,Blood,A,,,BAO_0000218,Autocuration,0,U,178.0,1,,,In vivo,CHEMBL629377,,14331,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in blood,13257,,
22224,Bone element,A,,,BAO_0000218,Autocuration,0,U,1474.0,1,,,In vivo,CHEMBL629378,,14332,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in bone,13257,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL629379,,14333,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in fat,13257,,
22224,Kidney,A,,,BAO_0000218,Autocuration,0,U,2113.0,1,,,In vivo,CHEMBL629151,,14334,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in kidney,13257,,
22224,Liver,A,,,BAO_0000218,Autocuration,0,U,2107.0,1,,,In vivo,CHEMBL629152,,14335,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in liver,13257,,
22224,Lung,A,,,BAO_0000218,Autocuration,0,U,2048.0,1,,,In vivo,CHEMBL629153,,14336,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in lung,13257,,
22224,Muscle tissue,A,,,BAO_0000218,Autocuration,0,U,2385.0,1,,,In vivo,CHEMBL629154,,14337,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in muscle,13257,,
22224,Prostate gland,A,,,BAO_0000218,Autocuration,0,U,2367.0,1,,,In vivo,CHEMBL629155,,14338,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d),13257,,
22224,Prostate gland,A,,,BAO_0000218,Autocuration,0,U,2367.0,1,,,In vivo,CHEMBL629156,,14339,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/biood,13257,,
22224,Muscle tissue,A,,,BAO_0000218,Autocuration,0,U,2385.0,1,,,In vivo,CHEMBL629157,,14340,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (d)/muscle,13257,,
22224,Prostate gland,A,,,BAO_0000218,Autocuration,0,U,2367.0,1,,,In vivo,CHEMBL629158,,14341,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v),13257,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL629159,,14342,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/blood,13257,,
22224,Muscle tissue,A,,,BAO_0000218,Autocuration,0,U,2385.0,1,,,In vivo,CHEMBL629160,,14343,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in prostate (v)/muscle,13257,,
22224,Spleen,A,,,BAO_0000218,Autocuration,0,U,2106.0,1,,,In vivo,CHEMBL629161,,14344,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour (low) in spleen,13257,,
22224,Urinary bladder,A,,,BAO_0000218,Autocuration,0,U,1255.0,1,,,In vivo,CHEMBL629162,,14345,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bladder,13257,,
22224,Blood,A,,,BAO_0000218,Autocuration,0,U,178.0,1,,,In vivo,CHEMBL629163,,14346,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in blood,13257,,
22224,Bone element,A,,,BAO_0000218,Autocuration,0,U,1474.0,1,,,In vivo,CHEMBL629164,,14347,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in bone,13257,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL629165,,14348,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in fat,13257,,
22224,Liver,A,,,BAO_0000218,Autocuration,0,U,2107.0,1,,,In vivo,CHEMBL629166,,14349,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in liver,13257,,
22224,Lung,A,,,BAO_0000218,Autocuration,0,U,2048.0,1,,,In vivo,CHEMBL629167,,14350,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in lung,13257,,
22224,Muscle tissue,A,,,BAO_0000218,Autocuration,0,U,2385.0,1,,,In vivo,CHEMBL629168,,14351,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in muscle,13257,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629169,,14352,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM,2193,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629170,,14353,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 100 uM; no inhibition is observed at this concentration,2193,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631153,,14354,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM,2193,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL875121,,14355,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 10 uM; too active and complete inhibition is observed,2193,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631154,,14356,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM,2193,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631155,,14357,,,Compound was tested for the pseudo first-order rate constants for the inhibition of the cleavage step (k2) of the hammerhead ribozyme at a concentration of 1 uM; too active and complete inhibition is observed,2193,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631156,,14358,,,Hydrolysis rate constant was determined,568,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631157,,14359,,,"K2, The intrinsic biomolecular reactivation rate constant on VX at 25 degree Centigrade",9680,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631158,,14360,,,"K2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",9680,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631159,,14361,,,"K2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",9680,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631160,,14362,,,Observed second order rate constant,10026,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631161,,14363,,,Rate constant (cyclization rate) in CD3CN-deuterated phosphate buffer at pH 7.4,10281,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631162,,14364,,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 24 degree celsius,10014,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630313,,14365,,,Rate constant for decay of compound was determined in 50 mM phosphate buffer (pH 7.4) at 37 degree celsius,10014,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630314,,14366,,,"k2, The intrinsic biomolecular reactivation rate constant on paraxon at 25 degree Centigrade",9680,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630315,,14367,,,"k2, The intrinsic biomolecular reactivation rate constant on sarin at 25 degree Centigrade",9680,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630316,,14368,,,Kinetic parameter of epimerization at a salt concentration (0.01 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630986,,14369,,,Kinetic parameter of epimerization at a salt concentration (0.1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630987,,14370,,,Kinetic parameter of epimerization at a salt concentration (1 M) of in Tris.HCl buffer(pH 9.0) and 37 degree C (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630988,,14371,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.0(or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630989,,14372,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 10.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630990,,14373,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 11.3 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630991,,14374,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 7.5 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630992,,14375,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 8.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630993,,14376,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.0 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630994,,14377,,,Kinetic parameter of epimerization in Tris.HCl buffer at a pH 9.6 (or )in RMPI 1640 cell culture medium containing 10%FCS,13028,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630995,,14378,,,Rate constants of compound was determined at muscarinic receptor in the rat cerebral cortex,10014,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629252,,14379,,,Association constant for compound at 31 degree C was determined,9962,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629253,,14380,,,Calculated antagonist equilibrium dissociation constant of the compound,12029,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629944,,14381,,,Calculated antagonist equilibrium dissociation constant of the compound; No statistically significant antagonism observed,12029,,
50512,Trachea,A,,,BAO_0000218,Intermediate,1,N,3126.0,1,,,,CHEMBL629945,,14382,,,Dissociation constants vs LTE4 on guinea pig trachea,10583,Cavia porcellus,10141.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629946,,14383,,,"Tested for hydrolysis in presence of boric acid by UV spectrophotometry, dissociation constant was evaluated at the pH < 8",568,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629947,,14384,,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 8.5",568,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629948,,14385,,,"Tested for hydrolysis in presence of boric acid, rate constant was evaluated at the pH 9.5",568,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL856024,,14386,,,"Tested for hydrolysis in presence of phenylboronic acid, rate constant was evaluated at the pH 9.5",568,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629949,,14387,,,Affinity constant KD value was derived from TMP,7493,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629950,,14388,,,Apparent dissociation (binding) rate constant was evaluated,8371,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL630127,,14389,,,Dissociation constant (KD) of the compound,13114,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL630128,,14390,,,Dissociation constant determined by heteronuclear 1H/15N correlation NMR spectroscopy,15515,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL630129,,14391,,,Dissociation constant from ESR titration experiments,522,,
22224,,,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630130,,14392,,,Dissociation constant was evaluated which is similar to Ki (inhibitory constant),13888,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL875234,,14393,,,Dissociation constant was evaluated.,2616,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL630131,,14394,,,Dissociation constant was reported,3798,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630132,,14395,,,Dissociation constant was determined in rat pituitary cells.,8731,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630133,,14396,,,Equilibrium dissociation constant of CA complex for enantiomer 1 of compound,11892,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630134,,14397,,,Equilibrium dissociation constant of CA complex for enantiomer 2 of compound,11892,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630135,,14398,,,Equilibrium dissociation constant of the compound,2582,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630136,,14399,,,Equilibrium dissociation constant was determined,11892,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630137,,14400,,,Kinetic constant KD was evaluated,13396,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630138,,14401,,,Tested for dissociation constant of the compound; Value ranges from 0.1-0.3,603,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630139,,14402,,,Equilibrium association constant interacting with unilamellar vesicles of electroneutral in PBS buffer at pH 7.4,15673,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630140,,14403,,,Rate constant for hydrolysis in aqueous acetone.,10368,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL875235,,14404,,,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,14228,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL876439,,14405,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.43/2.86,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630605,,14406,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.44/2.68,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630606,,14407,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.45/1.55,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630607,,14408,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.48/0.95,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630608,,14409,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.5/1.79,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630609,,14410,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.51/0.66,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630610,,14411,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.52/2.02,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630611,,14412,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.61//0.37,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629552,,14413,,,Mean sodium excretion in rats (Control/Drug treatment value); value 0.71/0.36,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629733,,14414,,,Mean sodium excretion in rats when compound administered at 0 mg/kg po and vehicle dosed at 0 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629734,,14415,,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 30.23 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629735,,14416,,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 33.59 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629736,,14417,,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 37.13 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629737,,14418,,,Mean sodium excretion in rats when compound administered at 10 mg/kg po and vehicle dosed at 39.48 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629738,,14419,,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 483.72 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629739,,14420,,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629740,,14421,,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 594.07 umol/kg; Not determined,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629741,,14422,,,Mean sodium excretion in rats when compound administered at 160 mg/kg po and vehicle dosed at 631.76 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629742,,14423,,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 7.56 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629743,,14424,,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 8.4 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629744,,14425,,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.28 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629745,,14426,,,Mean sodium excretion in rats when compound administered at 2.5 mg/kg po and vehicle dosed at 9.87 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629746,,14427,,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 60.46 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629747,,14428,,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 67.18 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629748,,14429,,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 74.26 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629749,,14430,,,Mean sodium excretion in rats when compound administered at 20 mg/kg po and vehicle dosed at 78.97 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629750,,14431,,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 120.93 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629751,,14432,,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 134.35 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629752,,14433,,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 148.52 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629753,,14434,,,Mean sodium excretion in rats when compound administered at 40 mg/kg po and vehicle dosed at 157.94 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629754,,14435,,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 15.12 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629755,,14436,,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 16.79 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629756,,14437,,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 18.56 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629757,,14438,,,Mean sodium excretion in rats when compound administered at 5 mg/kg po and vehicle dosed at 19.74 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629758,,14439,,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 241.86 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629759,,14440,,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 268.71 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629760,,14441,,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 297.03 umol/kg,11510,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL876443,,14442,,,Mean sodium excretion in rats when compound administered at 80 mg/kg po and vehicle dosed at 315.88 umol/kg,11510,Rattus norvegicus,10116.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629761,,14443,,,Na+ excretion mequiv /kg in 6 conscious female dogs administered perorally during 0-6 hr,8310,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629762,,14444,,,Na+ excretion mequiv /kg in conscious female dogs administered perorally during 0-6 hr,8310,Canis lupus familiaris,9615.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629763,,14445,,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,8310,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629764,,14446,,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,8310,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629765,,14447,,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 2 ml/kg perorally,8310,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629766,,14448,,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 50 ml/kg perorally,8310,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629767,,14449,,,Na+ excretion mequiv /kg in saline-loaded mice administered at a dose 10 ml/kg perorally,8310,Mus musculus,10090.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629768,,14450,,,Na+ excretion mequiv/kg in 4 conscious female dogs administered perorally during 0-6 hr,8310,Canis lupus familiaris,9615.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629769,,14451,,,Na+ excretion mequiv/kg in 4 saline-loaded mice administered at a dose 50 ml/kg perorally,8310,Mus musculus,10090.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629770,,14452,,,Na+ excretion mequiv/kg in 6 conscious female dogs administered perorally during 0-6 hr,8310,Canis lupus familiaris,9615.0
50588,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629771,,14453,,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 0.3 ml/kg perorally,8310,Canis lupus familiaris,9615.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629772,,14454,,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,8310,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL629773,,14455,,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 10 ml/kg perorally,8310,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625455,,14456,,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 2 ml/kg perorally,8310,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625456,,14457,,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 250 ml/kg perorally,8310,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625457,,14458,,,Na+ excretion mequiv/kg in saline-loaded mice administered at a dose 3 ml/kg perorally,8310,Mus musculus,10090.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL625458,,14459,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 25.9 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL625459,,14460,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 259 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL875483,,14461,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 26.5 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL634779,,14462,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 265 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL625460,,14463,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL626117,,14464,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 27.9 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL626118,,14465,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 270 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628342,,14466,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 279 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628343,,14467,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.2 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628344,,14468,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.22 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628345,,14469,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 28.9 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628346,,14470,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 282 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628347,,14471,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 289 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628348,,14472,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.40 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628349,,14473,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 3.76 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL875611,,14474,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 30.2 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628350,,14475,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 302 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628351,,14476,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 31.6 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628352,,14477,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 316 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628353,,14478,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 32.4 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628354,,14479,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 324 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL626667,,14480,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.0 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL626668,,14481,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.1 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL626669,,14482,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 34.8 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL626670,,14483,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 341 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL626671,,14484,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 348 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL626672,,14485,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 37.6 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL626673,,14486,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 50.8 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL626674,,14487,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 58.4 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL626675,,14488,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 65.2 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL626676,,14489,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 68.1 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL626677,,14490,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 7.94 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL626678,,14491,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.6 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL626679,,14492,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 71.8 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL875612,,14493,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 74.8 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL626680,,14494,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 77.5 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL626681,,14495,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 79.4 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL626682,,14496,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 80.9 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL626683,,14497,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 83.8 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL626684,,14498,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.5 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL626685,,14499,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 84.7 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL626686,,14500,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.7 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL626687,,14501,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 86.9 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL624978,,14502,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 9.06 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL624979,,14503,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 90.6 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL624980,,14504,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 94.9 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL624981,,14505,,,Total electrolytic excretion of potassium in urine of rats after peroral administration of 97.1 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL624982,,14506,,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 52.4 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
22224,Prostate gland,A,,,BAO_0000218,Autocuration,0,U,2367.0,1,,,In vivo,CHEMBL627564,,14507,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d),13257,,
22224,Prostate gland,A,,,BAO_0000218,Autocuration,0,U,2367.0,1,,,In vivo,CHEMBL627565,,14508,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v),13257,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL627566,,14509,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/blood,13257,,
22224,Muscle tissue,A,,,BAO_0000218,Autocuration,0,U,2385.0,1,,,In vivo,CHEMBL627567,,14510,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (v)/muscle,13257,,
22224,Spleen,A,,,BAO_0000218,Autocuration,0,U,2106.0,1,,,In vivo,CHEMBL627568,,14511,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in spleen,13257,,
22224,Kidney,A,,,BAO_0000218,Autocuration,0,U,2113.0,1,,,In vivo,CHEMBL627569,,14512,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hr in kidney,13257,,
22224,Urinary bladder,A,,,BAO_0000218,Autocuration,0,U,1255.0,1,,,In vivo,CHEMBL627570,,14513,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bladder,13257,,
22224,Blood,A,,,BAO_0000218,Autocuration,0,U,178.0,1,,,In vivo,CHEMBL627571,,14514,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in blood,13257,,
22224,Bone element,A,,,BAO_0000218,Autocuration,0,U,1474.0,1,,,In vivo,CHEMBL627572,,14515,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in bone,13257,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL627573,,14516,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in fat,13257,,
22224,Kidney,A,,,BAO_0000218,Autocuration,0,U,2113.0,1,,,In vivo,CHEMBL627574,,14517,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in kidney,13257,,
22224,Liver,A,,,BAO_0000218,Autocuration,0,U,2107.0,1,,,In vivo,CHEMBL627575,,14518,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in liver,13257,,
22224,Lung,A,,,BAO_0000218,Autocuration,0,U,2048.0,1,,,In vivo,CHEMBL627576,,14519,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in lung,13257,,
22224,Muscle tissue,A,,,BAO_0000218,Autocuration,0,U,2385.0,1,,,In vivo,CHEMBL627577,,14520,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in muscle,13257,,
22224,Prostate gland,A,,,BAO_0000218,Autocuration,0,U,2367.0,1,,,In vivo,CHEMBL627578,,14521,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d),13257,,
22224,Prostate gland,A,,,BAO_0000218,Autocuration,0,U,2367.0,1,,,In vivo,CHEMBL627579,,14522,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/biood,13257,,
22224,Muscle tissue,A,,,BAO_0000218,Autocuration,0,U,2385.0,1,,,In vivo,CHEMBL627580,,14523,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (d)/muscle,13257,,
22224,Prostate gland,A,,,BAO_0000218,Autocuration,0,U,2367.0,1,,,In vivo,CHEMBL627581,,14524,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v),13257,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL627582,,14525,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/blood,13257,,
22224,Muscle tissue,A,,,BAO_0000218,Autocuration,0,U,2385.0,1,,,In vivo,CHEMBL627583,,14526,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in prostate (v)/muscle,13257,,
22224,Spleen,A,,,BAO_0000218,Autocuration,0,U,2106.0,1,,,In vivo,CHEMBL627584,,14527,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 4 hour in spleen,13257,,
22224,Prostate gland,A,,,BAO_0000218,Autocuration,0,U,2367.0,1,,,In vivo,CHEMBL627585,,14528,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/biood,13257,,
22224,Muscle tissue,A,,,BAO_0000218,Autocuration,0,U,2385.0,1,,,In vivo,CHEMBL627586,,14529,,,%ID/g is percent injected dose per gram of tissue and in vivo distribution of compound obtained after 2 hour in prostate (d)/muscle,13257,,
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627587,,14530,,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 200 nmol of WAY 100635,15413,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL627588,,14531,,,Biodistribution of the Radiolabeled FBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,15413,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628250,,14532,,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 200 nmol of WAY 100635,15413,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628251,,14533,,,Biodistribution of the Radiolabeled FBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,15413,Rattus norvegicus,10116.0
50597,Hippocampus,A,,,BAO_0000218,Intermediate,1,N,10000000.0,1,,,In vivo,CHEMBL628252,,14534,,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 200 nmol of WAY 100635,15413,Rattus norvegicus,10116.0
50597,Hippocampus,A,,,BAO_0000218,Intermediate,1,N,10000000.0,1,,,In vivo,CHEMBL628253,,14535,,,Biodistribution of the Radiolabeled FBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,15413,Rattus norvegicus,10116.0
50597,Hypothalamus,A,,,BAO_0000218,Intermediate,1,N,1898.0,1,,,In vivo,CHEMBL628254,,14536,,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 200 nmol of WAY 100635,15413,Rattus norvegicus,10116.0
50597,Hypothalamus,A,,,BAO_0000218,Intermediate,1,N,1898.0,1,,,In vivo,CHEMBL877493,,14537,,,Biodistribution of the Radiolabeled FBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,15413,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628255,,14538,,,Biodistribution of the Radiolabeled FCWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,15413,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628256,,14539,,,Biodistribution of the Radiolabeled FCWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,15413,Rattus norvegicus,10116.0
50597,Hippocampus,A,,,BAO_0000218,Intermediate,1,N,10000000.0,1,,,In vivo,CHEMBL628257,,14540,,,Biodistribution of the Radiolabeled FCWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,15413,Rattus norvegicus,10116.0
50597,Hypothalamus,A,,,BAO_0000218,Intermediate,1,N,1898.0,1,,,In vivo,CHEMBL628258,,14541,,,Biodistribution of the Radiolabeled FCWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635,15413,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628259,,14542,,,Biodistribution of the Radiolabeled MeFBWAY compound in rat Cerebellum at 30 min co-injected with 50 nmol of WAY 100635,15413,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628429,,14543,,,Biodistribution of the Radiolabeled MeFBWAY compound in rat cortex at 30 min co-injected with 50 nmol of WAY 100635,15413,Rattus norvegicus,10116.0
50597,Hippocampus,A,,,BAO_0000218,Intermediate,1,N,10000000.0,1,,,In vivo,CHEMBL626862,,14544,,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hippocampus at 30 min co-injected with 50 nmol of WAY 100635,15413,Rattus norvegicus,10116.0
50597,Hypothalamus,A,,,BAO_0000218,Intermediate,1,N,1898.0,1,,,In vivo,CHEMBL626863,,14545,,,Biodistribution of the Radiolabeled MeFBWAY compound in rat hypothalamus at 30 min co-injected with 50 nmol of WAY 100635; Not determined,15413,Rattus norvegicus,10116.0
50597,Cerebellum,A,,,BAO_0000218,Intermediate,1,N,2037.0,1,,,In vivo,CHEMBL625886,,14546,,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum,15413,Rattus norvegicus,10116.0
50597,Cerebellum,A,,,BAO_0000218,Intermediate,1,N,2037.0,1,,,In vivo,CHEMBL625887,,14547,,,Biodistribution of the [11C]-radiolabeled compound in rat cerebellum co-injected with 50 nM of WAY 100635.,15413,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625888,,14548,,,Biodistribution of the [11C]-radiolabeled compound in rat cortex,15413,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625889,,14549,,,Biodistribution of the [11C]-radiolabeled compound in rat cortex co-injected with 50 nM of WAY 100635.,15413,Rattus norvegicus,10116.0
50597,Hippocampus,A,,,BAO_0000218,Intermediate,1,N,10000000.0,1,,,In vivo,CHEMBL625890,,14550,,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus,15413,Rattus norvegicus,10116.0
50597,Hippocampus,A,,,BAO_0000218,Intermediate,1,N,10000000.0,1,,,In vivo,CHEMBL625891,,14551,,,Biodistribution of the [11C]-radiolabeled compound in rat hippocampus co-injected with 50 nM of WAY 100635.,15413,Rattus norvegicus,10116.0
50597,Hypothalamus,A,,,BAO_0000218,Intermediate,1,N,1898.0,1,,,In vivo,CHEMBL625892,,14552,,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus,15413,Rattus norvegicus,10116.0
50597,Hypothalamus,A,,,BAO_0000218,Intermediate,1,N,1898.0,1,,,In vivo,CHEMBL625893,,14553,,,Biodistribution of the [11C]-radiolabeled compound in rat hypothalamus co-injected with 50 nM of WAY 100635.,15413,Rattus norvegicus,10116.0
50597,Cerebellum,A,,,BAO_0000218,Intermediate,1,N,2037.0,1,,,In vivo,CHEMBL625894,,14554,,,Biodistribution of the [18F]-radiolabeled compound in rat cerebellum,15413,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL625895,,14555,,,Biodistribution of the [18F]-radiolabeled compound in rat cortex,15413,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625896,,14556,,,Reaction rate parameter value for phosphate with transfer with respect to ATP,12404,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625897,,14557,,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 8.5(Apparent inhibition constant)",568,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625898,,14558,,,"Tested for hydrolysis in presence of boric acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",568,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL625899,,14559,,,"Tested for hydrolysis in presence of phenylboronic acid, dissociation constant was evaluated at the pH 9.5(Apparent inhibition constant)",568,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL626124,,14560,,,Reaction rate parameter value for phosphate with transfer with respect to ATP,12404,,
50212,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628500,,14561,,,Ability to inhibit Escherichia coli adenylate kinase II activity expressed as half maximal velocity,7624,Escherichia coli,562.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL857856,,14562,,,"Ability to inhibit rat adenylate kinase II, activity expressed as half-maximal velocity",7624,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628501,,14563,,,"Ability to inhibit rat adenylate kinase III, activity expressed as half-maximal velocity",7624,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628502,,14564,,,"Compound was evaluated for the Michaelis-Menten constant, Km in a generic protein phosphatase stopped assay system",4643,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628503,,14565,,,Kinetic parameter KM (nM) for the MAO-B catalyzed oxidation of the compound.,11532,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628504,,14566,,,Kinetic parameter KM at pH 7.4 and 37 degree Centigrade,11018,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628505,,14567,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",2276,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL874452,,14568,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as KM",2276,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628506,,14569,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as KM; Not determined",2276,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628507,,14570,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as KM; Not determined",2276,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628508,,14571,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as KM",2276,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628509,,14572,,,Michaelis constant (KM) was evaluated,8949,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628510,,14573,,,Reaction rate parameter value for phosphate with transfer with respect to ATP,12404,,
22224,,B,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628511,,14574,,,Substrate concentration for half maximal velocity was reported for rat hexokinase I,7625,,
22224,,B,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628512,,14575,,,Substrate concentration for half maximal velocity was reported for rat hexokinase II,7625,,
22224,,B,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628513,,14576,,,Substrate concentration for half maximal velocity was reported for rat hexokinase III,7625,,
22224,,B,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628514,,14577,,,Substrate concentration for half maximal velocity was reported for yeast hexokinase,7625,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628515,,14578,,,Pseudo-first-order rate constant for alkylation of NBP in 50% aqueous acetone at 66 degrees celsius with 50 uM and 25 uM of NBP.,12908,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628516,,14579,,,Rate constant for alkylation of 4-(4-nitrobenzyl)pyridine,10368,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628517,,14580,,,Bimolecular rate constant (KOH) at 25 degree C (m = 0.5),13108,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628518,,14581,,,its bimolecular rate constant (KOH) at 25 degree C (m = 0.5),13108,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628519,,14582,,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer,15217,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628520,,14583,,,Acid dissociation constant evaluated towards Hematin mu-oxo dimer; Not available,15217,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628521,,14584,,,Binding constant was determined,10933,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630443,,14585,,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree Centigrade,2363,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630444,,14586,,,Alkylation of 4-(4-nitrobenzyl)pyridine (NBP) by the compound at a temperature of 66 degree centigrade; Not determined,2363,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL857732,,14587,,,Rate constant with triethylamine at 30 degree C in 0.1 M potassium chloride was expressed as Kamine,2276,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL630445,,14588,,,Octanol-water apparent distribution coefficient measured in TRIS buffer at a pH 7.4.,14915,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630446,,14589,,,Catalytic rate constant of the compound,8847,,
22224,,B,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630447,,14590,,,inactivation rate constant calculated from experimental IC50 value for dipeptidyl peptidase IV inhibition,15357,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630448,,14591,,,Catalytic constant expressed as Kinetic behavior of enzyme (PicK/6-His),2869,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630449,,14592,,,Catalytic rate constant against phospholipase A2 was determined,3484,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630450,,14593,,,"Compound was evaluated for catalytic constant, Kcat",1373,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630451,,14594,,,Compound was tested for hydrolysis by acetylcholinesterase and the kinetic constant (kcat) which is a first-order rate constant was determined,8142,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630452,,14595,,,Kcat calculated from 0.693/T1/2,14131,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630453,,14596,,,Kcat was determined,17269,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630454,,14597,,,Kcat against class A PCI beta-lactamase catalyzed lactone hydrolysis,3485,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630455,,14598,,,Kcat against class A TEM beta-lactamase catalyzed lactone hydrolysis,3485,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631487,,14599,,,Kcat against class C P99 beta-lactamase catalyzed lactone hydrolysis,3485,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631488,,14600,,,Kcat value was determined,5962,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL876440,,14601,,,Kinetic constant for the hydrolysis by the catalyst CPA was evaluated,3133,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631489,,14602,,,Kinetic constant for the hydrolysis by the catalyst McAbIIF9D8 was evaluated,3133,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL857742,,14603,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",2276,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631490,,14604,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat",2276,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631491,,14605,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat; Not determined",2276,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631492,,14606,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat; Not determined",2276,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631493,,14607,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat",2276,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631494,,14608,,,Kinetic parameter for rate of conversion to PABA was determined,4892,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631495,,14609,,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,3133,,
50597,Feces,A,,,BAO_0000218,Intermediate,1,N,1988.0,1,,,,CHEMBL631496,,14610,,,"Compound was evaluated for the percentage of feces excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",11488,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631497,,14611,,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 0-24 hr",11488,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631498,,14612,,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after intravenous administration of compound dose (1 mg/kg) at 24-48 hr",11488,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL629776,,14613,,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 0-24 hr",11488,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL629777,,14614,,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 24-48 hr",11488,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL629778,,14615,,,"Compound was evaluated for the percentage of urine excretion of radioactivity, by male Sprague-Dawley rats after oral administration of compound dose (1 mg/kg) at 48-72 hr",11488,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630456,,14616,,,Cumulative dose excreted after intraduodenal administration at 0-0.5 hours in rats,11488,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630457,,14617,,,Cumulative dose excreted after intraduodenal administration at 0.5-1.0 hours in rats,11488,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630458,,14618,,,Cumulative dose excreted after intraduodenal administration at 1.0-1.5 hours in rats,11488,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630459,,14619,,,Cumulative dose excreted after intraduodenal administration at 1.5-2.0 hours in rats,11488,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630460,,14620,,,Cumulative dose excreted after intraduodenal administration at 2-3 hours in rats,11488,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL876550,,14621,,,Cumulative dose excreted after intraduodenal administration at 3-4 hours in rats,11488,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630461,,14622,,,Cumulative dose excreted after intraduodenal administration at 4-6 hours in rats,11488,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630462,,14623,,,Cumulative dose excreted after intraduodenal administration at 6-8 hours in rats,11488,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630463,,14624,,,Cumulative dose excreted after intraduodenal administration at 8-24 hours in rats,11488,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630464,,14625,,,Cumulative dose excreted after intravenous administration at 0-0.5 hours in rats,11488,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630465,,14626,,,Cumulative dose excreted after intravenous administration at 0.5-1 hours in rats,11488,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630466,,14627,,,Cumulative dose excreted after intravenous administration at 1.0-1.5 hours in rats,11488,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630467,,14628,,,Cumulative dose excreted after intravenous administration at 1.5-2 hours in rats,11488,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630633,,14629,,,Cumulative dose excreted after intravenous administration at 2-3 hours in rats,11488,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630634,,14630,,,Cumulative dose excreted after intravenous administration at 3-4 hours in rats,11488,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630635,,14631,,,Cumulative dose excreted after intravenous administration at 4-6 hours in rats,11488,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630636,,14632,,,Cumulative dose excreted after intravenous administration at 6-8 hours in rats,11488,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630637,,14633,,,Cumulative dose excreted after intravenous administration at 8-24 hours in rats,11488,Rattus norvegicus,10116.0
50592,Feces,A,,,BAO_0000218,Intermediate,1,N,1988.0,1,,,,CHEMBL630638,,14634,,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",7132,Oryctolagus cuniculus,9986.0
50592,Feces,A,,,BAO_0000218,Intermediate,1,N,1988.0,1,,,,CHEMBL630639,,14635,,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",7132,Oryctolagus cuniculus,9986.0
50592,Feces,A,,,BAO_0000218,Intermediate,1,N,1988.0,1,,,,CHEMBL630640,,14636,,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",7132,Oryctolagus cuniculus,9986.0
50592,Feces,A,,,BAO_0000218,Intermediate,1,N,1988.0,1,,,,CHEMBL876551,,14637,,,"10 mg/kg of [14C]- radiolabeled compound was intravenously (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",7132,Oryctolagus cuniculus,9986.0
50592,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL630641,,14638,,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated (total)",7132,Oryctolagus cuniculus,9986.0
50592,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL630642,,14639,,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",7132,Oryctolagus cuniculus,9986.0
50592,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL630643,,14640,,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",7132,Oryctolagus cuniculus,9986.0
50592,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL630644,,14641,,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",7132,Oryctolagus cuniculus,9986.0
50592,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL630645,,14642,,,"10 mg/kg of [14C]- radiolabeled compound was intravenously injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",7132,Oryctolagus cuniculus,9986.0
50592,Feces,A,,,BAO_0000218,Intermediate,1,N,1988.0,1,,,,CHEMBL625599,,14643,,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated (total)",7132,Oryctolagus cuniculus,9986.0
50592,Feces,A,,,BAO_0000218,Intermediate,1,N,1988.0,1,,,,CHEMBL625600,,14644,,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 0-24 h",7132,Oryctolagus cuniculus,9986.0
50592,Feces,A,,,BAO_0000218,Intermediate,1,N,1988.0,1,,,,CHEMBL625601,,14645,,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 24-48 h",7132,Oryctolagus cuniculus,9986.0
50592,Feces,A,,,BAO_0000218,Intermediate,1,N,1988.0,1,,,,CHEMBL625602,,14646,,,"25 mg/kg of [14C]- radiolabeled compound was orally (gavage) injected in rabbit, and radioactivity content in feces was estimated at 48-72 h",7132,Oryctolagus cuniculus,9986.0
50592,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627470,,14647,,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated (total)",7132,Oryctolagus cuniculus,9986.0
50592,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627471,,14648,,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 0-6 h",7132,Oryctolagus cuniculus,9986.0
50592,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627472,,14649,,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 24-48 h",7132,Oryctolagus cuniculus,9986.0
50592,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627473,,14650,,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 48-72 h",7132,Oryctolagus cuniculus,9986.0
50592,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627474,,14651,,,"25 mg/kg of [14C]- radiolabeled compound was perorally injected in rabbit, and radioactivity content in urine was estimated at 6-24 h",7132,Oryctolagus cuniculus,9986.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL627475,,14652,,,Biodistribution in rat blood post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL627476,,14653,,,Biodistribution in rat blood post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,10116.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627477,,14654,,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 11.9 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627478,,14655,,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 2.49 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627479,,14656,,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 26.2 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627480,,14657,,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 3.03 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627481,,14658,,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 30.3 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627482,,14659,,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 34.1 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL627483,,14660,,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 7.85 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL875636,,14661,,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 8.47 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL625764,,14662,,,Total electrolytic excretion of sodium in urine of dogs after intravenous administration of 9.09 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL625765,,14663,,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 10.1 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL625766,,14664,,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 102 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL625767,,14665,,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.40 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL625768,,14666,,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 3.76 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL625769,,14667,,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 34.1 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL625770,,14668,,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 50.8 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL625771,,14669,,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 68.1 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL625772,,14670,,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.060 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50588,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL625773,,14671,,,Total electrolytic excretion of sodium in urine of dogs after peroral administration of 9.6 uM/Kg of drug,12582,Canis lupus familiaris,9615.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL625774,,14672,,,Total electrolytic excretion of sodium in urine of rats after intravenous administration of 7.94 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL625775,,14673,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 0 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL625776,,14674,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.01 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL625777,,14675,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 1.13 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL625778,,14676,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 10.1 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL625779,,14677,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 102 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL625780,,14678,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 105 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL625781,,14679,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 11.3 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL875637,,14680,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 113 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL626473,,14681,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 19.5 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL626474,,14682,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 195 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL626475,,14683,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 21.7 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL626476,,14684,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 217 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL634397,,14685,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 23.9 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL626477,,14686,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 239 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631069,,14687,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 24.9 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631070,,14688,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 249 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631071,,14689,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 25.9 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631072,,14690,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 259 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631073,,14691,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 26.5 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631074,,14692,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 265 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631075,,14693,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631725,,14694,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 27.9 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631726,,14695,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 270 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631727,,14696,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 279 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631728,,14697,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.2 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631729,,14698,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 28.9 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631730,,14699,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 282 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631731,,14700,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 289 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631910,,14701,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.40 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Hippocampus,A,,,BAO_0000218,Intermediate,1,N,10000000.0,1,,,In vivo,CHEMBL631911,,14702,,,Biodistribution of the [18F]-radiolabeled compound in rat hippocampus,15413,Rattus norvegicus,10116.0
50597,Hypothalamus,A,,,BAO_0000218,Intermediate,1,N,1898.0,1,,,In vivo,CHEMBL631912,,14703,,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus,15413,Rattus norvegicus,10116.0
50597,Hypothalamus,A,,,BAO_0000218,Intermediate,1,N,1898.0,1,,,In vivo,CHEMBL631913,,14704,,,Biodistribution of the [18F]-radiolabeled compound in rat hypothalamus; Not determined,15413,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL631914,,14705,,,Biodistribution in blood of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL631915,,14706,,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL875778,,14707,,,Biodistribution in blood of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL631916,,14708,,,Biodistribution in blood of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL631917,,14709,,,Biodistribution in blood of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL631918,,14710,,,Biodistribution in blood of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL631919,,14711,,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL631920,,14712,,,Biodistribution in blood of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL631921,,14713,,,Biodistribution in blood of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL631922,,14714,,,Biodistribution in blood of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL631923,,14715,,,Biodistribution in blood of immature femalee rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL631924,,14716,,,Biodistribution in fat of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL630234,,14717,,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL630235,,14718,,,Biodistribution in fat of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL630236,,14719,,,Biodistribution in fat of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL630237,,14720,,,Biodistribution in fat of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL630238,,14721,,,Biodistribution in fat of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL630239,,14722,,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL630303,,14723,,,Biodistribution in fat of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL630304,,14724,,,Biodistribution in fat of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL630305,,14725,,,Biodistribution in fat of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL630306,,14726,,,Biodistribution in kidney of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL630307,,14727,,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL630308,,14728,,,Biodistribution in kidney of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL630309,,14729,,,Biodistribution in kidney of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL629309,,14730,,,Biodistribution in kidney of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL629993,,14731,,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL629994,,14732,,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL629995,,14733,,,Biodistribution in kidney of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL631993,,14734,,,Biodistribution in kidney of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL631994,,14735,,,Biodistribution in kidney of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL631995,,14736,,,Biodistribution in kidney of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL631996,,14737,,,Biodistribution in liver of Iimmature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL631997,,14738,,,Biodistribution in liver of Iimmature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL631998,,14739,,,Biodistribution in liver of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL631999,,14740,,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL632000,,14741,,,Biodistribution in liver of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL632001,,14742,,,Biodistribution in liver of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL874424,,14743,,,Biodistribution in liver of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL632002,,14744,,,Biodistribution in liver of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL632003,,14745,,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL632004,,14746,,,Rate acceleration expressed as ratio of Kcat to Kuncat was evaluated,3133,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL632005,,14747,,,Compound was tested for amidase rate in the presence of N62C fully characterised enzyme,2742,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL632006,,14748,,,Compound was tested for amidase rate in the presence of N62C screen enzyme,2742,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL632007,,14749,,,Compound was tested for amidase rate in the presence of S166C fully characterised enzyme,2742,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL632008,,14750,,,Compound was tested for amidase rate in the presence of S166C screen enzyme,2742,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL632009,,14751,,,Compound was tested for esterase rate in the presence of N62C fully characterised enzyme,2742,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL632010,,14752,,,Compound was tested for esterase rate in the presence of N62C screen enzyme,2742,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL857750,,14753,,,Compound was tested for esterase rate in the presence of S166C fully characterised enzyme,2742,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL632011,,14754,,,Compound was tested for esterase rate in the presence of S166C screen enzyme,2742,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL632012,,14755,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 0.25% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",2276,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL632013,,14756,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",2276,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL632014,,14757,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 6C2 as catalyst was expressed as Kcat/KM",2276,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629622,,14758,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 10% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",2276,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629623,,14759,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/KM",2276,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629624,,14760,,,"Rate constant at 30 degree C in phosphate buffer pH 7.1, 0.5 % acetonitrile was expressed as Kcat/KM",2276,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629625,,14761,,,Ratio of Kcat to that of Km was determined,17269,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629626,,14762,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 1% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",2276,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629627,,14763,,,"Kinetic parameter for antibody-catalyzed Kemp elimination, at pH 7.1, 30C, using 5% acetonitrile and 4B2 as catalyst was expressed as Kcat/Kuncat",2276,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629628,,14764,,,"Compound was evaluated for constant, Kd",15917,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629629,,14765,,,Deacylation rate constant(Kd fast) was determined by proflavin displacement assay,10933,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629630,,14766,,,Deacylation rate constant(Kd slow) was determined by proflavin displacement assay,10933,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL856030,,14767,,,Dissociation Constant of compound determined,14293,,
22224,,B,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629631,,14768,,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined,6698,,
22224,,B,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629632,,14769,,,Dissociation constant for the binding of compound to PDZ3 from PSD-95 was determined; No data,6698,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL629633,,14770,,,Dissociation constant of compound with Fructose was determined,4318,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL629634,,14771,,,Dissociation constant of compound with Fructose was determined; Not determined,4318,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL629635,,14772,,,Dissociation constant of compound with Lactulose was determined,4318,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL629636,,14773,,,Dissociation constant of compound with Lactulose was determined; Not determined,4318,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL629637,,14774,,,Dissociation constant of the Compound,14959,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL629638,,14775,,,Dissociation constant by non-linear regression analysis,5913,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL629639,,14776,,,Dissociation constant was determined,14218,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL629640,,14777,,,Dissociation constant of the compound; value ranges from 0.81-1.2 nM,10689,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL629641,,14778,,,Dissociation constant was determined,13925,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL631344,,14779,,,Dissociation constant was determined,16359,,
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL631345,,14780,,,Equilibrium dissociation constant based on membrane concentration in rat smooth muscle,10944,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631346,,14781,,,The dissociation constant determined by fluorescence displacement assay,11080,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631524,,14782,,,kd value surface plasmon resonance (SPR) method,17805,,
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL631525,,14783,,,Equilibrium dissociation constant based on aqueous concentration in rat smooth muscle,10944,Rattus norvegicus,10116.0
22224,,F,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631526,,14784,,,First dissociation constant of the binding of compound to V30M TTR,16645,,
22224,,F,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631527,,14785,,,Second dissociation constant of the binding of compound to V30M TTR,16645,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631528,,14786,,,"Compound was evaluated for equilibrium constant, Ke",7793,,
22224,Hypothalamus,A,,,BAO_0000019,Autocuration,0,U,1898.0,1,,,,CHEMBL631529,,14787,,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus,12199,,
22224,Hypothalamus,A,,,BAO_0000019,Autocuration,0,U,1898.0,1,,,,CHEMBL631530,,14788,,,Equilibrium constant from the dorsal raphe and the ventromedial hypothalamus; inactive,12199,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631531,,14789,,,Keff is the effective biomolecular rate constant on VX for reactivation at pH 7.8 at 25 degree Centigrade,9680,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631532,,14790,,,Keff is the effective biomolecular rate constant on paraxon for reactivation at pH 7.8 at 25 degree Centigrade,9680,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL631533,,14791,,,Keff is the effective biomolecular rate constant on sarin for reactivation at pH 7.8 at 25 degree Centigrade,9680,,
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL876552,,14792,,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,13758,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631534,,14793,,,In vitro biotransformation of compound along with coformycin in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,13758,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631535,,14794,,,In vitro biotransformation of compound in mice brain homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,13758,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631536,,14795,,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,13758,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631537,,14796,,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)-6-hypoxanthine(ara-H) analyte,13758,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631538,,14797,,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-A) analyte,13758,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631539,,14798,,,In vitro biotransformation of compound in mice liver homogenate 9-(beta-D-arabinifuranosyl)adenine(ara-H) analyte,13758,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631540,,14799,,,In vitro biotransformation of compound in mice serum 9-(beta-D-arabinifuranosyl)-6-azidopurine(6-AAP) analyte,13758,Mus musculus,10090.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625637,,14800,,,Pharmacokinetic Parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,14393,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625638,,14801,,,Pharmacokinetic parameter [Kel(1/h)] was evaluated at 10 mg/kg (p.o.) in Wistar rats,14393,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL625639,,14802,,,"The Kel value in female wistar rat at 100 mg/kg, p.o. dose",15078,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL625640,,14803,,,Biodistribution in rat brain post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL625641,,14804,,,Biodistribution in rat brain post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL625642,,14805,,,Biodistribution in rat heart post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL625643,,14806,,,Biodistribution in rat heart post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL625644,,14807,,,Biodistribution in rat kidney post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,10116.0
50597,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL625645,,14808,,,Biodistribution in rat kidney post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL625646,,14809,,,Biodistribution in rat liver post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL625647,,14810,,,Biodistribution in rat liver post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL625648,,14811,,,Biodistribution in rat lung post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL625649,,14812,,,Biodistribution in rat lung post intravenous injection for 60 min of [99mTc]-TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL625650,,14813,,,Biodistribution in rat muscle post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL625651,,14814,,,Biodistribution in rat muscle post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,10116.0
50597,Zone of skin,A,,,BAO_0000218,Intermediate,1,N,14.0,1,,,In vivo,CHEMBL625652,,14815,,,Biodistribution in rat skin post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,10116.0
50597,Zone of skin,A,,,BAO_0000218,Intermediate,1,N,14.0,1,,,In vivo,CHEMBL625653,,14816,,,Biodistribution in rat skin post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL625654,,14817,,,Biodistribution in rat spleen post intravenous injection for 2 min of [99mTc]TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL625655,,14818,,,Biodistribution in rat spleen post intravenous injection for 60 min of [99mTc]TRODAT ligand expressed as percent dose per organ,13925,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL625656,,14819,,,Biodistribution of Compound in rat blood after 15 minutes of administration,9712,Rattus norvegicus,10116.0
50597,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL625657,,14820,,,Biodistribution of Compound in rat blood after 2 minutes of administration,9712,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL625658,,14821,,,Biodistribution of Compound in rat brain after 15 minutes of administration,9712,Rattus norvegicus,10116.0
50597,Brain,A,,,BAO_0000218,Intermediate,1,N,955.0,1,,,In vivo,CHEMBL625659,,14822,,,Biodistribution of Compound in rat brain after 2 minutes of administration,9712,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL625660,,14823,,,Biodistribution of Compound in rat heart after 15 minutes of administration,9712,Rattus norvegicus,10116.0
50597,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL625661,,14824,,,Biodistribution of Compound in rat heart after 2 minutes of administration,9712,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL625662,,14825,,,Biodistribution of Compound in rat liver after 15 minutes of administration,9712,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL625663,,14826,,,Biodistribution of Compound in rat liver after 2 minutes of administration,9712,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL875621,,14827,,,Biodistribution of Compound in rat lung after 15 minutes of administration,9712,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL628382,,14828,,,Biodistribution of Compound in rat lung after 2 minutes of administration,9712,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL628383,,14829,,,Biodistribution of Compound in rat muscle after 15 minutes of administration,9712,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL628384,,14830,,,Biodistribution of Compound in rat muscle after 2 minutes of administration,9712,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628385,,14831,,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 2 mins,13925,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL875753,,14832,,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 30 mins,13925,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628386,,14833,,,Brain uptake of [99mTc]TRODAT in rat expressed as percent dose per organ at time of 60 mins,13925,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628387,,14834,,,Organ distribution in rat blood 2 minutes after intravenous injection,6941,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628388,,14835,,,Organ distribution in rat blood 2 hr after intravenous injection,6941,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628389,,14836,,,Organ distribution in rat blood 30 minutes after intravenous injection,6941,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL632756,,14837,,,Organ distribution in rat blood 30 min after intravenous injection,6941,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628390,,14838,,,Organ distribution in rat brain 2 minutes after intravenous injection,6941,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631811,,14839,,,Organ distribution in rat brain 2 hr after intravenous injection,6941,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631812,,14840,,,Organ distribution in rat brain 30 minutes after intravenous injection,6941,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631813,,14841,,,Organ distribution in rat heart 2 minutes after intravenous injection,6941,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631814,,14842,,,Organ distribution in rat heart 2 hr after intravenous injection,6941,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631815,,14843,,,Organ distribution in rat heart 30 minutes after intravenous injection,6941,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631816,,14844,,,Organ distribution in rat kidney 2 minutes after intravenous injection,6941,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL875758,,14845,,,Organ distribution in rat kidney 2 hr after intravenous injection,6941,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631817,,14846,,,Organ distribution in rat kidney 30 minutes after intravenous injection,6941,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL631818,,14847,,,Organ distribution in rat liver 2 minutes after intravenous injection,6941,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL631819,,14848,,,Organ distribution in rat liver 2 hr after intravenous injection,6941,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,,CHEMBL631820,,14849,,,Organ distribution in rat liver 30 minutes after intravenous injection,6941,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631821,,14850,,,Organ distribution in rat lung 2 minutes after intravenous injection,6941,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631822,,14851,,,Organ distribution in rat lung 2 hr after intravenous injection,6941,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL631823,,14852,,,Organ distribution in rat lung 30 minutes after intravenous injection,6941,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL631824,,14853,,,Organ distribution in rat muscle 2 minutes after intravenous injection,6941,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL631825,,14854,,,Organ distribution in rat muscle 2 hr after intravenous injection,6941,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,,CHEMBL631826,,14855,,,Organ distribution in rat muscle 30 minutes after intravenous injection,6941,Rattus norvegicus,10116.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL631827,,14856,,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Blood (B),14439,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL631828,,14857,,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Heart (H),14439,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL631829,,14858,,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Lung (L),14439,Mus musculus,10090.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL875759,,14859,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 3.76 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631830,,14860,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 30.20 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631831,,14861,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 302 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631832,,14862,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 31.6 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631833,,14863,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 316 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631834,,14864,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 32.4 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631835,,14865,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 324 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631836,,14866,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.0 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631837,,14867,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.1 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631838,,14868,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 34.8 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631839,,14869,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 341 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631840,,14870,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 348 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631841,,14871,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 37.6 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631842,,14872,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 58.4 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631843,,14873,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 65.2 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631844,,14874,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.6 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631845,,14875,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 71.8 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631846,,14876,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 74.8 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL875760,,14877,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 77.5 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL632199,,14878,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 79.4 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631847,,14879,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 80.9 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL631848,,14880,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 83.8 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628707,,14881,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.5 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628708,,14882,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 84.7 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628709,,14883,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.7 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628710,,14884,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 86.9 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628711,,14885,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 9.06 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628712,,14886,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 90.6 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628713,,14887,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 94.9 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,Urine,A,,,BAO_0000218,Intermediate,1,N,1088.0,1,,,,CHEMBL628714,,14888,,,Total electrolytic excretion of sodium in urine of rats after peroral administration of 97.1 uM/Kg of drug,12582,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL628715,,14889,,,"excretion rate in rats after the dose of 5 mg/kg intravenously, at the dose 4 hour Rate of biliary excretion; 0.06-0.15%/h",7415,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629179,,14890,,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 3.75-120 uM,7313,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629180,,14891,,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 30 uM,7313,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL875108,,14892,,,Extent rates of formation of metabolic intermediate Cytochrome P-450 at compound concentration of 7.5-120 uM,7313,,
22224,Adrenal cortex,A,,,BAO_0000019,Autocuration,0,U,1235.0,1,,,,CHEMBL629181,,14893,,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,7570,,
22224,Adrenal cortex,A,,,BAO_0000019,Autocuration,0,U,1235.0,1,,,,CHEMBL629182,,14894,,,Percent lipid extracted at 0.5 hr from adrenal cortex liver using CHCl3/CH3OH.,7570,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629183,,14895,,,Percent lipid extracted at 0.5 hr from liver plasma using CHCl3/CH3OH.,7570,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629184,,14896,,,Percent lipid extracted at 0.5 hr from liver using CHCl3/CH3OH.,7570,,
22224,Adrenal cortex,A,,,BAO_0000019,Autocuration,0,U,1235.0,1,,,,CHEMBL629185,,14897,,,Percent lipid extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,7570,,
22224,Adrenal cortex,A,,,BAO_0000019,Autocuration,0,U,1235.0,1,,,,CHEMBL629186,,14898,,,Percent lipid extracted at 24 hours from adrenal cortex liver using CHCl3/CH3OH.,7570,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629187,,14899,,,Percent lipid extracted at 24 hours from liverliver using CHCl3/CH3OH.,7570,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629887,,14900,,,Percent lipid extracted at 24 hours from plasma using CHCl3/CH3OH.,7570,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629888,,14901,,,Percent lipid extracted at 24 hours from plasmaliver using CHCl3/CH3OH.,7570,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629889,,14902,,,Percent lipid extracted at 24 hr from liver using CHCl3/CH3OH.,7570,,
22224,Adrenal cortex,A,,,BAO_0000019,Autocuration,0,U,1235.0,1,,,,CHEMBL629890,,14903,,,Percent parent compound extracted at 0.5 hr from adrenal cortex using CHCl3/CH3OH.,7570,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629891,,14904,,,Percent parent compound extracted at 0.5 hr from liver using CHCl3/CH3OH.,7570,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629892,,14905,,,Percent parent compound extracted at 0.5 hr from plasma using CHCl3/CH3OH.,7570,,
22224,Adrenal cortex,A,,,BAO_0000019,Autocuration,0,U,1235.0,1,,,,CHEMBL629893,,14906,,,Percent parent compound extracted at 24 hours from adrenal cortex using CHCl3/CH3OH.,7570,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629894,,14907,,,Percent parent compound extracted at 24 hours from liver using CHCl3/CH3OH.,7570,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629895,,14908,,,Percent parent compound extracted at 24 hours from plasma using CHCl3/CH3OH.,7570,,
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL875109,,14909,,,"+Ratio of intravenous to oral integrated area under the concentration vs time curve, for compound in dog plasma",14122,Canis lupus familiaris,9615.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL629896,,14910,,,Absolute bioavailability in male cynomolgus monkeys,16449,Macaca fascicularis,9541.0
22224,,A,,,BAO_0000218,Autocuration,0,U,,1,,,In vivo,CHEMBL629897,,14911,,,Absolute bioavailability in maleSprague-Dawley rats,16449,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL629898,,14912,,,Biodistribution in liver of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL630057,,14913,,,Biodistribution in liver of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL630058,,14914,,,Biodistribution in liver of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL630059,,14915,,,Biodistribution in lungs of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL630060,,14916,,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL630061,,14917,,,Biodistribution in lungs of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL630062,,14918,,,Biodistribution in lungs of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL630063,,14919,,,Biodistribution in lungs of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL630064,,14920,,,Biodistribution in lungs of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL630065,,14921,,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL630066,,14922,,,Biodistribution in lungs of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL630067,,14923,,,Biodistribution in lungs of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Lung,A,,,BAO_0000218,Intermediate,1,N,2048.0,1,,,In vivo,CHEMBL630068,,14924,,,Biodistribution in lungs of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL631113,,14925,,,Biodistribution in muscle of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL631114,,14926,,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL631115,,14927,,,Biodistribution in muscle of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL631116,,14928,,,Biodistribution in muscle of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL630528,,14929,,,Biodistribution in muscle of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL630529,,14930,,,Biodistribution in muscle of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL630530,,14931,,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL630531,,14932,,,Biodistribution in muscle of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL630532,,14933,,,Biodistribution in muscle of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Muscle tissue,A,,,BAO_0000218,Intermediate,1,N,2385.0,1,,,In vivo,CHEMBL630533,,14934,,,Biodistribution in muscle of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50594,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL630534,,14935,,,Biodistribution in normal mice blood after 120 hr,15045,Mus musculus,10090.0
50594,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL630535,,14936,,,Biodistribution in normal mice blood after 24 hr,15045,Mus musculus,10090.0
50594,Blood,A,,,BAO_0000218,Intermediate,1,N,178.0,1,,,In vivo,CHEMBL630536,,14937,,,Biodistribution in normal mice blood after 4 hr,15045,Mus musculus,10090.0
50594,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL630537,,14938,,,Biodistribution in normal mice bone after 120 hr,15045,Mus musculus,10090.0
50594,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL630538,,14939,,,Biodistribution in normal mice bone after 24 hr,15045,Mus musculus,10090.0
50594,Bone,A,,,BAO_0000218,Intermediate,1,N,10000001.0,1,,,In vivo,CHEMBL630539,,14940,,,Biodistribution in normal mice bone after 4 hr,15045,Mus musculus,10090.0
50594,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL630540,,14941,,,Biodistribution in normal mice heart after 120 hr,15045,Mus musculus,10090.0
50594,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL630541,,14942,,,Biodistribution in normal mice heart after 24 hr,15045,Mus musculus,10090.0
50594,Heart,A,,,BAO_0000218,Intermediate,1,N,948.0,1,,,In vivo,CHEMBL630542,,14943,,,Biodistribution in normal mice heart after 4 hr,15045,Mus musculus,10090.0
50594,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL630543,,14944,,,Biodistribution in normal mice kidney after 120 hr,15045,Mus musculus,10090.0
50594,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL630544,,14945,,,Biodistribution in normal mice kidney after 24 hr,15045,Mus musculus,10090.0
50594,Kidney,A,,,BAO_0000218,Intermediate,1,N,2113.0,1,,,In vivo,CHEMBL630545,,14946,,,Biodistribution in normal mice kidney after 4 hr,15045,Mus musculus,10090.0
50594,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL630546,,14947,,,Biodistribution in normal mice liver after 120 hr,15045,Mus musculus,10090.0
50594,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL630547,,14948,,,Biodistribution in normal mice liver after 24 hr,15045,Mus musculus,10090.0
50594,Liver,A,,,BAO_0000218,Intermediate,1,N,2107.0,1,,,In vivo,CHEMBL630548,,14949,,,Biodistribution in normal mice liver after 4 hr,15045,Mus musculus,10090.0
50594,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL630549,,14950,,,Biodistribution in normal mice spleen after 120 hr,15045,Mus musculus,10090.0
50594,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL630550,,14951,,,Biodistribution in normal mice spleen after 24 hr,15045,Mus musculus,10090.0
50594,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL876426,,14952,,,Biodistribution in normal mice spleen after 4 hr,15045,Mus musculus,10090.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL630551,,14953,,,Biodistribution in spleen of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL630552,,14954,,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL630553,,14955,,,Biodistribution in spleen of Immature Female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL630554,,14956,,,Biodistribution in spleen of Immature Female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL630555,,14957,,,Biodistribution in spleen of Immature Female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL630556,,14958,,,Biodistribution in spleen of immature female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL630557,,14959,,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL630558,,14960,,,Biodistribution in spleen of immature female rat after 1 hr administration of 3 micro Ci (111 kBq) in the presence of (+E2),12017,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL630559,,14961,,,Biodistribution in spleen of immature female rat after 3 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Spleen,A,,,BAO_0000218,Intermediate,1,N,2106.0,1,,,In vivo,CHEMBL630560,,14962,,,Biodistribution in spleen of immature female rat after 5 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,Thyroid gland,A,,,BAO_0000218,Intermediate,1,N,2046.0,1,,,In vivo,CHEMBL876427,,14963,,,Biodistribution in thyroid of Immature Female rat after 12 hour administration of 3 micro Ci (111 kBq) in the absence of 60 microg estradiol,12017,Rattus norvegicus,10116.0
50597,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL630561,,14964,,,The Kel values in female wistar rats.,14941,Rattus norvegicus,10116.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630562,,14965,,,The equilibrium constant pair at a pH of 7.0 and temperature of 25 degree Centigrade,4646,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL630563,,14966,,,Hydrolysis rate constant of the compound,8847,,
22229,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL629673,,14967,,,Headecane/water partition coefficient expressed as the equilibrium ratio of the molar concentration in n-hexadecane to that in the buffer,11778,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629674,,14968,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0, T=66 degree Centigrade",2363,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629675,,14969,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree Centigrade",2363,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629676,,14970,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; No data",2363,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629677,,14971,,,"Hydrolysis in acetone/water (50:50) at a pH of 8.0,T =66 degree centigrade; Not determined",2363,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629678,,14972,,,Apparent inactivation rate constant was evaluated,8371,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629679,,14973,,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 25 degree Centigrade.,14883,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629680,,14974,,,Compound was evaluated for equilibrium constant K obtained from the ratio of reverse rate constants at 37 degree Centigrade,14883,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629681,,14975,,,Compound was evaluated for the Ki value for peptide alcohol for competitive inhibition in the presence of Mn2+ ions at pH 7.5,4643,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629682,,14976,,,Compound was tested for the inhibition of antibody-catalyzed hydrolysis.,3519,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629683,,14977,,,DBH (dopamine beta-hydroxylase) activity expressed as Ki value determined by degree to which compound inhibited conversion of tyramine to octopamine,10600,,
22224,,F,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL629684,,14978,,,Dissociation constant against constrictor response to the compound blocked competitively by phentolamine for alpha-mediated events,8501,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL629685,,14979,,,Dissociation constant was determined,8505,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL629686,,14980,,,Dissociation constant was determined,9778,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL872932,,14981,,,Dissociation constant at pH 7.4,9778,,
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL629687,,14982,,,Dissociation constant in presence of 1 mM dithiothreitol,9778,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL872931,,14983,,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,13007,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628151,,14984,,,Kinetic Parameter Ki for Inhibition of Type 1 5-alpha-reductase,13007,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628152,,14985,,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,13007,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628153,,14986,,,Kinetic Parameter Ki for Inhibition of Type-2 5-alpha-reductase,13007,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628154,,14987,,,Kinetic constant for aromatization of androstenedione,11482,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628155,,14988,,,Kinetic constant for aromatization of testosterone,11482,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628156,,14989,,,Kinetic parameter for hydrolysis of 1 by Antibody 2D10 after addition of compound 12,2303,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628157,,14990,,,Local inhibition constant was determined,11964,,
50347,,A,,,BAO_0000218,Intermediate,1,N,,1,,,,CHEMBL857533,,14991,,,Rate of inactivation of sterol methyl transferase from Saccharomyces cerevisiae using mechanism based inhibitor,3140,Saccharomyces cerevisiae,4932.0
22224,,P,,,BAO_0000100,Autocuration,0,U,,1,,,,CHEMBL628158,,14992,,,Dissociation constant value of the compound,10650,,
22224,Cornea,A,,,BAO_0000019,Autocuration,0,U,964.0,1,,,,CHEMBL628159,,14993,,,In vitro permeability through cornea without epithelium,4667,,
22224,Cornea,A,,,BAO_0000019,Autocuration,0,U,964.0,1,,,,CHEMBL875616,,14994,,,In vitro permeability through intact cornea,4667,,
50592,Cornea,A,,,BAO_0000218,Intermediate,1,N,964.0,1,,,,CHEMBL628160,,14995,,,Evaluated for first order rate constant (Kin) for transcorneal penetration in anesthetized rabbits,9199,Oryctolagus cuniculus,9986.0
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628161,,14996,,,Rate of enzyme inactivation for the compound was determined,11966,,
22224,Cornea,A,,,BAO_0000019,Autocuration,0,U,964.0,1,,,,CHEMBL628162,,14997,,,In vitro permeability through cornea without epithelium,4667,,
22224,Cornea,A,,,BAO_0000019,Autocuration,0,U,964.0,1,,,,CHEMBL628163,,14998,,,In vitro permeability through intact cornea,4667,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628164,,14999,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0300 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628165,,15000,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0384 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628166,,15001,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0395 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628167,,15002,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0500 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628168,,15003,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.050 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628169,,15004,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0767 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628170,,15005,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0790 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628171,,15006,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.0800 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627434,,15007,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.100 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL627435,,15008,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.200 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628110,,15009,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.300 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628111,,15010,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.384 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628112,,15011,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.395 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628260,,15012,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.500 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,
22224,,A,,,BAO_0000019,Autocuration,0,U,,1,,,,CHEMBL628261,,15013,,,"Kinetic constant(1/ K obsd (min)) was calculated for the observed reaction rate constant at the concentration 0.767 mM [HOX] in the conditions of 25degreeC,pH 7.6",8354,,
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628262,,15014,,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Muscle (M),14439,Mus musculus,10090.0
50587,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628263,,15015,,,Biodistribution in athymic mice bearing Human Tumor (KB) Xenografts 1 hour after injection in Tumor (T) cells,14439,Homo sapiens,9606.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628264,,15016,,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Blood (B),14439,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628265,,15017,,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Heart (H),14439,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628266,,15018,,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Lung (L),14439,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628267,,15019,,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Muscle (M),14439,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628268,,15020,,,Biodistribution in athymic mice bearing Human Tumor (LS174T) Xenografts 1 hour after injection in Tumor (T) cells,14439,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628269,,15021,,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Blood (B),14439,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628270,,15022,,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Heart (H),14439,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628271,,15023,,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Lung (L),14439,Mus musculus,10090.0
50594,,A,,,BAO_0000218,Intermediate,1,N,,1,,,In vivo,CHEMBL628272,,15024,,,Biodistribution in athymic mice bearing Human Tumor (TE671) Xenografts 1 hour after injection in Muscle (M),14439,Mus musculus,10090.0
